Trait_category,Trait,Protein,Protein_definition,sample_size,Estimated_effect,se,lowerCI,upperCI,Pvalue
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,AGRP,Agouti-related protein,42753,0.226873052842234,0.00489658062937003,0.217275754808669,0.236470350875799,0
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CCN1,CCN family member 1,42568,0.29086290526952,0.00706883980261238,0.277007979256399,0.30471783128264,0
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LDLR,Low-density lipoprotein receptor,42643,0.344511680823315,0.00428020261635912,0.336122483695251,0.352900877951379,0
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PLTP,Phospholipid transfer protein,42751,-0.136652816040997,0.00345740112318251,-0.143429322242435,-0.129876309839559,1.1125369292536e-308
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NPY,Pro-neuropeptide Y,42720,0.243810779798526,0.00622359677502656,0.231612530119474,0.256009029477578,1.11253692948432e-308
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MFGE8,Lactadherin,42610,0.15676751947693,0.00423711873977024,0.14846276674698,0.16507227220688,2.03555801553729e-285
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CD4,T-cell surface glycoprotein CD4,42569,0.104624117073456,0.00302342542118575,0.0986982032479319,0.11055003089898,2.20019766608102e-251
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SMOC1,SPARC-related modular calcium-binding protein 1,42720,0.10821883572042,0.00321051124169952,0.101926233686689,0.114511437754151,3.04624891265991e-239
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,HHEX,Hematopoietically-expressed homeobox protein HHEX,40482,0.239401107981413,0.0073586127478048,0.224978226995716,0.253823988967111,5.2503401887712e-222
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CCL23,C-C motif chemokine 23,42675,0.129905499511485,0.00412077826605868,0.12182877411001,0.13798222491296,1.59309784253611e-210
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LPL,Lipoprotein lipase,42635,-0.142135633676561,0.00458712447667075,-0.151126397650836,-0.133144869702286,1.11659333861334e-203
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GPR37,Prosaposin receptor GPR37,42356,0.208394788672284,0.006724858807925,0.195214065408751,0.221575511935817,1.42906819680727e-203
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CES1,Liver carboxylesterase 1,42660,0.241995954277735,0.00797949408235918,0.226356145876311,0.257635762679159,1.73702802519943e-195
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CCL27,C-C motif chemokine 27,42635,0.173900728900741,0.00581392480827434,0.162505436276524,0.185296021524959,2.27220976226391e-190
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ASGR1,Asialoglycoprotein receptor 1,42494,0.0895741066582281,0.00301209829553217,0.0836703939989851,0.0954778193174712,3.32437768578661e-188
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CRIP2,Cysteine-rich protein 2,42494,0.107493557939839,0.00361487856632483,0.100408395949842,0.114578719929836,3.48455803441393e-188
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RARRES2,Retinoic acid receptor responder protein 2,42704,0.136980652086153,0.00464379545500026,0.127878812994353,0.146082491177954,2.18338626866025e-185
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,HS6ST1,Heparan-sulfate 6-O-sulfotransferase 1,42720,0.100439822157874,0.00340561758714186,0.0937648116870764,0.107114832628672,2.48176840941988e-185
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PTH,Parathyroid hormone,40181,0.231683761576966,0.00809609978000049,0.215815406008165,0.247552117145767,8.91603909621782e-174
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NOS3,"Nitric oxide synthase, endothelial",42310,0.154414658753606,0.0054258391216712,0.14378001407513,0.165049303432081,6.37220974330272e-173
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,42586,0.0945165348958286,0.00332366673893107,0.0880021480875237,0.101030921704133,8.99080051738454e-173
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SSC5D,Soluble scavenger receptor cysteine-rich domain-containing protein SSC5D,42688,0.118841728288784,0.00418082539796951,0.110647310508764,0.127036146068804,1.13939948547211e-172
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CXCL13,C-X-C motif chemokine 13,42710,0.175091856861522,0.00620501165668893,0.162930034014412,0.187253679708632,2.89914634060659e-170
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PLA2G7,Platelet-activating factor acetylhydrolase,42610,0.092083257026089,0.00328735119001688,0.0856400486936559,0.0985264653585221,7.59934398726524e-168
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ADIPOQ,Adiponectin,40538,-0.189121820121826,0.00684351418837587,-0.202535107931043,-0.175708532312609,9.58477314983057e-163
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,VMO1,Vitelline membrane outer layer protein 1 homolog,42586,0.190454487005913,0.00691130206324208,0.176908334961959,0.204000639049868,1.20281103473764e-162
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,42442,0.129576996473153,0.00480342709979256,0.12016227935756,0.138991713588747,4.47513490527218e-156
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SUMF2,Inactive C-alpha-formylglycine-generating enzyme 2,42710,0.138406231471326,0.00514214740853533,0.128327622550597,0.148484840392055,1.7245478754751e-155
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PON3,Serum paraoxonase/lactonase 3,42675,-0.0751145602630169,0.00282373079840734,-0.0806490726278953,-0.0695800478981385,5.32402276576049e-152
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IL1RN,Interleukin-1 receptor antagonist protein,42584,0.143400879733391,0.00539617764348762,0.132824371552155,0.153977387914626,1.10809909224353e-151
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,BPIFB1,BPI fold-containing family B member 1,42572,-0.165033282101091,0.00622226798860333,-0.177228927358753,-0.152837636843428,4.10248194314499e-151
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,AGRN,Agrin,42675,0.0953546357639052,0.00361074617255019,0.0882775732657068,0.102431698262104,6.86299101041557e-150
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PRAP1,Proline-rich acidic protein 1,40526,0.108733134252627,0.0041122941262565,0.100673037765164,0.116793230740089,1.50547663213872e-149
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LGALS9,Galectin-9,42619,0.0843546916542958,0.00319876699784107,0.0780851083385273,0.0906242749700643,1.8269344378796e-149
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FURIN,Furin,42678,0.0853079598969591,0.00323554239267575,0.0789662968073146,0.0916496229866035,2.00176145554346e-149
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GCG,Pro-glucagon,42345,0.32886887146738,0.0125576664678052,0.304255845190482,0.353481897744278,2.07889021849216e-147
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DPY30,Protein dpy-30 homolog,42650,0.153135796946287,0.00599239386221709,0.141390704976341,0.164880888916232,1.06612545207025e-140
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,42356,0.140236179827682,0.00551800371854494,0.129420892539334,0.15105146711603,3.8616638263463e-139
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IGSF9,Protein turtle homolog A,40510,0.207981612827643,0.00824288979542738,0.191825548828606,0.224137676826681,1.03836004240276e-136
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DNAJB1,DnaJ homolog subfamily B member 1,42586,0.216656558355781,0.00861166350186669,0.199777697892122,0.233535418819439,1.64573716543253e-136
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,HGF,Hepatocyte growth factor,42753,0.0869528246381584,0.00346904804168355,0.0801534904764586,0.0937521587998581,1.4163013418897e-135
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RBP5,Retinol-binding protein 5,42586,0.139227834750579,0.00556203826896699,0.128326239743404,0.150129429757755,3.44594652183269e-135
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IL16,Pro-interleukin-16,42753,0.101109861862762,0.00411722315409692,0.0930401044807316,0.109179619244792,2.46127422550194e-130
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DEFB4A_DEFB4B,Beta-defensin 4A,42476,0.366907895686807,0.0149636240024061,0.337579192642091,0.396236598731523,6.83195007332025e-130
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FGF21,Fibroblast growth factor 21,42688,0.284761613743444,0.0116836018643169,0.261861754089383,0.307661473397505,1.94962588046402e-128
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FGFR2,Fibroblast growth factor receptor 2,42678,0.0541978928097614,0.00222938426199827,0.0498282996562448,0.058567485963278,8.34526846441587e-128
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CXCL10,C-X-C motif chemokine 10,42675,0.162779415882405,0.00673880120571834,0.149571365519197,0.175987466245613,3.08623983396411e-126
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SMAD1,Mothers against decapentaplegic homolog 1,42345,0.195353598289261,0.00810302054377835,0.179471678023455,0.211235518555066,1.0597215926117e-125
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ANGPTL2,Angiopoietin-related protein 2,42639,0.0951876835537706,0.004000336943466,0.0873470231445772,0.103028343962964,1.26954408125289e-122
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SNCA,Alpha-synuclein,40282,0.272282465209029,0.0115139587577314,0.249715106043875,0.294849824374182,1.16418799264661e-120
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,42678,0.0857159400023532,0.00368385808791559,0.0784955781500386,0.0929363018546678,1.89871263364783e-117
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,COL18A1,Collagen alpha-1(XVIII) chain,42691,0.0563204923083031,0.00242413015802297,0.0515691971985781,0.0610717874180281,4.10987322551693e-117
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NOMO1,Nodal modulator 1,42610,0.0536416058160763,0.00231315139583748,0.0491078290802349,0.0581753825519178,1.1196748360475e-116
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CST3,Cystatin-C,42658,0.0694977871199216,0.00302414843228477,0.0635704561926435,0.0754251180471998,1.14683782542468e-114
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,STC1,Stanniocalcin-1,42710,0.103789774054973,0.00451878826593242,0.0949329490537453,0.1126465990562,1.48254190295319e-114
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GUSB,Beta-glucuronidase,42710,0.138501998289608,0.00605957275900279,0.126625235681963,0.150378760897254,1.75250053687514e-113
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FCAMR,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,40510,0.169492747267713,0.00740882833648153,0.15497144372821,0.184014050807217,2.84709270229007e-113
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CXCL17,C-X-C motif chemokine 17,42753,0.0925085564005003,0.00406089407171884,0.0845492040199314,0.100467908781069,9.27664476395806e-113
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GHR,Growth hormone receptor,40282,0.0648674020954447,0.00284232623340076,0.0592964426779792,0.0704383615129101,1.07027751761916e-112
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IGSF8,Immunoglobulin superfamily member 8,42635,0.0696853981807143,0.00306569790472733,0.0636766302874487,0.0756941660739799,2.87710616322068e-112
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CDKN1A,Cyclin-dependent kinase inhibitor 1,42586,0.237180114335045,0.0104467261019106,0.2167045311753,0.25765569749479,5.27933728939571e-112
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CLUL1,Clusterin-like protein 1,42620,-0.101720703672757,0.00449101530082765,-0.110523093662379,-0.0929183136831345,1.69861710495225e-111
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MXRA8,Matrix remodeling-associated protein 8,40282,-0.0697705523699882,0.00312927238062268,-0.0759039262360086,-0.0636371785039677,9.22327413386774e-108
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SIT1,Signaling threshold-regulating transmembrane adapter 1,42369,0.123533739074557,0.00557007649551223,0.112616389143353,0.134451089005761,5.02017548180394e-107
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RTN4R,Reticulon-4 receptor,42720,0.0764977780460661,0.00345021976213926,0.0697353473122732,0.0832602087798591,5.12148742485436e-107
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CXCL6,C-X-C motif chemokine 6,42753,0.16813796748534,0.00765874494419538,0.153126827394717,0.183149107575963,5.32925796512518e-105
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,42369,0.101166028543716,0.00461841370393662,0.0921139376839998,0.110218119403431,1.68987330305398e-104
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CD5,T-cell surface glycoprotein CD5,42705,0.0791277171553529,0.00361881638495004,0.0720348370408508,0.086220597269855,3.50030416296358e-104
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NUCB2,Nucleobindin-2,42682,0.0808272558061345,0.00370034779761412,0.0735745741228108,0.0880799374894582,5.67071939031812e-104
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SEMA3F,Semaphorin-3F,42635,0.0593493008223588,0.00271779865937666,0.0540224154499806,0.0646761861947371,6.51285229192411e-104
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CCL16,C-C motif chemokine 16,42793,0.113895245292408,0.00523105302451092,0.103642381364366,0.124148109220449,2.41782549040917e-103
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CD72,B-cell differentiation antigen CD72,40282,0.0972010290110637,0.00445641936099749,0.0884664470635086,0.105935610958619,2.63408795278971e-103
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,42637,0.0784777067255509,0.00360555908041281,0.0714108109279418,0.0855446025231601,2.94370402667521e-103
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,INHBC,Inhibin beta C chain,42610,0.0888980361794583,0.00411064081135355,0.0808411801892053,0.0969548921697112,5.55054446651165e-102
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CCL22,C-C motif chemokine 22,42508,0.114377964103948,0.00530203945515256,0.103985966771849,0.124769961436047,1.76457827023094e-101
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NPPC,C-type natriuretic peptide,42593,0.108158937163642,0.00501992341685784,0.0983198872666003,0.117997987060683,2.99451161969452e-101
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,P4HB,Protein disulfide-isomerase,42562,0.0824779931051396,0.00383007409415162,0.0749710478806025,0.0899849383296768,3.85079382983873e-101
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ERP44,Endoplasmic reticulum resident protein 44,42568,0.0548595862640748,0.00255828173374682,0.049845354065931,0.0598738184622185,2.52325525006508e-100
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CFP,Properdin,40538,0.0478887261594273,0.00223612421685285,0.0435059226943957,0.0522715296244588,8.83957345649272e-100
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ADH4,All-trans-retinol dehydrogenase [NAD(+)] ADH4,42356,0.173597324396075,0.00814774616474114,0.157627741913182,0.189566906878968,4.64469889147734e-99
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CANT1,Soluble calcium-activated nucleotidase 1,42579,0.0437007092165567,0.00205261683714222,0.0396775802157579,0.0477238382173554,6.06230030085289e-99
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CFH,Complement factor H,39955,0.0488243893528148,0.00229632508452151,0.0443235921871526,0.053325186518477,2.6440869149163e-98
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,AGR3,Anterior gradient protein 3,42325,0.127255622586954,0.00600080779677775,0.11549403930527,0.139017205868639,3.65668666025043e-98
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PGF,Placenta growth factor,42753,0.0561054924868419,0.00266992113690656,0.050872447058505,0.0613385379151787,1.67833135152732e-96
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PSRC1,Proline/serine-rich coiled-coil protein 1,42345,0.124272936729787,0.0059227545973071,0.112664337719065,0.135881535740509,3.55764354987048e-96
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RELT,Tumor necrosis factor receptor superfamily member 19L,42610,0.0649018210153107,0.00309926708553229,0.0588272575276674,0.0709763845029539,7.67940877143675e-96
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,KITLG,Kit ligand,42635,-0.0788600681520616,0.0037692249361674,-0.0862477490269497,-0.0714723872771734,1.120932144973e-95
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,VPS37A,Vacuolar protein sorting-associated protein 37A,42586,0.166537527645117,0.00796218124942101,0.150931652396252,0.182143402893982,1.28273541019612e-95
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PLAT,Tissue-type plasminogen activator,42759,0.105850950089151,0.0050614595561364,0.0959304893591236,0.115771410819178,1.30323213650266e-95
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TMPRSS15,Enteropeptidase,42586,0.191480112300091,0.00916048919691685,0.173525553474134,0.209434671126048,1.6782331981069e-95
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IGFBP4,Insulin-like growth factor-binding protein 4,42407,0.10075575454415,0.00483217737535729,0.0912846868884501,0.110226822199851,5.02238583611239e-95
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,KYNU,Kynureninase,42753,0.0929230887377967,0.00445783247771312,0.084185737081479,0.101660440394114,5.20479216149113e-95
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CCL3,C-C motif chemokine 3,42593,0.120041544066351,0.00575967865501166,0.108752573902528,0.131330514230174,5.77918155963784e-95
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,EFCAB14,EF-hand calcium-binding domain-containing protein 14,40448,0.0614795896460822,0.00294971485870994,0.0556981485230107,0.0672610307691537,1.08125169469626e-94
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CPM,Carboxypeptidase M,42654,0.0703147727285585,0.00338243482173707,0.0636852004779538,0.0769443449791631,1.67798501698208e-94
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,EPHA1,Ephrin type-A receptor 1,42657,0.068343200359215,0.00330671404797678,0.0618620408251805,0.0748243598932495,1.88580785562892e-93
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SCARB2,Lysosome membrane protein 2,42301,0.0726017531823505,0.00351291220518027,0.0657164452601972,0.0794870611045038,2.09803816037075e-93
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SKAP1,Src kinase-associated phosphoprotein 1,42475,0.152428034440239,0.007384357305775,0.13795469412092,0.166901374759558,3.32169196856333e-93
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,APOA1,Apolipoprotein A-I,40538,-0.0572954610392786,0.0027758433721569,-0.0627361140487061,-0.0518548080298511,5.96604618050758e-93
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,BTN3A2,Butyrophilin subfamily 3 member A2,42593,0.0802726570711232,0.00390873292444845,0.0726115405392042,0.0879337736030421,2.6506964572959e-92
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LATS1,Serine/threonine-protein kinase LATS1,40198,0.174006148060363,0.00845913726835565,0.157426239014386,0.19058605710634,2.73029526591919e-92
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CTSD,Cathepsin D,41746,0.0867282809597447,0.00422573343043736,0.0784458434360875,0.095010718483402,4.25198012865636e-92
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,42637,0.0653322336592503,0.00319255966225219,0.0590748167212361,0.0715896505972646,1.11988136891013e-91
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CC2D1A,Coiled-coil and C2 domain-containing protein 1A,42494,0.149487845883451,0.00730503002908919,0.135169987026436,0.163805704740466,1.16340675344452e-91
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GZMA,Granzyme A,42753,0.0729591764896168,0.00356929619612219,0.0659633559452173,0.0799549970340163,1.7268542846876e-91
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DTYMK,Thymidylate kinase,40510,0.138944376704421,0.00680921156052935,0.125598322045783,0.152290431363058,6.41632598487965e-91
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,APCS,Serum amyloid P-component,40418,0.0699465415526942,0.00343002322806967,0.0632236960256776,0.0766693870797107,8.52960618584415e-91
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FABP4,"Fatty acid-binding protein, adipocyte",42793,0.104500119968164,0.00514917191323501,0.0944077430182231,0.114592496918104,3.10065652877824e-90
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FLI1,Friend leukemia integration 1 transcription factor,42345,0.223458216003112,0.0110152032072844,0.201868417716835,0.245048014289389,4.03868657977557e-90
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IL18R1,Interleukin-18 receptor 1,42753,0.0671277572159719,0.0033129080594476,0.0606344574194546,0.0736210570124892,5.88875807742593e-90
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,42494,0.11932101710332,0.0058926681126209,0.107771387602583,0.130870646604057,8.1324279431351e-90
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LRCH4,Leucine-rich repeat and calponin homology domain-containing protein 4,40115,0.137871063622761,0.00681083405355865,0.124521828877786,0.151220298367736,1.77748812111722e-89
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CRELD2,Protein disulfide isomerase CRELD2,42653,0.104473896130991,0.00519181612755703,0.094297936520979,0.114649855741003,9.36595525446623e-89
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CFI,Complement factor I,40538,0.0395381090567415,0.00196559973374672,0.035685533578598,0.0433906845348851,1.88193958722212e-88
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LSP1,Lymphocyte-specific protein 1,42593,0.079946397137818,0.00398499946743658,0.0721357981816423,0.0877569960939937,3.12612546403145e-88
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PAMR1,Inactive serine protease PAMR1,42610,0.053585492879799,0.00268930449633775,0.048314456066977,0.058856529692621,4.43177321166585e-87
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RLN2,Prorelaxin H2,40256,0.100329497950632,0.00503320902398648,0.0904644082636185,0.110194587637646,6.92019632869046e-87
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PAXX,Protein PAXX,40282,0.0912016608586753,0.00457697485985676,0.082230790133356,0.100172531583995,7.90553393707439e-87
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,F7,Coagulation factor VII,42670,0.0618969671747923,0.0031141389147204,0.0557932549019403,0.0680006794476442,1.13774966533025e-86
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CLEC4A,C-type lectin domain family 4 member A,42593,-0.0700872051311338,0.00353213189270662,-0.0770101836408388,-0.0631642266214288,2.20418250277626e-86
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ELN,Elastin,40510,0.0731250493152187,0.00368533006740931,0.0659018023830965,0.080348296247341,3.72107406812288e-86
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,42494,0.067759408006964,0.00342923575841041,0.0610381059204797,0.0744807100934484,1.12422686562995e-85
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PBXIP1,Pre-B-cell leukemia transcription factor-interacting protein 1,40448,0.0603499149814759,0.00305626809211994,0.0543596295209208,0.066340200442031,2.38455930641438e-85
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,EFNA4,Ephrin-A4,42474,0.0673423266292467,0.00341938678808795,0.0606403285245943,0.0740443247338991,3.94079782910673e-85
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MENT,Protein MENT,40282,-0.0460882051310059,0.00233888809205436,-0.0506724257914324,-0.0415039844705793,5.48922928902295e-85
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CDH2,Cadherin-2,42635,0.070047881530678,0.0035692871268479,0.0630520787620562,0.0770436842992999,1.4330568478816e-84
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NUMB,Protein numb homolog,40198,0.16181076416285,0.00825312138901619,0.145634646240378,0.177986882085321,3.71760915124425e-84
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PRSS8,Prostasin,42567,0.0820522978384939,0.00421232072468937,0.0737961492181027,0.0903084464588851,2.34984366736798e-83
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GLA,Alpha-galactosidase A,40266,0.0728848120491735,0.00375611624189968,0.0655228242150502,0.0802467998832969,1.65147777593546e-82
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IL18,Interleukin-18,42565,0.0900935760547359,0.00465982571394955,0.0809603176553948,0.0992268344540771,3.65631008617293e-82
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RIDA,2-iminobutanoate/2-iminopropanoate deaminase,40282,0.0969608110141142,0.0050088219961183,0.0871435199017223,0.106778102126506,3.92500988736973e-82
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,UFD1,Ubiquitin recognition factor in ER-associated degradation protein 1,40448,0.269209267119073,0.01391849956079,0.241929007979924,0.296489526258221,5.08435375938932e-82
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DSG2,Desmoglein-2,42610,-0.0529085617916517,0.00273969522421134,-0.058278364431106,-0.0475387591521975,5.51614315927761e-82
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LGALS1,Galectin-1,42635,0.0678598996143598,0.00352820523699134,0.0609446173498568,0.0747751818788629,2.39346515401569e-81
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IL10RB,Interleukin-10 receptor subunit beta,42675,0.0581665323056325,0.00302627938561457,0.052235024709828,0.0640980399014371,3.03637393294675e-81
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SERPINA5,Plasma serine protease inhibitor,40386,0.0609597650261972,0.00316842352774353,0.0547496549118199,0.0671698751405745,3.49237911031632e-81
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,BPIFA2,BPI fold-containing family A member 2,39837,-0.219207473885737,0.0113970461997783,-0.241545684437303,-0.196869263334172,4.55184848668629e-81
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,42345,0.124049493819907,0.00647892823599914,0.111350794477349,0.136748193162466,1.28643053832286e-80
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,EGLN1,Egl nine homolog 1,42593,0.10639154392112,0.00556266057358745,0.0954887291968885,0.117294358645351,1.80505724383261e-80
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,HJV,Hemojuvelin,40481,0.0848400945352462,0.00444037588758039,0.0761369577955886,0.0935432312749037,4.07316934938464e-80
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,APBB1IP,Amyloid beta A4 precursor protein-binding family B member 1-interacting protein,42586,0.0849248360387375,0.00446516286067035,0.0761731168318236,0.0936765552456514,1.31509222674287e-79
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NPC2,NPC intracellular cholesterol transporter 2,40366,0.0656152478562217,0.0034473282528351,0.0588584844806649,0.0723720112317785,1.61675789605214e-79
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GOLM2,Protein GOLM2,42710,0.0440735684854261,0.00232065623315423,0.0395250822684438,0.0486220547024084,2.14666801627841e-79
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NCS1,Neuronal calcium sensor 1,42720,0.0552843349925349,0.00291155705804512,0.0495776831587665,0.0609909868263034,2.30638901979054e-79
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SMNDC1,Survival of motor neuron-related-splicing factor 30,40448,0.113882146330991,0.00599027450027178,0.102141208310458,0.125623084351523,2.3994150662574e-79
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,AIFM1,"Apoptosis-inducing factor 1, mitochondrial",42569,0.20000438461396,0.0105594370531615,0.179307887989763,0.220700881238157,5.6620021570769e-79
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FGFBP3,Fibroblast growth factor-binding protein 3,40482,0.0706170310267562,0.00372531583700647,0.0633154119862235,0.0779186500672889,6.58541900256364e-79
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SMAD2,Mothers against decapentaplegic homolog 2,40450,0.131850121226067,0.00696748333604787,0.118193853887414,0.145506388564721,1.20383501969435e-78
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,HEG1,Protein HEG homolog 1,40282,0.0514911773187529,0.0027228410184783,0.0461544089225355,0.0568279457149704,1.58804218347267e-78
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ABL1,Tyrosine-protein kinase ABL1,42586,0.126803451925519,0.00671697628155405,0.113638178413673,0.139968725437364,1.79929698632535e-78
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IGSF3,Immunoglobulin superfamily member 3,42586,0.0687801129337242,0.00364577740840078,0.0616343892132587,0.0759258366541898,2.25988735796474e-78
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PSIP1,PC4 and SFRS1-interacting protein,42593,0.121622514660893,0.00645610931842173,0.108968540396786,0.134276488925,3.73391251762947e-78
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,AMBP,Protein AMBP,42705,0.0397302897022122,0.00210958626147231,0.0355955006297265,0.043865078774698,4.02794643690128e-78
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PRCP,Lysosomal Pro-X carboxypeptidase,42732,0.0595825563594243,0.00316458710001638,0.0533799656433922,0.0657851470754564,4.42104690243016e-78
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CREG1,Protein CREG1,42444,0.0728926896173904,0.0038711041771858,0.0653053254301062,0.0804800538046746,4.47211748948841e-78
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IL12A_IL12B,Interleukin-12,42586,0.155135319227045,0.00826239218976588,0.138941030535104,0.171329607918986,1.17408928267343e-77
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NHLRC3,NHL repeat-containing protein 3,40012,0.0610292427638905,0.00325037187615534,0.054658513886626,0.0673999716411549,2.00281459647962e-77
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PARP1,Poly [ADP-ribose] polymerase 1,42593,0.109220803975978,0.00584317812316551,0.0977681748545738,0.120673433097383,5.46413927024968e-77
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CCL7,C-C motif chemokine 7,42593,0.11081625769435,0.00594280298191305,0.0991683638498007,0.1224641515389,1.23945146885047e-76
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NPL,N-acetylneuraminate lyase,40510,0.085424538752541,0.00458354220751805,0.0764407960258057,0.0944082814792764,2.21818681512426e-76
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CRELD1,Protein disulfide isomerase CRELD1,40282,0.0710501565661873,0.00382005283651392,0.0635628530066201,0.0785374601257546,4.65115558940043e-76
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SERPINF1,Pigment epithelium-derived factor,40350,0.0498711511536957,0.00268747701432831,0.0446036962056122,0.0551386061017792,9.84930043545243e-76
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SOST,Sclerostin,42612,0.0726704386522005,0.00392140889845052,0.0649844772112375,0.0803564000931635,1.006734858479e-75
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,EZR,Ezrin,42710,0.0444480176750202,0.00240141133766599,0.0397412514531949,0.0491547838968456,1.49255206870378e-75
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,YTHDF3,YTH domain-containing family protein 3,42369,0.157164479439002,0.00851642201514384,0.14047229228932,0.173856666588684,4.24561075648013e-75
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ELOA,Elongin-A,42586,0.0994812711111656,0.00539412487327445,0.0889087863595477,0.110053755862784,5.07050279468559e-75
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,UPB1,Beta-ureidopropionase,40510,0.166746777064729,0.00904486227091913,0.149018847013728,0.18447470711573,8.44308210091086e-75
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CD74,HLA class II histocompatibility antigen gamma chain,42710,0.0657865183169524,0.00357979112455862,0.0587701277128175,0.0728029089210873,1.6132986823486e-74
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SNCG,Gamma-synuclein,42494,0.127362808748528,0.0069371817592572,0.113765932500384,0.140959684996672,2.29450874207107e-74
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TNF,Tumor necrosis factor,42338,0.0711934101468251,0.00387964742481506,0.0635893011941876,0.0787975190994626,2.76215347075736e-74
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,AP1G2,AP-1 complex subunit gamma-like 2,40450,0.145997504390329,0.00795939309432311,0.130397093925456,0.161597914855202,4.50092453801431e-74
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CD83,CD83 antigen,42593,0.0650853619952386,0.00355630910181858,0.0581149961556742,0.072055727834803,6.40174180867821e-74
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LAT2,Linker for activation of T-cells family member 2,42586,0.227026141105906,0.0124060445907688,0.202710293708,0.251341988503813,6.61139335229026e-74
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,42586,0.0802164392208991,0.0043905416556986,0.0716109775757298,0.0888219008660683,1.11791767884173e-73
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LEFTY2,Left-right determination factor 2,42688,0.0918524386290606,0.00503279161724394,0.0819881670592625,0.101716710198859,1.55972662515042e-73
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MEGF9,Multiple epidermal growth factor-like domains protein 9,42759,0.0354422464481233,0.00194320536699149,0.0316335639288199,0.0392509289674266,1.90319310380215e-73
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FABP5,Fatty acid-binding protein 5,42677,0.123875658445178,0.00680319613271595,0.110541394025055,0.137209922865301,3.32584404622101e-73
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SRP14,Signal recognition particle 14 kDa protein,42586,0.108623308781473,0.00596579853443715,0.0969303436539759,0.12031627390897,3.41802781965393e-73
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CHMP6,Charged multivesicular body protein 6,40510,0.102541772628492,0.0056322371832163,0.0915025877493877,0.113580957507596,5.0541627237789e-73
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,OXT,Oxytocin-neurophysin 1,42710,0.253213192304581,0.0139268267162628,0.225916611940706,0.280509772668456,5.33151696808982e-73
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PLA2G10,Group 10 secretory phospholipase A2,42494,-0.1078873607847,0.00593591153938675,-0.119521747401898,-0.096252974167502,6.15990163434552e-73
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CD300LG,CMRF35-like molecule 9,42610,-0.0704542905325479,0.00387707244595658,-0.0780533525266228,-0.062855228538473,6.4241414677465e-73
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,KRT18,"Keratin, type I cytoskeletal 18",42586,0.147561327584381,0.00812693275813554,0.131632539378435,0.163490115790327,8.41141992231512e-73
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SLC39A5,Zinc transporter ZIP5,42593,0.0981865777229717,0.00541089621838607,0.087581221134935,0.108791934311008,1.02150257061631e-72
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",42793,0.0534764392337149,0.00294826006913887,0.0476978494982027,0.0592550289692271,1.13940392968489e-72
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PENK,Proenkephalin-A,40282,0.060219659518217,0.00331550626188067,0.0537212672449308,0.0667180517915031,1.1397796083738e-72
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,EEF1D,Elongation factor 1-delta,40510,0.166601697763183,0.00919262109706296,0.148584160412939,0.184619235113426,2.1893479022392e-72
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,OCLN,Occludin,40481,0.0823427682313798,0.0045437053498055,0.073437105745761,0.0912484307169986,2.24293419259319e-72
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TGFB1,Transforming growth factor beta-1 proprotein,42745,0.0692498893254145,0.00383175366922042,0.0617396521337425,0.0767601265170865,3.67580392240083e-72
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ITGA5,Integrin alpha-5,42610,0.0455974795885689,0.00252389680959114,0.0406506418417702,0.0505443173353675,4.1919318423879e-72
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NPDC1,Neural proliferation differentiation and control protein 1,42635,0.0631488578949541,0.00349625638179904,0.056296195386628,0.0700015204032802,4.51905753604747e-72
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DNAJA2,DnaJ homolog subfamily A member 2,42720,0.146916365642505,0.00815012726734881,0.130942116198502,0.162890615086509,8.37349470606092e-72
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TIMP1,Metalloproteinase inhibitor 1,42500,0.0531749922488593,0.00295049802270407,0.0473920161243593,0.0589579683733593,9.25472337028534e-72
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RNASE4,Ribonuclease 4,40168,0.0533019217838919,0.00295486966646924,0.0475103772376122,0.0590934663301716,1.04643330465601e-71
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,42494,0.0705388225532644,0.00392203821327231,0.0628516276552506,0.0782260174512781,1.78254314249525e-71
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GSTA1,Glutathione S-transferase A1,42610,0.148945111605407,0.00828519935621432,0.132706120867227,0.165184102343587,2.01833184231663e-71
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FAM20A,Pseudokinase FAM20A,40510,0.0511724337102616,0.00284670538859885,0.0455928911486079,0.0567519762719153,2.9297243401497e-71
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,HLA_E,,42593,0.0556625090852105,0.00310491425523742,0.0495768771449451,0.0617481410254758,4.87588969744181e-71
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MAPK9,Mitogen-activated protein kinase 9,42593,0.0758058119184263,0.00423688778425468,0.0675015118612872,0.0841101119755655,9.0685940889602e-71
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RTBDN,Retbindin,42586,0.0539049853326618,0.00301560819197108,0.0479943932763985,0.0598155773889252,1.21275822770867e-70
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,INPP5D,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1",40222,0.103114809475531,0.00576599108160306,0.0918134669555888,0.114416151995473,1.57058136753265e-70
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CDHR5,Cadherin-related family member 5,42635,0.0696812453971251,0.00390186321430135,0.0620335934970944,0.0773288972971557,1.61854180465552e-70
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GSTA3,Glutathione S-transferase A3,42345,0.13705371257134,0.00768710264547837,0.121986991386202,0.152120433756478,2.81829626580072e-70
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,F11R,Junctional adhesion molecule A,42610,0.0996359940882621,0.00559004286300027,0.0886795100767816,0.110592478099743,2.97487458780121e-70
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",42586,0.0611627015618514,0.00343319265340671,0.0544336439611743,0.0678917591625286,3.47582252553341e-70
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PRKRA,Interferon-inducible double-stranded RNA-dependent protein kinase activator A,42345,0.121733803148207,0.00683461032551166,0.108337966910204,0.13512963938621,3.83663376678532e-70
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LAMP2,Lysosome-associated membrane glycoprotein 2,42237,0.0353784119436681,0.00199682230661064,0.0314646402227113,0.039292183664625,2.00031629247438e-69
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CD274,Programmed cell death 1 ligand 1,42494,0.0624180876405504,0.00353342323374508,0.0554925781024101,0.0693435971786908,4.78132206365853e-69
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MASP1,Mannan-binding lectin serine protease 1,42475,0.0416387700047055,0.00236262242976679,0.0370080300423626,0.0462695099670484,9.75556972873918e-69
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IFI30,Gamma-interferon-inducible lysosomal thiol reductase,40170,0.0701794327971011,0.0039782608808957,0.0623820414705455,0.0779768241236567,1.05950366301229e-68
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MTDH,Protein LYRIC,40198,0.166393859609254,0.00945196827120131,0.1478680017977,0.184919717420809,1.9765295160472e-68
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DNAJC6,Putative tyrosine-protein phosphatase auxilin,40222,0.149127404046759,0.00847956388730244,0.132507458827646,0.165747349265872,2.65547830575709e-68
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,F9,Coagulation factor IX,42662,0.0319329673488117,0.00181960558628989,0.0283665403996835,0.0354993942979399,3.44461652803517e-68
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,KLRB1,Killer cell lectin-like receptor subfamily B member 1,42753,0.0709327623513224,0.00404206464204016,0.0630103156529237,0.0788552090497211,3.44894436837818e-68
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SH2D1A,SH2 domain-containing protein 1A,42593,0.101857692264382,0.00580551383173188,0.0904788851541875,0.113236499374576,3.74846587861607e-68
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SULT2A1,Bile salt sulfotransferase,42593,0.0989707307088965,0.00564436897664324,0.0879077675146758,0.110033693903117,4.4961095145054e-68
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SNAP29,Synaptosomal-associated protein 29,42678,0.160468949518382,0.00916433125609224,0.142506860256441,0.178431038780322,6.74788157937136e-68
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ACY1,Aminoacylase-1,42635,0.106341394061092,0.00608869574780964,0.0944075503953852,0.118275237726799,1.46274195004113e-67
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CA6,Carbonic anhydrase 6,42580,-0.110325456483666,0.00631953452938598,-0.122711744161262,-0.0979391688060692,1.67588413849075e-67
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SYAP1,Synapse-associated protein 1,40282,0.101154842384165,0.00578882009560135,0.089808754996786,0.112500929771543,1.80042709995865e-67
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,XCL1,Lymphotactin,42720,0.0988412908012936,0.00566857645896558,0.0877308809417211,0.109951700660866,2.36484660035655e-67
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,COL6A3,Collagen alpha-3(VI) chain,42793,0.0666955344798479,0.00383445157921727,0.0591800093845821,0.0742110595751138,4.88268598474541e-67
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GRP,Gastrin-releasing peptide,40222,0.0985475172561424,0.00566522467376475,0.0874436768955635,0.109651357616721,6.98687357292683e-67
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IPCEF1,Interactor protein for cytohesin exchange factors 1,42474,0.155528974957464,0.00895241305415763,0.137982245371315,0.173075704543613,7.25499393412202e-67
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SIGLEC7,Sialic acid-binding Ig-like lectin 7,42635,0.0483977812941243,0.0027878203778367,0.0429336533535643,0.0538619092346842,8.7866600635448e-67
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,42753,0.0727658998516399,0.00419292987025438,0.0645477573059413,0.0809840423973385,9.59497760965001e-67
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CD63,CD63 antigen,42474,0.0891377530520765,0.00514149633721778,0.0790604202311296,0.0992150858730233,1.33749050287542e-66
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TFPI,Tissue factor pathway inhibitor,42617,0.0540744051779084,0.00312057473084299,0.0479580787054562,0.0601907316503607,1.52048832525693e-66
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MLN,Promotilin,42593,0.154586148692953,0.00893317093064241,0.137077133668894,0.172095163717012,2.27790446493779e-66
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CD302,CD302 antigen,42586,0.0560693730031788,0.00324088521253577,0.0497172379866087,0.0624215080197489,2.44418799042764e-66
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,HCLS1,Hematopoietic lineage cell-specific protein,42753,0.0955676453448933,0.00553941004541701,0.084710401655876,0.106424889033911,5.43642510963112e-66
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,BECN1,Beclin-1,40222,0.104297411412275,0.00604417699544644,0.0924508245011995,0.11614399832335,7.38141816646818e-66
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CD300C,CMRF35-like molecule 6,42710,0.0625030225603383,0.0036305145188008,0.0553872141034887,0.0696188310171879,1.00971526084303e-65
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,VWA1,von Willebrand factor A domain-containing protein 1,42688,0.0715335486938906,0.00415645535818646,0.0633868961918452,0.0796802011959361,1.11648015855661e-65
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IL12B,Interleukin-12 subunit beta,42753,0.0985316693981654,0.00572782009637156,0.0873051420092772,0.109758196787054,1.2668733666115e-65
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MSR1,Macrophage scavenger receptor types I and II,42710,0.0799178588607856,0.00465231674459018,0.0707993180413889,0.0890363996801824,1.9162912294732e-65
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PDCD5,Programmed cell death protein 5,42710,0.0995452229240953,0.00579630720655882,0.08818446079924,0.110905985048951,2.05605056022175e-65
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ATP6V1G1,V-type proton ATPase subunit G 1,40222,0.125396326000667,0.00730153317449197,0.111085320978662,0.139707331022671,2.92594280037187e-65
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CXCL11,C-X-C motif chemokine 11,42710,0.137791720808743,0.00805089928249681,0.122011958215049,0.153571483402437,5.53613814280973e-65
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PCBD1,Pterin-4-alpha-carbinolamine dehydratase,40276,0.0805635946154631,0.00470280648522499,0.0713460939044221,0.0897810953265041,5.96176157410033e-65
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NRP1,Neuropilin-1,42704,-0.0478159396087305,0.00280132031794418,-0.0533065274319011,-0.0423253517855599,1.19913812409665e-64
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TOP2B,DNA topoisomerase 2-beta,40198,0.137077964452987,0.00802229120227241,0.121354273696533,0.152801655209441,1.25741475923713e-64
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PTS,6-pyruvoyl tetrahydrobiopterin synthase,42249,0.0948089330701333,0.00557291668909905,0.0838860163594992,0.105731849780767,3.26211996793876e-64
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MVK,Mevalonate kinase,42369,0.13632459429061,0.00804615497777969,0.120554130534162,0.152095058047058,1.02649603780216e-63
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GPKOW,G-patch domain and KOW motifs-containing protein,42310,0.0491627339048373,0.00290810801174939,0.0434628422018085,0.0548626256078661,1.92514349198501e-63
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NAA80,N-alpha-acetyltransferase 80,40181,0.205839248288155,0.0121709650067787,0.181984156874869,0.229694339701441,2.30474356276234e-63
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CRHBP,Corticotropin-releasing factor-binding protein,42617,0.0465975515456008,0.002758650290347,0.0411905969765207,0.0520045061146809,2.34459663932939e-63
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TGFBI,Transforming growth factor-beta-induced protein ig-h3,42581,0.0460970698606904,0.00273313301661921,0.0407401291481168,0.0514540105732641,3.58794028488712e-63
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CDHR2,Cadherin-related family member 2,42586,0.120050378990717,0.00712287410988184,0.106089545735349,0.134011212246086,4.36114383362932e-63
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,40282,0.0511386880336871,0.00303694755014483,0.0451862708354032,0.0570911052319709,7.62599098482823e-63
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ACAA1,"3-ketoacyl-CoA thiolase, peroxisomal",42345,0.138323517725625,0.00822609540152664,0.122200370738632,0.154446664712617,8.53893754494143e-63
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CD300E,CMRF35-like molecule 2,42676,0.0735319351124665,0.00437537629000021,0.0649561975840661,0.0821076726408669,9.60881440414613e-63
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LECT2,Leukocyte cell-derived chemotaxin-2,40510,0.113661151316442,0.00675815157794269,0.100415174223674,0.126907128409209,1.03105918683105e-62
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CNTN3,Contactin-3,42610,0.0528281760134463,0.00314957193152402,0.0466550150276592,0.0590013369992334,1.66071834953258e-62
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PSME1,Proteasome activator complex subunit 1,42479,0.0627735373990506,0.00374417654118552,0.055434951378327,0.0701121234197742,1.9056387448485e-62
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,C9,Complement component C9,40531,-0.0900269786086331,0.00537030023136444,-0.100552767062107,-0.0795011901551588,2.51859613720981e-62
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FCN2,Ficolin-2,42596,0.0694439003139549,0.0041479986094641,0.0613138230394052,0.0775739775885045,2.79830226618519e-62
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,COLEC12,Collectin-12,42617,0.0472371113657738,0.0028229532378623,0.0417041230195637,0.0527700997119839,3.20156636556666e-62
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,KLK10,Kallikrein-10,42635,0.0685699000526151,0.00409977655867535,0.0605343379976114,0.0766054621076188,3.64162644827861e-62
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TGFA,Protransforming growth factor alpha,42593,0.0799727256869869,0.00478275060226024,0.0705985345065568,0.089346916867417,3.91966060798104e-62
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SCLY,Selenocysteine lyase,42673,0.0787974136607179,0.00471373150069114,0.0695584999193633,0.0880363274020725,4.18532204519961e-62
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LBR,Delta(14)-sterol reductase LBR,42710,0.112051897763804,0.00670326869773646,0.0989134911162409,0.125190304411368,4.20760079398908e-62
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GFRA1,GDNF family receptor alpha-1,42688,0.050173580228489,0.00300157872652174,0.0442904859245064,0.0560566745324716,4.23666613672918e-62
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LCAT,Phosphatidylcholine-sterol acyltransferase,40531,0.0374422478452067,0.00224286511273966,0.0330462322242369,0.0418382634661764,7.91981043634138e-62
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SERPINA4,Kallistatin,40341,0.0406101656553943,0.0024328541133326,0.0358417715932624,0.0453785597175262,8.35612181995327e-62
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CD300A,CMRF35-like molecule 8,40282,0.0527963721314323,0.0031630304473804,0.0465968324545667,0.0589959118082979,8.52769413279783e-62
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SIGLEC8,Sialic acid-binding Ig-like lectin 8,40222,0.0770477963519884,0.004620868722367,0.0679908936561491,0.0861046990478278,1.15160021446508e-61
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FLT4,Vascular endothelial growth factor receptor 3,42678,0.0552926619380853,0.00332617628429807,0.0487733564208611,0.0618119674553095,1.92354223901282e-61
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DUT,"Deoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial",40448,0.175830871623112,0.0105717087365601,0.155110322499454,0.19655142074677,2.19567011943247e-61
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,STAB2,Stabilin-2,40526,0.046971575096074,0.00282943393171769,0.0414258845899073,0.0525172656022406,3.60504255809306e-61
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PXN,Paxillin,42310,0.0856577118416833,0.00516519694477457,0.0755339258299251,0.0957814978534414,3.83302655996246e-61
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",42586,0.0735710146844636,0.00444174470867134,0.0648651950554678,0.0822768343134594,5.16539299647818e-61
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,HYOU1,Hypoxia up-regulated protein 1,42793,0.0386346737464378,0.00233377868087959,0.0340604675319138,0.0432088799609618,5.85519333064459e-61
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NAGK,N-acetyl-D-glucosamine kinase,40208,0.093239955101292,0.00562793102249147,0.0822092102972087,0.104270699905375,6.5312662669461e-61
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,HDGFL2,Hepatoma-derived growth factor-related protein 2,40482,0.10617254050741,0.00641603388280044,0.0935971140971215,0.118747966917699,8.5863172962627e-61
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FUOM,Fucose mutarotase,40282,0.106081973038286,0.00641007572335624,0.0935182246205073,0.118645721456064,8.6632314740543e-61
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SERPINH1,Serpin H1,40301,0.215523893223438,0.013030923839863,0.189983282497307,0.241064503949569,1.0131681256089e-60
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ADAMTSL2,ADAMTS-like protein 2,40526,0.057053680172617,0.0034501288861029,0.0502914275558553,0.0638159327893787,1.02512745155775e-60
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SNAPIN,SNARE-associated protein Snapin,40481,0.0959767132069134,0.00581317166356027,0.0845828967463352,0.107370529667491,1.58370610029359e-60
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,APEX1,DNA-(apurinic or apyrimidinic site) endonuclease,42650,0.0968353464990604,0.005880954024828,0.0853086766103975,0.108362016387723,2.50591076402339e-60
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CD244,Natural killer cell receptor 2B4,42753,0.0455144853131563,0.00276661340181987,0.0400919230455893,0.0509370475807232,3.1416638561592e-60
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CES3,Carboxylesterase 3,42586,0.117031245432491,0.00711386582706922,0.103088068411436,0.130974422453547,3.20381430451035e-60
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MYDGF,Myeloid-derived growth factor,40510,0.16284581449521,0.00989841915908992,0.143444912943394,0.182246716047026,4.05877671826154e-60
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MYH9,Myosin-9,40526,0.189495253468998,0.0115415886964312,0.166873739623993,0.212116767314003,6.91702199473127e-60
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IFNLR1,Interferon lambda receptor 1,42593,0.0601785770666535,0.00366950644566556,0.052986344433149,0.067370809700158,7.35980896305618e-60
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,EIF2AK2,"Interferon-induced, double-stranded RNA-activated protein kinase",40407,0.180569348361467,0.0110062409712062,0.158997116057903,0.202141580665031,8.58334864332538e-60
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ENO3,Beta-enolase,40222,0.0977487964167284,0.00596226347483221,0.0860627600060573,0.1094348328274,1.06036405845225e-59
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,HNMT,Histamine N-methyltransferase,42438,0.0792579491062353,0.00484749218263731,0.0697568644282662,0.0887590337842045,1.65492617394886e-59
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FUS,RNA-binding protein FUS,42335,0.0655664462273476,0.00401651759571825,0.0576940717397399,0.0734388207149554,2.54352232170179e-59
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CEP20,Centrosomal protein 20,42345,0.123088243682383,0.00754112022960109,0.108307648032365,0.137868839332402,2.62080684720911e-59
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DAB2,Disabled homolog 2,42720,0.179475194437172,0.0109981403816846,0.15791883928907,0.201031549585274,2.67633919796105e-59
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FETUB,Fetuin-B,42662,0.0529691577892335,0.0032465144211508,0.0466059895237779,0.059332326054689,2.82336092310798e-59
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SORT1,Sortilin,42612,0.0607581939852471,0.00372665394639098,0.0534539522503208,0.0680624357201734,3.44048138550108e-59
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PTGDS,Prostaglandin-H2 D-isomerase,42554,0.0537840755882882,0.00330511668497963,0.0473060468857282,0.0602621042908483,5.66080015155397e-59
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,OGFR,Opioid growth factor receptor,42586,0.0533679341977497,0.00328431642233355,0.046930674009976,0.0598051943855235,8.23967224785184e-59
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CSTB,Cystatin-B,42436,0.0698111938049086,0.00430053494228604,0.061382145318028,0.0782402422917893,1.08281210782645e-58
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,APOD,Apolipoprotein D,40032,-0.0718007750659627,0.0044189732200163,-0.0804619625771946,-0.0631395875547307,1.1308964571888e-58
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FTCD,Formimidoyltransferase-cyclodeaminase,40461,0.140180871677638,0.00863849593396731,0.123249419647062,0.157112323708214,1.48438517775345e-58
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TXNDC5,Thioredoxin domain-containing protein 5,42710,0.109154542452749,0.00674042454488646,0.0959433103447711,0.122365774560726,1.97010718595833e-58
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CD80,T-lymphocyte activation antigen CD80,40510,0.0571354789288238,0.00352940700303147,0.0502178412028822,0.0640531166547655,2.74415081717269e-58
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GCC1,GRIP and coiled-coil domain-containing protein 1,40482,0.175199480228992,0.0108229193089194,0.15398655838351,0.196412402074474,2.78003883390782e-58
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,AP3S2,AP-3 complex subunit sigma-2,40482,0.077753611459104,0.00480485335680317,0.0683360988797698,0.0871711240384382,3.03441134825944e-58
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ICAM1,Intercellular adhesion molecule 1,42594,0.0476265981773445,0.00294991377179148,0.0418447671846332,0.0534084291700558,4.34034104130191e-58
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FYB1,FYN-binding protein 1,42589,0.14951223909349,0.00926329832888124,0.131356174368883,0.167668303818098,4.68665429752898e-58
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,HNRNPUL1,Heterogeneous nuclear ribonucleoprotein U-like protein 1,40481,0.0788581450133968,0.00489962177526787,0.0692548863338718,0.0884614036929219,1.21425515864176e-57
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CA5A,"Carbonic anhydrase 5A, mitochondrial",42356,0.14982329981322,0.00932381850163239,0.131548615550021,0.168097984076419,1.48611384092082e-57
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,COCH,Cochlin,40510,0.0760993351134105,0.00473783657401268,0.0668131754283457,0.0853854947984754,2.02662633841525e-57
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PROC,Vitamin K-dependent protein C,42662,0.0406796057085591,0.00253674877414028,0.0357075781112441,0.045651633305874,2.42510152001615e-57
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CSF1,Macrophage colony-stimulating factor 1,42675,0.0450841080478177,0.00281205227585166,0.0395724855871484,0.0505957305084869,2.56651635607916e-57
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,42610,0.0524423406060419,0.00327177514460004,0.0460296613226258,0.0588550198894579,2.73881592185741e-57
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PRKAR2A,cAMP-dependent protein kinase type II-alpha regulatory subunit,40464,0.130356431612051,0.0081314763982536,0.114418737871474,0.146294125352628,3.31913868874783e-57
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MUC13,Mucin-13,42310,0.0845658167896095,0.00528194014485829,0.0742132141056872,0.0949184194735317,3.760163083638e-57
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,BID,BH3-interacting domain death agonist,42593,0.107980581123902,0.00676310789165208,0.0947248896562637,0.12123627259154,7.35539157365145e-57
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TMSB10,Thymosin beta-10,42610,0.119295378070422,0.00748076701193079,0.104633074727038,0.133957681413807,9.92781255393991e-57
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GPRC5C,G-protein coupled receptor family C group 5 member C,40450,0.091804727827465,0.00575303334174049,0.0805287824776536,0.103080673177276,1.05372517079036e-56
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FST,Follistatin,42653,0.0789444510735458,0.00495819114170292,0.0692263964358081,0.0886625057112835,1.46257605590759e-56
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NIT2,Omega-amidase NIT2,40461,0.117430294077763,0.00737216905850727,0.102980842723089,0.131879745432437,1.65044204922154e-56
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LAT,Linker for activation of T-cells family member 1,42753,0.120672157897655,0.00759231440792562,0.10579122165812,0.135553094137189,2.25041999103863e-56
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CD6,T-cell differentiation antigen CD6,42745,0.0846427537588483,0.00532982509262864,0.0741962965772962,0.0950892109404004,2.76146282707546e-56
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ARF6,ADP-ribosylation factor 6,40448,0.172260345094235,0.0108376397790073,0.151018571127381,0.193502119061089,2.82191089510563e-56
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SARG,Specifically androgen-regulated gene protein,40455,0.173924211483147,0.0109502785262937,0.152461665571612,0.195386757394683,3.37624301910484e-56
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SHISA5,Protein shisa-5,40526,0.0447327219171363,0.00281740381417931,0.0392106104413449,0.0502548333929278,3.66406026871457e-56
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,B2M,Beta-2-microglobulin,40538,0.0504846528601554,0.00318140392049276,0.0442491011759896,0.0567202045443212,4.18453103084662e-56
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DKK1,Dickkopf-related protein 1,42710,0.0938507670385812,0.00591953159834868,0.0822484851058178,0.105453048971345,4.19451181739972e-56
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PLA2G15,Phospholipase A2 group XV,42678,0.0425555211904804,0.00268507205831806,0.037292779956177,0.0478182624247838,4.58291067509509e-56
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,AHNAK,Neuroblast differentiation-associated protein AHNAK,40222,0.0512388846239158,0.00323081685638274,0.0449064835854057,0.057571285662426,5.02594471216688e-56
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LRP11,Low-density lipoprotein receptor-related protein 11,42635,0.0599630872154866,0.00378657204943431,0.0525414059985954,0.0673847684323778,5.65370443176767e-56
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IL18BP,Interleukin-18-binding protein,42688,0.0517344778667505,0.00327215697379367,0.0453210501981149,0.0581479055353861,8.33874670192959e-56
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ERBB3,Receptor tyrosine-protein kinase erbB-3,42585,0.030221510217327,0.00191186079098749,0.0264742630669915,0.0339687573676625,8.83280336150041e-56
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SIGLEC10,Sialic acid-binding Ig-like lectin 10,42593,0.0562677376968881,0.00356547214881759,0.0492794122852056,0.0632560631085706,1.32499554805175e-55
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,EIF4G1,Eukaryotic translation initiation factor 4 gamma 1,42753,0.155890214606607,0.00988070038483215,0.136524041852336,0.175256387360878,1.39218269978965e-55
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,42494,0.0723688332912801,0.00458787285577268,0.0633766024939657,0.0813610640885945,1.49796725310182e-55
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RNASE6,Ribonuclease K6,40467,0.0544893506523846,0.00345413508887108,0.0477192458781973,0.0612594554265719,1.80645484503303e-55
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TOMM20,Mitochondrial import receptor subunit TOM20 homolog,40510,0.123840894939707,0.00785430634704844,0.108446454499492,0.139235335379922,2.02957186214509e-55
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,OTUD7B,OTU domain-containing protein 7B,40481,0.0985882982345782,0.00625742090478218,0.0863237532612051,0.110852843207951,2.44631957503908e-55
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SMOC2,SPARC-related modular calcium-binding protein 2,42675,0.0625024317373567,0.00397509431518719,0.0547112468795898,0.0702936165951236,3.22760651602003e-55
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RRM2,Ribonucleoside-diphosphate reductase subunit M2,42345,0.0810964299564678,0.00515952182826664,0.0709837671730651,0.0912090927398704,3.62507487900873e-55
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CKAP4,Cytoskeleton-associated protein 4,42712,0.0459899935605693,0.002929354345735,0.0402484590429287,0.0517315280782099,4.65288208314948e-55
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,BCHE,Cholinesterase,40345,0.0443155672382411,0.00282308513044122,0.0387823203825763,0.0498488140939059,6.07722805477621e-55
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",40482,0.0665040503083374,0.00424153202268487,0.058190647543875,0.0748174530727997,7.93033977802628e-55
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TIMP3,Metalloproteinase inhibitor 3,42675,0.20540064739569,0.0131182839839599,0.179688810787129,0.231112484004252,8.95011736966156e-55
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GPD1,Glycerol-3-phosphate dehydrogenase,40450,0.0822446297749495,0.0052530548210457,0.0719486423256999,0.0925406172241991,1.12930203248972e-54
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PON2,Serum paraoxonase/arylesterase 2,42356,0.0552368010802935,0.00353922230374403,0.0482999253649552,0.0621736767956318,2.00264760118117e-54
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GGT1,Glutathione hydrolase 1 proenzyme,42589,0.0792768330454772,0.00508358450069729,0.0693130074241105,0.0892406586668439,2.37627299535014e-54
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PLSCR3,Phospholipid scramblase 3,40456,0.0914234666162214,0.00585759542638664,0.0799425795805035,0.102904353651939,2.39031806978408e-54
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PDCD1,Programmed cell death protein 1,42688,0.071101610382106,0.00456314004352627,0.0621578558967945,0.0800453648674175,2.87646943195225e-54
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,KHK,Ketohexokinase,40222,0.0989574416684728,0.00634718709481394,0.0865169549626375,0.111397928374308,3.18402999964192e-54
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PCSK9,Proprotein convertase subtilisin/kexin type 9,42793,0.0621226891574014,0.00399240519747588,0.0542975749703487,0.0699478033444541,3.96976290516056e-54
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SIAE,Sialate O-acetylesterase,42645,0.0718860669235351,0.0046230148892991,0.0628249577405088,0.0809471761065613,4.72635009156591e-54
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SCAMP3,Secretory carrier-associated membrane protein 3,42586,0.132470886392865,0.00852993128482162,0.115752221074615,0.149189551711116,6.40131305395757e-54
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CDNF,Cerebral dopamine neurotrophic factor,42586,0.0528605682555002,0.00340696275365168,0.0461829212583429,0.0595382152526575,8.01356768982899e-54
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,YES1,Tyrosine-protein kinase Yes,42586,0.177344250726878,0.0114362642116052,0.154929172872132,0.199759328581625,9.094305008236e-54
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TPD52L2,Tumor protein D54,40282,0.168415303521809,0.0108557487130838,0.147138036044165,0.189692570999453,1.02285424014204e-53
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CD22,B-cell receptor CD22,42753,0.0682889222035393,0.00440833647557288,0.0596485827114165,0.0769292616956621,1.15211218962735e-53
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IDUA,Alpha-L-iduronidase,42720,0.0724837815753624,0.00468450064829036,0.0633021603047133,0.0816654028460115,1.51485909703024e-53
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SSC4D,Scavenger receptor cysteine-rich domain-containing group B protein,42612,0.177366472039415,0.0114746962776258,0.154876067335269,0.199856876743562,1.94779073621153e-53
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CALCA,Calcitonin,42475,0.098804959859708,0.00639480417027283,0.0862711436859732,0.111338776033443,2.16952306690555e-53
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NBL1,Neuroblastoma suppressor of tumorigenicity 1,42678,0.0440133069591564,0.00284920849575035,0.0384288583074857,0.0495977556108271,2.24417992705683e-53
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LEP,Leptin,42635,0.103514991711839,0.00670171317982603,0.0903796338793801,0.116650349544298,2.30395346162216e-53
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NAGPA,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase,40282,0.0339221450797878,0.0021950708021617,0.0296198063075509,0.0382244838520248,2.55474423970257e-53
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,BMPER,BMP-binding endothelial regulator protein,40282,0.036419124073613,0.00235685975109075,0.0317996789614751,0.0410385691857508,2.60919327333909e-53
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,AP3B1,AP-3 complex subunit beta-1,40448,0.119533028200134,0.00773866259083001,0.104365249522107,0.134700806878161,2.81326443627014e-53
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SRPK2,SRSF protein kinase 2,42593,0.129480592892381,0.00839139642596048,0.113033455897499,0.145927729887264,2.94439828492112e-53
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,42745,0.0630679478628914,0.00408977955566393,0.0550519799337901,0.0710839157919927,3.35241579574094e-53
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,APOF,Apolipoprotein F,40531,-0.0373034043053155,0.00241760983133025,-0.0420419195747228,-0.0325648890359082,3.57300095793385e-53
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,VEGFA,Vascular endothelial growth factor A,42715,0.0910169114898059,0.00591202231778313,0.079429347746951,0.102604475232661,4.96230299143062e-53
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GP1BA,Platelet glycoprotein Ib alpha chain,42582,0.0513054085787107,0.00333573767550841,0.0447673627347142,0.0578434544227072,6.26624649223809e-53
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,42617,0.0622738545204972,0.00404974243032786,0.0543363593570546,0.0702113496839398,6.56941926446705e-53
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MMP12,Macrophage metalloelastase,42591,0.0872669586173957,0.0056759352156634,0.0761421255946955,0.098391791640096,6.81984044872942e-53
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,BLOC1S3,Biogenesis of lysosome-related organelles complex 1 subunit 3,40482,0.0620464690370935,0.00403868091566929,0.0541306544423817,0.0699622836318053,9.88008062026295e-53
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SLA2,Src-like-adapter 2,40481,0.160816887511151,0.0104907243960589,0.140255067694875,0.181378707327426,1.64135495364998e-52
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CTSO,Cathepsin O,42753,0.0475595410200007,0.00310647900496795,0.0414708421702635,0.0536482398697379,1.80591128826748e-52
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TXLNA,Alpha-taxilin,42494,0.135447700261993,0.00884749258829839,0.118106614788928,0.152788785735057,1.85890576443457e-52
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,STK11,Serine/threonine-protein kinase STK11,42356,0.111884611382573,0.00730994080108243,0.0975571274124517,0.126212095352695,1.97622651078609e-52
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TALDO1,Transaldolase,40498,0.0681072256149794,0.00444852610418449,0.0593881144507778,0.076826336779181,2.19385686800549e-52
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,KLRD1,Natural killer cells antigen CD94,42753,0.0728088886660619,0.00476144412742689,0.0634764581763052,0.0821413191558187,2.38609043723527e-52
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ITPR1,"Inositol 1,4,5-trisphosphate receptor type 1",40222,0.106105020009206,0.00694031980672161,0.0925019931880313,0.11970804683038,3.14056101891732e-52
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PCDH9,Protocadherin-9,40448,0.0534626169542474,0.00349885810094337,0.0466048550763984,0.0603203788320964,3.46625512975969e-52
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NFKBIE,NF-kappa-B inhibitor epsilon,42345,0.076294307299607,0.00500487741127268,0.0664847475735125,0.0861038670257014,5.02236583645385e-52
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CTSZ,Cathepsin Z,42647,0.0496687129171295,0.00325903535266206,0.0432810036259118,0.0560564222083471,5.18911693574964e-52
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DAG1,Dystroglycan,42675,0.0703842947804903,0.00462230387613573,0.0613245791832642,0.0794440103777163,6.3165180485107e-52
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FKBP4,Peptidyl-prolyl cis-trans isomerase FKBP4,42494,0.0670686359561301,0.00440490151169775,0.0584350289932025,0.0757022429190577,6.51729381382579e-52
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SERPIND1,Heparin cofactor 2,40515,0.0432177142063738,0.00284342761473619,0.0376445960814909,0.0487908323312568,1.15728448544618e-51
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,42610,0.0589350766697135,0.00388401168922201,0.0513224137588384,0.0665477395805887,1.41312915797328e-51
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CACNB3,Voltage-dependent L-type calcium channel subunit beta-3,40481,0.128239191514936,0.00845811247325025,0.111661291067366,0.144817091962507,2.03309589738628e-51
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ISM1,Isthmin-1,42593,0.0587482410724205,0.00388260053314943,0.0511383440274476,0.0663581381173934,2.67646344309723e-51
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,HBEGF,Proheparin-binding EGF-like growth factor,42673,0.111027604949054,0.00734115404725631,0.0966389430164313,0.125416266881676,2.96157685066324e-51
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,HS3ST3B1,Heparan sulfate glucosamine 3-O-sulfotransferase 3B1,42586,0.0579739020167812,0.00383514098053487,0.0504570256949329,0.0654907783386296,3.33318802551374e-51
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GBP1,Guanylate-binding protein 1,40465,0.100507054338197,0.00664463739039431,0.0874835650530239,0.11353054362337,3.46401549986079e-51
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,WFDC2,WAP four-disulfide core domain protein 2,41947,0.0670544525940775,0.00443712195056205,0.0583576935709759,0.0757512116171791,3.73189929858066e-51
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PPP1R9B,Neurabin-2,42753,0.142673915866317,0.00944460038629637,0.124162499109176,0.161185332623458,3.82976357024747e-51
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CD59,CD59 glycoprotein,42129,0.0382649718714718,0.00253408750829172,0.03329816035522,0.0432317833877236,4.40354518470618e-51
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LYN,Tyrosine-protein kinase Lyn,42586,0.12789142094008,0.00847290778475239,0.111284521681966,0.144498320198195,4.65133070360114e-51
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PRSS2,Trypsin-2,42688,0.0852500979139161,0.00565005223262173,0.0741759955379775,0.0963242002898547,5.03377764005039e-51
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CCL20,C-C motif chemokine 20,42753,0.139906933817244,0.00927884728163311,0.121720393145243,0.158093474489245,5.8440283451419e-51
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IGF2R,Cation-independent mannose-6-phosphate receptor,42610,0.0354790736994631,0.00235817260014162,0.0308570554031856,0.0401010919957407,9.62912099375875e-51
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IL1RL2,Interleukin-1 receptor-like 2,42369,0.0586605551134852,0.00389965814933678,0.0510172251407851,0.0663038850861853,1.0192655818144e-50
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PDLIM7,PDZ and LIM domain protein 7,42675,0.187204790871799,0.0124482009027599,0.162806317102389,0.211603264641208,1.05500635963321e-50
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ACE2,Angiotensin-converting enzyme 2,42356,0.0816502954652265,0.00543175808835222,0.0710040496120562,0.0922965413183969,1.19176858849232e-50
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MINK1,Misshapen-like kinase 1,40482,0.140898456783584,0.00936850505152345,0.122536186882598,0.15926072668457,1.24842337912379e-50
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LDLRAP1,Low density lipoprotein receptor adapter protein 1,40481,0.147896272388391,0.00983826510976567,0.12861327277325,0.167179272003531,1.38137861909655e-50
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MARCO,Macrophage receptor MARCO,42635,0.0397937238676908,0.00265474994677997,0.0345904139720021,0.0449970337633796,2.19048741799913e-50
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PPP1R12A,Protein phosphatase 1 regulatory subunit 12A,42678,0.144327405819205,0.00963071237011926,0.125451209573771,0.163203602064638,2.29919867028021e-50
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IGFBP6,Insulin-like growth factor-binding protein 6,42594,0.0491560980308777,0.00328038141146723,0.0427265504644019,0.0555856455973535,2.35706230807103e-50
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ECHS1,"Enoyl-CoA hydratase, mitochondrial",40222,0.147329940768625,0.00982608140896265,0.128070821207059,0.166589060330192,2.5229487329394e-50
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,YOD1,Ubiquitin thioesterase OTU1,40115,0.0963655368496873,0.00642702103963045,0.0837685756120116,0.108962498087363,2.54913808398665e-50
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PAK4,Serine/threonine-protein kinase PAK 4,42310,0.0919044468032534,0.0061396927260395,0.0798706490602159,0.103938244546291,3.04575728270208e-50
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DAAM1,Disheveled-associated activator of morphogenesis 1,40282,0.126459584349126,0.00844466304522672,0.109908044780481,0.14301112391777,3.30294892497485e-50
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SNX15,Sorting nexin-15,40282,0.0823946845877841,0.00550390603418103,0.0716070287607893,0.0931823404147789,3.54874512654687e-50
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CTSS,Cathepsin S,39872,0.0368383409412973,0.00246301249400234,0.0320108364530527,0.0416658454295419,4.52446277760726e-50
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CD27,CD27 antigen,42678,0.0669394666261331,0.00448196254312586,0.0581548200416065,0.0757241132106598,4.87602421845104e-50
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SCPEP1,Retinoid-inducible serine carboxypeptidase,40168,0.0743843564762423,0.00498480234984854,0.0646141438705392,0.0841545690819455,7.2736605512684e-50
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RNASET2,Ribonuclease T2,42748,0.0417299408585524,0.00279932802737424,0.0362432579248989,0.0472166237922059,7.35274976073798e-50
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NUDT5,ADP-sugar pyrophosphatase,42610,0.0760961026289404,0.00510576927582982,0.066088794848314,0.0861034104095669,7.77728482694485e-50
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CD163,Scavenger receptor cysteine-rich type 1 protein M130,42688,0.0652869411872893,0.00438205669672361,0.056698110061711,0.0738757723128675,8.35795490514049e-50
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MFAP5,Microfibrillar-associated protein 5,42793,0.0619745484809957,0.00416177654872608,0.0538174664454926,0.0701316305164988,9.24571451710634e-50
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SFRP4,Secreted frizzled-related protein 4,40282,0.0609987901573519,0.00409364712131659,0.0529752417995714,0.0690223385151324,9.84403369814597e-50
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PYY,Peptide YY,40115,0.154873307273532,0.0103982819629253,0.134492674626199,0.175253939920866,1.10462052376133e-49
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SUGP1,SURP and G-patch domain-containing protein 1,40448,0.0602603167014093,0.00404894555748418,0.0523243834087403,0.0681962499940783,1.25911353966687e-49
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NT5C1A,Cytosolic 5'-nucleotidase 1A,40482,0.0486431793864147,0.00327103994469069,0.0422319410948209,0.0550544176780084,1.49868612175487e-49
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TREML2,Trem-like transcript 2 protein,42610,0.0523514381642177,0.00352395995797595,0.0454444766465849,0.0592583996818506,1.57731544350217e-49
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CD40,Tumor necrosis factor receptor superfamily member 5,42619,0.0737251817923191,0.00496656861376405,0.0639907073093416,0.0834596562752967,1.86797944167208e-49
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GORASP2,Golgi reassembly-stacking protein 2,40448,0.0707093486619412,0.00476282430890723,0.061374213016483,0.0800444843073994,2.16042929469406e-49
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MTSS1,Protein MTSS 1,40448,0.167915429184073,0.0113155939562973,0.14573686502973,0.190093993338415,2.38637274259351e-49
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,UBE2L6,Ubiquitin/ISG15-conjugating enzyme E2 L6,40510,0.0912218976485891,0.00615261900188507,0.0791627644048944,0.103281030892284,2.8597893069496e-49
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FGF23,Fibroblast growth factor 23,42710,0.0817236642007695,0.00551689007121028,0.0709105596611973,0.0925367687403416,2.92186536274336e-49
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NCK2,Cytoplasmic protein NCK2,42675,0.156047343364806,0.0105361562510884,0.135396477112673,0.176698209616939,3.04686990754742e-49
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FSTL3,Follistatin-related protein 3,42573,0.0506446775160486,0.00342355079183575,0.0439345179640506,0.0573548370680467,3.96965922010686e-49
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SELP,P-selectin,42688,0.0835978813089824,0.00565228514650422,0.0725194024218341,0.0946763601961307,4.11191681131589e-49
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ERBIN,Erbin,42586,0.152165367859356,0.0102929189616181,0.131991246694585,0.172339489024128,4.55883173359135e-49
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ARHGEF1,Rho guanine nucleotide exchange factor 1,40482,0.134366046740293,0.00909053936064183,0.116548589593435,0.152183503887151,5.58033537059458e-49
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,EHBP1,EH domain-binding protein 1,40510,0.110827108300499,0.00749988416288419,0.0961273353412464,0.125526881259752,5.87334541521255e-49
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,BAG4,BAG family molecular chaperone regulator 4,40198,0.0731469030852379,0.00495572135632523,0.0634336892268404,0.0828601169436353,7.75490809659904e-49
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ZFYVE19,Abscission/NoCut checkpoint regulator,40448,0.135007688434958,0.00914999595601367,0.117073696361171,0.152941680508745,8.16306877266013e-49
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DNAJB6,DnaJ homolog subfamily B member 6,40182,0.12492730167907,0.00847175688440897,0.108322658185628,0.141531945172511,9.48680429563138e-49
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NOTCH3,Neurogenic locus notch homolog protein 3,42793,-0.0507734203413775,0.00345137632637385,-0.0575381179410703,-0.0440087227416848,1.29340048114015e-48
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DCTN1,Dynactin subunit 1,42720,0.0960298401585207,0.00653078439001455,0.0832295027540922,0.108830177562949,1.43614457209883e-48
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NECTIN2,Nectin-2,42612,0.0469641118700707,0.00319399586905094,0.0407038799667309,0.0532243437734106,1.45253563247624e-48
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CCL15,C-C motif chemokine 15,42793,0.066514071783266,0.00453109576481606,0.0576331240842265,0.0753950194823055,2.04714556601783e-48
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,WDR46,WD repeat-containing protein 46,40450,0.0535420294900878,0.00364500640021504,0.0463978169456664,0.0606862420345093,2.12039023475673e-48
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CDCP1,CUB domain-containing protein 1,42494,0.0805820099963355,0.0055025380669823,0.0697970353850502,0.0913669846076208,3.46262996999224e-48
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ARSB,Arylsulfatase B,42586,0.0813996878896728,0.0055586962279351,0.0705046432829201,0.0922947324964256,3.4850561911654e-48
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MTHFSD,Methenyltetrahydrofolate synthase domain-containing protein,40301,0.165901611067884,0.0113276713678872,0.143699375186825,0.188103846948943,4.02826823046556e-48
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TCOF1,Treacle protein,40510,0.0477486693220733,0.0032641478380934,0.0413509395594102,0.0541463990847363,5.08708884545968e-48
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GRHPR,Glyoxylate reductase/hydroxypyruvate reductase,40510,0.0932918766674578,0.00638989526285824,0.0807676819522557,0.10581607138266,7.64978741459324e-48
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,EBAG9,Receptor-binding cancer antigen expressed on SiSo cells,42494,0.139584386753138,0.00956826476554627,0.120830587812668,0.158338185693609,7.80660882149137e-48
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RBPMS2,RNA-binding protein with multiple splicing 2,40222,0.151348734251637,0.0103665532487601,0.131030289884067,0.171667178619207,7.8713345386221e-48
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CD99L2,CD99 antigen-like protein 2,42610,0.035817198194752,0.00245615540808946,0.0310031335948967,0.0406312627946074,8.40669547731075e-48
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RET,Proto-oncogene tyrosine-protein kinase receptor Ret,42586,0.0587175870184273,0.00402863006212064,0.0508214720966708,0.0666137019401837,9.38769481459765e-48
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CD2AP,CD2-associated protein,42635,0.0936102295924629,0.0064249952077727,0.0810172389852284,0.106203220199697,1.01136894379935e-47
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TARBP2,RISC-loading complex subunit TARBP2,42310,0.114874522794808,0.00789241129917656,0.0994053966484215,0.130343648941194,1.27450042344181e-47
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CCL17,C-C motif chemokine 17,42603,0.134345988569545,0.00924226571444034,0.116231147769242,0.152460829369848,1.6448509976231e-47
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ALDH1A1,Retinal dehydrogenase 1,42610,0.0788088270924926,0.00542329571046295,0.0681791674999852,0.089438486685,1.75419518851709e-47
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ATRN,"Attractin, Isoform 2",40538,0.0246767216024915,0.00169800353945366,0.0213486346651624,0.0280048085398207,2.0014953818216e-47
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,EIF4B,Eukaryotic translation initiation factor 4B,42494,0.084292760954001,0.00580797483496647,0.0729091302774667,0.0956763916305353,2.29657826827383e-47
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SORD,Sorbitol dehydrogenase,42657,0.0980137123672681,0.00675643807521047,0.0847710937398556,0.111256330994681,2.49847229050544e-47
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,WWP2,NEDD4-like E3 ubiquitin-protein ligase WWP2,42494,0.0782364419008997,0.00539603042866562,0.0676602222607151,0.0888126615410843,2.82326726143464e-47
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SELPLG,P-selectin glycoprotein ligand 1,42593,0.0402335530967491,0.00277723118008992,0.0347901799837729,0.0456769262097253,3.33098686762714e-47
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,AFM,Afamin,40538,0.0292744928303553,0.00201975834901778,0.0253157664662804,0.0332332191944301,3.48451151554352e-47
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PSMG3,Proteasome assembly chaperone 3,42593,0.0747706382423476,0.00516798258304712,0.0646413923795753,0.0848998841051199,4.36509873924202e-47
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RASSF2,Ras association domain-containing protein 2,42345,0.0831287852438047,0.00574637274671622,0.0718658946602409,0.0943916758273685,4.54424667302039e-47
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,METAP2,Methionine aminopeptidase 2,42688,0.083149176906877,0.00575564719154982,0.0718681084114394,0.0944302454023147,5.90429813620517e-47
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DTX3,Probable E3 ubiquitin-protein ligase DTX3,42586,0.0367146933026409,0.00254155820100016,0.0317332392286806,0.0416961473766012,6.00830599303083e-47
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SDC1,Syndecan-1,42635,0.0594919112477445,0.0041205169119305,0.0514156981003608,0.0675681243951283,6.69404920673095e-47
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TNFSF14,Tumor necrosis factor ligand superfamily member 14,42494,0.0841061122237194,0.00582514729500979,0.0726888235255002,0.0955234009219386,6.7049282515264e-47
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,S100A4,Protein S100-A4,42678,0.0829354630955406,0.00574550416211456,0.071674274937796,0.0941966512532851,6.98207162961662e-47
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CIRBP,Cold-inducible RNA-binding protein,40448,0.139002674554097,0.00962513340578641,0.120137413078755,0.157867936029438,7.41928271689766e-47
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TRIAP1,TP53-regulated inhibitor of apoptosis 1,42720,0.0895296677763465,0.00620685299144762,0.0773642359131092,0.101695099639584,8.09363549321216e-47
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PTN,Pleiotrophin,42356,0.0722827659306634,0.00501377435175219,0.0624557682012291,0.0821097636600977,9.20532369848216e-47
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FMNL1,Formin-like protein 1,42310,0.0903199331754211,0.00626636493193189,0.0780378579088346,0.102602008442008,9.68835309205925e-47
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CD28,T-cell-specific surface glycoprotein CD28,42345,0.0554569105097416,0.00384951458060052,0.0479118619317645,0.0630019590877186,1.07184153693614e-46
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NSFL1C,NSFL1 cofactor p47,42710,0.0943441696998196,0.0065498858239174,0.0815063934849415,0.107181945914698,1.08310598147861e-46
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,C3,Complement C3,39988,0.0687478982810556,0.00476918488616716,0.059400295904168,0.0780955006579432,1.12816201647173e-46
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SEMA4D,Semaphorin-4D,42710,0.0434402288749448,0.00302229109850896,0.0375165383218673,0.0493639194280224,1.6760855854426e-46
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NT5E,5'-nucleotidase,42678,0.0821705731718909,0.00572037762746184,0.0709586330220657,0.0933825133217161,1.90144448930191e-46
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,HAVCR1,Hepatitis A virus cellular receptor 1,42705,0.0964178693807649,0.00671849135177348,0.0832496263312889,0.109586112430241,2.29725375042689e-46
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CXCL9,C-X-C motif chemokine 9,42675,0.0983705213321917,0.00685699062147292,0.0849308197141047,0.111810222950279,2.47405865226422e-46
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IL12RB1,Interleukin-12 receptor subunit beta-1,42369,0.0564867780401273,0.00393798351767535,0.0487683303454836,0.064205225734771,2.58916744872341e-46
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GFER,FAD-linked sulfhydryl oxidase ALR,42345,0.0910443985369138,0.00634963095233434,0.0785991218703385,0.103489675203489,2.80548406941962e-46
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MTSS2,Protein MTSS 2,40450,0.14315378551531,0.00998330416311926,0.123586509355596,0.162721061675024,3.17095298903393e-46
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,VAMP8,Vesicle-associated membrane protein 8,40198,0.127611478867663,0.00890589941815511,0.110155916008079,0.145067041727247,3.75451723597341e-46
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PHACTR2,Phosphatase and actin regulator 2,40481,0.164280814853894,0.0114733366404316,0.141793075038648,0.18676855466914,4.24644688171594e-46
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SIRPB1,Signal-regulatory protein beta-1,42599,0.0697311141327691,0.00487362864790004,0.0601788019828851,0.0792834262826532,4.26980247063257e-46
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TTR,Transthyretin,40423,0.0365824941163383,0.00255748688378441,0.0315698198241209,0.0415951684085558,5.22941253043035e-46
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PDGFC,Platelet-derived growth factor C,42345,0.0412714147094502,0.00288815969543717,0.0356106217063933,0.046932207712507,5.58926322947787e-46
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LZTFL1,Leucine zipper transcription factor-like protein 1,40282,0.10297100594056,0.00720211148562263,0.0888548674287394,0.11708714445238,5.81897781401935e-46
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PLIN1,Perilipin-1,42310,0.0505198641834712,0.00353676294197886,0.0435878088171926,0.0574519195497497,6.06718775277125e-46
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CES2,Cocaine esterase,42586,0.0793349532620788,0.00555572522518303,0.06844573182072,0.0902241747034375,6.34881286183434e-46
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,HAVCR2,Hepatitis A virus cellular receptor 2,42610,0.0532405074718522,0.0037285673648772,0.0459325154366929,0.0605484995070115,6.41006920887864e-46
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SEMA7A,Semaphorin-7A,42759,0.0411721776126809,0.00288420632240893,0.0355191332207594,0.0468252220046024,6.72915649569877e-46
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PLAUR,Urokinase plasminogen activator surface receptor,42546,0.0405403085700941,0.00283997222969825,0.0349739629998855,0.0461066541403026,6.82539200955192e-46
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GRPEL1,"GrpE protein homolog 1, mitochondrial",42586,0.0856358527856173,0.00600684394094944,0.0738624386613564,0.0974092669098782,8.84454652401013e-46
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PTPRC,Receptor-type tyrosine-protein phosphatase C,40526,0.0336425286357162,0.00236038603764834,0.0290161720019255,0.038268885269507,1.06566923450376e-45
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SWAP70,Switch-associated protein 70,40448,0.0516529800064222,0.00362391324583483,0.0445501100445859,0.0587558499682584,1.0663982578209e-45
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CASC3,Protein CASC3,40181,0.0605798142670725,0.00425166228874163,0.0522465561811389,0.0689130723530061,1.16733825858434e-45
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NDUFB7,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 7,40448,0.128320147005748,0.00900816370469879,0.110664146144538,0.145976147866957,1.20178950266749e-45
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CD79B,B-cell antigen receptor complex-associated protein beta chain,42753,0.0691437420825923,0.00485854587795025,0.0596209921618098,0.0786664920033747,1.24680625589727e-45
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FCRL1,Fc receptor-like protein 1,42635,0.0677589027263828,0.00476217156586673,0.0584250464572841,0.0770927589954816,1.30539589864106e-45
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TAFA5,Chemokine-like protein TAFA-5,42586,0.0556783761319763,0.00391499565704254,0.0480049846441729,0.0633517676197796,1.43951930514704e-45
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NFKB1,Nuclear factor NF-kappa-B p105 subunit,40115,0.106128189724457,0.00746244915720794,0.0915017893763291,0.120754590072584,1.71204850950345e-45
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CCN5,CCN family member 5,42610,0.0556682297435012,0.00391774756532626,0.0479894445154617,0.0633470149715406,1.71599244897211e-45
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,AMN,Protein amnionless,42369,0.067628863236463,0.00475979192254262,0.0582996710682795,0.0769580554046466,1.76137599793755e-45
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LTBP3,Latent-transforming growth factor beta-binding protein 3,42345,0.0750660363330276,0.0052860428903608,0.0647053922679204,0.0854266803981347,1.9617875939378e-45
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,QDPR,Dihydropteridine reductase,42580,0.0609535731698727,0.00429265241249212,0.0525399744413882,0.0693671718983573,1.97094401967123e-45
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IST1,IST1 homolog,40374,0.142183797883273,0.0100089686951719,0.122566219240736,0.16180137652581,2.09730055265346e-45
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PCBP2,Poly(rC)-binding protein 2,40481,0.103450831901857,0.00729116629976733,0.0891601459543132,0.117741517849401,2.64359686420601e-45
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,BLNK,B-cell linker protein,40198,0.0587370554282431,0.00413956576005329,0.0506235065385386,0.0668506043179475,2.67934645404405e-45
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ATG16L1,Autophagy-related protein 16-1,40448,0.121384321044305,0.00855778580688923,0.104611060862802,0.138157581225808,2.82036376645821e-45
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PLEKHO1,Pleckstrin homology domain-containing family O member 1,40482,0.09923490978774,0.00699720497484438,0.085520388037045,0.112949431538435,2.89280634479812e-45
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RNF41,E3 ubiquitin-protein ligase NRDP1,42345,0.0945045197369136,0.00666871789479895,0.0814338326631076,0.107575206810719,2.96777696512733e-45
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DNMBP,Dynamin-binding protein,42494,0.0858901114702486,0.00606144158023702,0.074009685972984,0.0977705369675132,3.00113210089827e-45
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SAMD9L,Sterile alpha motif domain-containing protein 9-like,42593,0.101827684236795,0.00718652536609563,0.0877420945192473,0.115913273954342,3.0124552147454e-45
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,UBXN1,UBX domain-containing protein 1,40282,0.098417419517079,0.00694126300736198,0.0848125440226495,0.112022295011508,3.08575003844031e-45
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PALM2,Paralemmin-2,40482,0.0542844544695015,0.00382931976648265,0.0467789877271955,0.0617899212118074,3.14954663676469e-45
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SIGLEC1,Sialoadhesin,42675,0.0618801026507109,0.00437418607415183,0.0533066979453733,0.0704535073560485,4.116525085399e-45
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CD207,C-type lectin domain family 4 member K,42364,0.0569203543936286,0.00402721704157063,0.0490270089921501,0.064813699795107,5.00617997447601e-45
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MME,Neprilysin,42586,0.116177516596342,0.00822231866961682,0.100061772003893,0.132293261188791,5.25724207270944e-45
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ADH1B,All-trans-retinol dehydrogenase,40282,0.106819044813656,0.00755839647151796,0.0920045877294806,0.121633501897831,5.87668465610419e-45
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,BTN2A1,Butyrophilin subfamily 2 member A1,42675,0.0400607364290826,0.00283833076466124,0.0344976081303465,0.0456238647278186,6.48388680483693e-45
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SNRPB2,U2 small nuclear ribonucleoprotein B'',40482,0.061891568297643,0.00438321473730883,0.0533004674125177,0.0704826691827683,6.87453017048551e-45
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NFASC,Neurofascin,42753,0.0414308162426777,0.00293943446116963,0.0356695246987852,0.0471921077865702,8.4623370854684e-45
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FAM3C,Protein FAM3C,42612,0.0444325582688013,0.00315292343701936,0.0382528283322434,0.0506122882053593,8.80859164616335e-45
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SORCS2,VPS10 domain-containing receptor SorCS2,42345,0.0536142367712285,0.00380605640981401,0.046154366207993,0.0610741073344639,9.71151487090175e-45
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FKBPL,FK506-binding protein-like,40448,0.083682703978106,0.00593972664670882,0.0720408397505567,0.0953245682056553,1.06866342433666e-44
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,AAMDC,Mth938 domain-containing protein,40222,0.0759034273574145,0.00538837025662328,0.0653422216544329,0.0864646330603962,1.1202571729251e-44
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,BST2,Bone marrow stromal antigen 2,42710,0.0729258589619067,0.00518396270004281,0.0627652920698228,0.0830864258539906,1.24010338441907e-44
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LY9,T-lymphocyte surface antigen Ly-9,42442,0.0436752296919167,0.00310815070607824,0.0375832543080034,0.0497672050758301,1.56676042551138e-44
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DTNB,Dystrobrevin beta,40429,0.0610136749453096,0.00434021662286131,0.0525068503645015,0.0695204995261178,1.64425996772769e-44
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CMC1,COX assembly mitochondrial protein homolog,40510,0.128560384489472,0.00915035331959105,0.110625691983073,0.14649507699587,1.82553609710924e-44
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,USO1,General vesicular transport factor p115,42586,0.127624935383084,0.00909088210876796,0.109806806449899,0.145443064316269,1.86405929670204e-44
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SHBG,Sex hormone-binding globulin,40531,-0.07204841807827,0.00512870516512387,-0.0821006802019128,-0.0619961559546272,1.86620237120237e-44
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,EFNA1,Ephrin-A1,42589,0.0431660727588028,0.00307567065336496,0.0371377582782075,0.0491943872393982,1.97303482432666e-44
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IGBP1,Immunoglobulin-binding protein 1,40481,0.0866899774780616,0.0061791069007207,0.074578927952649,0.0988010270034741,2.42239325133734e-44
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SPINK2,Serine protease inhibitor Kazal-type 2,40282,0.0538332505700138,0.00384035213821761,0.0463061603791073,0.0613603407609203,2.89377587899257e-44
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GDF15,Growth/differentiation factor 15,42793,0.0656845739563262,0.00469282852559143,0.056486630046167,0.0748825178664854,3.30327892344871e-44
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RGCC,Regulator of cell cycle RGCC,40481,0.106714633360285,0.00763565241246076,0.0917487546318615,0.121680512088708,5.09124217681638e-44
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CD48,CD48 antigen,42653,0.0438238670331386,0.00314015264938869,0.0376691678403368,0.0499785662259404,5.85647091049896e-44
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,KCTD5,BTB/POZ domain-containing protein KCTD5,40289,0.062710771112522,0.00449153045002006,0.0539073714304827,0.0715141707945613,6.25135496584772e-44
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,EREG,Proepiregulin,42475,0.113405378517784,0.00813614004677171,0.0974585440261116,0.129352213009457,7.5276598786606e-44
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DNM3,Dynamin-3,40481,0.0776030734116697,0.00556605067407995,0.066693614090473,0.0885125327328664,8.09490756833175e-44
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,HSPA1A,Heat shock 70 kDa protein 1A,42657,0.0984008110870432,0.00706286423798918,0.0845575971805844,0.112244024993502,8.13786268655163e-44
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,STAT5B,Signal transducer and activator of transcription 5B,42586,0.192624988102817,0.0138378948255038,0.165502714244829,0.219747261960804,9.64280595256577e-44
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",42586,0.0498037385340582,0.00357932887158237,0.0427882539457568,0.0568192231223597,1.04515159234617e-43
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ASPSCR1,Tether containing UBX domain for GLUT4,40481,0.0944961010122977,0.00679782068152035,0.0811723724765178,0.107819829548078,1.42823048599923e-43
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ATP6AP2,Renin receptor,42345,0.0567892046736177,0.0040887283596727,0.0487752970886592,0.0648031122585762,1.49470661686388e-43
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,USP8,Ubiquitin carboxyl-terminal hydrolase 8,42356,0.132458285145834,0.00953999321358399,0.11375989844721,0.151156671844459,1.59324169480037e-43
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CTSL,Cathepsin L1,42635,0.0348955866228035,0.00251355314128652,0.0299690224658819,0.0398221507797251,1.60421674887332e-43
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LONP1,"Lon protease homolog, mitochondrial",40222,0.121899003365575,0.00879888204882472,0.104653194549878,0.139144812181271,2.77387438954473e-43
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SERPINB8,Serpin B8,42753,0.0808784617427893,0.00584513269342527,0.0694220016636758,0.0923349218219029,3.00318731019497e-43
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,VEGFC,Vascular endothelial growth factor C,42678,0.0775534618271778,0.00560727130380275,0.0665632100717244,0.0885437135826312,3.27362414491612e-43
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TNFRSF19,Tumor necrosis factor receptor superfamily member 19,42720,0.0488613956100599,0.0035361828098665,0.0419304773027216,0.0557923139173983,3.92091232943887e-43
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CD300LF,CMRF35-like molecule 1,42720,0.0853768212485232,0.00618448773438947,0.0732552252891199,0.0974984172079266,4.65644604547561e-43
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PIGR,Polymeric immunoglobulin receptor,42463,0.05015401229869,0.00363642970071788,0.0430266100852829,0.057281414512097,5.62618873791679e-43
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SEL1L,Protein sel-1 homolog 1,40222,0.045760649176819,0.0033201080811574,0.0392532373377505,0.0522680610158875,7.3169858338727e-43
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IL13RA1,Interleukin-13 receptor subunit alpha-1,42447,0.030520483701655,0.00221715857350745,0.0261748528975804,0.0348661145057296,8.08780250262294e-43
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NFX1,Transcriptional repressor NF-X1,40115,0.095009627324005,0.00689709973203954,0.0814913118492075,0.108527942798802,8.17666054088754e-43
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SSNA1,Sjoegren syndrome nuclear autoantigen 1,40448,0.072419901152773,0.00526136127934367,0.0621076330452594,0.0827321692602866,9.24880841745116e-43
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PIBF1,"Progesterone-induced-blocking factor 1, Isoform 4",40481,0.107920956043966,0.00784363824738955,0.092547425079082,0.123294487008849,9.93595799821683e-43
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FCER2,Low affinity immunoglobulin epsilon Fc receptor,42610,0.0753907463912307,0.00548358518322844,0.0646429194321029,0.0861385733503584,1.01348179294401e-42
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SIRT2,NAD-dependent protein deacetylase sirtuin-2,42586,0.122017505306444,0.00888077244007293,0.104611191323901,0.139423819288987,1.14588838733938e-42
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,STIP1,Stress-induced-phosphoprotein 1,42585,0.0898610356314175,0.00654202922671119,0.0770386583470636,0.102683412915771,1.20282534515246e-42
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CPXM2,Inactive carboxypeptidase-like protein X2,40510,0.0372710290464853,0.00271480578540133,0.0319500097070987,0.0425920483858719,1.4955921248686e-42
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CLIP2,CAP-Gly domain-containing linker protein 2,42593,0.153578048670838,0.0112039880214013,0.131618232148891,0.175537865192785,1.7720325235967e-42
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IGFBP2,Insulin-like growth factor-binding protein 2,42770,-0.0860297181999523,0.00627712891660778,-0.0983328908765035,-0.073726545523401,1.80981751971949e-42
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ERMAP,Erythroid membrane-associated protein,40198,0.0622720616702854,0.00454015393533288,0.053373359957033,0.0711707633835379,1.8224647962344e-42
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MDK,Midkine,42637,0.0707436948829031,0.00516834162408132,0.0606137452997037,0.0808736444661025,2.30606487840941e-42
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CTBS,Di-N-acetylchitobiase,40382,0.0372586073275147,0.00272486936085237,0.031917863380244,0.0425993512747853,3.18989006624093e-42
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TP53I3,Quinone oxidoreductase PIG3,40057,0.0737359261248229,0.00539259381241752,0.0631664422524846,0.0843054099971612,3.26372852823116e-42
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TJAP1,Tight junction-associated protein 1,42678,0.113344932270506,0.00830769978399859,0.0970618406938691,0.129628023847144,4.20800994197936e-42
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,HAO1,Hydroxyacid oxidase 1,42720,0.17264667958804,0.0126601728374919,0.147832740826556,0.197460618349524,4.57740760798534e-42
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TNFRSF13C,Tumor necrosis factor receptor superfamily member 13C,42369,0.0597989932420004,0.00438466772805487,0.0512050444950128,0.0683929419889879,4.57977030656734e-42
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CLEC4D,C-type lectin domain family 4 member D,42593,0.0858344178210324,0.00630074968978044,0.0734849484290627,0.098183887213002,5.57194917410518e-42
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MAP2,Microtubule-associated protein 2,40482,0.0641707722145194,0.00471107488335035,0.0549370654431527,0.0734044789858861,6.41586636367099e-42
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GADD45GIP1,Growth arrest and DNA damage-inducible proteins-interacting protein 1,40222,0.0728968977378529,0.00535495464563269,0.0624011866324128,0.083392608843293,7.30088921671191e-42
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,KLF4,Krueppel-like factor 4,40135,0.0555981323396528,0.00408435135988367,0.0475928036742808,0.0636034610050248,7.39589053670481e-42
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CCL11,Eotaxin,42753,0.050537184851549,0.00371638482797219,0.0432530705887235,0.0578212991143745,7.68847921922062e-42
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,S100P,Protein S100-P,42356,0.0751069048164486,0.0055259000395318,0.0642761407389663,0.0859376688939309,8.57363055274211e-42
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MTIF3,"Translation initiation factor IF-3, mitochondrial",40448,0.121029696407755,0.00891839817454154,0.103549635985654,0.138509756829857,1.26768285718903e-41
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,QPCT,Glutaminyl-peptide cyclotransferase,42680,0.037525587699454,0.00276733921289204,0.0321016028421856,0.0429495725567224,1.29239643195055e-41
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CNPY4,Protein canopy homolog 4,42586,0.101465084610767,0.00748354784538001,0.086797330833822,0.116132838387712,1.32894757004557e-41
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ST13,Hsc70-interacting protein,40282,0.0777624006550867,0.00573141063265052,0.0665288358150917,0.0889959654950817,1.33508785808874e-41
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PILRA,Paired immunoglobulin-like type 2 receptor alpha,42610,0.059152736958309,0.00437211039425602,0.0505834005855672,0.0677220733310508,1.95605876438677e-41
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,INPPL1,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2",42586,0.132625403142414,0.00980595055941246,0.113405740045966,0.151845066238863,2.08205004909551e-41
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GDNF,Glial cell line-derived neurotrophic factor,42310,0.0524475022082555,0.00387812540617763,0.0448463764121474,0.0600486280043637,2.13961012645436e-41
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IRAK1,Interleukin-1 receptor-associated kinase 1,42369,0.0929376255311226,0.0068756450073464,0.0794613613167237,0.106413889745522,2.34347886515096e-41
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ERBB2,Receptor tyrosine-protein kinase erbB-2,42678,0.0322252079988512,0.00238452484260598,0.0275515393073435,0.0368988766903589,2.39259348449305e-41
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,USP25,Ubiquitin carboxyl-terminal hydrolase 25,40450,0.0978317662403084,0.00724134845181656,0.083638723274748,0.112024809205869,2.85541566765508e-41
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MCAM,Cell surface glycoprotein MUC18,42688,-0.0459626286700787,0.00340474103487808,-0.0526359210984397,-0.0392893362417177,2.91268628955856e-41
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SEC31A,Protein transport protein Sec31A,40222,0.104908096403688,0.0077748228879034,0.089669443543397,0.120146749263978,3.63042887776782e-41
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CCN4,CCN family member 4,42720,0.0547366375761786,0.00406225108964369,0.0467746254404769,0.0626986497118802,4.07132623527672e-41
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,42345,0.105341100173324,0.00781857798753577,0.0900166873177541,0.120665513028894,4.21365885175537e-41
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,BSG,Basigin,42745,0.0296962621825799,0.00220529036683508,0.0253738930635832,0.0340186313015767,4.55847530031505e-41
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PEBP1,Phosphatidylethanolamine-binding protein 1,42610,0.0772694117655652,0.00574304329112625,0.0660130469149578,0.0885257766161727,5.34618748225503e-41
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MIA,Melanoma-derived growth regulatory protein,42678,0.0513457599588716,0.00381804515866163,0.0438623914478948,0.0588291284698484,5.79397818053053e-41
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,YARS1,"Tyrosine--tRNA ligase, cytoplasmic",40448,0.198826400623677,0.014779447415724,0.169858683688858,0.227794117558496,6.12985896541862e-41
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,COX5B,"Cytochrome c oxidase subunit 5B, mitochondrial",42586,0.0934968330994162,0.00695533694309099,0.0798643726909579,0.107129293507875,6.2793751354108e-41
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DPT,Dermatopontin,42793,0.0344684250515715,0.00256535811653242,0.029440323143168,0.0394965269599751,6.77183001571163e-41
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ANGPTL7,Angiopoietin-related protein 7,42720,0.0495426940771307,0.00368880247386152,0.0423126412283621,0.0567727469258992,7.31461541077113e-41
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CEP43,Centrosomal protein 43,42254,0.0938452830328416,0.00698872748549735,0.0801473771612668,0.107543188904416,7.72206331055381e-41
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,COMMD1,COMM domain-containing protein 1,40222,0.08230888143909,0.00612576363981689,0.0703023847050489,0.0943153781731312,7.73612026973384e-41
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GLOD4,Glyoxalase domain-containing protein 4,42601,0.0472671422651736,0.00352529756872417,0.0403575590304742,0.054176725499873,9.93201580996711e-41
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CAMKK1,Calcium/calmodulin-dependent protein kinase kinase 1,42345,0.0591853548686065,0.00441513426169515,0.050531691715684,0.0678390180215289,1.04404203328919e-40
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,HS1BP3,HCLS1-binding protein 3,40222,0.120382363849857,0.00897518911175276,0.102790993190822,0.137973734508892,1.06001795854537e-40
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CLEC1B,C-type lectin domain family 1 member B,42710,0.128897808255709,0.00962661887145233,0.110029635267662,0.147765981243755,1.26000629612227e-40
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TIA1,Nucleolysin TIA-1 isoform p40,42189,0.163604173221443,0.0122171147743749,0.139658628263668,0.187549718179218,1.26199164441088e-40
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TPK1,Thiamin pyrophosphokinase 1,40510,0.037215547902052,0.00277779537814943,0.0317710689608792,0.0426600268432249,1.27451387665373e-40
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SELE,E-selectin,42793,0.0688014857774871,0.00513910519923748,0.0587288395869816,0.0788741319679925,1.28747344900801e-40
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TNIP1,TNFAIP3-interacting protein 1,40482,0.120341235721908,0.00898403319542549,0.102732530658874,0.137949940784942,1.31977480018513e-40
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SERPINE1,Plasminogen activator inhibitor 1,42793,0.0893010806900046,0.00667846105072676,0.0762112970305801,0.102390864349429,1.59918865016705e-40
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SH3GLB2,Endophilin-B2,40482,0.0904044473270946,0.00675837251766092,0.0771580371924792,0.10365085746171,1.68308225704334e-40
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,AHSG,Alpha-2-HS-glycoprotein,40531,0.0369016441452319,0.00276008798305511,0.0314918716984439,0.04231141659202,1.83907540177402e-40
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CLSTN3,Calsyntenin-3,40482,0.0416706199816729,0.00311786384439468,0.0355596068466593,0.0477816331166864,1.96083887677923e-40
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ACVRL1,Serine/threonine-protein kinase receptor R3,42474,0.0361193314831415,0.00270816345727951,0.0308113311068737,0.0414273318594093,2.5549240330767e-40
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MAX,Protein max,42310,0.141501221533438,0.0106101204097283,0.12070538553037,0.162297057536505,2.60012740515431e-40
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,STAT2,Signal transducer and activator of transcription 2,40198,0.102741741911978,0.00770107625574113,0.0876476324507251,0.11783585137323,2.73798225566995e-40
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IDO1,"Indoleamine 2,3-dioxygenase 1",40222,0.0872902888050598,0.00654669527574829,0.0744587660645932,0.100121811545526,3.02736373826075e-40
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,AXIN1,Axin-1,42593,0.127087943861051,0.00954904444165063,0.108371816755415,0.145804070966686,3.69174077491122e-40
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GIGYF2,GRB10-interacting GYF protein 2,40481,0.101473033665706,0.00762545139267501,0.086527148936063,0.116418918395349,4.21536445863645e-40
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CLEC6A,C-type lectin domain family 6 member A,42345,0.0641112952780203,0.00483028526019972,0.0546439361680289,0.0735786543880117,6.01581502446937e-40
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TDRKH,Tudor and KH domain-containing protein,42310,0.113639329390658,0.00856472475034668,0.0968524688799785,0.130426189901338,6.39113655894035e-40
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,KDR,Vascular endothelial growth factor receptor 2,42678,0.0331219165207575,0.00249734120008591,0.0282271277685892,0.0380167052729259,6.75549177574009e-40
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,VSIG4,V-set and immunoglobulin domain-containing protein 4,42590,0.058990372601255,0.00444810017252887,0.0502720962630984,0.0677086489394116,6.865866317197e-40
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,KAZN,Kazrin,40448,0.140120370848983,0.0105754140856009,0.119392559241206,0.160848182456761,8.9972391442746e-40
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DKK4,Dickkopf-related protein 4,42476,0.062304358125011,0.00470703194374125,0.0530785755152781,0.0715301407347438,9.64640998592204e-40
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,C1S,Complement C1s subcomponent,40538,0.0279604423154982,0.00211241806001371,0.0238201029178714,0.0321007817131251,1.06694987020297e-39
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RBM17,Splicing factor 45,40481,0.102468683658744,0.00774307998857147,0.087292246881144,0.117645120436344,1.10831304119493e-39
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,STAMBP,STAM-binding protein,42475,0.0844658807194025,0.00638982879864859,0.0719418162740512,0.0969899451647537,1.21610897715107e-39
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RAB11FIP3,Rab11 family-interacting protein 3,40510,0.142830220278672,0.0108000899351813,0.121662044005717,0.163998396551628,1.23952091910794e-39
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LTA,Lymphotoxin-alpha,42593,0.0546184758817093,0.00413401560551116,0.0465158052949074,0.0627211464685112,1.32352491249288e-39
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LGALS7_LGALS7B,Galectin-7,42523,0.0579770893374687,0.00439506663000889,0.0493627587426513,0.0665914199322862,1.73806712688363e-39
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CEP85,Centrosomal protein of 85 kDa,42345,0.0852964269682195,0.00647189261304904,0.0726115174466434,0.0979813364897957,2.04610555599607e-39
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RNASE1,Ribonuclease pancreatic,40531,0.0354845878378979,0.00269286979417664,0.0302065630413116,0.0407626126344841,2.3089444196832e-39
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LAMP3,Lysosome-associated membrane glycoprotein 3,42745,0.0701297847550434,0.00532612890701102,0.0596905720973018,0.080568997412785,2.3661637932178e-39
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NTRK3,NT-3 growth factor receptor,42710,-0.0290677313889308,0.00220853894847703,-0.0333964677279458,-0.0247389950499158,2.54951925509362e-39
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ZBTB16,Zinc finger and BTB domain-containing protein 16,42345,0.0958540573970659,0.00728625531905079,0.0815729969717264,0.110135117822405,2.8020618616098e-39
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CHI3L1,Chitinase-3-like protein 1,42415,0.109976116462152,0.00836128658062514,0.0935879947641267,0.126364238160177,2.88445146469527e-39
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ASGR2,Asialoglycoprotein receptor 2,40531,0.0361107539260872,0.00274410934595172,0.0307322996080219,0.0414892082441526,2.91493825846472e-39
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TXNRD1,"Thioredoxin reductase 1, cytoplasmic",42610,0.0602707263020557,0.00458400506138931,0.0512860763817326,0.0692553762223787,3.05253354254928e-39
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ADM,Pro-adrenomedullin,42720,0.0358009027772271,0.00272354725100544,0.0304627501652564,0.0411390553891977,3.16414972603229e-39
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,AMOT,Angiomotin,40282,0.0518756008144021,0.00394419006256261,0.0441449882917794,0.0596062133370248,3.23901764107456e-39
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CCN2,CCN family member 2,42623,0.0731595973721139,0.00556816088160753,0.0622460020441632,0.0840731927000647,3.43713927300809e-39
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NFE2,Transcription factor NF-E2 45 kDa subunit,40222,0.0992557432047113,0.00755090329823789,0.0844559727401651,0.114055513669258,3.58546688689144e-39
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,AKT1S1,Proline-rich AKT1 substrate 1,42310,0.0885931921016413,0.00674470522112841,0.0753735698682296,0.101812814335053,3.65461468843362e-39
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PBLD,Phenazine biosynthesis-like domain-containing protein,42310,0.0680742336817173,0.00518808042489467,0.0579055960489238,0.0782428713145109,4.38297090847137e-39
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ATXN2L,Ataxin-2-like protein,40481,0.06423976923393,0.00489574875817928,0.0546441016678987,0.0738354367999614,4.78348940333448e-39
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SEPTIN9,Septin-9,42586,0.0378532602037234,0.00288791944682522,0.032192938087946,0.0435135823195009,5.18718752075931e-39
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ULBP2,UL16-binding protein 2,42494,0.0531890382772394,0.0040586487110785,0.0452340868035255,0.0611439897509532,5.36788959550622e-39
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,WASHC3,WASH complex subunit 3,40482,0.0993678745004802,0.0075843641621423,0.0845025207426813,0.114233228258279,6.19138283665873e-39
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GMPR2,GMP reductase 2,40282,0.0896091606620861,0.00684357290335017,0.0761957577715198,0.103022563552652,6.92748550137015e-39
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MPHOSPH8,M-phase phosphoprotein 8,42356,0.0997969448962583,0.00762753573051717,0.0848469748644446,0.114746914928072,7.12501664646488e-39
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FOXO1,Forkhead box protein O1,42593,0.111921986057876,0.0085612129616595,0.0951420086530237,0.128701963462729,8.09985243842079e-39
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GLB1,Beta-galactosidase,42494,0.0547789829419391,0.00419078694213805,0.0465650405353485,0.0629929253485297,8.33112731264136e-39
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CCL5,C-C motif chemokine 5,42688,0.131666281050633,0.010073841368526,0.111921551968322,0.151411010132944,8.3926649115636e-39
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ESYT2,Extended synaptotagmin-2,40482,0.108990716974907,0.00833839229654231,0.0926474680736844,0.12533396587613,9.22115514089465e-39
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GMPR,GMP reductase 1,42753,0.0652590730907587,0.0049972007609313,0.0554645595993333,0.075053586582184,9.65433142882164e-39
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PPP3R1,Calcineurin subunit B type 1,42494,0.0529702739281697,0.00405784719426325,0.0450168934274138,0.0609236544289257,1.04543124532913e-38
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,VPS53,Vacuolar protein sorting-associated protein 53 homolog,42586,0.101145306199432,0.00775732738708614,0.0859409445207431,0.116349667878121,1.26674966133442e-38
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IMMT,MICOS complex subunit MIC60,40450,0.0599196617728818,0.00459323382500607,0.0509169234758699,0.0689224000698937,1.28901207188976e-38
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DBI,Acyl-CoA-binding protein,42561,0.100758465868128,0.00772873061191347,0.0856101538687776,0.115906777867478,1.29806440384924e-38
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,VWC2,Brorin,42455,0.0544755186748185,0.00417854016976031,0.0462855799420882,0.0626654574075487,1.30192328808279e-38
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PHLDB1,Pleckstrin homology-like domain family B member 1,40448,0.0698139780462623,0.00535296538131437,0.0593221658988861,0.0803057901936384,1.34166502879807e-38
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CETN3,Centrin-3,40448,0.100247434031996,0.00769050885974253,0.0851740366669009,0.115320831397092,1.46672142463823e-38
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,YWHAQ,14-3-3 protein theta,40282,0.0973363537023043,0.00746791701893151,0.0826992363451986,0.11197347105941,1.50540216775859e-38
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CHRDL1,Chordin-like protein 1,42653,0.0426488095028012,0.00327504669627368,0.0362297179781048,0.0490679010274976,1.56067235391267e-38
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FCRL2,Fc receptor-like protein 2,42680,0.0694272324473768,0.00534212621458621,0.0589566650667878,0.0798977998279657,2.18643618035829e-38
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DOK2,Docking protein 2,42635,0.157897047959774,0.0121541307230884,0.134074951742521,0.181719144177028,2.33494331998168e-38
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SYTL4,Synaptotagmin-like protein 4,40510,0.0970897894391172,0.0074703183391639,0.082447965494356,0.111731613383878,2.40082922023404e-38
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,EVI5,Ecotropic viral integration site 5 protein homolog,40198,0.117122076825512,0.00901849328450795,0.0994458299878766,0.134798323663148,2.77449575471849e-38
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TGFBR2,TGF-beta receptor type-2,42678,0.0471464501049291,0.00363767655330078,0.0400166040604596,0.0542762961493986,3.45966080385579e-38
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ZBTB17,Zinc finger and BTB domain-containing protein 17,42356,0.0554080254641314,0.00428204105949391,0.0470152249875233,0.0638008259407395,4.58855752498684e-38
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CD160,CD160 antigen,42753,0.0644097374973574,0.00497996041468328,0.0546490150845782,0.0741704599101367,4.87040788276796e-38
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,AP2B1,AP-2 complex subunit beta,40181,0.0634492228348302,0.00490746139913252,0.0538305984925305,0.07306784717713,5.8287194004439e-38
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,VTI1A,Vesicle transport through interaction with t-SNAREs homolog 1A,40282,0.0758447787706673,0.0058723224401908,0.0643350267878934,0.0873545307534413,6.88882316490866e-38
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GPI,Glucose-6-phosphate isomerase,40531,0.061526736331542,0.00476900984416124,0.0521794770369859,0.070873995626098,8.15680428722329e-38
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DLK1,Protein delta homolog 1,42793,0.0718777419973811,0.00557761083191922,0.0609456247668194,0.0828098592279428,8.88208918523246e-38
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,BAP18,Chromatin complexes subunit BAP18,40482,0.088635961122102,0.00687604244153987,0.0751589179366839,0.10211300430752,9.39107245832297e-38
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LETM1,Mitochondrial proton/calcium exchanger protein,40481,0.0693896169354986,0.00538632843302361,0.0588324132067723,0.0799468206642248,1.04027310208069e-37
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,WARS,"Tryptophan--tRNA ligase, cytoplasmic",42610,0.0508165745450638,0.00394982855666145,0.0430749105740074,0.0585582385161202,1.17482160885436e-37
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,HMOX2,Heme oxygenase 2,42310,0.0596287953965969,0.00463557234656466,0.0505430735973301,0.0687145171958636,1.2225416269456e-37
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CCL18,C-C motif chemokine 18,42476,0.0907311092161088,0.00706112072675165,0.0768913125916756,0.104570905840542,1.45093129991809e-37
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NUDT16,U8 snoRNA-decapping enzyme,40428,0.112968714769876,0.00879502896081344,0.095730458006682,0.130206971533071,1.69233205262229e-37
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CCL13,C-C motif chemokine 13,42733,0.0897496171977028,0.00699549374243401,0.0760384494625321,0.103460784932873,1.84902001369174e-37
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,HIP1R,Huntingtin-interacting protein 1-related protein,40448,0.0582101730189145,0.0045362453609453,0.0493191321114617,0.0671012139263673,1.97889430664322e-37
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CCL21,C-C motif chemokine 21,42675,0.0548563872253589,0.00427823691135252,0.046471042879108,0.0632417315716099,2.03728156591284e-37
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CXCL5,C-X-C motif chemokine 5,42604,0.146680443940832,0.0114539467897741,0.124230708232874,0.169130179648789,2.50720853035556e-37
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CPB1,Carboxypeptidase B,42793,0.0787699619578284,0.00615154612696364,0.0667129315489797,0.0908269923666772,2.52819710877251e-37
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PSAP,Prosaposin,40439,0.0376822835784864,0.0029432801338039,0.0319134545162308,0.0434511126407421,2.8773733372687e-37
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RBKS,Ribokinase,42316,0.0644514604264992,0.00503833076305897,0.0545763321309036,0.0743265887220948,3.02420200859475e-37
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,B4GALT1,"Beta-1,4-galactosyltransferase 1",42675,0.0366102873629399,0.00286530359229969,0.0309942923220325,0.0422262824038473,3.61556621731371e-37
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CRYBB1,Beta-crystallin B1,40510,0.0826652803986964,0.0064680223130701,0.069987956665079,0.0953426041323138,3.79951513794444e-37
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TAX1BP1,Tax1-binding protein 1,40482,0.0818865370361164,0.00640867502550783,0.0693255339861211,0.0944475400861117,3.960486543612e-37
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CCL8,C-C motif chemokine 8,42705,0.0782789117462025,0.006131515575071,0.0662611412190633,0.0902966822733416,4.12433906445386e-37
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,39982,0.0639765548969194,0.00500929405536718,0.0541583385483997,0.0737947712454391,4.38408062768579e-37
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TRIM58,E3 ubiquitin-protein ligase TRIM58,40450,0.113525989278642,0.00889124495573222,0.096099149165407,0.130952829391877,4.45528460287141e-37
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MMP7,Matrilysin,42332,0.0653363530082344,0.00512534335460379,0.055290680033211,0.0753820259832578,5.31752812910529e-37
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CD46,Membrane cofactor protein,42579,0.0374091991226359,0.00293488827438363,0.031656818104844,0.0431615801404278,5.35773040445987e-37
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SHMT1,"Serine hydroxymethyltransferase, cytosolic",42653,0.109419524985425,0.00858463055630076,0.0925936490950752,0.126245400875774,5.37041829635427e-37
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TRIM24,Transcription intermediary factor 1-alpha,40286,0.0840324860017432,0.00658963292492885,0.0711168054688826,0.0969481665346037,5.50686707387364e-37
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DCXR,L-xylulose reductase,42678,0.0676308818280187,0.00531408599416562,0.0572152732794541,0.0780464903765833,6.84735486463734e-37
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,42680,0.0388001028817816,0.00304966971191502,0.0328227502464281,0.044777455517135,7.20192637028549e-37
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PDGFB,Platelet-derived growth factor subunit B,42675,0.109764518852337,0.00863292331342244,0.0928439891580289,0.126685048546645,7.97829052210502e-37
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ITGAL,Integrin alpha-L,40198,0.0576176530675514,0.00452899120988497,0.0487408302961768,0.0664944758389259,8.10851171157095e-37
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,OGN,Mimecan,42610,0.0572561456953048,0.0045051730677518,0.0484260064825113,0.0660862849080984,8.59022855803317e-37
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MCFD2,Multiple coagulation factor deficiency protein 2,42564,0.055685200379929,0.00438357576346566,0.0470933918835363,0.0642770088763217,9.26242210375677e-37
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LGALS8,Galectin-8,42710,0.0768970564039194,0.00605393380799011,0.0650313461402588,0.08876276666758,9.34847739160315e-37
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ENPP7,Ectonucleotide pyrophosphatase/phosphodiesterase family member 7,42191,0.110111268227085,0.00867198355533994,0.0931141804586182,0.127108355995551,1.01041601034185e-36
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TPP1,Tripeptidyl-peptidase 1,42544,0.0579147872413585,0.0045621750415685,0.0489729241598842,0.0668566503228327,1.03307462552676e-36
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CLEC4G,C-type lectin domain family 4 member G,42593,0.0425452868850723,0.00335266436131097,0.0359740647369028,0.0491165090332418,1.09236874977203e-36
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MATN2,Matrilin-2,42637,0.0380269660379681,0.00299737567845307,0.0321521097082001,0.0439018223677361,1.13614069080989e-36
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,BIRC2,Baculoviral IAP repeat-containing protein 2,42345,0.0804477334889061,0.00634194464216931,0.0680175219902542,0.0928779449875579,1.17359856257774e-36
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ATP5IF1,"ATPase inhibitor, mitochondrial",42675,0.140412573797903,0.0110704448193004,0.118714501952075,0.162110645643732,1.18133888501712e-36
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,AREG,Amphiregulin,42586,0.0548994438178511,0.00432849193935442,0.0464155996167164,0.0633832880189858,1.18929542994639e-36
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CMIP,C-Maf-inducing protein,40450,0.10662413323953,0.00840226426104161,0.0901556952878889,0.123092571191172,1.19818794893917e-36
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TWF2,Twinfilin-2,40526,0.106518122780514,0.00839756315533862,0.0900588989960505,0.122977346564978,1.27947214784021e-36
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SLAMF6,SLAM family member 6,42345,0.0499199774528217,0.00393998673646379,0.0421976034493526,0.0576423514562907,1.41668687519609e-36
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SPINT2,Kunitz-type protease inhibitor 2,42675,0.0517650070551706,0.00408693313436427,0.0437546181118166,0.0597753959985245,1.47422450346325e-36
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FAM13A,Protein FAM13A,40448,0.0865769729000223,0.00683669210425182,0.0731770563756887,0.0999768894243559,1.6691142495957e-36
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DNAJB2,DnaJ homolog subfamily B member 2,40282,0.0691948026408438,0.00547707049804687,0.0584597444646719,0.0799298608170156,2.45366968147616e-36
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SERPINA9,Serpin A9,42537,0.0920149411742722,0.00728802948458711,0.0777304033844814,0.106299478964063,2.46482972734439e-36
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PTP4A3,Protein tyrosine phosphatase type IVA 3,40198,0.0682757584927813,0.00540441236796917,0.0576831102515618,0.0788684067340009,2.47075597190605e-36
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,STX4,Syntaxin-4,42586,0.0759261890221762,0.00602290332557916,0.0641212985040411,0.0877310795403114,3.13247930198837e-36
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,C2,Complement C2,42662,0.0292951620506253,0.00232486455031989,0.0247384275319983,0.0338518965692523,3.34464602963949e-36
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SIGLEC6,Sialic acid-binding Ig-like lectin 6,42720,0.0438182406856014,0.00347840567529158,0.0370005655620299,0.0506359158091729,3.49128408077568e-36
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SCGB3A2,Secretoglobin family 3A member 2,42653,-0.110924513465387,0.00880764476969538,-0.12818749721399,-0.0936615297167838,3.63801864301262e-36
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MECR,"Enoyl-[acyl-carrier-protein] reductase, mitochondrial",40222,0.117145234217119,0.00930202267810574,0.0989132697680313,0.135377198666206,4.06083524911466e-36
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FGF19,Fibroblast growth factor 19,42675,0.0987660390218275,0.00784967261024124,0.0833806807057547,0.1141513973379,4.22094101950322e-36
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,42610,0.038425329756475,0.00305534892177503,0.032436845869796,0.0444138136431541,4.5472491565362e-36
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CR1,Complement receptor type 1,40508,0.0463216277750414,0.00368223201681527,0.0391044530220835,0.0535388025279994,4.7533676290183e-36
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SLC9A3R1,Na(+)/H(+) exchange regulatory cofactor NHE-RF1,40282,0.107861502415846,0.00857717270684952,0.0910502439104212,0.124672760921271,5.07535851254939e-36
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,42544,0.0361118667466334,0.00287479210553945,0.0304772742197761,0.0417464592734907,5.48768257614761e-36
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SDCCAG8,Serologically defined colon cancer antigen 8,40450,0.144772528540724,0.011524901185672,0.122183722216807,0.167361334864641,5.97085599552423e-36
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RTN4IP1,"Reticulon-4-interacting protein 1, mitochondrial",40481,0.117158302463445,0.00932807673454131,0.0988752720637439,0.135441332863146,6.109784789589e-36
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NFATC1,"Nuclear factor of activated T-cells, cytoplasmic 1",42593,0.122252613673508,0.00974071934352494,0.103160803760199,0.141344423586817,6.2757482884118e-36
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DDT,D-dopachrome decarboxylase,40526,0.0528714493447365,0.00421549647493662,0.0446090762538607,0.0611338224356122,7.58945096048112e-36
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SCRG1,Scrapie-responsive protein 1,40510,0.0363640716489973,0.00290186082324236,0.0306764244354422,0.0420517188625523,8.69527658207855e-36
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MZB1,Marginal zone B- and B1-cell-specific protein,42659,0.0671425673309302,0.00536261475586689,0.0566318424094311,0.0776532922524293,9.12309822264547e-36
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RAPGEF2,Rap guanine nucleotide exchange factor 2,40301,0.0671413206337251,0.00536083678323544,0.0566340805385836,0.0776485607288665,9.56912731627018e-36
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ADA2,Adenosine deaminase 2,42571,0.0564334438055975,0.004509609635746,0.0475946089195353,0.0652722786916596,9.91541535874498e-36
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,THOP1,Thimet oligopeptidase,42570,0.0391146407540503,0.00312679556020008,0.0329861214560581,0.0452431600520424,1.0492719864992e-35
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,STX8,Syntaxin-8,42593,0.0604799467320819,0.00483496556883994,0.0510034142171556,0.0699564792470082,1.05669092461719e-35
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FAS,Tumor necrosis factor receptor superfamily member 6,42759,0.0423023373322415,0.00338506048501625,0.0356676187816096,0.0489370558828733,1.2213954577944e-35
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ANXA2,Annexin A2,40053,0.0921618266995729,0.00737946405425284,0.0776980771532373,0.106625576245908,1.50435845415334e-35
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MPI,Mannose-6-phosphate isomerase,42586,0.106739963864323,0.0085529034777428,0.0899762730479469,0.123503654680699,1.51371142518543e-35
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PARK7,Parkinson disease protein 7,42610,0.0654415735646702,0.00524895965875193,0.0551536126335164,0.075729534495824,1.76486719865276e-35
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TP53,Cellular tumor antigen p53,42345,0.0543766596341236,0.0043624364320445,0.0458262842273164,0.0629270350409309,1.84351810829515e-35
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CRKL,Crk-like protein,42635,0.131599473214766,0.0105631503123275,0.110895698602604,0.152303247826928,1.9759140276335e-35
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TREM2,Triggering receptor expressed on myeloid cells 2,42617,0.0659807627184605,0.00529698954553133,0.0555986632092191,0.0763628622277019,2.0286988912621e-35
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SUOX,"Sulfite oxidase, mitochondrial",40481,0.0787009303359523,0.00632012302693913,0.0663134892031516,0.091088371468753,2.3149348616671e-35
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SCARF1,Scavenger receptor class F member 1,42793,0.0527623861020543,0.0042403266379629,0.044451345891647,0.0610734263124616,2.37752030425827e-35
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PPP2R5A,Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform,40448,0.148156276834625,0.0119079393953583,0.124816715619722,0.171495838049527,2.64397372340447e-35
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PPP1CC,Serine/threonine-protein phosphatase PP1-gamma catalytic subunit,40450,0.103603630167564,0.00833118717098433,0.0872745033124342,0.119932757022693,2.85295480407123e-35
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,OSCAR,Osteoclast-associated immunoglobulin-like receptor,42637,0.0438959302417825,0.00353289144429866,0.0369714630109571,0.0508203974726079,2.98830441146433e-35
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FARSA,Phenylalanine--tRNA ligase alpha subunit,40181,0.087682024891412,0.00705678820905952,0.0738507200016553,0.101513329781169,3.28715773692776e-35
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,40198,0.0561837586953406,0.00452259025862523,0.0473194817884352,0.0650480356022461,3.37835435148127e-35
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ASAH1,Acid ceramidase,40418,0.0576161620574004,0.00463886340642519,0.048523989780807,0.0667083343339937,3.45170620993961e-35
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ECHDC3,"Enoyl-CoA hydratase domain-containing protein 3, mitochondrial",40510,0.0930440328969962,0.00749198471313276,0.078359742859256,0.107728322934736,3.48711337151688e-35
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PPP1R2,Protein phosphatase inhibitor 2,42635,0.0987277961680977,0.00795877413556045,0.0831285988623992,0.114326993473796,3.8274726556526e-35
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RSPO3,R-spondin-3,42720,0.0374882996622562,0.00302258279289079,0.0315640373881903,0.0434125619363222,3.92018314564151e-35
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PDIA4,Protein disulfide-isomerase A4,40526,0.0752288121234567,0.00606589969856546,0.0633396487142684,0.087117975532645,4.30834889366893e-35
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,KRT5,"Keratin, type II cytoskeletal 5",42310,0.064528720891987,0.00521950719605551,0.0542984867877182,0.0747589549962558,6.4843492538194e-35
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DNAJB14,DnaJ homolog subfamily B member 14,40448,0.0795709032807576,0.00643801587720708,0.0669523921614317,0.0921894144000835,7.28030693136168e-35
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PQBP1,Polyglutamine-binding protein 1,42345,0.0712857800314359,0.00577598428718029,0.0599648508285625,0.0826067092343092,8.40814208942011e-35
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TBCA,Tubulin-specific chaperone A,40282,0.106437692067847,0.00861979388678427,0.0895428960497501,0.123332488085944,8.44631471045862e-35
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LMNB2,Lamin-B2,40482,0.0360241523256034,0.00291855751557457,0.0303037795950772,0.0417445250561295,8.88887652775228e-35
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GYS1,"Glycogen [starch] synthase, muscle",42356,0.115355841578075,0.0093555008986802,0.0970190598166623,0.133692623339489,9.67754822007039e-35
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LRRC59,Leucine-rich repeat-containing protein 59,40510,0.0607930943779058,0.00492916733591753,0.0511319263995074,0.0704542623563041,1.00099009037523e-34
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GOLGA3,Golgin subfamily A member 3,40481,0.0978558350990706,0.00795150958018481,0.0822708763219083,0.113440793876233,1.39068531838381e-34
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PRDX3,"Thioredoxin-dependent peroxide reductase, mitochondrial",42369,0.0891099989093206,0.00724837419855434,0.0749031854801541,0.103316812338487,1.51238553699469e-34
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,C1RL,Complement C1r subcomponent-like protein,40518,0.0247868566400116,0.00201596721514054,0.0208355608983361,0.028738152381687,1.59404383869672e-34
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,VSIR,V-type immunoglobulin domain-containing suppressor of T-cell activation,42610,0.0757273421896999,0.00616293435756536,0.0636479908488718,0.0878066935305279,1.6198125335299e-34
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,L3HYPDH,Trans-3-hydroxy-L-proline dehydratase,40510,0.112440692485494,0.00914768454409627,0.0945112307790649,0.130370154191922,1.66539491861205e-34
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ITGBL1,Integrin beta-like protein 1,40526,0.0485985584815317,0.00395479521865459,0.0408471598529687,0.0563499571100946,1.73043370781049e-34
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,APOA2,Apolipoprotein A-II,40531,-0.0615212218943239,0.00501020844247157,-0.0713412304415682,-0.0517012133470796,1.93889982984398e-34
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RABGAP1L,Rab GTPase-activating protein 1-like,42369,0.0745574014480029,0.00607682166812941,0.0626468309784693,0.0864679719175366,2.04402595422248e-34
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GGCT,Gamma-glutamylcyclotransferase,40499,0.0593480250864302,0.00483490249318745,0.0498716161997828,0.0688244339730776,2.04511260302126e-34
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,EGFL7,Epidermal growth factor-like protein 7,42345,0.0495467642150846,0.00404139342847551,0.0416256330952726,0.0574678953348966,2.29213819432278e-34
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NACC1,Nucleus accumbens-associated protein 1,40450,0.0687991652834766,0.00561045314207708,0.0578026771250055,0.0797956534419477,2.37929619302378e-34
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DGKA,Diacylglycerol kinase alpha,40198,0.0680378890352431,0.00554823397712105,0.0571633504400859,0.0789124276304004,2.3977421496639e-34
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PTPRB,Receptor-type tyrosine-protein phosphatase beta,40510,0.0367099307543042,0.00299632594998409,0.0308371318923353,0.042582729616273,2.7139980513444e-34
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ABHD14B,Protein ABHD14B,42459,0.0706857740747941,0.00577639552746132,0.0593640388409699,0.0820075093086183,3.01614883393118e-34
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,42586,0.0344744465526027,0.00281765813950159,0.0289518365991796,0.0399970565060258,3.0730218017001e-34
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NIT1,Deaminated glutathione amidase,40222,0.0590388729774066,0.00482381635206042,0.0495841929273682,0.068493553027445,3.20497545966888e-34
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DFFA,DNA fragmentation factor subunit alpha,42753,0.0826620500248521,0.00676009000969944,0.0694122736058412,0.095911826443863,3.33703399786492e-34
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RGMB,RGM domain family member B,42710,0.0353574942860539,0.00289286624570521,0.0296874764444717,0.0410275121276361,3.57909223270299e-34
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FGD3,"FYVE, RhoGEF and PH domain-containing protein 3",40481,0.0986421310769017,0.0080719716380103,0.0828210666664015,0.114463195487402,3.97656399070183e-34
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NDUFA5,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5,40188,0.0436567125554407,0.00357291064646179,0.0366538076883756,0.0506596174225059,4.1039248885249e-34
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CDC27,Cell division cycle protein 27 homolog,42345,0.0744631820299732,0.00609874737449379,0.0625096371759654,0.0864167268839811,4.22574187165442e-34
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PI3,Elafin,42445,0.0704914090023923,0.00577474529247338,0.0591729082291445,0.0818099097756402,4.35510677312854e-34
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MAP4K5,Mitogen-activated protein kinase kinase kinase kinase 5,42475,0.137183701039738,0.0112441847907322,0.115145098849903,0.159222303229573,4.70447629848765e-34
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CALB2,Calretinin,42310,0.0397553371763362,0.00325867056555406,0.0333683428678502,0.0461423314848222,4.76084132618074e-34
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ROBO1,Roundabout homolog 1,42637,0.0303165636934258,0.00248557876234675,0.0254448293192262,0.0351882980676254,4.88001211473722e-34
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GHRL,Appetite-regulating hormone,42635,0.105014092166662,0.00861438282233573,0.0881299018348842,0.12189828249844,5.2765780225648e-34
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NBN,Nibrin,42369,0.0660881040781199,0.00542405934976525,0.0554569477525801,0.0767192604036598,5.74314685554962e-34
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NCR1,Natural cytotoxicity triggering receptor 1,42565,0.0478102273526246,0.00392735409334808,0.0401126133296624,0.0555078413755868,6.49126148575511e-34
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ACYP1,Acylphosphatase-1,40249,0.0811860857394927,0.00666617332645395,0.0681203860196429,0.0942517854593424,6.64431401676845e-34
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,KYAT1,Kynurenine--oxoglutarate transaminase 1,42619,0.0697363553758438,0.00573325744222005,0.0584991707890926,0.0809735399625951,7.33033094259141e-34
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TCTN3,Tectonic-3,40510,0.0370160680488476,0.00304450265704396,0.0310488428410414,0.0429832932566537,8.41500488516742e-34
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,HSDL2,Hydroxysteroid dehydrogenase-like protein 2,40222,0.0606040753641011,0.00498484542087947,0.0508337783391773,0.0703743723890248,8.59015983654572e-34
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ERP29,Endoplasmic reticulum resident protein 29,40282,0.146336825962257,0.0120372719159727,0.122743773006951,0.169929878917564,8.63874198072858e-34
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TBCC,Tubulin-specific chaperone C,42494,0.0986028264056714,0.00811548608987006,0.0826964736695261,0.114509179141817,8.66661056564197e-34
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RABEP1,Rab GTPase-binding effector protein 1,40282,0.0966112057611569,0.0079472590388784,0.0810345780449553,0.112187833477359,8.68391092835989e-34
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CDC42BPB,Serine/threonine-protein kinase MRCK beta,40448,0.1267477813697,0.010435339899222,0.106294515167225,0.147201047572176,9.79022369036453e-34
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RILPL2,RILP-like protein 2,40510,0.119028396528099,0.00981794040977925,0.0997852333249316,0.138271559731266,1.28008319110982e-33
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CCL4,C-C motif chemokine 4,42641,0.0838481861364726,0.00692483827703573,0.0702755031134826,0.0974208691594626,1.42661664251168e-33
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ASAH2,Neutral ceramidase,42494,0.0656960919777076,0.00543044706271632,0.0550524157347836,0.0763397682206315,1.62803667084948e-33
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ESAM,Endothelial cell-selective adhesion molecule,42793,0.0398337382084719,0.00329577183070557,0.033374025420289,0.0462934509966548,1.85156022249326e-33
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,BACH1,Transcription regulator protein BACH1,42593,0.0891044948663605,0.00737763553105204,0.0746443292254985,0.103564660507223,2.06711935110628e-33
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IMPACT,Protein IMPACT,40482,0.0687179471294175,0.00568756944218923,0.0575703110227266,0.0798655832361083,2.10951454500437e-33
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SPRY2,Protein sprouty homolog 2,42369,0.112292612680969,0.00930332547142604,0.0940580947569742,0.130527130604964,2.27722859485678e-33
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,HARS1,"Histidine--tRNA ligase, cytoplasmic",42610,0.0933090750143886,0.00773928413452802,0.0781400781107137,0.108478071918064,2.66237895063662e-33
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CNP,"2',3'-cyclic-nucleotide 3'-phosphodiesterase",40208,0.0977778484447562,0.00810550600827899,0.0818910566685294,0.113664640220983,2.6803473902747e-33
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PSME2,Proteasome activator complex subunit 2,42440,0.0442384412531922,0.00367047235393313,0.0370443154394833,0.0514325670669011,2.80853395315746e-33
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MITD1,MIT domain-containing protein 1,42494,0.116723444910812,0.00969052867712403,0.0977300087036489,0.135716881117975,3.06489228512455e-33
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,BCR,Breakpoint cluster region protein,42593,0.110827252227292,0.00920189817174755,0.0927915318106669,0.128862972643917,3.09842127903186e-33
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DBNL,Drebrin-like protein,42675,0.111365093492243,0.00925754012637507,0.0932203148445474,0.129509872139938,3.66880103400198e-33
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RWDD1,RWD domain-containing protein 1,42710,0.076526074701208,0.00636444659106168,0.0640517593827271,0.0890003900196889,3.92266737401886e-33
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CWC15,Spliceosome-associated protein CWC15 homolog,40382,0.072957255801082,0.00606515857867052,0.0610695449868878,0.0848449666152762,4.0080153973726e-33
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MDH1,"Malate dehydrogenase, cytoplasmic",40480,0.0485160776951155,0.0040394883760327,0.0405986804780914,0.0564334749121396,4.97699668187134e-33
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SCARA5,Scavenger receptor class A member 5,42710,0.0375356263225047,0.00313245465958518,0.0313960151897178,0.0436752374552917,6.41861221961938e-33
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ADAM22,Disintegrin and metalloproteinase domain-containing protein 22,42494,0.0444177042171248,0.0037067298754702,0.0371525136612033,0.0516828947730464,6.44509557016913e-33
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FNTA,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,40450,0.0419014823850377,0.00349715152078061,0.0350470654043077,0.0487558993657677,7.02927480094206e-33
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DNAJC9,DnaJ homolog subfamily C member 9,40448,0.0934650158457237,0.00780587787259966,0.0781654952154283,0.108764536476019,7.72622965969348e-33
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",40482,0.117936482732564,0.00985652856672287,0.0986176867417875,0.137255278723341,8.52225005398509e-33
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,AZI2,5-azacytidine-induced protein 2,40481,0.0668743460370915,0.00559038809753976,0.0559171853659136,0.0778315067082695,8.82555615198487e-33
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NADK,NAD kinase,42635,0.0662967064077687,0.00554893046801948,0.0554208026904506,0.0771726101250869,9.78125799998854e-33
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,VAT1,Synaptic vesicle membrane protein VAT-1 homolog,42586,-0.0238985561081952,0.00200075219955139,-0.0278200304193159,-0.0199770817970744,1.01351013512463e-32
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MAP2K1,Dual specificity mitogen-activated protein kinase kinase 1,40448,0.0777264266745715,0.00650789242473817,0.0649709575220847,0.0904818958270583,1.10720860101924e-32
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DXO,Decapping and exoribonuclease protein,40482,0.0553022451137195,0.0046378558657356,0.0462120476168777,0.0643924426105612,1.39049445581506e-32
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,YJU2,Splicing factor YJU2,40450,0.0392613187415117,0.00329829535913011,0.0327966598376167,0.0457259776454067,1.77665967448764e-32
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,UMOD,Uromodulin,42763,-0.0665819361297204,0.00560419947316522,-0.0775661670971243,-0.0555977051623166,2.15757861512071e-32
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RETN,Resistin,42597,0.0522862900776809,0.00440114003305632,0.0436600556128905,0.0609125245424713,2.18163317934312e-32
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CSF1R,Macrophage colony-stimulating factor 1 receptor,40531,0.0492734003102032,0.00414628969304722,0.0411466725118306,0.0574001281085757,2.23802353470557e-32
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CD14,Monocyte differentiation antigen CD14,42415,0.050491770493869,0.00425080519212897,0.0421601923172962,0.0588233486704417,2.24543872268117e-32
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CCL14,C-C motif chemokine 14,42617,0.0486288435827093,0.00409617788521846,0.0406003349276811,0.0566573522377375,2.4085786490003e-32
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SFRP1,Secreted frizzled-related protein 1,42456,0.0532865060116365,0.0044900900564331,0.0444859295010276,0.0620870825222454,2.54203707706803e-32
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FOXJ3,Forkhead box protein J3,40198,0.0527128068272444,0.00443977393045674,0.0440108499235492,0.0614147637309396,2.57873021282232e-32
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,HPSE,Heparanase,40407,0.112811793191932,0.00950241165935022,0.0941870663396057,0.131436520044259,2.58591857709335e-32
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LCN2,Neutrophil gelatinase-associated lipocalin,42239,0.0485537751982606,0.00409527277610011,0.0405270405571043,0.0565805098394168,2.93116965735453e-32
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PKD2,Polycystin-2,40115,0.0703727263175286,0.00593320490099849,0.0587436447115715,0.0820018079234856,2.98214402698061e-32
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CPPED1,Serine/threonine-protein phosphatase CPPED1,42710,0.0781119311715744,0.00659211665114944,0.0651913825353215,0.0910324798078273,3.1332042752553e-32
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PPY,Pancreatic prohormone,42599,0.124336136440096,0.0104953210958138,0.103765307092301,0.144906965787891,3.23601496527998e-32
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TRIM25,E3 ubiquitin/ISG15 ligase TRIM25,40448,0.130994210767322,0.0110539623189261,0.109328444622227,0.152659976912417,3.32637897276011e-32
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DEFA1_DEFA1B,Neutrophil defensin 1,42350,0.0660697651315431,0.00557975705202387,0.0551334413095763,0.0770060889535098,3.49112213473998e-32
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SNAP23,Synaptosomal-associated protein 23,42635,0.103589617475817,0.00876571724276314,0.0864088116800009,0.120770423271632,4.56335207995691e-32
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PRELP,Prolargin,42617,0.0291743332708106,0.0024696132046942,0.0243338913896099,0.0340147751520112,4.80074911715902e-32
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,F2R,Proteinase-activated receptor 1,42653,0.0667487060762112,0.00565880865890368,0.0556574411047599,0.0778399710476624,5.91214824583281e-32
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,42682,0.0368889061685687,0.00313221048948066,0.0307497736091866,0.0430280387279508,7.32160532013085e-32
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PRKAB1,5'-AMP-activated protein kinase subunit beta-1,42369,0.0634174454367206,0.00538480608141787,0.0528632255171415,0.0739716653562996,7.39842314787887e-32
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CHMP1A,Charged multivesicular body protein 1a,42494,0.0940809349628095,0.0079914531282064,0.078417686831525,0.109744183094094,7.76510867043781e-32
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ILKAP,Integrin-linked kinase-associated serine/threonine phosphatase 2C,42294,0.0686820991649172,0.00583450514182315,0.0572464690869438,0.0801177292428906,7.89879291116276e-32
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TNFRSF8,Tumor necrosis factor receptor superfamily member 8,42710,0.05568384413099,0.00473084133399957,0.0464113951163509,0.0649562931456292,7.93208883319e-32
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LGALS3BP,Galectin-3-binding protein,40538,0.0366935070649757,0.00311599795568368,0.0305861510718357,0.0428008630581157,7.9641753810912e-32
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TANK,TRAF family member-associated NF-kappa-B activator,42369,0.082492013716109,0.00701540284242104,0.0687418241449637,0.0962422032872542,9.18135981105178e-32
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FN1,Fibronectin,40538,0.0318358725848723,0.00270845487222389,0.0265273010353135,0.0371444441344311,1.02539669821629e-31
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,YAP1,Transcriptional coactivator YAP1,40482,0.0344172863092755,0.00293012440885446,0.0286742424679207,0.0401603301506302,1.13145825815368e-31
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MRC1,Macrophage mannose receptor 1,40531,0.0349733406606845,0.00298057890712536,0.0291314060027188,0.0408152753186502,1.30353059385295e-31
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,BANK1,B-cell scaffold protein with ankyrin repeats,42593,0.125241767994884,0.0106850861173599,0.104298999204859,0.146184536784909,1.41578879974847e-31
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,HTRA2,"Serine protease HTRA2, mitochondrial",42678,0.0718463403192565,0.00613103303122626,0.0598295155780531,0.08386316506046,1.45797801895934e-31
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PLXNA4,Plexin-A4,42593,0.0969576170552923,0.00828266060048459,0.0807236022783425,0.113191631832242,1.68841611157193e-31
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CXCL3,C-X-C motif chemokine 3,42619,0.110228154261784,0.00941707823427407,0.0917706809226066,0.128685627600961,1.70633017227968e-31
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,COL15A1,Collagen alpha-1(XV) chain,40526,0.0333104105064948,0.00284901965574088,0.0277263319812427,0.0388944890317469,2.12362801016884e-31
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,UROD,Uroporphyrinogen decarboxylase,40282,0.0820258046572609,0.00701568737953266,0.0682750573933769,0.095776551921145,2.14581610958237e-31
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ZHX2,Zinc fingers and homeoboxes protein 2,40482,0.038727162974388,0.00331332244223669,0.0322330509876041,0.0452212749611719,2.21719006584059e-31
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IGFBPL1,Insulin-like growth factor-binding protein-like 1,42635,0.0413427269855932,0.00354630292432579,0.0343919732539147,0.0482934807172717,2.95399433134851e-31
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RPL14,60S ribosomal protein L14,40222,0.0475730042438354,0.00407959965759898,0.0395769889149414,0.0555690195727294,3.06797152072203e-31
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MSRA,Mitochondrial peptide methionine sulfoxide reductase,42678,0.0846342155418369,0.00726336159325049,0.0703980268190659,0.0988704042646078,3.15540512646905e-31
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MAN1A2,"Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB",40222,0.0304961580515074,0.00261592375749695,0.0253689474868133,0.0356233686162014,3.18776641151109e-31
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ITGA11,Integrin alpha-11,42593,-0.0400880219628365,0.00344318507220884,-0.0468366647043659,-0.0333393792213072,3.53096288016373e-31
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ATXN3,Ataxin-3,40482,0.0736116769189924,0.00632115318089115,0.0612222166844458,0.0860011371535391,3.65395909581694e-31
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,EIF4E,Eukaryotic translation initiation factor 4E,40198,0.106589474185767,0.00915335549021821,0.0886488974249391,0.124530050946594,3.71138470117895e-31
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PLXNB2,Plexin-B2,42742,0.0285093296528456,0.0024509639864384,0.0237054402394263,0.0333132190662648,3.98881308362998e-31
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CTF1,Cardiotrophin-1,42356,0.099084807429705,0.00851825741680493,0.0823890228927674,0.115780591966643,4.02078121576568e-31
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SPART,Spartin,40282,0.0906848934283082,0.00779636826073542,0.0754040116372668,0.10596577521935,4.30920461669902e-31
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PRKG1,cGMP-dependent protein kinase 1,40282,0.147235455751701,0.0126609588359297,0.122419976433278,0.172050935070123,4.44044492875262e-31
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MEP1A,Meprin A subunit alpha,40448,0.0858066336554996,0.00738153574285772,0.0713388235994985,0.100274443711501,4.65465173534355e-31
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ZBP1,Z-DNA-binding protein 1,40198,0.0473370781531099,0.00407436317735668,0.0393513263254908,0.055322829980729,5.04801193150008e-31
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DUSP13,Dual specificity protein phosphatase 13 isoform A,40450,0.0496869086206938,0.00428108999086435,0.0412959722385997,0.0580778450027879,5.75505260898941e-31
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CHRDL2,Chordin-like protein 2,42635,0.055632049009273,0.00479569859386088,0.0462324797653057,0.0650316182532404,5.75954061949274e-31
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RRAS,Ras-related protein R-Ras,40181,0.15282337531038,0.0131711393993449,0.127007942087664,0.178638808533096,6.03347730048528e-31
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MOCS2,Molybdopterin synthase catalytic subunit,40282,0.0781097567652612,0.00673518834173729,0.0649087876154561,0.0913107259150663,6.4147949002011e-31
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CACYBP,Calcyclin-binding protein,40266,0.120316853273829,0.0103755566662716,0.0999807622079363,0.140652944339721,6.4991521670589e-31
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,EPHA2,Ephrin type-A receptor 2,42124,0.0398066289016512,0.00343579513401968,0.0330724704389726,0.0465407873643297,6.90568965022717e-31
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MIF,Macrophage migration inhibitory factor,42585,0.0795319363400582,0.00686518872052081,0.0660761664478374,0.092987706232279,6.90591347892407e-31
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DSCAM,Down syndrome cell adhesion molecule,40481,0.0427197778731484,0.00368708281040478,0.035493095564755,0.0499464601815418,7.22490629801648e-31
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MARS1,"Methionine--tRNA ligase, cytoplasmic",40266,0.100037512391034,0.00863735635064342,0.0831082939437727,0.116966730838295,7.65781293019165e-31
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GLO1,Lactoylglutathione lyase,42356,0.0681192001956649,0.0058843638454596,0.056585847058564,0.0796525533327657,7.66360861853272e-31
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PDIA3,Protein disulfide-isomerase A3,40282,0.0292217964426496,0.00252542102281894,0.0242719712379245,0.0341716216473748,8.67754027293129e-31
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NT5C,"5'(3')-deoxyribonucleotidase, cytosolic type",40510,0.0855066621373779,0.00739056530482836,0.0710211541399143,0.0999921701348415,8.74253877995624e-31
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,THY1,Thy-1 membrane glycoprotein,42710,0.0353969810840208,0.00306158448854789,0.029396275486467,0.0413976866815747,8.9945902923025e-31
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DLG4,Disks large homolog 4,40482,0.0822010025245239,0.00711029298378297,0.0682648282763093,0.0961371767727385,9.69089580654326e-31
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NUB1,NEDD8 ultimate buster 1,42593,0.096962284718489,0.00839630012414864,0.0805055364751577,0.11341903296182,1.05317836608364e-30
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TRIM21,E3 ubiquitin-protein ligase TRIM21,42593,0.0919249374839334,0.00796403763070546,0.0763154237277507,0.107534451240116,1.12477977011858e-30
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,JAM3,Junctional adhesion molecule C,40282,0.0597072067747812,0.00517067237608165,0.0495726889176612,0.0698417246319013,1.14081283986459e-30
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IQGAP2,Ras GTPase-activating-like protein IQGAP2,42586,0.0624042842006006,0.00540805309946769,0.0518045001256439,0.0730040682755573,1.16939075236623e-30
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,HEXIM1,Protein HEXIM1,42593,0.0939923941885186,0.0081494414137043,0.0780194890176581,0.109965299359379,1.24616498621569e-30
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DYNLT1,Dynein light chain Tctex-type 1,40181,0.0945431119189552,0.008193462119133,0.0784839261654545,0.110602297672456,1.26151347414685e-30
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ADGRE1,Adhesion G protein-coupled receptor E1,40448,0.0661025514377338,0.0057340123268106,0.0548638872771851,0.0773412155982826,1.41283912378337e-30
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,AIF1,Allograft inflammatory factor 1,42345,0.0608976942360371,0.00528555268813795,0.0505380109672867,0.0712573775047874,1.44048789126402e-30
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,OGA,Protein O-GlcNAcase,40448,0.0819542386802432,0.00712258131619798,0.0679939793004952,0.0959144980599912,1.81607152021097e-30
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DDX58,Antiviral innate immune response receptor RIG-I,42345,0.066064017779131,0.0057463719053713,0.0548011288446032,0.0773269067136587,1.91685670175754e-30
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RNF149,E3 ubiquitin-protein ligase RNF149,40222,0.038013643433964,0.00330564914656598,0.0315345711066947,0.0444927157612333,1.97557193913375e-30
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LRRC25,Leucine-rich repeat-containing protein 25,42586,0.0458678940052107,0.00399246477455499,0.0380426630470829,0.0536931249633384,2.0892311393039e-30
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PDAP1,28 kDa heat- and acid-stable phosphoprotein,40510,0.113310559893802,0.00986754811635697,0.0939701655857419,0.132650954201861,2.36078711191255e-30
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,AK2,"Adenylate kinase 2, mitochondrial",40482,0.122948484232201,0.0107125055638964,0.101951973326964,0.143944995137438,2.53237323602463e-30
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ANG,Angiogenin,42617,0.039061080573681,0.00340564739214696,0.0323860116850729,0.045736149462289,2.59851630007768e-30
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TSC22D1,TSC22 domain family protein 1,40481,0.07600824941842,0.00662501518317626,0.0630232196593945,0.0889932791774454,2.65641621923949e-30
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,S100A11,Protein S100-A11,42530,0.0530036659748094,0.0046244960276952,0.0439396537605268,0.062067678189092,2.85357156952424e-30
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NEXN,Nexilin,40531,0.0804287768210018,0.00701514116554014,0.0666791001365432,0.0941784535054605,2.90205274091334e-30
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PPIB,Peptidyl-prolyl cis-trans isomerase B,42655,0.10809110432675,0.00943635527146392,0.0895958479946808,0.126586360658819,3.07322079903006e-30
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ARHGEF12,Rho guanine nucleotide exchange factor 12,42593,0.119904126787287,0.010468920020756,0.0993850435466055,0.140423210027969,3.1277393034944e-30
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DLL1,Delta-like protein 1,42678,0.0365865281709704,0.00319596848954198,0.0303224299314681,0.0428506264104727,3.3287891852518e-30
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,VEGFB,Vascular endothelial growth factor B,40198,0.0345205508437328,0.0030139622558377,0.0286131848222909,0.0404279168651747,3.34657621068592e-30
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RFC4,Replication factor C subunit 4,40450,0.0246248067989442,0.00215035114570875,0.020410118553355,0.0288394950445333,3.39460096530708e-30
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CAPG,Macrophage-capping protein,42460,0.0680882087031342,0.00594903936328434,0.0564280915510969,0.0797483258551715,3.44194934053804e-30
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FEN1,Flap endonuclease 1,42345,0.0739700615237586,0.00646525382263079,0.0612981640314023,0.086641959016115,3.61608985974322e-30
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,VASP,Vasodilator-stimulated phosphoprotein,40531,0.083941027335153,0.00733497830470425,0.0695644698579327,0.0983175848123734,3.69143890258982e-30
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LTBR,Tumor necrosis factor receptor superfamily member 3,42565,0.0350672530587107,0.00306570305674097,0.0290584750674985,0.041076031049923,3.70510088563276e-30
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SOD1,Superoxide dismutase [Cu-Zn],42364,0.0556129796832297,0.00486347692398638,0.0460805649122164,0.065145394454243,3.88598897592072e-30
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,42688,0.0495556748736456,0.00433963453113856,0.0410499911926141,0.0580613585546772,4.60115254978543e-30
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IL2RA,Interleukin-2 receptor subunit alpha,42516,0.0484142961051072,0.00423961321397907,0.0401046542057082,0.0567239380045062,4.61006800012402e-30
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FABP1,"Fatty acid-binding protein, liver",42617,0.109139620095023,0.00956080814180455,0.0904004361370857,0.12787880405296,4.8241000001342e-30
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LRRFIP1,Leucine-rich repeat flightless-interacting protein 1,40450,0.0556573424858067,0.00487526937252751,0.0461018145156528,0.0652128704559607,5.07239710950036e-30
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CCDC80,Coiled-coil domain-containing protein 80,42635,0.0435902230148674,0.00382072231913657,0.0361016072693598,0.0510788387603751,5.18765506988917e-30
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CRLF1,Cytokine receptor-like factor 1,42675,0.0290731569536617,0.00255021155878429,0.0240747422984444,0.0340715716088789,5.71596988265396e-30
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,OPHN1,Oligophrenin-1,40482,0.123656015088384,0.0108459986605449,0.102397857713716,0.144914172463052,6.02149730733725e-30
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TADA3,Transcriptional adapter 3,40450,0.0458456749769665,0.00402146651213874,0.0379636006131746,0.0537277493407584,6.08529528515209e-30
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GET3,ATPase GET3,40510,0.0624861386651852,0.0054910261612611,0.0517237273891134,0.0732485499412569,7.66838581334603e-30
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SDHB,Succinate dehydrogenase,40448,0.0770388274708613,0.00677163161821803,0.0637664294991539,0.0903112254425686,7.94824404740856e-30
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,OTUD6B,Deubiquitinase OTUD6B,40448,0.0676942404635028,0.00595420303377286,0.056024002517308,0.0793644784096977,8.65790426281455e-30
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,EIF4EBP1,Eukaryotic translation initiation factor 4E-binding protein 1,42635,0.0726890883459356,0.00640009741299753,0.0601448974164604,0.0852332792754107,9.30155286018788e-30
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SCRN1,Secernin-1,42593,0.0635138638171856,0.00559735077863223,0.0525430562910664,0.0744846713433048,1.04711254902591e-29
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SLAMF8,SLAM family member 8,42345,0.0638884491218732,0.00563021807084555,0.0528532217030159,0.0749236765407305,1.04979442593947e-29
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SMAD3,Mothers against decapentaplegic homolog 3,40450,0.0596213801527119,0.00525433129988894,0.0493228908049296,0.0699198695004942,1.1111962060665e-29
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FHIT,Bis(5'-adenosyl)-triphosphatase,42310,0.0841684524255258,0.00742152435175892,0.0696222646960784,0.0987146401549733,1.12825356655276e-29
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TFF3,Trefoil factor 3,42612,0.0496900128139883,0.00438276006660308,0.0410998030834462,0.0582802225445303,1.16578355710279e-29
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FXN,"Frataxin, mitochondrial",42720,0.084191249936246,0.00742697992549607,0.0696343692822737,0.0987481305902183,1.18605531145002e-29
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GNE,Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase,42345,0.0746953343041151,0.00659331865205248,0.0617724297460922,0.087618238862138,1.29388063373401e-29
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GAPDH,Glyceraldehyde-3-phosphate dehydrogenase,40029,0.0384601209642327,0.00340091185291134,0.0317943337325265,0.0451259081959389,1.73688352500867e-29
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ANXA11,Annexin A11,42569,0.0761832290335144,0.00674243809625371,0.0629680503648571,0.0893984077021716,1.80368787110826e-29
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ALCAM,CD166 antigen,42793,0.0225762494484444,0.00199817183584962,0.0186598326501791,0.0264926662467096,1.80702345926056e-29
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PTPN1,Tyrosine-protein phosphatase non-receptor type 1,42494,0.0893508856636308,0.00790816393699269,0.0738508843471251,0.104850886980136,1.8170108563542e-29
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FKBP5,Peptidyl-prolyl cis-trans isomerase FKBP5,42494,0.10683297522432,0.00945744616857406,0.0882963807339153,0.125369569714726,1.86657800642931e-29
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,VPS28,Vacuolar protein sorting-associated protein 28 homolog,40301,0.0756386615589178,0.00669309607422904,0.0625201932534289,0.0887571298644067,1.87828368756274e-29
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TNFAIP8L2,Tumor necrosis factor alpha-induced protein 8-like protein 2,40282,0.071851383050848,0.00636418937525933,0.0593775718753397,0.0843251942263563,2.12825118817531e-29
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MYCBP2,E3 ubiquitin-protein ligase MYCBP2,40481,0.0767904543754923,0.00680420525727929,0.0634542120712249,0.0901266966797597,2.21723440658778e-29
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ELAC1,Zinc phosphodiesterase ELAC protein 1,40481,0.0974087518639935,0.00863452606748786,0.0804850807717173,0.11433242295627,2.3303712773627e-29
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SKAP2,Src kinase-associated phosphoprotein 2,42675,0.118772681801533,0.0105332392327241,0.0981275329053941,0.139417830697673,2.33365827095719e-29
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SERPINF2,Alpha-2-antiplasmin,40316,0.0155148849299852,0.00137562525778033,0.0128186594247358,0.0182111104352347,2.42000542707128e-29
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PTRHD1,Putative peptidyl-tRNA hydrolase PTRHD1,40282,0.0689160291819293,0.00611159213186679,0.0569373086034704,0.0808947497603882,2.48175459136344e-29
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GIT1,ARF GTPase-activating protein GIT1,40198,0.110745286117227,0.00983039427443567,0.091477713339333,0.130012858895121,2.80579022261556e-29
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NUDC,Nuclear migration protein nudC,42753,0.0706567093328614,0.00627975143314898,0.0583483965238894,0.0829650221418334,3.06775600238546e-29
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PACS2,Phosphofurin acidic cluster sorting protein 2,40115,0.0708727219429043,0.00629789034885296,0.0585288568591525,0.0832165870266561,3.22596213402288e-29
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MESD,LRP chaperone MESD,42610,0.137105389043304,0.0121938810406263,0.113205382203677,0.161005395882932,3.35644647848766e-29
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SH3BP1,SH3 domain-binding protein 1,40448,0.0548218127123629,0.00487443889863247,0.0452679124710433,0.0643757129536826,3.43664642227579e-29
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LAMA4,Laminin subunit alpha-4,42675,0.0377557581832144,0.0033586332884268,0.0311728369378979,0.044338679428531,3.4423867287726e-29
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LILRA2,Leukocyte immunoglobulin-like receptor subfamily A member 2,42610,0.0406695849133315,0.0036188542811838,0.0335766305222112,0.0477625393044517,3.57164397566509e-29
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GRSF1,G-rich sequence factor 1,40013,0.0923943220337695,0.00822053723381436,0.0762820690554934,0.108506575012046,3.78499473349722e-29
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GOPC,Golgi-associated PDZ and coiled-coil motif-containing protein,42593,0.114001279055941,0.0101513303641681,0.0941046715421716,0.133897886569711,3.91139082705275e-29
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ARHGAP45,Rho GTPase-activating protein 45,40282,0.0941024389351222,0.00838408959958194,0.0776696233199416,0.110535254550303,4.46288697810597e-29
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CIAPIN1,Anamorsin,42678,0.0703401039864648,0.00627435067384922,0.0580423766657204,0.0826378313072093,4.85420438632415e-29
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ARHGAP25,Rho GTPase-activating protein 25,42345,0.0675125569416746,0.00602581936679449,0.0557019509827574,0.0793231629005918,5.28048999075417e-29
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,XIAP,E3 ubiquitin-protein ligase XIAP,40198,0.0647001633963422,0.005780452715468,0.053370476074025,0.0760298507186595,6.32709804120666e-29
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RAB27B,Ras-related protein Rab-27B,40510,0.0934623631148386,0.00835671667736151,0.07708319842721,0.109841527802467,6.91294907497558e-29
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SLITRK2,SLIT and NTRK-like protein 2,42720,0.0451044080006318,0.00403594315704546,0.0371939594128227,0.0530148565884409,7.17645688643284e-29
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TMED8,Protein TMED8,40448,0.116052196367983,0.0103823117624412,0.0957028653135979,0.136401527422368,7.42370652857988e-29
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CPA1,Carboxypeptidase A1,42793,0.0708056151545595,0.00634146801306296,0.0583763378489561,0.0832348924601629,8.02772763648719e-29
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ADGRF5,Adhesion G protein-coupled receptor F5,40510,0.0322864764900113,0.00289041672964622,0.0266212596999047,0.0379516932801179,8.07280887919243e-29
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PPP1R14A,Protein phosphatase 1 regulatory subunit 14A,40481,0.0912775816624476,0.00818767654393699,0.0752297356363311,0.107325427688564,1.03220620310574e-28
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,WASF1,Wiskott-Aldrich syndrome protein family member 1,42356,0.104497569323482,0.00938250467813632,0.0861078601543348,0.122887278492629,1.10695655224064e-28
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,STXBP1,Syntaxin-binding protein 1,40481,0.0868955324323522,0.0078056844760101,0.0715963908593724,0.102194674005332,1.2305697677324e-28
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DRG2,Developmentally-regulated GTP-binding protein 2,42586,0.0633543568001726,0.00569872915336023,0.0521848476595865,0.0745238659407586,1.37880106020499e-28
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GH1,Somatotropin,42612,-0.193548576222572,0.0174123578587821,-0.227676797625784,-0.159420354819359,1.40415683943717e-28
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PILRB,Paired immunoglobulin-like type 2 receptor beta,42635,0.0657941288693427,0.00592059130239846,0.0541897699166417,0.0773984878220436,1.44815973786662e-28
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DECR1,"2,4-dienoyl-CoA reductase, mitochondrial",42593,0.107243848064234,0.00965616246199863,0.0883177696387168,0.126169926489751,1.55791405141624e-28
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,KIFBP,KIF-binding protein,42586,0.0918852222848243,0.00827594488888984,0.0756643703026002,0.108106074267048,1.62113446165288e-28
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RNASEH2A,Ribonuclease H2 subunit A,40481,0.0541149771867367,0.00487984497602804,0.0445504810337217,0.0636794733397516,1.97825637749627e-28
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,A1BG,Alpha-1B-glycoprotein,40538,0.019176879464475,0.00172987031764768,0.0157863336418856,0.0225674252870645,2.05863266333466e-28
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PTGES2,Prostaglandin E synthase 2,40101,0.0613054707625808,0.00553513773870564,0.0504566007947178,0.0721543407304439,2.33104239828558e-28
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GZMH,Granzyme H,42356,0.0874158970618724,0.0078979928455582,0.0719358310845783,0.102895963039166,2.38889774994925e-28
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NID1,Nidogen-1,42651,0.0431190918481343,0.0038966575558756,0.0354816430386181,0.0507565406576505,2.43925532284156e-28
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PAM,Peptidyl-glycine alpha-amidating monooxygenase,42721,0.0319972110955872,0.00289223238109348,0.026328435628644,0.0376659865625304,2.50417982885018e-28
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PCYT2,Ethanolamine-phosphate cytidylyltransferase,40448,0.0854964783205368,0.00772628248114623,0.0703529646574902,0.100639991983583,2.57616302812613e-28
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,BRAP,BRCA1-associated protein,40341,0.122729616697683,0.0110908978048127,0.10099145700025,0.144467776395116,2.58077429880052e-28
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TACC3,Transforming acidic coiled-coil-containing protein 3,42586,0.129347987655396,0.0117003624224552,0.106415277307384,0.152280698003409,2.74665538289928e-28
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TIMM10,Mitochondrial import inner membrane translocase subunit Tim10,40510,0.0451607275981351,0.00408339595216752,0.0371572715318868,0.0531641836643835,2.7494867508245e-28
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ADD1,Alpha-adducin,40282,0.0799369534105672,0.00724849433473541,0.0657299045144858,0.0941440023066486,3.91710560061193e-28
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FAM172A,Cotranscriptional regulator FAM172A,40222,0.0683465651963615,0.00619802707353679,0.0561984321322294,0.0804946982604936,3.96449765841769e-28
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,EIF4G3,Eukaryotic translation initiation factor 4 gamma 3,40481,0.0737531512951592,0.00669815066970429,0.0606247759825387,0.0868815266077796,4.69948379705993e-28
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TXNDC9,Thioredoxin domain-containing protein 9,40482,0.0589226180348521,0.00535198763458253,0.0484327222710704,0.0694125137986339,4.77682487521114e-28
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GNLY,Granulysin,42610,0.0599363523572415,0.00544832521131237,0.0492576349430692,0.0706150697714137,4.98599410944118e-28
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PDLIM5,PDZ and LIM domain protein 5,40481,0.130480936307123,0.011860575652235,0.107234208028743,0.153727664585504,5.22986694468747e-28
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TTF2,Transcription termination factor 2,40181,0.054841456844389,0.00498521000679065,0.0450704452310793,0.0646124684576987,5.29966884942769e-28
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SERPINB6,Serpin B6,42678,0.0644302900928528,0.00586314888833111,0.0529385182717239,0.0759220619139818,5.67147259692805e-28
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NGRN,Neugrin,40482,0.0259250442644426,0.00235930364189042,0.0213008091263374,0.0305492794025479,6.01791714080412e-28
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LACTB2,Endoribonuclease LACTB2,42635,0.0724035147783546,0.00659352411942539,0.0594802075042808,0.0853268220524283,6.19880878231555e-28
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FGR,Tyrosine-protein kinase Fgr,42310,0.0639133838680318,0.00582028424594422,0.0525056267459811,0.0753211409900825,6.23104311682547e-28
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ADA,Adenosine deaminase,42753,0.0386521764779952,0.00352037079902093,0.0317522497119141,0.0455521032440762,6.28187417247749e-28
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,HNRNPK,Heterogeneous nuclear ribonucleoprotein K,42306,0.0868993763164503,0.00791958532543163,0.0713769890786043,0.102421763554296,6.83485332034703e-28
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ATOX1,Copper transport protein ATOX1,42678,0.0772794719815045,0.00704463898094723,0.0634719795788479,0.0910869643841611,6.99022166258949e-28
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CSNK2A1,Casein kinase II subunit alpha,40481,-0.0501047771582265,0.00456576547073254,-0.0590536774808623,-0.0411558768355907,7.04754205603805e-28
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CALCOCO2,Calcium-binding and coiled-coil domain-containing protein 2,40222,0.0849811403488736,0.00775601625934872,0.0697793484805501,0.100182932217197,8.57170749212125e-28
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PPCDC,Phosphopantothenoylcysteine decarboxylase,42710,0.0512072585702186,0.00467771559719105,0.0420389359997241,0.0603755811407131,8.97723617436114e-28
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FNDC1,Fibronectin type III domain-containing protein 1,40482,0.0525802805082894,0.00480148640129771,0.0431693671617459,0.0619911938548329,9.08067149536249e-28
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IRAK4,Interleukin-1 receptor-associated kinase 4,42593,0.114844255426954,0.0104977002741597,0.0942687628896008,0.135419747964307,9.72692054374562e-28
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SF3B4,Splicing factor 3B subunit 4,42586,0.0808240665968381,0.0073906557367794,0.0663383813527505,0.0953097518409258,1.01590284085613e-27
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CD36,Platelet glycoprotein 4,40198,0.0497764668766577,0.00455412478784214,0.0408503822924871,0.0587025514608283,1.14960134696731e-27
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ANXA3,Annexin A3,42680,0.0768532133060634,0.00703887802418961,0.0630570123786518,0.0906494142334751,1.22876294804012e-27
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CHCHD6,MICOS complex subunit MIC25,40450,0.032164648210452,0.00294559611385229,0.0263912798273015,0.0379380165936025,1.27828411592476e-27
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,HSPB6,Heat shock protein beta-6,42720,0.0437973765263247,0.00401324482160484,0.0359314166759792,0.0516633363766702,1.29920633591822e-27
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NCF2,Neutrophil cytosol factor 2,42577,0.0917214545239422,0.00840485616593737,0.0752479364387049,0.108194972609179,1.30708721897616e-27
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CASP10,Caspase-10,42310,0.079192765623965,0.00726122549158353,0.0649607636604613,0.0934247675874687,1.41312288246727e-27
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,BPIFB2,BPI fold-containing family B member 2,40472,0.0763499442261375,0.00700190338221611,0.062626213596994,0.0900736748552811,1.51071400855784e-27
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ARSA,Arylsulfatase A,42610,0.0492315616597861,0.00452405348075573,0.0403644168375048,0.0580987064820673,1.8255215971411e-27
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CD8A,T-cell surface glycoprotein CD8 alpha chain,42710,0.0574714988329385,0.00528744985400505,0.0471080971190886,0.0678349005467883,2.09313083925116e-27
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,BOLA2_BOLA2B,BolA-like protein 2,40222,0.0599706239940316,0.00551616676132213,0.0491589371418403,0.070782310846223,2.16272067638087e-27
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IKBKG,NF-kappa-B essential modulator,42593,0.0998701370953426,0.00919672354812957,0.0818445589410086,0.117895715249677,2.341068505539e-27
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PHYKPL,5-phosphohydroxy-L-lysine phospho-lyase,40282,0.0464243477430295,0.0042790107469323,0.0380374866790422,0.0548112088070168,2.75436670596906e-27
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PRKAR1A,cAMP-dependent protein kinase type I-alpha regulatory subunit,42635,0.0911255276124961,0.00840622286657713,0.074649330794005,0.107601724430987,2.87663724559184e-27
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,METAP1D,"Methionine aminopeptidase 1D, mitochondrial",42593,0.0895269316529239,0.0082601609002337,0.0733370162884658,0.105716847017382,2.93712962456755e-27
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TIMP4,Metalloproteinase inhibitor 4,42610,-0.0454641590315073,0.00419710027219852,-0.0536904755650164,-0.0372378424979982,3.13746047077143e-27
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RILP,Rab-interacting lysosomal protein,42673,0.0653220283983507,0.00603825193579245,0.0534870546041975,0.0771570021925039,3.65587908709746e-27
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FAM3B,Protein FAM3B,42586,0.0388012936088214,0.00358999669513699,0.0317649000863529,0.0458376871312899,4.07409934203444e-27
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CD226,CD226 antigen,40198,0.046596895936945,0.00431202234087023,0.0381453321488394,0.0550484597250507,4.39558761705115e-27
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MPO,Myeloperoxidase,42610,0.0510666471826961,0.00473022888579006,0.0417953985665475,0.0603378957988446,4.6537681960004e-27
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CD5L,CD5 antigen-like,40478,0.0524860099882388,0.00486421115507043,0.0429521561243007,0.0620198638521768,5.18462223766818e-27
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,APRT,Adenine phosphoribosyltransferase,42479,0.0518271871220141,0.00480542945856795,0.0424085453832209,0.0612458288608073,5.23500668070484e-27
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LGMN,Legumain,42675,0.0389519700716699,0.00361850122526442,0.0318597076701516,0.0460442324731882,6.50184918224099e-27
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PTPRM,Receptor-type tyrosine-protein phosphatase mu,42578,0.026755750721834,0.0024876845500362,0.021879889003763,0.0316316124399049,7.20581166310025e-27
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MCEMP1,Mast cell-expressed membrane protein 1,40198,0.0995651557812429,0.00925553225980625,0.0814243125520226,0.117705999010463,7.43957334079563e-27
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CXCL16,C-X-C motif chemokine 16,42777,0.0260816180382075,0.00242619923971246,0.021326267528371,0.0308369685480439,7.59973568326087e-27
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SCG2,Secretogranin-2,42635,0.0373558137895492,0.00347847220311414,0.0305380082714455,0.0441736193076529,8.56132464141143e-27
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CDH3,Cadherin-3,42710,0.0409484989818549,0.00381389990412469,0.0334732551697705,0.0484237427939393,8.78179296768615e-27
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ACOT13,Acyl-coenzyme A thioesterase 13,40448,0.123877151213265,0.0115347739214286,0.101268994327265,0.146485308099265,8.95537353831717e-27
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ICA1,Islet cell autoantigen 1,42369,0.0854589215378842,0.00796288249742583,0.0698516718429296,0.101066171232839,9.27432212569337e-27
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GM2A,Ganglioside GM2 activator,40269,0.0447093131443628,0.00416821594466681,0.0365396098928158,0.0528790163959097,1.03658200098959e-26
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,40301,0.114792044268681,0.0107068579062776,0.0938066027723772,0.135777485764985,1.09134481524774e-26
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,AGXT,Serine--pyruvate aminotransferase,42635,0.0816403637544692,0.00765026053243239,0.0666458531109017,0.0966348743980367,1.76474941810779e-26
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SH2B3,SH2B adapter protein 3,42345,0.105285165942264,0.00986742745542479,0.0859450081296317,0.124625323754897,1.80493186690821e-26
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TPR,Nucleoprotein TPR,40115,0.0528306075340323,0.00495084260758334,0.043126956023169,0.0625342590448957,1.87715544872611e-26
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PGLYRP1,Peptidoglycan recognition protein 1,42736,0.0461554437932925,0.00433102717211854,0.0376666305359401,0.0546442570506448,2.05954796121316e-26
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PLXNB3,Plexin-B3,42596,0.050524020809574,0.00474697499434303,0.0412199498206617,0.0598280917984864,2.38438425576769e-26
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GMFG,Glia maturation factor gamma,40510,0.0772644527376758,0.0072570426407211,0.0630406491618625,0.0914882563134892,2.40380889509602e-26
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CDC26,Anaphase-promoting complex subunit CDC26,40427,0.075001927101288,0.0070462036108899,0.0611913680239438,0.0888124861786322,2.47429340209353e-26
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NECAP2,Adaptin ear-binding coat-associated protein 2,40115,0.0743233835996268,0.0069892931192328,0.0606243690859305,0.0880223981133231,2.78636149990089e-26
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CETN2,Centrin-2,42310,0.0724443127322977,0.00682873085959443,0.0590600002474926,0.0858286252171028,3.46443597109149e-26
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CRADD,Death domain-containing protein CRADD,42475,0.080442499194905,0.00758480788533323,0.0655762757396518,0.0953087226501581,3.56616718201829e-26
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ACP5,Tartrate-resistant acid phosphatase type 5,42710,0.0340238709299102,0.00320881983506734,0.0277345840531782,0.0403131578066422,3.64697070923431e-26
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TBCB,Tubulin-folding cofactor B,42494,0.106933437853458,0.0100878980545807,0.0871611576664795,0.126705718040436,3.78187162456914e-26
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CPB2,Carboxypeptidase B2,40515,0.0238571988292557,0.00225935669665789,0.0194288597038062,0.0282855379547051,6.07375445685079e-26
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PROS1,Vitamin K-dependent protein S,40538,0.0280470268893358,0.00266036539196596,0.0228327107210825,0.0332613430575891,7.24189453938732e-26
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SERPINE2,Glia-derived nexin,40510,0.0687855376490081,0.0065251938651799,0.0559961576732556,0.0815749176247607,7.32469884131229e-26
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CXCL1,Growth-regulated alpha protein,42606,0.101949778283575,0.00968042329055372,0.0829761486340899,0.12092340793306,7.79663904665308e-26
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,C19orf12,Protein C19orf12,42310,0.0680749845041107,0.00646781094187247,0.0553980750580406,0.0807518939501807,8.37897429157616e-26
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TBC1D23,TBC1 domain family member 23,42586,0.0954560695446746,0.00907332735470789,0.0776723479294471,0.113239791159902,8.75984253535375e-26
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,STX7,Syntaxin-7,40198,0.0535510771381764,0.00509282661630073,0.0435691369702269,0.0635330173061258,9.75724323249772e-26
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LAP3,Cytosol aminopeptidase,42369,0.0516031207638248,0.00491509178299165,0.0419695408691611,0.0612367006584884,1.10354053139286e-25
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GRAP2,GRB2-related adapter protein 2,42635,0.134883148948636,0.0128655625604971,0.109666646330062,0.160099651567211,1.28405115545406e-25
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SEPTIN8,Septin-8,40469,0.0347086744991287,0.00330956282075433,0.0282219313704502,0.0411954176278072,1.29488417093427e-25
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NOTCH1,Neurogenic locus notch homolog protein 1,42793,0.0169827840420218,0.00162270062897238,0.013802290809236,0.0201632772748077,1.55142659344043e-25
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FKBP14,Peptidyl-prolyl cis-trans isomerase FKBP14,40481,0.105681222472725,0.010096016393622,0.0858930303412262,0.125469414604225,1.59225737425043e-25
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,THBD,Thrombomodulin,42635,0.0321236435652244,0.00307046643506954,0.0261055293524881,0.0381417577779607,1.61550096843555e-25
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GRN,Progranulin,42551,0.0261247179817751,0.00249783021193759,0.0212289707663774,0.0310204651971728,1.67242909416005e-25
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CCT5,T-complex protein 1 subunit epsilon,42345,0.0487593202948093,0.00466349366562775,0.0396188727101789,0.0578997678794397,1.73968049480367e-25
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TMEM106A,Transmembrane protein 106A,40450,0.0745604533213219,0.00713271818919964,0.0605803256704906,0.0885405809721531,1.85060982751771e-25
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PAGR1,PAXIP1-associated glutamate-rich protein 1,40222,0.0464616335306995,0.00444665216838446,0.0377461952806659,0.055177071780733,1.95288836038377e-25
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SERPINB1,Leukocyte elastase inhibitor,42568,0.0939085486541641,0.00899713202229946,0.0762741698904571,0.111542927417871,2.09028998835649e-25
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CAMSAP1,Calmodulin-regulated spectrin-associated protein 1,40481,0.114199119106746,0.0109371337265673,0.0927623370026745,0.135635901210818,2.09366052719162e-25
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PF4,Platelet factor 4,40462,0.104157236383758,0.00998232937298528,0.0845918708127071,0.123722601954809,2.25915478878214e-25
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CCL26,C-C motif chemokine 26,42593,0.098684565056241,0.00946583221250939,0.0801315339197226,0.117237596192759,2.37485617983153e-25
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,VPS4B,Vacuolar protein sorting-associated protein 4B,40450,0.0998116831363599,0.00957422383618271,0.0810462044174418,0.118577161855278,2.48513723415433e-25
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,JPT2,Jupiter microtubule associated homolog 2,40448,0.0921724692784997,0.00885109610206357,0.0748243209184551,0.109520617638544,2.79743260783619e-25
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PGD,"6-phosphogluconate dehydrogenase, decarboxylating",40510,0.0556778416606427,0.00534692090292736,0.0451978766909051,0.0661578066303804,2.8112664702813e-25
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,THTPA,Thiamine-triphosphatase,40435,0.0930586195417097,0.00894537130503802,0.0755256917838352,0.110591547299584,3.12732924925482e-25
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MED18,Mediator of RNA polymerase II transcription subunit 18,42345,0.0796168851848093,0.007664572640905,0.0645943228086355,0.0946394475609831,3.53155173890403e-25
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PAFAH2,"Platelet-activating factor acetylhydrolase 2, cytoplasmic",40301,0.0519300268482927,0.00500369741470044,0.0421227799154799,0.0617372737811056,4.05284642114861e-25
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ACRBP,Acrosin-binding protein,40450,0.0414209744845546,0.00399481642863217,0.0335911342844355,0.0492508146846736,4.46384006253451e-25
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DNPH1,2'-deoxynucleoside 5'-phosphate N-hydrolase 1,42657,0.0538300431464782,0.00519752965399169,0.0436428850246545,0.0640172012683019,4.83732184709579e-25
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CRYZL1,Quinone oxidoreductase-like protein 1,40222,0.0965417056148548,0.00931799339908524,0.0782784385526478,0.114804972677062,4.87029174786241e-25
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,EPHB6,Ephrin type-B receptor 6,42475,0.0354092912930525,0.00341916249582006,0.0287077328012452,0.0421108497848598,4.88804731909089e-25
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ABRAXAS2,BRISC complex subunit Abraxas 2,40115,0.070184124557689,0.00678292113090247,0.0568895991411202,0.0834786499742579,5.62066600783363e-25
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SCGB1A1,Uteroglobin,42645,0.0585486743592352,0.00566299171848282,0.0474492105910089,0.0696481381274615,5.83179177527551e-25
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,KLK11,Kallikrein-11,42542,0.034367999614814,0.00332507494906356,0.0278508527146495,0.0408851465149786,6.01420913961258e-25
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,INHBB,Inhibin beta B chain,40282,0.0576815040642526,0.00558151135727514,0.0467417418039933,0.0686212663245119,6.38992956588159e-25
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SLMAP,Sarcolemmal membrane-associated protein,40448,0.0869182272909998,0.00841135103893069,0.0704319792546956,0.103404475327304,6.42796015513667e-25
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IFT20,Intraflagellar transport protein 20 homolog,40181,0.0452375302108911,0.00437771585325708,0.0366572071385072,0.053817853283275,6.45800806342096e-25
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CD164,Sialomucin core protein 24,42610,0.0287374388603816,0.00278222906275302,0.0232842698973856,0.0341906078233775,6.46426525781642e-25
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CKB,Creatine kinase B-type,40526,-0.0632250966852761,0.00613378302624294,-0.0752473114167123,-0.05120288195384,8.37052923022204e-25
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TINAGL1,Tubulointerstitial nephritis antigen-like,42606,0.0233333666443448,0.00226609539185091,0.018891819676317,0.0277749136123726,9.01457733991754e-25
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FCAR,Immunoglobulin alpha Fc receptor,42593,0.051024132896301,0.00495564076131145,0.0413110770041306,0.0607371887884715,9.0681481370958e-25
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IL1R2,Interleukin-1 receptor type 2,42599,0.0207571300428377,0.00201735257842294,0.0168031189891288,0.0247111410965467,9.7336461446089e-25
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CIT,Citron Rho-interacting kinase,40181,0.0475694391649814,0.0046278457144716,0.0384988615646171,0.0566400167653457,1.1337801601785e-24
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LY75,Lymphocyte antigen 75,42593,0.0406202226685521,0.00395478697907994,0.0328688401895554,0.0483716051475488,1.17331187381075e-24
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PIK3AP1,Phosphoinositide 3-kinase adapter protein 1,42593,0.0637676484946215,0.0062094324317062,0.0515971609284774,0.0759381360607657,1.19366452067945e-24
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,APOM,Apolipoprotein M,42662,-0.0294646659456203,0.00286959374921859,-0.0350890696940887,-0.0238402621971518,1.21208589765935e-24
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CFD,Complement factor D,40538,0.0219704248400659,0.00213905953571711,0.0177778681500604,0.0261629815300714,1.21970014185589e-24
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ZNRD2,Protein ZNRD2,40448,0.0729914532495609,0.00710694722883337,0.0590618366810475,0.0869210698180743,1.23005002620327e-24
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ING1,Inhibitor of growth protein 1,42291,0.0492083908610556,0.0047932542004931,0.0398136126280891,0.0586031690940221,1.24089277884327e-24
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DDHD2,Phospholipase DDHD2,40481,0.0683738949950843,0.00666693562944781,0.0553067011613666,0.081441088828802,1.43028616841428e-24
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,BTD,Biotinidase,40538,0.021493915402957,0.00209615395714826,0.0173854536469464,0.0256023771589676,1.45353471367234e-24
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PDGFA,Platelet-derived growth factor subunit A,42793,0.0745194129686891,0.00727372308061059,0.0602629157306923,0.0887759102066858,1.53002786777411e-24
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IGFBP1,Insulin-like growth factor-binding protein 1,42769,-0.124947299428194,0.0122011793390601,-0.148861610932752,-0.101032987923637,1.60165852463451e-24
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FCN1,Ficolin-1,40514,0.0581399845726654,0.00568207844932872,0.0470031108119811,0.0692768583333497,1.81834615072724e-24
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FABP6,Gastrotropin,42333,0.0611746425504834,0.00598170657962298,0.0494504976544223,0.0728987874465444,1.85441977273375e-24
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,BCL2L1,Bcl-2-like protein 1,40482,0.103022081804508,0.0100722762461751,0.0832804203620051,0.122763743247012,1.89341680348268e-24
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,KLRF1,Killer cell lectin-like receptor subfamily F member 1,40198,0.0469058352408473,0.00458749065745697,0.0379143535522317,0.055897316929463,1.97593201187e-24
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PLPBP,Pyridoxal phosphate homeostasis protein,42635,0.0691718377780401,0.00677553057150531,0.0558917978578897,0.0824518776981905,2.21652523554092e-24
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PON1,Serum paraoxonase/arylesterase 1,40531,-0.0285173263087464,0.00279274911340541,-0.033991114571021,-0.0230435380464718,2.25220562643261e-24
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ORM1,Alpha-1-acid glycoprotein 1,40482,0.0208838011446556,0.00204598724975959,0.0168736661351268,0.0248939361541843,2.3486143806859e-24
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RP2,Protein XRP2,42586,0.0434476130969272,0.0042656254825948,0.0350869871510414,0.051808239042813,2.82127979165799e-24
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IL6R,Interleukin-6 receptor subunit alpha,42581,0.0353012126248494,0.00346595699799186,0.0285079369087854,0.0420944883409134,2.8328218498152e-24
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,APP,Amyloid-beta precursor protein,42591,0.0687140254611344,0.00674984628697372,0.0554843267386659,0.0819437241836029,2.98179935453662e-24
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ECI2,Enoyl-CoA delta isomerase 2,40115,0.063936109856447,0.00628447646945624,0.0516185359763128,0.0762536837365812,3.33260014341488e-24
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SPINK1,Serine protease inhibitor Kazal-type 1,42610,0.0472836623344792,0.00465014716692259,0.0381693738873109,0.0563979507816475,3.36463132561319e-24
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,BCAT1,"Branched-chain-amino-acid aminotransferase, cytosolic",40510,0.0314217925421432,0.00308995436719158,0.0253654819824477,0.0374781031018387,3.46380657103836e-24
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,HPCAL1,Hippocalcin-like protein 1,42753,0.0746888781331292,0.00734965306973255,0.0602835581164534,0.089094198149805,3.56818963334068e-24
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IL17D,Interleukin-17D,42369,0.0355747604220901,0.00350284213722959,0.0287091898331201,0.0424403310110601,3.82500001933811e-24
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CCL19,C-C motif chemokine 19,42710,0.13530531271072,0.013326053702523,0.109186247453774,0.161424377967665,3.90454693618699e-24
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GLRX5,"Glutaredoxin-related protein 5, mitochondrial",40282,0.0914203355497477,0.00900080479919267,0.0737787581433301,0.109061912956165,3.93668116861965e-24
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FKBP1B,Peptidyl-prolyl cis-trans isomerase FKBP1B,42666,0.114185844524403,0.0112502835222145,0.092135288820863,0.136236400227944,4.06288657870029e-24
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NFU1,"NFU1 iron-sulfur cluster scaffold homolog, mitochondrial",40448,0.105594097380142,0.0104027051936206,0.0852047952006457,0.125983399559638,4.18056309813109e-24
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ANKRD54,Ankyrin repeat domain-containing protein 54,42345,0.059835054470692,0.00589946696319581,0.0482720992228282,0.0713980097185558,4.39018066856808e-24
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,BOLA1,BolA-like protein 1,40135,0.0561696774635963,0.00553698820277102,0.0453171805861651,0.0670221743410275,4.48206303257048e-24
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CYB5R2,NADH-cytochrome b5 reductase 2,40328,0.0577524304346273,0.00570061637875595,0.0465792223322656,0.068925638536989,5.11986400990849e-24
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,HSPB1,Heat shock protein beta-1,42447,0.0694627668878271,0.00686363584602403,0.05601004062962,0.0829154931460342,5.48259794883307e-24
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CLTA,Clathrin light chain A,42356,0.0489364408390773,0.00484732862038557,0.0394356767431216,0.0584372049350331,7.06149539248577e-24
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GTPBP2,GTP-binding protein 2,40181,0.0829586990423025,0.0082164581357228,0.0668544410962859,0.0990629569883192,7.26386000355679e-24
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NARS1,"Asparagine--tRNA ligase, cytoplasmic",40481,0.0487505330842997,0.00483257775570023,0.0392786806831273,0.0582223854854722,7.88526750865457e-24
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,VAV3,Guanine nucleotide exchange factor VAV3,40135,0.10171977370929,0.0100959510685505,0.0819317096149311,0.121507837803649,9.01852272625431e-24
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LAYN,Layilin,42475,0.0388033425874236,0.00385328510313864,0.0312509037852719,0.0463557813895753,9.10649200098768e-24
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DTD1,D-aminoacyl-tRNA deacylase 1,40282,0.088287426369247,0.00878206454776491,0.0710745798556278,0.105500272882866,1.12368884640337e-23
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,BMP6,Bone morphogenetic protein 6,42341,0.0414414332144886,0.00412492485621822,0.0333565804963009,0.0495262859326763,1.15755470268899e-23
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LARP1,La-related protein 1,40450,0.0626251169384905,0.00623687233308036,0.050400847165653,0.074849386711328,1.26393998504522e-23
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ABCA2,ATP-binding cassette sub-family A member 2,40115,0.0369555480046587,0.0036869873123938,0.0297290528723669,0.0441820431369506,1.52288019897457e-23
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CERT,Ceramide transfer protein,42310,0.0621921920988897,0.00621032298613051,0.0500199590460739,0.0743644251517055,1.60172962611951e-23
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LPP,Lipoma-preferred partner,40115,0.0670676433072186,0.00670226819061848,0.0539311976536064,0.0802040889608308,1.79721015948819e-23
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TRIM5,Tripartite motif-containing protein 5,42593,0.0862589195202246,0.00863131755867531,0.069341537105221,0.103176301935228,1.96141133692305e-23
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ITGB1BP2,Integrin beta-1-binding protein 2,42356,0.110898528145699,0.0111158616117063,0.0891114393867542,0.132685616904643,2.33566719390749e-23
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,VSNL1,Visinin-like protein 1,40482,0.0390107349747325,0.00391112918777158,0.0313449217667002,0.0466765481827648,2.46677336666031e-23
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MANF,Mesencephalic astrocyte-derived neurotrophic factor,42675,0.118989367949349,0.011938384663739,0.0955901340084203,0.142388601890277,2.56053310985056e-23
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IGF1R,Insulin-like growth factor 1 receptor,42586,0.0220540202693435,0.00221294440363639,0.0177166492382162,0.0263913913004708,2.59045989563885e-23
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GGACT,Gamma-glutamylaminecyclotransferase,40510,0.0711641254910959,0.00713859143319977,0.0571724862820243,0.0851557647001674,2.60089171712184e-23
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TFPI2,Tissue factor pathway inhibitor 2,42634,0.0381038680094531,0.00382589330226293,0.0306051171370177,0.0456026188818884,2.76091962915157e-23
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ATG4A,Cysteine protease ATG4A,42345,0.059506869777049,0.00597668045318524,0.0477925760888059,0.0712211634652921,2.85531252544168e-23
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DCTD,Deoxycytidylate deaminase,40282,0.0953883468527014,0.00958639992815107,0.0765990029935253,0.114177690711877,3.14333882673085e-23
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GIMAP8,GTPase IMAP family member 8,40079,0.053519129053157,0.00538096173371105,0.0429724440550833,0.0640658140512306,3.29669340840293e-23
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CLPP,"ATP-dependent Clp protease proteolytic subunit, mitochondrial",42475,0.0962753281811814,0.00968922642465728,0.0772844443888531,0.11526621197351,3.48529459936093e-23
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",40282,0.104898597511038,0.010562438089427,0.084196218855761,0.125600976166315,3.80116582418053e-23
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IGFBP7,Insulin-like growth factor-binding protein 7,42793,0.0317523015310808,0.00320080009152617,0.0254787333516895,0.0380258697104721,4.07806372583902e-23
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PPBP,Platelet basic protein,40470,0.0848813742257947,0.00856133378207003,0.0681011600129375,0.101661588438652,4.47433114952589e-23
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PMVK,Phosphomevalonate kinase,42302,0.108787783080992,0.010976183783798,0.0872744628647477,0.130301103297236,4.48345295793949e-23
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CASP7,Caspase-7,40482,0.0840925706655388,0.0084973381475199,0.0674377878963998,0.100747353434678,5.35617252271756e-23
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TNFRSF17,Tumor necrosis factor receptor superfamily member 17,40282,0.0438447904949347,0.00443061729946256,0.035160780587988,0.0525288004018813,5.40242512427652e-23
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CCL2,C-C motif chemokine 2,42474,0.0534236723849049,0.00540622421548961,0.0428274729225452,0.0640198718472645,5.98620065950825e-23
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PCDH7,Protocadherin-7,40448,0.0366356485090328,0.00370672900626989,0.0293704596567438,0.0439008373613218,6.0834059925111e-23
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PFKFB2,"6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2",42568,0.0767098944045589,0.00777002093636762,0.0614806533692784,0.0919391354398394,6.55773808861565e-23
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TST,Thiosulfate sulfurtransferase,42276,0.0747874672561904,0.00757915848218534,0.0599323166311071,0.0896426178812736,6.92012308630354e-23
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MAPKAPK2,MAP kinase-activated protein kinase 2,40301,0.0742763228550622,0.00752666578467806,0.0595240579170932,0.0890285877930312,7.08509922303447e-23
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TNFSF12,Tumor necrosis factor ligand superfamily member 12,42753,0.0282276352444601,0.00286427564113991,0.0226136549878259,0.0338416155010943,7.77633931103754e-23
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DMP1,Dentin matrix acidic phosphoprotein 1,40222,-0.0609732060506593,0.00618443513864057,-0.0730946989223948,-0.0488517131789237,7.77743197546496e-23
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,VASH1,Tubulinyl-Tyr carboxypeptidase 1,42593,0.0812551373461943,0.00824755711248763,0.0650899254057186,0.0974203492866701,8.0306854348863e-23
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GP5,Platelet glycoprotein V,40282,0.0363852590835055,0.00369199461861506,0.0291489496310199,0.043621568535991,8.07818105715928e-23
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IL15RA,Interleukin-15 receptor subunit alpha,42369,0.0362404553106612,0.00368033545333576,0.0290269978221231,0.0434539127991993,8.46044440708095e-23
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CD7,T-cell antigen CD7,40165,0.0449005207851728,0.00455904258293372,0.0359647973226227,0.0538362442477229,8.63311042920079e-23
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,BNIP3L,BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like,40198,0.0439285720947641,0.00446449850443989,0.0351781550260619,0.0526789891634663,9.44106651137833e-23
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RSPO1,R-spondin-1,42494,0.0339674476949215,0.00345437966912234,0.0271968635434417,0.0407380318464013,9.68764570246917e-23
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,F10,Coagulation factor X,40531,0.0284633901660187,0.0028941848995035,0.0227907877629919,0.0341359925690456,9.84071150135049e-23
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CXADR,Coxsackievirus and adenovirus receptor,42593,0.0517756643564592,0.00526684160535861,0.0414526548099563,0.0620986739029621,9.93189066996112e-23
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SPARC,SPARC,42678,0.0696857734841363,0.00709419732592208,0.0557811467253291,0.0835904002429436,1.06893738733988e-22
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,AKR1B1,Aldo-keto reductase family 1 member B1,42345,0.0736910610595635,0.00750511580773901,0.058981034076395,0.088401088042732,1.11844428226467e-22
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,AMIGO2,Amphoterin-induced protein 2,42586,0.0234717191890854,0.00239067798146362,0.0187859903454167,0.0281574480327541,1.12322386749914e-22
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TBL1X,F-box-like/WD repeat-containing protein TBL1X,42345,0.0841158176771854,0.00856742940875469,0.0673236560360262,0.100907979318345,1.12600726276218e-22
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IL7R,Interleukin-7 receptor subunit alpha,42610,-0.0525870996830963,0.00536048629084052,-0.0630936528131437,-0.0420805465530489,1.21345619525411e-22
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FOXO3,Forkhead box protein O3,42345,0.0944905154342669,0.00963974441445685,0.0755966163819315,0.113384414486602,1.31682560454685e-22
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SNX9,Sorting nexin-9,42635,0.0665599333012978,0.0067963846649036,0.0532390193580868,0.0798808472445089,1.42956532098e-22
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IFIT3,Interferon-induced protein with tetratricopeptide repeats 3,40301,0.0381769618004237,0.00389895803070418,0.0305350040602436,0.0458189195406039,1.50961106090339e-22
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CTRB1,Chymotrypsinogen B,42610,0.0577188132050965,0.00590368870244627,0.0461475833483018,0.0692900430618912,1.6846506445699e-22
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MAGED1,Melanoma-associated antigen D1,42345,0.0480157165905845,0.00491380210134276,0.0383846644719527,0.0576467687092163,1.77779303028131e-22
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LGALS4,Galectin-4,42617,0.0560092376197891,0.00574000932423764,0.0447588193442833,0.0672596558952949,2.03009223045962e-22
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,42777,0.0283853147792766,0.00291172538915743,0.022678333016528,0.0340922965420252,2.21398876036534e-22
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,KRT19,"Keratin, type I cytoskeletal 19",42561,0.0698151790566583,0.00716715344472173,0.0557675583050037,0.0838627998083129,2.39198982040089e-22
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ARL13B,ADP-ribosylation factor-like protein 13B,40115,0.0685263539220769,0.00703419006351883,0.05473934139758,0.0823133664465738,2.46303900034606e-22
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NMNAT1,Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1,42494,0.0710387862417766,0.00729682251953849,0.0567370141034811,0.085340558380072,2.52405069480943e-22
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CEACAM1,Carcinoembryonic antigen-related cell adhesion molecule 1,42648,0.0211999748554874,0.0021810911431727,0.0169250362148689,0.0254749134961059,2.93581214598157e-22
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ADGRG1,Adhesion G-protein coupled receptor G1,42586,0.0803797811732568,0.00827019929421512,0.0641701905565951,0.0965893717899184,2.95783661894628e-22
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TNFSF8,Tumor necrosis factor ligand superfamily member 8,40526,0.0366374805177296,0.00376932214937179,0.0292496091049608,0.0440253519304983,3.02889848849262e-22
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TNFSF13,Tumor necrosis factor ligand superfamily member 13,42675,0.0272994692272345,0.00281006306303918,0.0217917456236777,0.0328071928307913,3.08139656050691e-22
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TNFSF10,Tumor necrosis factor ligand superfamily member 10,42753,0.0251961836746943,0.0025948374711306,0.0201103022312783,0.0302820651181103,3.22508926750637e-22
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RNASE3,Eosinophil cationic protein,42577,0.108207447529019,0.0111651018474318,0.0863238479080528,0.130091047149986,3.87144025118328e-22
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,STXBP3,Syntaxin-binding protein 3,42345,0.0426562137104677,0.00440438034926847,0.0340236282259015,0.0512887991950339,4.14110451559046e-22
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PVR,Poliovirus receptor,42710,0.0361455135937718,0.00373575062463345,0.0288234423694902,0.0434675848180534,4.51561635042655e-22
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ANGPT2,Angiopoietin-2,42720,0.0372304538081417,0.00384903526028003,0.0296863446979928,0.0447745629182906,4.64388488359441e-22
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CNST,Consortin,42635,0.106023411120336,0.01099628165351,0.0844706990794561,0.127576123161215,6.27296027946819e-22
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IL6,Interleukin-6,42586,0.0755194737879095,0.00783697338673978,0.0601590059498996,0.0908799416259195,6.61617320255397e-22
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GSR,"Glutathione reductase, mitochondrial",40489,0.0221306597213789,0.00229610637110147,0.0176302912340201,0.0266310282087378,6.68633720207375e-22
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TFF1,Trefoil factor 1,42555,0.0813731952822003,0.0084496028057314,0.0648119737829668,0.0979344167814338,7.00646357043081e-22
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,EDA2R,Tumor necrosis factor receptor superfamily member 27,42720,0.0403425487173973,0.00419001155007426,0.0321301260792518,0.0485549713555428,7.13936807528719e-22
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,STK24,Serine/threonine-protein kinase 24,42310,0.0601510538020737,0.00624708412579867,0.0479067689155083,0.0723953386886391,7.14807000626011e-22
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PCDH17,Protocadherin-17,42635,0.0364586777072627,0.00379082480284264,0.0290286610936911,0.0438886943208342,7.92131539068488e-22
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PPM1F,Protein phosphatase 1F,40510,0.0508645864390041,0.00529594911779812,0.0404845261681198,0.0612446467098885,9.26964230830104e-22
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TOR1AIP1,Torsin-1A-interacting protein 1,40222,0.0511482098502255,0.00532556570534703,0.0407101010677453,0.0615863186327056,9.32967948018434e-22
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,JAM2,Junctional adhesion molecule B,42710,0.0277821167619624,0.00289401650251002,0.0221098444170427,0.033454389106882,9.39321496991731e-22
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GASK1A,Golgi-associated kinase 1A,40115,0.0423837978498016,0.00441560171731241,0.0337292184838693,0.0510383772157339,9.8679827113741e-22
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SLIT2,Slit homolog 2 protein,42310,0.0513544233657588,0.00535430992729949,0.0408599759082518,0.0618488708232658,1.02554878750514e-21
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PSTPIP2,Proline-serine-threonine phosphatase-interacting protein 2,39939,0.104187398399112,0.0108601227126742,0.0829015578822711,0.125473238915954,1.03944848731329e-21
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SART1,U4/U6.U5 tri-snRNP-associated protein 1,40115,0.0366308990498238,0.00382101033815317,0.0291417187870436,0.044120079312604,1.10683873436322e-21
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,REEP4,Receptor expression-enhancing protein 4,40481,0.0604545450503946,0.00630738229018515,0.0480920757616317,0.0728170143391575,1.12094097237192e-21
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DCTN6,Dynactin subunit 6,42310,0.0699313271351233,0.0072986392603103,0.0556259941849152,0.0842366600853315,1.12707015554335e-21
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ARHGEF10,Rho guanine nucleotide exchange factor 10,40481,0.0908222446516778,0.00947875577470194,0.072243883333262,0.109400605970094,1.15444016769143e-21
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SUSD1,Sushi domain-containing protein 1,42356,0.0478963310660391,0.00500803290010404,0.0380805865818352,0.057712075550243,1.33292377897989e-21
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SMAD5,Mothers against decapentaplegic homolog 5,42586,0.0194977419171156,0.00203941358336635,0.0155004912937176,0.0234949925405137,1.37382040703841e-21
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,APPL2,DCC-interacting protein 13-beta,40282,0.108213533130615,0.0113148373176987,0.0860364519879254,0.130390614273304,1.37413553700824e-21
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DOK1,Docking protein 1,40482,0.131915915468755,0.0138094569080572,0.104849379928963,0.158982451008548,1.52588302989674e-21
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TNFAIP2,Tumor necrosis factor alpha-induced protein 2,40448,0.0449392227918054,0.00470582819350047,0.0357157995325444,0.0541626460510663,1.5694848219934e-21
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RARRES1,Retinoic acid receptor responder protein 1,42345,0.0320185721373059,0.003357286161706,0.0254382912603622,0.0385988530142497,1.72463154804337e-21
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PTH1R,Parathyroid hormone/parathyroid hormone-related peptide receptor,42593,0.0370668643146838,0.003888579274384,0.0294452489368911,0.0446884796924764,1.8004354521194e-21
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,C7orf50,Uncharacterized protein C7orf50,40482,0.02211421882112,0.00232052109045915,0.01756599748382,0.0266624401584199,1.89648390297372e-21
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CASP8,Caspase-8,42673,0.0593309464404531,0.00622906020213123,0.0471219884442759,0.0715399044366303,1.93026800613264e-21
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CEMIP2,Cell surface hyaluronidase,40198,0.0334083232546471,0.00350995929659789,0.0265288030333153,0.040287843475979,2.13074712096284e-21
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,40198,0.0325235654270546,0.00341804715380075,0.0258241930056052,0.0392229378485041,2.19059821390496e-21
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,AMOTL2,Angiomotin-like protein 2,40403,0.0468280969275779,0.00492309505433005,0.037178830621091,0.0564773632340648,2.25343373878991e-21
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PALM,Paralemmin-1,40383,0.0306269945210681,0.00322285509879292,0.024310198527434,0.0369437905147022,2.45283583825344e-21
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ADAMTS4,A disintegrin and metalloproteinase with thrombospondin motifs 4,40198,0.0340594912347352,0.00358602308455412,0.0270308859890091,0.0410880964804613,2.5858250742849e-21
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FCRL6,Fc receptor-like protein 6,42593,0.0675883916663403,0.00712364349778374,0.0536260504106842,0.0815507329219965,2.74952751812036e-21
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MRI1,Methylthioribose-1-phosphate isomerase,40181,0.0665116536012473,0.00701138221396403,0.0527693444618778,0.0802539627406167,2.88862481270202e-21
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,VSIG2,V-set and immunoglobulin domain-containing protein 2,40450,0.0641157093036845,0.00675925775741621,0.0508675640991488,0.0773638545082203,2.8929667765707e-21
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LTA4H,Leukotriene A-4 hydrolase,42720,0.056498131584312,0.00596043583526997,0.0448156773471829,0.0681805858214411,2.99233932330169e-21
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CR2,Complement receptor type 2,42688,0.0462314259749705,0.00487810148008724,0.0366703470739995,0.0557925048759415,3.03701025887055e-21
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CXCL8,Interleukin-8,42493,0.0672162634437176,0.0070947063357886,0.0533106390255719,0.0811218878618633,3.13776474976248e-21
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,INPP1,Inositol polyphosphate 1-phosphatase,42586,0.0509515248504476,0.0053784061961779,0.0404098487059389,0.0614932009949563,3.15816039402644e-21
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,OPLAH,5-oxoprolinase,40222,0.0652983684419113,0.00689584527555901,0.0517825117018157,0.078814225182007,3.39298639898758e-21
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ENAH,Protein enabled homolog,42369,0.0454062016354266,0.00479852546368593,0.0360010917266022,0.054811311544251,3.50903245416856e-21
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MTUS1,Microtubule-associated tumor suppressor 1,40301,0.0546105534998757,0.00577050537124474,0.043300362972236,0.0659207440275154,3.56999662263568e-21
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CDKN2D,Cyclin-dependent kinase 4 inhibitor D,42586,0.0892846121679594,0.00945550029939702,0.0707518315811412,0.107817392754778,4.22892981134958e-21
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LRPAP1,Alpha-2-macroglobulin receptor-associated protein,42710,0.0552139918931637,0.00584771986093607,0.043752460965729,0.0666755228205984,4.24887770909179e-21
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TRAF2,TNF receptor-associated factor 2,42593,0.0663821963084552,0.00703253446473786,0.052598428757569,0.0801659638593414,4.36349454774644e-21
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RPE,Ribulose-phosphate 3-epimerase,40301,0.06730931311351,0.00713034897592928,0.0533338291206886,0.0812847971063314,4.47789710130026e-21
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RAB33A,Ras-related protein Rab-33A,40115,0.0631130773017679,0.00669011298918216,0.0500004558429709,0.076225698760565,4.75641345054874e-21
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SPINT1,Kunitz-type protease inhibitor 1,42564,0.0250919178936876,0.00266563946315527,0.0198672645459033,0.030316571241472,5.59388536913538e-21
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MAMDC4,Apical endosomal glycoprotein,40450,0.0527544436307228,0.00560512015691278,0.0417684081231738,0.0637404791382719,5.82134918407565e-21
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,AKT2,RAC-beta serine/threonine-protein kinase,40481,0.120368597211549,0.0127949641827687,0.0952904674133227,0.145446727009776,6.06146457178862e-21
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CDK5RAP3,CDK5 regulatory subunit-associated protein 3,40481,0.0557010683111934,0.00592361637555921,0.0440907802150974,0.0673113564072895,6.31112332467537e-21
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FABP3,"Fatty acid-binding protein, heart",40510,0.0502506129367686,0.00535221161797363,0.0397602781655403,0.0607409477079969,7.22974667000404e-21
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PRSS27,Serine protease 27,42602,0.0384733813065408,0.00409986648420002,0.0304376429975087,0.0465091196155728,7.35503645751236e-21
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DHPS,Deoxyhypusine synthase,40450,0.0387403437010066,0.00412777848730745,0.030649897865884,0.0468307895361292,7.47752965800055e-21
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RAD23B,UV excision repair protein RAD23 homolog B,42345,0.0444935906727807,0.0047469527152452,0.0351895633509001,0.0537976179946613,8.17930287754361e-21
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RBFOX3,RNA binding protein fox-1 homolog 3,40481,0.0384486047205743,0.00410561733363964,0.0304015947466406,0.046495614694508,9.05484498861978e-21
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GAS6,Growth arrest-specific protein 6,42717,-0.0241287933041794,0.00257758625229369,-0.029180862358675,-0.0190767242496837,9.12673596534272e-21
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TDP1,Tyrosyl-DNA phosphodiesterase 1,40450,0.0644186213125626,0.00688307056840096,0.0509278029984967,0.0779094396266285,9.5738581827247e-21
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ARAF,Serine/threonine-protein kinase A-Raf,40301,0.0654787415214638,0.00700071607529961,0.0517573380138765,0.079200145029051,1.01372904167045e-20
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,BAMBI,BMP and activin membrane-bound inhibitor homolog,42345,0.0285009814068756,0.00305221743143805,0.022518635241257,0.0344833275724942,1.13957412946298e-20
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,KLKB1,Plasma kallikrein,40292,0.0234453763229401,0.00251177605103269,0.018522295262916,0.0283684573829642,1.21116264779198e-20
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GNAS,Neuroendocrine secretory protein 55,40481,0.0817780384979125,0.00876516941342301,0.0645983064476034,0.0989577705482216,1.25722925909709e-20
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TCL1A,T-cell leukemia/lymphoma protein 1A,42489,0.0959568051159715,0.01028805218217,0.0757922228389184,0.116121387393025,1.25879075478995e-20
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MOG,Myelin-oligodendrocyte glycoprotein,42720,0.0322380028635804,0.00346038159737689,0.0254556549327217,0.0390203507944391,1.38805351375702e-20
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,COX6B1,Cytochrome c oxidase subunit 6B1,40510,0.0310284512007619,0.00333212226960101,0.0244974915523439,0.0375594108491799,1.48668697829454e-20
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TSPYL1,Testis-specific Y-encoded-like protein 1,40198,0.0381992480296268,0.00410906517189455,0.0301454802927135,0.0462530157665402,1.72771541858165e-20
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NEDD4L,E3 ubiquitin-protein ligase NEDD4-like,40198,0.0473521444108034,0.00509439432808184,0.037367131527763,0.0573371572938438,1.75017433031829e-20
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,VAMP5,Vesicle-associated membrane protein 5,42356,0.0525133819565715,0.00565310640756235,0.0414332933977493,0.0635934705153937,1.79378693728119e-20
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PPL,Periplakin,40198,0.0315913238999018,0.00340063451254853,0.0249260802553067,0.0382565675444969,1.83573221612972e-20
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PNMA1,Paraneoplastic antigen Ma1,40222,0.0527302700616282,0.00568845352354894,0.0415809011554723,0.0638796389677841,2.21339943820404e-20
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CDC37,Hsp90 co-chaperone Cdc37,42678,0.0783447139664495,0.00845654609937124,0.0617698836116819,0.0949195443212171,2.25495678977692e-20
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IGFBP3,Insulin-like growth factor-binding protein 3,42688,0.0298740816744387,0.00322474933746895,0.0235535729729996,0.0361945903758779,2.26283470558804e-20
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CD200R1,Cell surface glycoprotein CD200 receptor 1,42557,0.0331225808086401,0.0035766342877268,0.0261123776046956,0.0401327840125846,2.33391944320354e-20
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FADD,FAS-associated death domain protein,42635,0.0709522263255332,0.00766337084429452,0.0559320194707159,0.0859724331803505,2.38039022153252e-20
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,OSM,Oncostatin-M,42533,0.0658334597053159,0.00711042216457915,0.0518970322627407,0.079769887147891,2.38050275481045e-20
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ANKMY2,Ankyrin repeat and MYND domain-containing protein 2,40198,0.0751675894333666,0.00812467499921381,0.0592432264349075,0.0910919524318256,2.6158755861621e-20
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SLC9A3R2,Na(+)/H(+) exchange regulatory cofactor NHE-RF2,40448,0.0483336306371973,0.00522474757388726,0.0380931253923783,0.0585741358820163,2.62706988668752e-20
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GLRX,Glutaredoxin-1,42545,0.0526508351085942,0.00569622601689968,0.0414862321154708,0.0638154381017175,2.75218248909043e-20
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CHM,Rab proteins geranylgeranyltransferase component A 1,40181,0.0573794518104319,0.00621160251254824,0.0452047108858373,0.0695541927350264,2.98786135900494e-20
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ZNRF4,E3 ubiquitin-protein ligase ZNRF4,40450,0.051947675426391,0.00563176167424068,0.0409094225448793,0.0629859283079028,3.36963413606913e-20
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,VNN1,Pantetheinase,40531,0.0685100749593525,0.00742954788973255,0.0539481610954767,0.0830719888232283,3.45271685546955e-20
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PPIF,"Peptidyl-prolyl cis-trans isomerase F, mitochondrial",40526,0.0592935867207373,0.00643531995485993,0.0466803596092118,0.0719068138322627,3.70193930739193e-20
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,XG,Glycoprotein Xg,42733,0.0322785061623299,0.00351114443713291,0.0253966630655495,0.0391603492591104,4.3636533825893e-20
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DNAJC21,DnaJ homolog subfamily C member 21,40482,0.0358822102854314,0.00390367721752669,0.0282310029390791,0.0435334176317837,4.53397867888243e-20
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FXYD5,FXYD domain-containing ion transport regulator 5,42369,0.0614168121072538,0.00668696699290347,0.048310356801163,0.0745232674133446,4.74206628208654e-20
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CASP2,Caspase-2,42593,0.0625379120349584,0.00681907367506989,0.0491725276318214,0.0759032964380954,5.3601126644737e-20
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,S100A12,Protein S100-A12,42433,0.0702428279810829,0.00766377942095346,0.0552218203160141,0.0852638356461517,5.64628157972218e-20
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GGH,Gamma-glutamyl hydrolase,42436,0.0318838734491675,0.00347868374214753,0.0250656533145583,0.0387020935837766,5.64925198960855e-20
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CEBPB,CCAAT/enhancer-binding protein beta,42356,0.0354901647865368,0.00387236705474695,0.0279003253592327,0.0430800042138408,5.68103814223358e-20
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,EHD3,EH domain-containing protein 3,40222,0.109378903261371,0.0119504892713493,0.0859559442895259,0.132801862233215,6.53135894040667e-20
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LILRB2,Leukocyte immunoglobulin-like receptor subfamily B member 2,42736,0.0323051936284958,0.00353325675890894,0.0253800103810343,0.0392303768759573,6.91698467074323e-20
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SCRIB,Protein scribble homolog,40222,0.0846903688205195,0.00926567286473166,0.0665296500056454,0.102851087635394,7.32201691558978e-20
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,EPCAM,Epithelial cell adhesion molecule,42615,-0.0917190202553342,0.0100431009864648,-0.111403498188805,-0.0720345423218632,7.63616504633686e-20
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ACADSB,"Short/branched chain specific acyl-CoA dehydrogenase, mitochondrial",40510,0.0829134846590549,0.00908611978857747,0.0651046898734431,0.100722279444667,8.36299575888383e-20
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IL32,Interleukin-32,42593,-0.0409877146920429,0.00449600727395091,-0.0497998889489867,-0.0321755404350991,8.8511519133038e-20
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SLC16A1,Monocarboxylate transporter 1,42310,0.0534020826209901,0.00586046989605998,0.0419155616247126,0.0648886036172677,9.22590471069416e-20
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NRGN,Neurogranin,40531,0.0842905713316871,0.00925760265524257,0.0661456701274117,0.102435472535963,1.00663440254028e-19
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,WNT9A,Protein Wnt-9a,42369,0.0275028822536818,0.00302249613741053,0.0215787898243572,0.0334269746830065,1.03724004967019e-19
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,42617,0.0271063705440037,0.00298090011366961,0.0212638063212112,0.0329489347667961,1.0935164602236e-19
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,KLB,Beta-klotho,42310,-0.0690966869525626,0.00760471622460779,-0.0840019307527938,-0.0541914431523313,1.17272123461914e-19
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IL7,Interleukin-7,42593,0.0584532103804247,0.00643407091059458,0.0458424313956593,0.0710639893651901,1.18106833232563e-19
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LGALS3,Galectin-3,42668,0.0275941257430793,0.00304506193434176,0.0216258043517694,0.0335624471343891,1.45615623451008e-19
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LILRB1,Leukocyte immunoglobulin-like receptor subfamily B member 1,42793,0.0253046006939057,0.00279249927411143,0.0198313021166473,0.0307778992711641,1.45835803830688e-19
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PIKFYVE,1-phosphatidylinositol 3-phosphate 5-kinase,40198,0.0500121972584534,0.00552644023246375,0.0391803744028245,0.0608440201140824,1.67568178369697e-19
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PSPN,Persephin,42593,0.0854331437080797,0.00946038700816722,0.066890785172072,0.103975502244087,1.93744541485532e-19
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,AK1,Adenylate kinase isoenzyme 1,42635,0.0577796300770695,0.00640473240521684,0.0452263545628445,0.0703329055912945,2.10581590888748e-19
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CTSE,Cathepsin E,40282,0.0472606937631581,0.00524297433543009,0.0369844640657152,0.0575369234606011,2.31024774559395e-19
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PRSS22,Brain-specific serine protease 4,40198,0.0336038159564829,0.00373170952637259,0.0262896652847926,0.0409179666281732,2.51286828858066e-19
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IL1B,Interleukin-1 beta,42292,0.0520742769972007,0.00579007691865087,0.040725726236645,0.0634228277577564,2.71504793817864e-19
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SUGT1,Protein SGT1 homolog,42345,0.0731510344416488,0.00813459471728736,0.0572072287957655,0.089094840087532,2.74143563782211e-19
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RGS10,Regulator of G-protein signaling 10,40481,0.05437388971889,0.00605048457386601,0.0425149399541126,0.0662328394836674,2.95203563991618e-19
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SLC27A4,Long-chain fatty acid transport protein 4,42310,0.0608296760168645,0.00678556747792846,0.0475299637601248,0.0741293882736043,3.53202044355186e-19
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MAVS,Mitochondrial antiviral-signaling protein,42345,0.0825149324074423,0.00920809657269825,0.0644670631249537,0.100562801689931,3.64205260521474e-19
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PTPRN2,Receptor-type tyrosine-protein phosphatase N2,42457,0.0317185451472989,0.00353965155612993,0.0247808280972842,0.0386562621973136,3.64495267175875e-19
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ERI1,3'-5' exoribonuclease 1,40301,0.0314958504161233,0.00351630673020334,0.0246038892249248,0.0383878116073219,3.86469130545165e-19
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GPC5,Glypican-5,42494,0.0512436278725898,0.00572626497907848,0.040020148513596,0.0624671072315837,4.0614913910823e-19
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CARHSP1,Calcium-regulated heat-stable protein 1,42310,0.0475015201243741,0.00531030374996121,0.0370933247744501,0.0579097154742981,4.20679304188395e-19
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FDX2,"Ferredoxin-2, mitochondrial",40115,0.0516888862179169,0.00577746830089386,0.040365048348165,0.0630127240876689,4.25623384041531e-19
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ACOX1,Peroxisomal acyl-coenzyme A oxidase 1,42635,0.044695128645748,0.00499918605456325,0.034896723978804,0.0544935333126919,4.37457220351566e-19
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RAB10,Ras-related protein Rab-10,40510,0.0485702232185153,0.00544236808847143,0.0379031817651113,0.0592372646719193,5.16696228383335e-19
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MICALL2,MICAL-like protein 2,40181,0.062523846040517,0.00701777695610492,0.0487690032065513,0.0762786888744826,5.94160784040285e-19
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CD40LG,CD40 ligand,42753,0.0701153045575173,0.00787701936032782,0.0546763466112747,0.0855542625037598,6.21505457354848e-19
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CCDC134,Coiled-coil domain-containing protein 134,40450,0.0442979439913269,0.00497529568686047,0.0345463644450804,0.0540495235375734,6.23498923635353e-19
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SIGLEC9,Sialic acid-binding Ig-like lectin 9,42705,0.0267278836624234,0.00300654664611285,0.0208350522360422,0.0326207150888046,6.8828827813736e-19
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,42688,-0.0338708473941711,0.00381337775341638,-0.0413450677908672,-0.026396626997475,7.38015121478323e-19
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LY6D,Lymphocyte antigen 6D,42547,0.0368680728694559,0.00415434419441581,0.0287255582484009,0.0450105874905109,7.90349536165733e-19
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PECAM1,Platelet endothelial cell adhesion molecule,42610,0.0271484386706615,0.00305930359781592,0.0211522036189423,0.0331446737223807,7.93622263360462e-19
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MNDA,Myeloid cell nuclear differentiation antigen,42610,0.0875836882906788,0.00987308159731362,0.0682324483599441,0.106934928221414,8.15904792501754e-19
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TSNAX,Translin-associated protein X,40115,0.0357649418959257,0.00403084315017102,0.0278644893215905,0.0436653944702609,8.24267838968903e-19
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TFF2,Trefoil factor 2,42653,0.0524901210783691,0.0059200517766339,0.0408868195961666,0.0640934225605715,8.48729898153887e-19
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,AGER,Advanced glycosylation end product-specific receptor,42586,0.0378197467270784,0.00426783994139337,0.0294547804419474,0.0461847130122094,8.87417290158237e-19
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GAL,Galanin peptides,42675,-0.0578673444505116,0.00653448795638259,-0.0706749408450215,-0.0450597480560017,9.34504020871907e-19
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CFC1,Cryptic protein,42345,0.0427344495382434,0.00482679356992831,0.0332739341411839,0.0521949649353029,9.54865235709238e-19
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LAIR2,Leukocyte-associated immunoglobulin-like receptor 2,42494,0.0967269325288963,0.0109273093672618,0.0753094061690631,0.118144458888729,9.68468688912786e-19
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CRACR2A,EF-hand calcium-binding domain-containing protein 4B,42345,0.0759391206574164,0.00857944375873305,0.0591234108902997,0.0927548304245332,9.74655471892615e-19
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PTPRK,Receptor-type tyrosine-protein phosphatase kappa,40448,0.0194991343204408,0.00220341353170595,0.0151804437982971,0.0238178248425845,1.01017390925425e-18
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,EGF,Pro-epidermal growth factor,42596,0.091973494956852,0.0104027909400191,0.0715840247144145,0.11236296519929,1.06357594252422e-18
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IFNG,Interferon gamma,42369,0.101558940351985,0.0114958090596591,0.0790271545950536,0.124090726108917,1.13216590898138e-18
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,EIF2S2,Eukaryotic translation initiation factor 2 subunit 2,40222,0.0375893032826559,0.00425378405776881,0.029251886529429,0.0459267200358827,1.13552206492537e-18
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GNPDA2,Glucosamine-6-phosphate isomerase 2,40282,0.0330362546039728,0.0037400171586231,0.0257058209730716,0.0403666882348741,1.17040105778604e-18
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LAMB1,Laminin subunit beta-1,40222,0.0274139937351107,0.00310488053934575,0.021328427877993,0.0334995595922284,1.21212255344249e-18
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SETMAR,Histone-lysine N-methyltransferase SETMAR,42458,0.026742784983236,0.00303538938685158,0.0207934217850069,0.0326921481814651,1.40127040602666e-18
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TEK,Angiopoietin-1 receptor,42678,0.0196514016606799,0.00223237031080095,0.01527595585151,0.0240268474698497,1.49347387950026e-18
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FCRL3,Fc receptor-like protein 3,42369,0.0505706752176826,0.00574638931202403,0.0393077521661155,0.0618335982692497,1.5310523051079e-18
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SPINK4,Serine protease inhibitor Kazal-type 4,42593,0.0620188638563093,0.0070550492754736,0.0481909672763811,0.0758467604362376,1.66544918310648e-18
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MYO9B,Unconventional myosin-IXb,42369,0.0587578522871702,0.00669906728226104,0.0456276804139385,0.0718880241604018,1.98533737853708e-18
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PNLIPRP1,Inactive pancreatic lipase-related protein 1,40482,0.0734274575979596,0.00837181418761677,0.0570187017902307,0.0898362134056884,2.02818960064516e-18
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FOLR1,Folate receptor alpha,42599,0.0270965101805845,0.00309042327863673,0.0210392805544565,0.0331537398067125,2.03739907480483e-18
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ITIH4,Inter-alpha-trypsin inhibitor heavy chain H4,40538,0.0229004528864407,0.0026114717873617,0.0177819681832118,0.0280189375896696,2.05601230669394e-18
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ADGRD1,Adhesion G-protein coupled receptor D1,40282,0.0343146714374041,0.00391757361233041,0.0266362271572365,0.0419931157175717,2.25255131043064e-18
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NMT1,Glycylpeptide N-tetradecanoyltransferase 1,40481,0.0591032775011215,0.00675906548312357,0.0458555091541993,0.0723510458480437,2.56143329991619e-18
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RAB2B,Ras-related protein Rab-2B,40450,0.05398624604196,0.00617465051076312,0.0418839310408642,0.0660885610430557,2.58705685208172e-18
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,COMT,Catechol O-methyltransferase,42213,0.073704766409958,0.00844956917331384,0.0571436108302628,0.0902659219896531,3.03793970613536e-18
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ATRAID,All-trans retinoic acid-induced differentiation factor,40448,0.0265250731086018,0.00304149514518271,0.0205637426240437,0.0324864035931599,3.14261374414992e-18
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,42356,0.0435438013184744,0.00499420656848199,0.0337551564442497,0.0533324461926991,3.14377816473371e-18
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GIPC2,PDZ domain-containing protein GIPC2,40482,0.0275748558799307,0.00316348381270979,0.0213744276070195,0.0337752841528418,3.26651754207582e-18
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PLA2G4A,Cytosolic phospholipase A2,42675,0.0764832741959064,0.00878062121776033,0.0592732566090961,0.0936932917827166,3.3753773823769e-18
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,EPPK1,Epiplakin,40222,0.0645050624460426,0.00740948359559205,0.0499824745986821,0.079027650293403,3.60389752667142e-18
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PRTFDC1,Phosphoribosyltransferase domain-containing protein 1,42310,0.0979560870682515,0.0112610622830842,0.0758844049934064,0.120027769143097,3.75484031222785e-18
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CPXM1,Probable carboxypeptidase X1,42678,0.0613718901430343,0.00706015065391272,0.0475339948613654,0.0752097854247032,3.94329340311453e-18
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LRIG3,Leucine-rich repeats and immunoglobulin-like domains protein 3,40172,0.0243366075304809,0.00279942479080172,0.0188497349405096,0.0298234801204523,4.01631324668412e-18
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CASP1,Caspase-1,42310,0.0612616961026926,0.00705240119953396,0.047438989751606,0.0750844024537791,4.17114634346824e-18
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,INSR,Insulin receptor,40198,0.0154070924432711,0.00177445576462001,0.0119291591446159,0.0188850257419263,4.40933250164328e-18
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TACSTD2,Tumor-associated calcium signal transducer 2,40979,-0.0280707521987473,0.00323372660690854,-0.034408856348288,-0.0217326480492065,4.45183422690669e-18
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NFYA,Nuclear transcription factor Y subunit alpha,40115,0.0347039005107878,0.00399852339828216,0.0268667946501548,0.0425410063714209,4.55212769267428e-18
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TRIM40,E3 ubiquitin ligase TRIM40,40181,0.0634947406575131,0.00731963038257495,0.0491482651076662,0.07784121620736,4.7347204603766e-18
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TIGAR,"Fructose-2,6-bisphosphatase TIGAR",42291,0.0414715546658338,0.00478479973711043,0.0320933471810974,0.0508497621505703,4.93781525064667e-18
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FCRL5,Fc receptor-like protein 5,42610,0.0520827655684888,0.00601289115269452,0.0402974989092075,0.06386803222777,5.16729974003793e-18
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RRM2B,Ribonucleoside-diphosphate reductase subunit M2 B,42345,0.0585304208503508,0.00675924633232059,0.0452822980390024,0.0717785436616992,5.29441613890922e-18
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CALCOCO1,Calcium-binding and coiled-coil domain-containing protein 1,42656,0.0902978773351067,0.010444246786274,0.0698271536340097,0.110768601036204,5.94613621167877e-18
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DAPP1,Dual adapter for phosphotyrosine and 3-phosphotyrosine and 3-phosphoinositide,42593,0.104730853498156,0.0121195165879867,0.0809766009857024,0.12848510601061,6.17074249367269e-18
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GATD3,"Glutamine amidotransferase-like class 1 domain-containing protein 3B, mitochondrial",40222,0.0674501728741067,0.007804018102409,0.052154297393385,0.0827460483548283,6.2310238844338e-18
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ERN1,Serine/threonine-protein kinase/endoribonuclease IRE1,40450,0.033621827667096,0.00389179436736239,0.0259939107070657,0.0412497446271263,6.4262473971431e-18
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,EDN1,Endothelin-1,40222,0.0268811807081055,0.00311249374000876,0.0207806929776883,0.0329816684385227,6.59123326804498e-18
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PRDX5,"Peroxiredoxin-5, mitochondrial",42753,0.0579195105998365,0.00671093979660139,0.0447660685984978,0.0710729526011752,6.77575359713169e-18
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GIPC3,PDZ domain-containing protein GIPC3,40448,0.0856186451573089,0.00991818926333848,0.0661789942011655,0.105058296113452,6.80998225815112e-18
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,F12,Coagulation factor XII,40538,0.0365129836521033,0.00423166444269961,0.028218921344412,0.0448070459597945,7.0420065003869e-18
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MGLL,Monoglyceride lipase,42653,0.0748718877341178,0.00869089922314978,0.0578377252567443,0.0919060502114914,7.76758776793431e-18
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ALDH5A1,"Succinate-semialdehyde dehydrogenase, mitochondrial",40481,0.0421985474501679,0.00489795346773906,0.0325985586533994,0.0517985362469365,7.88580994073621e-18
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NFATC3,"Nuclear factor of activated T-cells, cytoplasmic 3",42369,0.052127381914705,0.00605569644064316,0.0402582168910444,0.0639965469383656,8.27141550622589e-18
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MGMT,Methylated-DNA--protein-cysteine methyltransferase,42593,0.104410129416264,0.0121417916918506,0.0806122177002367,0.128208041132291,8.90783702138757e-18
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CCN3,CCN family member 3,42778,0.0310513763167058,0.00361483647143924,0.0239662968326848,0.0381364558007267,9.63758133616833e-18
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DBN1,Drebrin,40198,0.0437624902810314,0.00509411778512343,0.0337780194221895,0.0537469611398734,9.80231722852968e-18
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PINLYP,phospholipase A2 inhibitor and Ly6/PLAUR domain-containing protein,40282,0.0617873711600721,0.00721141662253524,0.0476529945799031,0.0759217477402412,1.1923561119163e-17
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TIMM8A,Mitochondrial import inner membrane translocase subunit Tim8 A,40482,0.0746736402356089,0.00872516072070808,0.0575723252230211,0.0917749552481968,1.29204083921591e-17
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,BLMH,Bleomycin hydrolase,42793,0.0272359418234507,0.00318358866844318,0.0209961080333021,0.0334757756135994,1.30247432665028e-17
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ITPA,Inosine triphosphate pyrophosphatase,40115,0.058520435039951,0.00685448809290498,0.0450856383778572,0.0719552317020447,1.55276456169814e-17
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PTPRR,Receptor-type tyrosine-protein phosphatase R,40482,0.0329256821655484,0.00385792645006554,0.0253641463234199,0.0404872180076768,1.58666340886431e-17
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GALNT2,Polypeptide N-acetylgalactosaminyltransferase 2,42720,0.0231493251406308,0.00271457330255383,0.0178287614676253,0.0284698888136363,1.64861802285324e-17
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IFNGR1,Interferon gamma receptor 1,42675,0.0189252871199757,0.00222844280133748,0.0145575392293542,0.0232930350105971,2.23031150875393e-17
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IL1RAP,Interleukin-1 receptor accessory protein,42610,-0.0388120670699608,0.004573532315889,-0.0477761904091032,-0.0298479437308183,2.3564335765444e-17
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CSF3R,Granulocyte colony-stimulating factor receptor,40198,0.0261132782777515,0.00307869877340247,0.0200790286818827,0.0321475278736204,2.49827421331202e-17
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GP1BB,Platelet glycoprotein Ib beta chain,40115,0.0596459669794813,0.00704900516947672,0.0458299168473069,0.0734620171116557,2.97347353086254e-17
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CRTAM,Cytotoxic and regulatory T-cell molecule,42494,0.0448039092801205,0.00530230286557554,0.0344113956635925,0.0551964228966486,3.21628962060214e-17
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SFTPA2,Pulmonary surfactant-associated protein A2,42345,0.0448794436158853,0.00532057378973736,0.0344511189880001,0.0553077682437706,3.65275954155514e-17
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TXN,Thioredoxin,40383,0.0383777830299531,0.00455193423783546,0.0294559919237956,0.0472995741361106,3.84403916845921e-17
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FRZB,Secreted frizzled-related protein 3,42453,0.0213955700605616,0.00253833909863423,0.0164204254272385,0.0263707146938847,3.84449164539268e-17
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RALY,RNA-binding protein Raly,40450,0.0407709379438012,0.00484424154029072,0.0312762245248314,0.050265651362771,4.35255778829017e-17
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,BGLAP,Osteocalcin,40526,0.0775043861133444,0.00922581873692323,0.0594217813889749,0.095586990837714,4.96195858184573e-17
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SPINK6,Serine protease inhibitor Kazal-type 6,42720,0.0457396644119204,0.00544641684492519,0.0350646873958671,0.0564146414279738,4.98498481395529e-17
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CASP3,Caspase-3,42793,0.0739039796834924,0.00880576096134922,0.056644688199248,0.0911632711677369,5.21713652997233e-17
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DEFB103A_DEFB103B,Beta-defensin 103,40134,0.0365269267830679,0.00435093771771838,0.0279990888563399,0.0450547647097959,5.22488166032053e-17
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SGSH,N-sulphoglucosamine sulphohydrolase,40331,0.0488253849080122,0.00582079853443924,0.0374166197805113,0.0602341500355131,5.53649954035436e-17
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IL19,Interleukin-19,42260,0.0617221482188152,0.00736722503565752,0.0472823871489264,0.0761619092887039,5.93255782515367e-17
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CD84,SLAM family member 5,42593,0.0266797961237556,0.00318493547482215,0.0204373225931042,0.0329222696544071,5.97189754975656e-17
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ANGPT1,Angiopoietin-1,42553,0.071087890783486,0.0085013255126487,0.0544252927786945,0.0877504887882774,6.77389813305505e-17
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CYTL1,Cytokine-like protein 1,40526,0.0218224649448584,0.0026096625090143,0.0167075264271904,0.0269374034625264,6.87631077495013e-17
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,AKT3,RAC-gamma serine/threonine-protein kinase,42296,0.0481518904808218,0.00576302789697865,0.0368563558027436,0.0594474251589,7.1786181847298e-17
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",42458,0.0353693653749676,0.00423618100311628,0.0270664506088597,0.0436722801410755,7.53946129494915e-17
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MPRIP,Myosin phosphatase Rho-interacting protein,40416,0.0370233197486157,0.00443375416342738,0.028333161588298,0.0457134779089334,7.60582997889567e-17
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CCL24,C-C motif chemokine 24,42653,0.0700095323459966,0.00840746968140502,0.0535308917704428,0.0864881729215504,9.08180852613939e-17
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MINDY1,Ubiquitin carboxyl-terminal hydrolase MINDY-1,40450,0.0913111513812075,0.0109705512435837,0.0698088709437834,0.112813431818632,9.54220211762039e-17
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TIGIT,T-cell immunoreceptor with Ig and ITIM domains,40301,0.0316843631794039,0.00380746051958158,0.024221740561024,0.0391469857977838,9.68881834921913e-17
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PKN3,Serine/threonine-protein kinase N3,40301,0.0634835629957556,0.00763984108876058,0.0485094744617849,0.0784576515297264,1.07239774210699e-16
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,REG4,Regenerating islet-derived protein 4,42637,0.0444596855143201,0.00535385504600273,0.0339661296241548,0.0549532414044855,1.09997894477585e-16
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,AKR7L,Aflatoxin B1 aldehyde reductase member 4,40198,0.0580140706550216,0.0069849885928492,0.0443234930130372,0.071704648297006,1.11009526026916e-16
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ARFIP1,Arfaptin-1,40481,0.0577432535099633,0.00697139650455736,0.0440793163610309,0.0714071906588957,1.33786653932126e-16
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DENR,Density-regulated protein,40198,0.0480013490799047,0.00581406717400947,0.0366057774188462,0.0593969207409633,1.6774786700077e-16
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,42494,0.0255266636710373,0.00309586379760452,0.0194587706277324,0.0315945567143421,1.79938543994105e-16
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NAP1L4,Nucleosome assembly protein 1-like 4,40427,0.0349336299918522,0.00423601845810369,0.0266310338139689,0.0432362261697354,1.80787340189467e-16
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DAPK2,Death-associated protein kinase 2,40198,0.045536068632572,0.00552516236399246,0.0347067503991468,0.0563653868659972,1.89228283889403e-16
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NECTIN4,Nectin-4,42678,0.0289445698568624,0.00351507526803625,0.0220550223315114,0.0358341173822135,1.96935292417663e-16
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DNPEP,Aspartyl aminopeptidase,40482,0.047978384308774,0.0058266205607607,0.036558208009683,0.0593985606078649,2.00414019693838e-16
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PDCD1LG2,Programmed cell death 1 ligand 2,42586,0.026756743475958,0.0032514689169486,0.0203838643987387,0.0331296225531772,2.05897835681973e-16
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RBP7,Retinoid-binding protein 7,40448,0.0505426525223796,0.0061444476424033,0.0384995351432691,0.0625857699014901,2.15302883827548e-16
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MAP2K6,Dual specificity mitogen-activated protein kinase kinase 6,42593,0.0825186865385101,0.0100353977573623,0.06284930693408,0.10218806614294,2.17057064981238e-16
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DMD,Dystrophin,40222,0.0432919578662517,0.00526543698718047,0.032971701371378,0.0536122143611254,2.22727164245067e-16
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DHRS4L2,Dehydrogenase/reductase SDR family member 4-like 2,40482,0.0393933706147528,0.00479454227507773,0.0299960677556004,0.0487906734739051,2.32773556290667e-16
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GOT1,"Aspartate aminotransferase, cytoplasmic",40526,0.0343414047172341,0.00418875054573188,0.0261314536475996,0.0425513557868686,2.69636540516207e-16
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GAST,Gastrin,40482,0.12146912558856,0.0148609329960935,0.0923416969162171,0.150596554260904,3.30930572611836e-16
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,BAG3,BAG family molecular chaperone regulator 3,42474,0.0337452553468353,0.00413190273604942,0.0256467259841784,0.0418437847094921,3.44527810115143e-16
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SERPINB9,Serpin B9,42494,0.0272427024673256,0.00334063655344035,0.0206950548225825,0.0337903501120687,3.80462712826044e-16
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,KLRK1,NKG2-D type II integral membrane protein,40482,0.0406857965605512,0.00499067724466209,0.0309040691610136,0.0504675239600889,3.945669725754e-16
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SNX5,Sorting nexin-5,40222,0.0241708986374243,0.00297058888137934,0.0183485444299208,0.0299932528449278,4.49656242168854e-16
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,AHCY,Adenosylhomocysteinase,42635,0.0554179329311058,0.00682401786591185,0.0420428579139186,0.068793007948293,5.02354233502715e-16
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PARD3,Partitioning defective 3 homolog,40301,0.0615687330899385,0.0075932610092586,0.0466859415117917,0.0764515246680854,5.6704353997749e-16
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MMP1,Interstitial collagenase,42135,0.0752846593031457,0.00929035807621024,0.0570755574737736,0.0934937611325178,5.81564914015611e-16
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GBP2,Guanylate-binding protein 2,42369,0.0500702178582637,0.0061843924004838,0.0379488087533155,0.0621916269632119,6.16429510903328e-16
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NDUFS6,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial",42345,0.0637929166832381,0.00788074049562812,0.048346665311807,0.0792391680546692,6.23800998903403e-16
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,EGFLAM,Pikachurin,40448,0.0256815565407966,0.00317328013607293,0.0194619274740936,0.0319011856074995,6.41612553418675e-16
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,STX16,Syntaxin-16,42345,0.047559156715588,0.00588957404279648,0.0360155915917069,0.0591027218394691,7.32314985169406e-16
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GP6,Platelet glycoprotein VI,42589,0.0712923735180561,0.00884439114442142,0.0539573668749901,0.0886273801611221,8.22247904353766e-16
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TRDMT1,tRNA (cytosine(38)-C(5))-methyltransferase,40301,0.0748747409439005,0.0092881498987521,0.0566699671423463,0.0930795147454546,8.32117737525032e-16
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,BAG6,Large proline-rich protein BAG6,42356,0.0291693104499255,0.00362050506468725,0.0220731205231385,0.0362655003767125,8.51001406228163e-16
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PLG,Plasminogen,40284,0.0176075891661768,0.00218658083028563,0.013321890738817,0.0218932875935367,8.93615223060642e-16
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DSC2,Desmocollin-2,42487,0.0291327594065981,0.00361904385723787,0.0220394334464119,0.0362260853667843,8.99013983728121e-16
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IFNL1,Interferon lambda-1,42310,0.0375488232511261,0.00467624037654397,0.0283833921131,0.0467142543891523,1.0599631179206e-15
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FOLR2,Folate receptor beta,42710,0.024211235768994,0.00301623649633932,0.0182994122361689,0.030123059301819,1.08113650777951e-15
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SDK2,Protein sidekick-2,40282,0.0332497387074703,0.00414304744533679,0.0251293657146102,0.0413701117003304,1.1136976873085e-15
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,KLK6,Kallikrein-6,42655,0.0258845982731936,0.00322830471259825,0.019557121036501,0.0322120755098862,1.16287422629157e-15
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,KRT8,"Keratin, type II cytoskeletal 8",40135,0.0666939628037204,0.00831655000401124,0.0503935247958584,0.0829944008115825,1.17066980878713e-15
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RNF5,E3 ubiquitin-protein ligase RNF5,40222,0.0598819268778792,0.00747122195088874,0.0452383318541373,0.0745255219016212,1.21232546847427e-15
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ASRGL1,Isoaspartyl peptidase/L-asparaginase,40222,0.0831757912874344,0.0103865495438436,0.0628181541815009,0.103533428393368,1.28273451216896e-15
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TXNDC15,Thioredoxin domain-containing protein 15,42678,0.0223594295250437,0.00280373804370493,0.016864102959382,0.0278547560907053,1.647744129299e-15
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ICAM5,Intercellular adhesion molecule 5,42635,0.0372200992567018,0.0046726087579467,0.0280617860911263,0.0463784124222774,1.77592525895467e-15
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DDR1,Epithelial discoidin domain-containing receptor 1,42710,0.0188652511658429,0.00237372920704904,0.0142127419200268,0.023517760411659,2.05289050819126e-15
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CA2,Carbonic anhydrase 2,42572,0.0561176555453673,0.00707240100569875,0.0422557495741977,0.0699795615165368,2.27634830476973e-15
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SPON1,Spondin-1,42637,0.0273684319988019,0.00344931591913788,0.0206077727972917,0.0341290912003122,2.28075229753879e-15
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SMS,Spermine synthase,40135,0.0517980723842529,0.0065305060386202,0.0389982805485573,0.0645978642199485,2.37202753141661e-15
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,OXCT1,"Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial",40222,0.0561033211354705,0.00707648983547158,0.0422334010579462,0.0699732412129948,2.43922538071578e-15
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DIABLO,"Diablo homolog, mitochondrial",42602,0.0875184187663171,0.0110434555140201,0.0658732459588378,0.109163591573796,2.46245155340276e-15
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PZP,Pregnancy zone protein,40538,0.0412164247333924,0.00520721399047771,0.0310102853120561,0.0514225641547287,2.69693531695988e-15
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ERBB4,Receptor tyrosine-protein kinase erbB-4,42678,-0.0193237064950188,0.00244269700238976,-0.0241113926197027,-0.0145360203703349,2.75554460914368e-15
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SCGB3A1,Secretoglobin family 3A member 1,40282,-0.0216667346733058,0.00273972252975603,-0.0270365908316277,-0.016296878514984,2.85530626966192e-15
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NID2,Nidogen-2,42610,0.0594834027068328,0.00753060031752649,0.0447234260844809,0.0742433793291847,3.03193094986549e-15
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DRAXIN,Draxin,42494,0.0353024225832009,0.00447118919038523,0.0265388917700458,0.044065953396356,3.11635822491239e-15
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CD55,Complement decay-accelerating factor,42200,0.0218992043227196,0.00277565567994047,0.0164589191900363,0.0273394894554029,3.26926349405189e-15
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SERPINA7,Thyroxine-binding globulin,40538,0.0148849362983082,0.00188717255731515,0.0111860780859705,0.0185837945106459,3.36754521115831e-15
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TLR3,Toll-like receptor 3,42753,0.0489537703647568,0.0062144357431075,0.0367734763082661,0.0611340644212475,3.59514614457544e-15
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,KLK13,Kallikrein-13,42380,0.0368601317559936,0.00469984829025717,0.0276484291070896,0.0460718344048977,4.74236400866296e-15
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CORO1A,Coronin-1A,42352,0.0711378934912258,0.00907405157416586,0.0533527524058607,0.0889230345765909,4.86222671821131e-15
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,KIF1C,Kinesin-like protein KIF1C,40115,0.0287931763082781,0.00367837384624245,0.0215835635696429,0.0360027890469133,5.42835798210621e-15
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LEPR,Leptin receptor,42635,-0.0248215950818452,0.0031719675288536,-0.0310386514383982,-0.0186045387252921,5.44145823614448e-15
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GRK5,G protein-coupled receptor kinase 5,42356,0.0404569976574569,0.00517451074258143,0.0303149566019973,0.0505990387129165,5.75005518432761e-15
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CSDE1,Cold shock domain-containing protein E1,40115,0.0931862352120601,0.0119180644920046,0.0698268288077312,0.116545641616389,5.81862026159664e-15
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CD1C,T-cell surface glycoprotein CD1c,42678,0.0200231199973034,0.00256342507413259,0.0149988068520035,0.0250474331426033,6.08749152970466e-15
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,THBS2,Thrombospondin-2,42610,0.0308699333361377,0.00396039022266872,0.023107568499707,0.0386322981725684,6.93166189537445e-15
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CA13,Carbonic anhydrase 13,42482,0.0814186796981719,0.0104457128077661,0.0609450825949504,0.101892276801393,6.94790660595915e-15
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,C4BPB,C4b-binding protein beta chain,42678,0.0318939110100048,0.00409850494245884,0.0238608413227855,0.0399269806972242,7.66606502236708e-15
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,HDGF,Hepatoma-derived growth factor,42699,0.0734693611862565,0.00946944267549658,0.0549092535422832,0.0920294688302298,9.20339354426449e-15
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3,42369,0.0339959301375191,0.00438654935917057,0.0253982933935448,0.0425935668814934,9.85747577383199e-15
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CD69,Early activation antigen CD69,42584,0.0688193594386219,0.00888106033484102,0.0514124811823335,0.0862262376949103,9.92670944630184e-15
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MAN2B2,Epididymis-specific alpha-mannosidase,40510,0.0475562466567217,0.00613694827302012,0.0355278280416023,0.0595846652718412,1.00401611534515e-14
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ENOX2,Ecto-NOX disulfide-thiol exchanger 2,40115,0.0225317614469279,0.00291078461444673,0.0168266236026124,0.0282368992912435,1.07527127983985e-14
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CGREF1,Cell growth regulator with EF hand domain protein 1,42635,0.0341628300063555,0.00441648420410436,0.0255065209663109,0.0428191390464,1.10484591773694e-14
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,UXS1,UDP-glucuronic acid decarboxylase 1,42345,0.041624505536471,0.00539805764318558,0.0310443125558273,0.0522046985171147,1.33770218070181e-14
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IL4R,Interleukin-4 receptor subunit alpha,42593,0.0297396589274091,0.00386003904186889,0.0221739824053461,0.0373053354494722,1.40566709865964e-14
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SMTN,Smoothelin,40459,0.0723749587268662,0.00940352737465451,0.0539440450725434,0.0908058723811891,1.514326982994e-14
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,OLR1,Oxidized low-density lipoprotein receptor 1,42520,0.045307260199147,0.00588938495150179,0.0337640656942035,0.0568504547040905,1.53748661559105e-14
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ITGAV,Integrin alpha-V,42720,-0.0128547993927077,0.00167132060769191,-0.0161305877837839,-0.0095790110016316,1.55562802485432e-14
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,STX6,Syntaxin-6,42345,0.0517917128226051,0.00673586960031311,0.0385894084059914,0.0649940172392188,1.5887015433053e-14
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FGFBP1,Fibroblast growth factor-binding protein 1,42678,0.025803884051838,0.00335709607819509,0.0192239757385757,0.0323837923651004,1.61807807051307e-14
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NEDD9,Enhancer of filamentation 1,40198,0.0261452361578427,0.00340478610406717,0.019471855393871,0.0328186169218143,1.73972940104194e-14
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SDC4,Syndecan-4,42635,0.0368091062982121,0.00479529057878954,0.0274103367637846,0.0462078758326396,1.75299270697961e-14
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,HMGCL,"Hydroxymethylglutaryl-CoA lyase, mitochondrial",40222,0.038160194647751,0.00497063037881134,0.0284177591052808,0.0479026301902213,1.76433593032754e-14
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DNM1,Dynamin-1,40448,0.0893702104041841,0.0116426711491851,0.0665505749517813,0.112189845856587,1.77578200921459e-14
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CAT,Catalase,40360,0.0425094089018679,0.00555071914429576,0.0316299993790483,0.0533888184246876,2.03873230605473e-14
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CHAC2,Glutathione-specific gamma-glutamylcyclotransferase 2,42345,0.0469836073636412,0.00613915398473938,0.034950865553552,0.0590163491737304,2.09820820823316e-14
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PECR,Peroxisomal trans-2-enoyl-CoA reductase,40222,0.0221325120843055,0.00289293135078617,0.0164623666367646,0.0278026575318464,2.16794752667337e-14
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LPCAT2,Lysophosphatidylcholine acyltransferase 2,42586,0.0308564933397445,0.00403877507046617,0.0229404942016308,0.0387724924778582,2.31831790399192e-14
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CEP170,Centrosomal protein of 170 kDa,40222,0.0601796999109048,0.00787726061093996,0.0447402691134624,0.0756191307083471,2.35809405265425e-14
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ELOB,Elongin-B,40115,0.0313355525399298,0.00410314257590624,0.0232933930911536,0.0393777119887061,2.40983480698402e-14
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,BGN,Biglycan,42327,-0.0935205001601056,0.0122495051216417,-0.117529530198523,-0.0695114701216879,2.42076557177483e-14
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CALCB,Calcitonin gene-related peptide 2,40482,0.0320014783816179,0.0041945684709067,0.0237801241786408,0.0402228325845951,2.55075390593259e-14
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SNX2,Sorting nexin-2,40450,0.0639869206914899,0.00839390181195508,0.0475348731400579,0.0804389682429219,2.67713814845306e-14
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,STK4,Serine/threonine-protein kinase 4,42635,0.0663543489170719,0.00870674021273929,0.0492891381001029,0.0834195597340409,2.68475759180238e-14
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,THPO,Thrombopoietin,42356,0.0301776334345229,0.00396898656365228,0.0223984197697644,0.0379568470992813,3.08062257535633e-14
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FUT8,"Alpha-(1,6)-fucosyltransferase",42494,0.0454916495226663,0.00599303916556019,0.0337452927581683,0.0572380062871643,3.39211789683452e-14
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,BIN2,Bridging integrator 2,42610,0.0696810259772896,0.00918091837929449,0.0516864259538724,0.0876756260007068,3.41590351116526e-14
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,AXL,Tyrosine-protein kinase receptor UFO,42688,0.0214248858546683,0.0028239785510613,0.0158898878945882,0.0269598838147485,3.49407411601191e-14
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RANBP1,Ran-specific GTPase-activating protein,40222,0.0406397171113008,0.00535692561310933,0.0301401429096065,0.0511392913129951,3.55422178012513e-14
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,HEPH,Hephaestin,40510,0.0205043600683625,0.00270326916470535,0.01520595250554,0.025802767631185,3.58459528817764e-14
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IGLC2,Immunoglobulin lambda constant 2,40518,0.0196418172406733,0.00259003731631471,0.0145653441006965,0.0247182903806502,3.62365922363377e-14
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,KIT,Mast/stem cell growth factor receptor Kit,42662,-0.0232689290578686,0.00306918062849968,-0.029284523089728,-0.0172533350260093,3.63949743970466e-14
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,VSTM2L,V-set and transmembrane domain-containing protein 2-like protein,42356,0.0446873811721321,0.0059018689536826,0.0331197180229142,0.05625504432135,3.92775179387133e-14
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ITGA6,Integrin alpha-6,42593,0.0390723788207299,0.00516779495928325,0.0289435007005347,0.0492012569409251,4.2679047731579e-14
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ANXA4,Annexin A4,42583,0.0548406351764066,0.00726150842193873,0.0406080786694066,0.0690731916834065,4.55519311084397e-14
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FGF2,Fibroblast growth factor 2,42593,0.0524822112962897,0.00694945365851134,0.0388612821256075,0.0661031404669719,4.56357152415286e-14
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ADAMTSL4,ADAMTS-like protein 4,40222,0.0183508488894106,0.00243045158038848,0.0135871637918492,0.023114533986972,4.68226326569115e-14
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,EDF1,Endothelial differentiation-related factor 1,40481,0.0516562022442271,0.00684297165783589,0.0382439777948688,0.0650684266935855,4.73124556004815e-14
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GIP,Gastric inhibitory polypeptide,40222,0.0448848707366254,0.00599357289157096,0.0331374678691464,0.0566322736041045,7.47938695394374e-14
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CEACAM19,Carcinoembryonic antigen-related cell adhesion molecule 19,40448,0.0312761896337338,0.0041861769619876,0.0230712827882381,0.0394810964792294,8.52862086816637e-14
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PTGR1,Prostaglandin reductase 1,40510,0.063871587344107,0.00855072897589428,0.0471121585513542,0.0806310161368598,8.62758675924006e-14
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ARL2BP,ADP-ribosylation factor-like protein 2-binding protein,40115,0.0308862727936353,0.00413762913809184,0.0227765196829753,0.0389960259042953,8.98262374081603e-14
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CDA,Cytidine deaminase,40493,0.035706773567579,0.00478362243877085,0.0263308735875881,0.0450826735475699,8.98424778115704e-14
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LHPP,Phospholysine phosphohistidine inorganic pyrophosphate phosphatase,42618,0.0443777165350026,0.00595234911839174,0.0327111122629548,0.0560443208070504,9.50123344912589e-14
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TMCO5A,Transmembrane and coiled-coil domain-containing protein 5A,40181,0.0420457647783977,0.0056394634087717,0.0309924164972052,0.0530991130595903,9.61701726428985e-14
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ADGRE5,Adhesion G protein-coupled receptor E5,42736,0.0236652683727055,0.00317664560383886,0.0174390429891813,0.0298914937562296,9.91621993445852e-14
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CBLIF,Cobalamin binding intrinsic factor,42612,0.0614144837227458,0.0082499696819674,0.0452445431460897,0.0775844242994019,1.03466447542325e-13
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ICAM3,Intercellular adhesion molecule 3,42793,0.0204109720712521,0.00274302436681123,0.0150346443123021,0.0257872998302021,1.05879281967773e-13
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CBS,Cystathionine beta-synthase,40222,0.0390679908849031,0.00525262323201209,0.0287728493501594,0.0493631324196468,1.09973284401701e-13
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CSNK1D,Casein kinase I isoform delta,40198,0.0477313404639234,0.0064211401446263,0.0351459057804559,0.060316775147391,1.13641136035979e-13
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SIL1,Nucleotide exchange factor SIL1,40222,0.0235628068878268,0.00316995037816691,0.0173497041466196,0.0297759096290339,1.13871421061077e-13
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IMPA1,Inositol monophosphatase 1,42494,0.045718968795594,0.00615370276877722,0.0336577113687906,0.0577802262223973,1.15648410685966e-13
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LUZP2,Leucine zipper protein 2,40450,0.034906576356611,0.0047048249723586,0.0256851194107881,0.0441280333024338,1.26201224110398e-13
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SRC,Proto-oncogene tyrosine-protein kinase Src,42663,0.0893432754208077,0.0120495871741843,0.0657260845594065,0.112960466282209,1.29240236287508e-13
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RAB44,Ras-related protein Rab-44,40450,0.031812258357169,0.0042933448287028,0.0233973024929115,0.0402272142214265,1.35681192385306e-13
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,STAU1,Double-stranded RNA-binding protein Staufen homolog 1,40079,0.0495218052899465,0.00668622201581368,0.0364168101389517,0.0626268004409413,1.39223145034361e-13
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,VGF,Neurosecretory protein VGF,40481,0.0238904811203353,0.00322680657990946,0.0175659402237128,0.0302150220169579,1.41808526479395e-13
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GZMB,Granzyme B,42593,0.0499588108957079,0.0067540953121786,0.0367207840838378,0.0631968377075779,1.47775456011546e-13
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PMM2,Phosphomannomutase 2,40115,0.0452676548966095,0.00614170556817381,0.0332299119829889,0.0573053978102302,1.82229934707436e-13
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,BCL2L15,Bcl-2-like protein 15,40198,0.0423340696022698,0.00575250052633904,0.0310591685706453,0.0536089706338944,1.98134710271479e-13
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,POMC,Pro-opiomelanocortin,40222,0.0524171482892687,0.00715288938030662,0.0383974851038678,0.0664368114746697,2.49742172668435e-13
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GBA,Lysosomal acid glucosylceramidase,40181,0.0416089726296224,0.0056789898902994,0.0304781524446356,0.0527397928146092,2.52193526521643e-13
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,AGR2,Anterior gradient protein 2 homolog,42214,0.0756916866320999,0.0103468007730299,0.0554119571169613,0.0959714161472384,2.71497201158007e-13
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PPME1,Protein phosphatase methylesterase 1,42586,0.0444255878558028,0.00607667017506818,0.0325153143126692,0.0563358613989365,2.80525076622398e-13
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MRPL58,"Peptidyl-tRNA hydrolase ICT1, mitochondrial",40481,0.0542154046986144,0.00741731058910806,0.0396774759439626,0.0687533334532662,2.86660686780873e-13
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,BDNF,Brain-derived neurotrophic factor,40526,0.0623204372037265,0.00854218652386728,0.0455777516169466,0.0790631227905063,3.17164822935505e-13
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,AZU1,Azurocidin,42215,0.056627713563295,0.00776663797572358,0.0414051031308767,0.0718503239957132,3.250673909768e-13
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,XRCC4,DNA repair protein XRCC4,42310,0.0273958115056123,0.00375940117231834,0.0200273852078684,0.0347642378033563,3.34360405338735e-13
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,BAX,Apoptosis regulator BAX,42291,0.0659358900324431,0.00905744033935706,0.0481833069673033,0.0836884730975829,3.53517025789584e-13
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ANXA1,Annexin A1,40234,0.0309040685841815,0.00425712464706885,0.0225601042759265,0.0392480328924364,4.15017598275451e-13
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CFB,Complement factor B,40343,0.0239697179301984,0.00330247576922831,0.0174968654225109,0.0304425704378859,4.18649143135181e-13
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MMP8,Neutrophil collagenase,42680,0.0539227490122761,0.00743775612262394,0.0393447470119331,0.068500751012619,4.39889203695631e-13
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CLEC7A,C-type lectin domain family 7 member A,42753,0.0449479190231661,0.00620115615957262,0.0327936529504038,0.0571021850959285,4.44822032094568e-13
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,WFDC1,WAP four-disulfide core domain protein 1,40228,0.0418603237206891,0.00577677930721367,0.0305378362785503,0.0531828111628279,4.56877447313011e-13
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,USP28,Ubiquitin carboxyl-terminal hydrolase 28,40482,0.0281149809560802,0.00388720567515269,0.0204960578327809,0.0357339040793795,5.04140195243021e-13
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ANGPTL1,Angiopoietin-related protein 1,42438,0.0214019817082202,0.00296269374324666,0.0155951019714568,0.0272088614449837,5.33080218421846e-13
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DYNLT3,Dynein light chain Tctex-type 3,40450,0.0319975074659764,0.00443810100786653,0.023298829490558,0.0406961854413947,5.96557412883574e-13
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NEFL,Neurofilament light polypeptide,42261,0.0340252836843819,0.00472411051170928,0.0247660270814317,0.0432845402873321,6.23677093330874e-13
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MAP3K5,Mitogen-activated protein kinase kinase kinase 5,42345,0.0717337472163953,0.00997615781781933,0.0521804778934694,0.0912870165393212,6.80338411376375e-13
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TMPRSS11D,Transmembrane protease serine 11D,40469,0.0301306136774131,0.00419067230748878,0.0219168959547351,0.0383443314000912,6.89287422196956e-13
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TIE1,Tyrosine-protein kinase receptor Tie-1,42793,0.0301574590532829,0.00419586355698466,0.021933566481593,0.0383813516249729,6.94659197149285e-13
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ENO2,Gamma-enolase,42710,0.0471000654984545,0.00655402968184975,0.034254167322029,0.05994596367488,6.99949554565261e-13
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TBC1D5,TBC1 domain family member 5,42593,0.0571169812637781,0.0079541930082539,0.0415267629676005,0.0727071995599558,7.29916880575375e-13
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ANXA10,Annexin A10,42310,0.0632488585126197,0.00881460691724414,0.0459722289548212,0.0805254880704183,7.59367682235543e-13
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LCP1,Plastin-2,40526,0.0351330210523608,0.00489733980827602,0.0255342350281397,0.0447318070765818,7.74376796048226e-13
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GPR15L,Protein GPR15L,40448,0.0445525904242318,0.00622957857212998,0.032342616422857,0.0567625644256066,9.0972178763193e-13
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LTB,Lymphotoxin-beta,40450,0.0261606071138172,0.00366652671597238,0.0189742147505114,0.0333469994771231,1.02746043858379e-12
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FCGR3B,Low affinity immunoglobulin gamma Fc region receptor III-B,42652,0.0357846557693445,0.00501642615170001,0.0259524605120125,0.0456168510266765,1.02852959134199e-12
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,POSTN,Periostin,40526,-0.0280006064798806,0.0039344601927149,-0.0357121484576018,-0.0202890645021594,1.1716674629427e-12
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,C5,Complement C5,40538,0.0109224142476413,0.00153849777876417,0.00790695860126353,0.0139378698940191,1.32782105245747e-12
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TSHB,Thyrotropin subunit beta,42635,0.0573462675868566,0.00808047253739131,0.0415085414135696,0.0731839937601436,1.33987451608135e-12
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SV2A,Synaptic vesicle glycoprotein 2A,40181,0.0453549971747682,0.0064023251881266,0.03280643980604,0.0579035545434963,1.48466872426265e-12
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TARS1,"Threonine--tRNA ligase 1, cytoplasmic",40450,0.0272987839956844,0.00385498014184113,0.0197430229176758,0.034854545073693,1.51174274115408e-12
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PGLYRP2,N-acetylmuramoyl-L-alanine amidase,40420,0.0217562180788022,0.00308569438653922,0.0157082570811853,0.027804179076419,1.88512036219937e-12
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CLGN,Calmegin,40181,0.0334382172449864,0.00475894326519551,0.0241106884452032,0.0427657460447696,2.24484879942942e-12
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,C1R,Complement C1r subcomponent,40538,0.0139461965626767,0.00198572473129905,0.0100541760893305,0.0178382170360228,2.29199653111791e-12
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,WAS,Wiskott-Aldrich syndrome protein,42369,0.0472846318080719,0.00674910960473622,0.0340563769827889,0.0605128866333549,2.57043136265216e-12
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LAG3,Lymphocyte activation gene 3 protein,42586,0.0293400960286254,0.00419169606705137,0.0211243717372048,0.0375558203200461,2.68961253595083e-12
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MYOM3,Myomesin-3,40282,-0.0664822789865182,0.00949677485375586,-0.0850959576998797,-0.0478686002731567,2.69767239902986e-12
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CTSC,Dipeptidyl peptidase 1,42615,0.0313480171602711,0.00448011559471225,0.0225669905946351,0.0401290437259071,2.73623986419898e-12
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,EPHB4,Ephrin type-B receptor 4,42793,0.0188107045818254,0.00269171109331765,0.0135349508389228,0.024086458324728,2.91025144262223e-12
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FLT1,Vascular endothelial growth factor receptor 1,42558,0.0154385140912415,0.00220933191380281,0.0111082235401879,0.019768804642295,2.92327218330543e-12
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SPAG1,Sperm-associated antigen 1,40481,0.04093735686966,0.00585859006419207,0.0294545203438435,0.0524201933954765,2.95422711791579e-12
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LYAR,Cell growth-regulating nucleolar protein,42345,0.038720939419362,0.00554306375238561,0.0278565344646862,0.0495853443740377,2.97549766101593e-12
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,F13B,Coagulation factor XIII B chain,40478,0.0184608545127678,0.00264235059533806,0.0132818473459052,0.0236398616796304,2.9763798625421e-12
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CCS,Copper chaperone for superoxide dismutase,42494,0.0337933658624598,0.00483894779321614,0.0243090281877562,0.0432777035371635,3.01339571213127e-12
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PTPRH,Receptor-type tyrosine-protein phosphatase H,40448,0.0351443492608336,0.00503277610308678,0.0252801080987835,0.0450085904228836,3.05018053737868e-12
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CA1,Carbonic anhydrase 1,42361,0.0426625075275038,0.00613192464780786,0.0306439352178004,0.0546810798372072,3.6289127081895e-12
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,AARSD1,Alanyl-tRNA editing protein Aarsd1,42586,0.0389074918003536,0.0055935094170391,0.027944213342957,0.0498707702577503,3.66769283114697e-12
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IL17RB,Interleukin-17 receptor B,42415,-0.0377306358299264,0.00542911133077716,-0.0483716940382496,-0.0270895776216032,3.83252818015259e-12
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LIF,Leukemia inhibitory factor,42310,0.0365089907696407,0.00525347415938725,0.0262121814172417,0.0468058001220397,3.83919785887885e-12
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NAA10,N-alpha-acetyltransferase 10,40115,0.0365212186437939,0.00525849526414542,0.0262145679260689,0.046827869361519,3.99452507173425e-12
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DPEP2,Dipeptidase 2,42586,0.02090267449617,0.00301362224657927,0.0149959748928746,0.0268093740994654,4.21683955482448e-12
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TLR1,Toll-like receptor 1,40198,0.0190003843094949,0.00273989698980629,0.0136301862094746,0.0243705824095152,4.29884369088567e-12
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SPRR3,Small proline-rich protein 3,40482,0.0496956420910228,0.00716737417434325,0.03564758870931,0.0637436954727356,4.32685144571014e-12
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SESTD1,SEC14 domain and spectrin repeat-containing protein 1,42310,0.0449759730427125,0.00648795620305216,0.0322595788847303,0.0576923672006947,4.33653406594467e-12
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,JUN,Transcription factor AP-1,42369,0.0338389104812247,0.00488223983101965,0.0242697204124262,0.0434081005500232,4.37255983550218e-12
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PREB,Prolactin regulatory element-binding protein,42369,0.0207730301439704,0.00300424316444396,0.0148847135416602,0.0266613467462805,4.9093978933404e-12
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,COQ7,"5-demethoxyubiquinone hydroxylase, mitochondrial",40222,0.0312421291884931,0.00452115425430189,0.0223806668500614,0.0401035915269248,5.10622556602861e-12
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LY96,Lymphocyte antigen 96,42494,0.025164174893569,0.00364322006034104,0.0180234635753006,0.0323048862118374,5.17058340475877e-12
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SNAP25,Synaptosomal-associated protein 25,40135,0.0335228604061891,0.00485542786606754,0.0240062217886968,0.0430394990236815,5.32831588211739e-12
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MERTK,Tyrosine-protein kinase Mer,42753,0.0179383705432085,0.0026045073909305,0.0128335360569847,0.0230432050294323,5.93114214291274e-12
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CLMP,CXADR-like membrane protein,42720,0.0154198063735733,0.00224147928840332,0.0110265069683028,0.0198131057788438,6.27923702836057e-12
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FIS1,Mitochondrial fission 1 protein,42623,0.0523540888054072,0.0076404603878496,0.037378786445222,0.0673293911655924,7.58846470096909e-12
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,VCAM1,Vascular cell adhesion protein 1,42662,0.0195193504579706,0.00285176422772068,0.0139298925716381,0.0251088083443032,7.99765526328537e-12
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,C2CD2L,Phospholipid transfer protein C2CD2L,42291,0.0300451283123949,0.00439219437621273,0.021436427335018,0.0386538292897719,8.23806781296222e-12
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RCOR1,REST corepressor 1,42356,0.0308453844049262,0.00451982684248135,0.0219865237936627,0.0397042450161896,9.21198980632335e-12
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FCGR2A,Low affinity immunoglobulin gamma Fc region receptor II-a,42585,0.0421153480489376,0.00617391656313155,0.0300144715851998,0.0542162245126754,9.39665293943392e-12
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NEK7,Serine/threonine-protein kinase Nek7,40301,0.0531333480964579,0.0077927946598602,0.0378594705631319,0.0684072256297839,9.69263318563073e-12
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CABP2,Calcium-binding protein 2,40181,0.0450871620204534,0.00661448604613431,0.0321227693700302,0.0580515546708767,9.82234319273794e-12
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RAB6A,Ras-related protein Rab-6A,42593,-0.0318338160014773,0.00467122589221173,-0.0409894187502123,-0.0226782132527423,9.83800799130397e-12
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PSMD9,26S proteasome non-ATPase regulatory subunit 9,42586,0.0379116434653799,0.00556470426541019,0.027004823105176,0.0488184638255839,9.97536910964795e-12
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MSLN,Mesothelin,42552,0.0413952288799431,0.00608469640645463,0.029469223923292,0.0533212338365942,1.06700316984416e-11
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ATP6V1F,V-type proton ATPase subunit F,42291,0.0460613690724729,0.00677045499927263,0.0327912772738985,0.0593314608710472,1.06700756179896e-11
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DIPK2B,Divergent protein kinase domain 2B,40282,0.0194575059981979,0.00286213697930632,0.0138477175187575,0.0250672944776383,1.11341120384323e-11
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NAMPT,Nicotinamide phosphoribosyltransferase,42345,0.0362522926736547,0.00533730104610467,0.0257911826232896,0.0467134027240199,1.1514371540546e-11
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,UNC79,Protein unc-79 homolog,40079,0.0385644454165644,0.00568786222573361,0.0274162354541265,0.0497126553790023,1.26285319022355e-11
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CEACAM3,Carcinoembryonic antigen-related cell adhesion molecule 3,42345,0.032990703364455,0.00486785959029265,0.0234496985674814,0.0425317081614286,1.27705028625558e-11
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TPMT,Thiopurine S-methyltransferase,42345,0.0501754587596719,0.00741515487727281,0.0356417552002172,0.0647091623191266,1.37419014661714e-11
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NT5C3A,Cytosolic 5'-nucleotidase 3A,42569,0.0595780978703362,0.00880745329175049,0.0423154894185053,0.0768407063221672,1.39323963922801e-11
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NXPH1,Neurexophilin-1,42310,0.0268400956493861,0.00397481281867585,0.0190494625247814,0.0346307287739907,1.5139452621437e-11
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,KAZALD1,Kazal-type serine protease inhibitor domain-containing protein 1,42586,0.0314010702999221,0.00465202343292682,0.0222831043713855,0.0405190362284586,1.53952373790068e-11
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,COPB2,Coatomer subunit beta',40115,0.0299388727994236,0.00443824964467686,0.0212399034958569,0.0386378421029902,1.60048095436133e-11
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IGHMBP2,DNA-binding protein SMUBP-2,40115,0.0379003224331638,0.00561941291952131,0.026886273110902,0.0489143717554256,1.61276221843554e-11
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DDC,Aromatic-L-amino-acid decarboxylase,42612,-0.0326402846166063,0.00484266144668112,-0.0421319010521013,-0.0231486681811113,1.64682420566849e-11
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CCER2,Coiled-coil domain-containing glutamate-rich protein 2,40222,0.0446962303235572,0.00663172259076545,0.0316980540456569,0.0576944066014575,1.66561149953174e-11
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,COL4A1,Collagen alpha-1(IV) chain,42635,-0.0272641204304351,0.00406508305906964,-0.0352316832262116,-0.0192965576346586,2.06746359824453e-11
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ACP6,Lysophosphatidic acid phosphatase type 6,42688,0.0468089274123209,0.00698290046280224,0.0331224425052285,0.0604954123194133,2.11768840415605e-11
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SCN4B,Sodium channel subunit beta-4,40222,0.0302124603840387,0.00450708923502018,0.0213785654833992,0.0390463552846783,2.13682646141489e-11
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CDH1,Cadherin-1,42187,0.0271862936852726,0.00406005668711288,0.0192285825785314,0.0351440047920139,2.2295219575022e-11
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,BRSK2,Serine/threonine-protein kinase BRSK2,40481,0.0260005283133159,0.00389021506635034,0.0183757067832693,0.0336253498433626,2.44175228756548e-11
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,KLK8,Kallikrein-8,42153,0.0253899401622605,0.00381400307094104,0.017914494143216,0.0328653861813049,2.90667744699734e-11
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PLIN3,Perilipin-3,42635,0.0284693395822688,0.00428640784755664,0.0200679802010578,0.0368706989634798,3.21856063596512e-11
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MAMDC2,MAM domain-containing protein 2,40510,0.0247719479673694,0.00373353321232389,0.0174542228712146,0.0320896730635242,3.39340157712167e-11
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MPIG6B,Megakaryocyte and platelet inhibitory receptor G6b,42653,0.0509695806716376,0.00768576607729968,0.0359054791601303,0.066033682183145,3.44545354374949e-11
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,S100A13,Protein S100-A13,40198,0.0241259081169407,0.00364046178506871,0.016990603018206,0.0312612132156754,3.58210486509927e-11
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CLEC11A,C-type lectin domain family 11 member A,42591,0.033167544615631,0.00500781047238819,0.0233522360897502,0.0429828531415118,3.6500952151658e-11
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,HSPA2,Heat shock-related 70 kDa protein 2,40450,0.02325649175906,0.00351528281487237,0.0163665374419102,0.0301464460762099,3.86248075487811e-11
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CRYGD,Gamma-crystallin D,40482,0.0657984354978065,0.00994808087213855,0.0463001969884149,0.085296674007198,3.90488242689042e-11
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NFAT5,Nuclear factor of activated T-cells 5,40198,0.0582630496807528,0.00882914881212112,0.0409579180089954,0.0755681813525102,4.33126411704513e-11
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CD86,T-lymphocyte activation antigen CD86,40448,0.02052028878047,0.00311265663581925,0.0144194817742642,0.0266210957866757,4.51729678949005e-11
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SFTPA1,Pulmonary surfactant-associated protein A1,42345,0.0387637316967594,0.00588725296863654,0.0272247158782318,0.0503027475152871,4.74235524204813e-11
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NFIC,Nuclear factor 1 C-type,40481,0.0320030147133047,0.00486188416420461,0.0224737217514637,0.0415323076751457,4.83334672863998e-11
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,EFCAB2,Dynein regulatory complex protein 8,40301,0.0235021286074633,0.00357042701717809,0.0165040916537942,0.0305001655611323,4.83636585508022e-11
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SERPINI1,Neuroserpin,40266,0.0203988606368423,0.00310024294768018,0.0143223844593891,0.0264753368142955,4.92468257351224e-11
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,HRG,Histidine-rich glycoprotein,40478,0.0207509543677369,0.00315445459793413,0.014568223355786,0.0269336853796878,4.96897801069218e-11
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TGOLN2,Trans-Golgi network integral membrane protein 2,40531,0.0183312199950876,0.00279135710931465,0.0128601600608309,0.0238022799293443,5.35349291521138e-11
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TSPAN1,Tetraspanin-1,42356,0.0454624071173959,0.00692909042754389,0.0318813898794098,0.0590434243553819,5.54136416672308e-11
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SMARCA2,Probable global transcription activator SNF2L2,42310,0.048595191675357,0.00741690296839083,0.0340580618573109,0.063132321493403,5.89107690462635e-11
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SELL,L-selectin,40538,0.0159363894497595,0.0024408489838777,0.0111523254413592,0.0207204534581598,6.90204396545345e-11
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ARHGAP1,Rho GTPase-activating protein 1,42345,0.0300016088819798,0.00460388996855372,0.0209779845436145,0.0390252332203451,7.45513359509654e-11
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,EPHA4,Ephrin type-A receptor 4,40282,0.0194813397965268,0.00299245455501908,0.0136161288686894,0.0253465507243642,7.83164312842808e-11
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PDP1,"[Pyruvate dehydrogenase [acetyl-transferring]]-phosphatase 1, mitochondrial",42345,0.0330354490192307,0.00507570813649384,0.0230870610717027,0.0429838369667586,7.86373884872846e-11
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,BNIP2,BCL2/adenovirus E1B 19 kDa protein-interacting protein 2,40510,0.0221126836145668,0.0034025820718149,0.0154436227538096,0.028781744475324,8.43674250351887e-11
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FKBP7,Peptidyl-prolyl cis-trans isomerase FKBP7,42291,0.0321099382620069,0.00494158052125777,0.0224244404403417,0.0417954360836721,8.4391748002068e-11
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CRYM,Ketimine reductase mu-crystallin,40135,0.0504530288463628,0.00777339544409042,0.0352171737759456,0.06568888391678,8.9267563827593e-11
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SLAMF1,Signaling lymphocytic activation molecule,42369,0.0400202300130765,0.00617720760428215,0.0279129031086834,0.0521275569174695,9.58099173163106e-11
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,UBE2Z,Ubiquitin-conjugating enzyme E2 Z,40198,0.0387575385388395,0.00598541663174555,0.0270261219406182,0.0504889551370607,9.86367682682723e-11
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,HYAL1,Hyaluronidase-1,42543,0.0152832670971375,0.00236248812876968,0.0106527903647489,0.0199137438295261,1.01999484074091e-10
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ATXN2,Ataxin-2,40135,0.0732644362769711,0.0113354525846684,0.051046949211021,0.0954819233429213,1.06801522392789e-10
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ALDH3A1,"Aldehyde dehydrogenase, dimeric NADP-preferring",42561,0.044350601274694,0.00687037616718531,0.0308846639870108,0.0578165385623772,1.11706396457008e-10
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,BTC,Probetacellulin,42345,0.0490375498921017,0.0076183029298142,0.0341056761496658,0.0639694236345375,1.26247614513202e-10
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,INSL5,Insulin-like peptide INSL5,40448,0.0649943828503518,0.0100988782557746,0.0452005814690335,0.0847881842316701,1.27814359735769e-10
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TREML1,Trem-like transcript 1 protein,40531,0.0345160309931871,0.00536566547878894,0.0239993266547608,0.0450327353316135,1.30353575514192e-10
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CPA2,Carboxypeptidase A2,42669,0.0431837639466183,0.00673010809384229,0.0299927520826874,0.0563747758105492,1.44102611760516e-10
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,EPO,Erythropoietin,42593,0.0482881688360896,0.00752577215530912,0.0335376554116838,0.0630386822604955,1.44251913787041e-10
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NMI,N-myc-interactor,40420,0.0471328656670612,0.00736966372868433,0.0326883247588399,0.0615774065752825,1.66354855174721e-10
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MUC16,Mucin-16,42586,0.125219406427155,0.01960398584879,0.0867955941635266,0.163643218690784,1.74253894751116e-10
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DGKZ,Diacylglycerol kinase zeta,42369,0.0226831829527909,0.00355149307075216,0.0157222565341167,0.0296441093714652,1.74920073993355e-10
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FBLN2,Fibulin-2,40526,0.0212926190726209,0.00333757238563415,0.0147509771967779,0.0278342609484638,1.84383234798496e-10
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CEACAM16,Carcinoembryonic antigen-related cell adhesion molecule 16,40448,0.0517179520718507,0.0081098675186444,0.0358226117353077,0.0676132924083937,1.87466660320074e-10
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CST7,Cystatin-F,42641,0.0606993193509436,0.00954012426088669,0.0420006757996057,0.0793979629022815,2.04889866774055e-10
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,C2orf69,UPF0565 protein C2orf69,40181,0.0397245819158356,0.00624277590747368,0.0274887411371872,0.051960422694484,2.05340902760801e-10
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SEZ6L,Seizure 6-like protein,42678,0.0181862096797895,0.00286018751525823,0.0125802421498834,0.0237921772096957,2.10440718927498e-10
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NELL2,Protein kinase C-binding protein NELL2,42675,0.0187553953612905,0.00295008369416406,0.012973231320729,0.0245375594018521,2.11560683770478e-10
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NRCAM,Neuronal cell adhesion molecule,42635,0.0187841426372895,0.00296357122600581,0.0129755430343181,0.0245927422402609,2.39660440892106e-10
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NCAM2,Neural cell adhesion molecule 2,42610,-0.0175695318600509,0.00277299610989357,-0.0230046042354423,-0.0121344594846595,2.43438150601902e-10
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CLPS,Colipase,42589,0.0471342623310371,0.00743934340739002,0.0325531492525526,0.0617153754095215,2.4365284231782e-10
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PODXL2,Podocalyxin-like protein 2,42678,0.0182569086357917,0.0028830392985551,0.0126061516106237,0.0239076656609597,2.4883633849898e-10
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,BCL2L11,"Bcl-2-like protein 11, Isoform BimL ",42593,0.0273903895334872,0.00432686817160663,0.0189097279171382,0.0358710511498362,2.52478826073981e-10
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GABARAP,Gamma-aminobutyric acid receptor-associated protein,40450,0.0324015904413439,0.00512181026890175,0.0223628423142965,0.0424403385683913,2.60809217865947e-10
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ENSA,Alpha-endosulfine,40450,0.0343787757299276,0.00543619606858287,0.0237238314355052,0.04503372002435,2.64451115034486e-10
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SPTLC1,Serine palmitoyltransferase 1,40482,0.0250382019141992,0.00396108101520252,0.0172744831244023,0.0328019207039962,2.69585606001231e-10
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ST3GAL1,"CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1",42586,-0.0267470599726859,0.00423240059941032,-0.0350425651475301,-0.0184515547978416,2.70557001792152e-10
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LAMTOR5,Ragulator complex protein LAMTOR5,40450,0.025893213932978,0.0041130787328692,0.0178315796165543,0.0339548482494016,3.18149957158915e-10
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PDZD2,PDZ domain-containing protein 2,40115,0.0388931342491368,0.00618033217321807,0.0267796831896294,0.0510065853086442,3.23219121486642e-10
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PROK1,Prokineticin-1,42593,0.0353863568749528,0.00562785937455731,0.0243557525008205,0.0464169612490852,3.32178696808462e-10
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ADAMTS13,A disintegrin and metalloproteinase with thrombospondin motifs 13,42793,0.0151182870774178,0.00240486921952972,0.0104047434071396,0.0198318307476961,3.34554120407173e-10
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MRPL46,"39S ribosomal protein L46, mitochondrial",42310,0.018009454431524,0.00286799387845,0.012388186429762,0.023630722433286,3.50468842630369e-10
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FGA,Fibrinogen alpha chain,40283,0.0198582565249842,0.00316579461360635,0.0136532990823157,0.0260632139676526,3.67926612796799e-10
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GGT5,Glutathione hydrolase 5 proenzyme,42494,0.0150659651531035,0.00240726360507185,0.0103477284871627,0.0197842018190444,4.00517644705368e-10
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,KIF22,Kinesin-like protein KIF22,40115,0.0799720219520476,0.0127820202839505,0.0549192621955046,0.105024781708591,4.08188377611584e-10
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ENTR1,Endosome-associated-trafficking regulator 1,40222,0.0373829365003098,0.00597555148965135,0.0256708555805931,0.0490950174200264,4.09666302159251e-10
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,APLP1,Amyloid-like protein 1,42635,-0.0328280110632142,0.0052565918713989,-0.043130931131156,-0.0225250909952723,4.3624719876819e-10
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,HS6ST2,Heparan-sulfate 6-O-sulfotransferase 2,40198,0.0221953477119394,0.0035609525929877,0.0152158806296835,0.0291748147941953,4.74396580450096e-10
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ADAMTS1,A disintegrin and metalloproteinase with thrombospondin motifs 1,40198,0.0197792825747519,0.0031794979929579,0.0135474665085545,0.0260110986409494,5.12325591280166e-10
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LRRC37A2,Leucine-rich repeat-containing protein 37A2,40448,0.0276119326841185,0.00444743525204154,0.018894959590117,0.0363289057781199,5.53746885080807e-10
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PPP1R12B,Protein phosphatase 1 regulatory subunit 12B,40301,0.0464973072706865,0.00749048512882688,0.0318159564181858,0.0611786581231872,5.57490965417432e-10
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CALB1,Calbindin,42586,0.0288969110845884,0.00465876092436823,0.0197657396728267,0.0380280824963502,5.7134492249566e-10
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CCL25,C-C motif chemokine 25,42753,0.0302627533236484,0.00488516033858096,0.0206878390600297,0.0398376675872671,6.00336381669684e-10
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FCGR2B,Low affinity immunoglobulin gamma Fc region receptor II-b,42345,0.0365783830359303,0.0059133463601168,0.0249882241701013,0.0481685419017592,6.36470303828691e-10
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GLYR1,Putative oxidoreductase GLYR1,40450,0.0372638493603046,0.00602675678527072,0.025451406061174,0.0490762926594352,6.50459658652503e-10
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CD101,Immunoglobulin superfamily member 2,40448,0.0275961445464108,0.0044659365029147,0.018842909000698,0.0363493800921237,6.66330211017633e-10
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CXCL12,Stromal cell-derived factor 1,42369,0.0252630912214024,0.0040994252275574,0.0172282177753899,0.0332979646674149,7.36495492099736e-10
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,HSBP1,Heat shock factor-binding protein 1,40222,0.0595631486631176,0.00968140792420186,0.0405875891316819,0.0785387081945532,7.9004749099522e-10
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FUT3_FUT5,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3_4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5,42710,-0.0294740347415848,0.00480388859051179,-0.0388896563789879,-0.0200584131041817,8.72875263187674e-10
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,VSIG10,V-set and immunoglobulin domain-containing protein 10,40450,0.0210468954442668,0.00342996130943677,0.0143241712777707,0.0277696196107629,8.73658069132732e-10
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ROBO2,Roundabout homolog 2,42710,0.014633262139622,0.00238749886161261,0.00995376437086132,0.0193127599083827,9.08247851323708e-10
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CFHR5,Complement factor H-related protein 5,40381,0.0264833024621352,0.00433197682900637,0.0179926278772827,0.0349739770469877,1.00753594256545e-09
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RPA2,Replication protein A 32 kDa subunit,40198,0.0197564873748982,0.0032433465660705,0.0133995281054001,0.0261134466443964,1.15675640559606e-09
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CAMLG,Guided entry of tail-anchored proteins factor CAMLG,40181,0.0340325240937977,0.0055912310771629,0.0230737111825584,0.0449913370050369,1.19057891461096e-09
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LMNB1,Lamin-B1,40433,0.0372025329487708,0.00612600964988434,0.0251955540349975,0.0492095118625441,1.29695352955613e-09
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GFRA2,GDNF family receptor alpha-2,42586,0.0132018672613351,0.00217557709160634,0.00893773616178671,0.0174659983608836,1.328303411003e-09
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MZT1,Mitotic-spindle organizing protein 1,42345,0.0318987431297053,0.00525770196220582,0.0215936472837819,0.0422038389756287,1.33858274245218e-09
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FLT3LG,Fms-related tyrosine kinase 3 ligand,42753,0.0214322432898989,0.00353266509725315,0.0145082196992827,0.0283562668805151,1.33893793187156e-09
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CLEC12A,C-type lectin domain family 12 member A,40198,0.0128526800335106,0.00212009795582624,0.00869728804009115,0.01700807202693,1.38584863792941e-09
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,VNN2,Vascular non-inflammatory molecule 2,42586,0.0281525829127853,0.00464948632877234,0.0190395897083916,0.0372655761171791,1.44184809541852e-09
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PNLIP,Pancreatic triacylglycerol lipase,40531,0.0404198286096632,0.0066828682601114,0.0273214068198448,0.0535182503994815,1.51019968582832e-09
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,COL5A1,Collagen alpha-1(V) chain,40282,0.0256062800858527,0.00423896370583095,0.0172979112224241,0.0339146489492814,1.58376746682456e-09
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PRUNE2,Protein prune homolog 2,40301,0.0186221233698073,0.00308322395115834,0.0125790044255369,0.0246652423140776,1.59223165517544e-09
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ANGPTL3,Angiopoietin-related protein 3,42651,0.0219669752929015,0.00364195333501575,0.0148287467562706,0.0291052038295324,1.66552383691523e-09
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,POF1B,Protein POF1B,40198,0.0288007710866784,0.00477650722162363,0.0194388169322961,0.0381627252410608,1.69566700322246e-09
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,AKR1B10,Aldo-keto reductase family 1 member B10,40181,0.0397397416496927,0.00659310294773485,0.0268172598721324,0.0526622234272531,1.71891057799249e-09
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DCTPP1,dCTP pyrophosphatase 1,42635,0.0194577402250689,0.00322989230996904,0.0131271512975296,0.0257883291526082,1.74313101291485e-09
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ICAM4,Intercellular adhesion molecule 4,42593,-0.0322998796938287,0.00537171572825755,-0.0428284425212135,-0.0217713168664438,1.86911265043088e-09
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DARS1,"Aspartate--tRNA ligase, cytoplasmic",42475,0.0444109298640954,0.00741443560305658,0.0298786360821046,0.0589432236460863,2.15540107051334e-09
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,STC2,Stanniocalcin-2,42590,0.0152073010756894,0.00254017098336383,0.0102285659482963,0.0201860362030825,2.19585775818949e-09
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,BRK1,Protein BRICK1,42310,0.02743873370405,0.00459115378346593,0.0184400722884568,0.0364373951196432,2.33991051319355e-09
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LEO1,RNA polymerase-associated protein LEO1,40481,0.0198681394613066,0.00333198386780403,0.0133374510804107,0.0263988278422025,2.55287381603886e-09
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,HMOX1,Heme oxygenase 1,42499,-0.0293361597406018,0.00492783104996702,-0.0389947085985372,-0.0196776108826664,2.69640270159749e-09
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GSTT2B,Glutathione S-transferase theta-2B,40482,0.145625551363283,0.0245352570286745,0.0975364475870808,0.193714655139485,3.0182175529989e-09
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CEBPA,CCAAT/enhancer-binding protein alpha,40198,0.0224813847297185,0.00378767680477072,0.0150575381923679,0.0299052312670691,3.01967455977887e-09
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PCDH1,Protocadherin-1,42720,0.0131257228235772,0.00221599711672201,0.00878236847480205,0.0174690771723523,3.23466263571765e-09
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SNED1,"Sushi, nidogen and EGF-like domain-containing protein 1",40222,0.0203263724033423,0.00343396599430189,0.0135957990545106,0.027056945752174,3.33118984145621e-09
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SERPINA12,Serpin A12,42248,0.062280469233786,0.0105247339959503,0.0416519906017234,0.0829089478658486,3.34999165347838e-09
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FCRLB,Fc receptor-like B,42345,0.0392417139828003,0.00663523051887864,0.0262366621657982,0.0522467657998024,3.4188823739587e-09
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SOD2,"Superoxide dismutase [Mn], mitochondrial",42610,0.0227233061834425,0.00385249466713785,0.0151724166358523,0.0302741957310326,3.76028875891344e-09
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,F2,Prothrombin,40538,0.00895864078240881,0.00152008238099576,0.00597927931565711,0.0119380022491605,3.8879893199338e-09
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,APOBR,Apolipoprotein B receptor,40222,-0.0256925686724806,0.00436742058474544,-0.0342527130185817,-0.0171324243263796,4.15157430144038e-09
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,C1QTNF5,Complement C1q tumor necrosis factor-related protein 5,40282,0.0227374360196427,0.00387328535264136,0.0151457967284656,0.0303290753108197,4.47410880660712e-09
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,EGFR,Epidermal growth factor receptor,42793,-0.00975293514806407,0.001662214527681,-0.0130108756223188,-0.00649499467380931,4.52887292149242e-09
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FASLG,Tumor necrosis factor ligand superfamily member 6,42753,0.0218703732570399,0.00372935248281556,0.0145608423907214,0.0291799041233584,4.61288417217401e-09
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ADAM23,Disintegrin and metalloproteinase domain-containing protein 23,42753,0.0212935930533112,0.00364180131541991,0.0141556624750881,0.0284315236315342,5.1205505325594e-09
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,STX3,Syntaxin-3,40482,0.0232144727860182,0.00397295705105764,0.0154274769659452,0.0310014686060912,5.26470876264864e-09
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,KEL,Kell blood group glycoprotein,42310,0.0216492526484499,0.00370607396468894,0.0143853476776595,0.0289131576192402,5.29408272692913e-09
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SLAMF7,SLAM family member 7,42593,0.0352857689025405,0.00605989160282264,0.0234083813610082,0.0471631564440729,5.91826079070603e-09
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",40222,0.0220614195638025,0.00379038243486996,0.0146322699914574,0.0294905691361476,6.03541561264294e-09
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,UBAC1,Ubiquitin-associated domain-containing protein 1,42586,0.0203579122572209,0.00350606745020292,0.0134860200548232,0.0272298044596187,6.52466797988317e-09
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,KLK7,Kallikrein-7,40008,0.0233132737633317,0.00401738510838011,0.0154391989509067,0.0311873485757567,6.69297339439396e-09
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SIGLEC5,Sialic acid-binding Ig-like lectin 5,42610,0.0702982675703379,0.0121211162055964,0.0465408798073689,0.0940556553333068,6.794977278165e-09
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TNFRSF21,Tumor necrosis factor receptor superfamily member 21,42710,0.0168456734880482,0.00290491225666153,0.0111520454649916,0.0225393015111048,6.81907714745234e-09
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GCLM,Glutamate--cysteine ligase regulatory subunit,40115,0.0271574547524843,0.00468511376542125,0.0179746317722586,0.0363402777327099,6.9570725409681e-09
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CST6,Cystatin-M,42331,0.0299742689735741,0.00517300602203993,0.0198351771703758,0.0401133607767723,7.01543745073326e-09
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FRMD4B,FERM domain-containing protein 4B,40115,0.041535867649475,0.00717369414157739,0.0274754271319833,0.0555963081669667,7.23157061636814e-09
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MEPE,Matrix extracellular phosphoglycoprotein,42617,0.0151361371861455,0.00261934753597049,0.0100022160156433,0.0202700583566476,7.70014842080665e-09
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PSG1,Pregnancy-specific beta-1-glycoprotein 1,42494,-0.0704937465247106,0.0122092607762693,-0.0944238976461984,-0.0465635954032228,7.92378531728069e-09
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PRDX6,Peroxiredoxin-6,42720,-0.0357172949002286,0.00618825110858888,-0.0478462670730628,-0.0235883227273944,8.01532441107561e-09
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,AMFR,E3 ubiquitin-protein ligase AMFR,42310,0.03699353759841,0.00641191749222762,0.0244261793136438,0.0495608958831761,8.13044761898519e-09
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CTSH,Pro-cathepsin H,42331,0.0438192541776157,0.00760058186770489,0.0289221137169141,0.0587163946383173,8.33703419706715e-09
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FDX1,"Adrenodoxin, mitochondrial",40115,0.0366104398983534,0.00635314412272689,0.0241582774178087,0.0490626023788981,8.50834762900964e-09
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LAMP1,Lysosome-associated membrane glycoprotein 1,40185,0.0163566102413908,0.00284217739729109,0.0107859425427003,0.0219272779400813,8.89807286894204e-09
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PER3,Period circadian protein homolog 3,40198,0.0724448118164692,0.0125887183866939,0.0477709237785491,0.0971186998543892,8.90918259548852e-09
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,BOC,Brother of CDO,42356,-0.0137661723237664,0.00239264672144376,-0.0184557598977962,-0.00907658474973663,8.93431042280457e-09
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,EDAR,Tumor necrosis factor receptor superfamily member EDAR,42593,0.0527928840922061,0.00919228337368862,0.0347760086797764,0.0708097595046358,9.49355694509211e-09
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DPP7,Dipeptidyl peptidase 2,42550,0.0352062662885643,0.00613662709452736,0.0231784771832907,0.047234055393838,9.84173648883669e-09
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ARHGAP5,Rho GTPase-activating protein 5,40079,0.0467809558382388,0.00818378144777313,0.0307407442006035,0.0628211674758742,1.11730575502909e-08
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SEMA3G,Semaphorin-3G,40282,0.0262434526187157,0.00459583118027488,0.017235623505377,0.0352512817320545,1.1569370201654e-08
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,HSD17B14,17-beta-hydroxysteroid dehydrogenase 14,40482,0.0374568300252414,0.00656366478841811,0.0245920470399419,0.0503216130105409,1.18091541986072e-08
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GAS2,Growth arrest-specific protein 2,40301,0.0307832625681064,0.00539706478527373,0.0202050155889699,0.0413615095472429,1.20225370064976e-08
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ALPP,"Alkaline phosphatase, placental type",42586,0.0586935174279585,0.0102932740531508,0.0385187002837829,0.0788683345721341,1.2082331004307e-08
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ADGRG2,Adhesion G-protein coupled receptor G2,42635,-0.0157347495102783,0.00275979807629639,-0.0211439537398192,-0.0103255452807373,1.21317229357049e-08
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,EFHD1,EF-hand domain-containing protein D1,40481,0.0210782391317557,0.00369858060407411,0.0138290211477705,0.028327457115741,1.23525204702332e-08
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SNU13,NHP2-like protein 1,40115,0.0369930297388497,0.00649627767179079,0.0242603255021397,0.0497257339755596,1.26930917651953e-08
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SORBS1,Sorbin and SH3 domain-containing protein 1,40481,0.023955606733916,0.00421106766146042,0.0157019141174536,0.0322092993503784,1.31174410966674e-08
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TRAF3,"TNF receptor-associated factor 3, Isoform 2",40198,0.0212000787288726,0.00372823778750967,0.0138927326653536,0.0285074247923915,1.33086609808137e-08
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NAGA,Alpha-N-acetylgalactosaminidase,40165,0.0326015478001812,0.00573592890724536,0.0213591271419803,0.0438439684583821,1.3513915113947e-08
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ITGB6,Integrin beta-6,42369,0.0180851433792414,0.00318358824913296,0.0118453104109408,0.024324976347542,1.36949149601496e-08
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GBP4,Guanylate-binding protein 4,42310,0.0286019846599824,0.00504644335281492,0.0187109556884651,0.0384930136314996,1.47731524436408e-08
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,QSOX1,Sulfhydryl oxidase 1,40341,0.025111478515262,0.00443085791296104,0.0164269970058584,0.0337959600246656,1.4857187612155e-08
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CFHR2,Complement factor H-related protein 2,40450,0.0334046802803865,0.00591379846308042,0.0218136352927489,0.0449957252680241,1.65683576020957e-08
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,APOC1,Apolipoprotein C-I,40515,-0.0212349609572535,0.00377112677573951,-0.028626369437703,-0.0138435524768041,1.83507126255398e-08
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CD2,T-cell surface antigen CD2,40115,0.022192060368542,0.00395189188326142,0.0144463522773496,0.0299377684597343,2.0072213760277e-08
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IRAG2,"Inositol 1,4,5-triphosphate receptor associated 2",42356,0.0501620177175944,0.00893678916292433,0.0326459109582627,0.0676781244769261,2.02889976172347e-08
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ATP6V1G2,V-type proton ATPase subunit G 2,40115,0.0577677391581387,0.0102978270333328,0.0375839981728065,0.0779514801434709,2.07608155103974e-08
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MCTS1,Malignant T-cell-amplified sequence 1,40448,0.0156907104035469,0.0028032911014087,0.0101962598447858,0.021185160962308,2.22880660756222e-08
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CST5,Cystatin-D,42356,0.0325622657733593,0.0058217731519849,0.0211515903954689,0.0439729411512498,2.27381580701447e-08
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,REG3G,Regenerating islet-derived protein 3-gamma,40450,0.0234543481809641,0.00420157639809968,0.0152192584406887,0.0316894379212395,2.42892039434972e-08
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,40448,0.0176999426695026,0.00317093382450182,0.011484912373479,0.0239149729655261,2.43366590904233e-08
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SAFB2,Scaffold attachment factor B2,40481,0.0157021226539625,0.00281490289864424,0.0101849129726198,0.0212193323353052,2.48600155656525e-08
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PCSK7,Proprotein convertase subtilisin/kexin type 7,40450,0.026078443037598,0.00468240790304658,0.0169009235476267,0.0352559625275693,2.61407068828173e-08
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MMP9,Matrix metalloproteinase-9,42593,0.0341111145008181,0.00613282511572101,0.0220907772740049,0.0461314517276312,2.71720653095475e-08
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CASP9,Caspase-9,40198,0.0355558151806439,0.00639389054386592,0.0230237897146667,0.0480878406466211,2.7464344019189e-08
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,THBS4,Thrombospondin-4,42651,0.0259041696566783,0.00467142544375119,0.016748175786926,0.0350601635264306,2.9908410149428e-08
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CD209,CD209 antigen,42667,-0.0218013191600923,0.00396065497402332,-0.029564202909178,-0.0140384354110066,3.77043507202756e-08
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PTK7,Inactive tyrosine-protein kinase 7,42310,0.0214248020126417,0.00390602868757456,0.0137689857849956,0.0290806182402878,4.20986569934516e-08
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FBP1,"Fructose-1,6-bisphosphatase 1",42635,0.0407578261720037,0.00744741083791465,0.026160900929691,0.0553547514143165,4.51041369731089e-08
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CSF3,Granulocyte colony-stimulating factor,42369,0.0272476683999826,0.00498177710280982,0.0174833852784753,0.0370119515214898,4.59622345825425e-08
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,REG3A,Regenerating islet-derived protein 3-alpha,42793,0.0364678499384541,0.0066758294056455,0.0233832243033889,0.0495524755735193,4.77272964540198e-08
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FSTL1,Follistatin-related protein 1,40222,0.0126779000353801,0.00232127999411557,0.00812819124691361,0.0172276088238466,4.82104667919585e-08
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,REG1B,Lithostathine-1-beta,42793,0.0326143575226474,0.00597738092918361,0.0208986909014475,0.0443300241438472,4.94678418957214e-08
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PSMG4,Proteasome assembly chaperone 4,40198,0.0317682886879811,0.00583073699052569,0.0203400441865507,0.0431965331894114,5.19147719121067e-08
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,BLVRB,Flavin reductase,42610,0.0365289848338037,0.00671105022383162,0.0233753263950937,0.0496826432725136,5.32784248418008e-08
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GIMAP7,GTPase IMAP family member 7,40282,-0.0177754717322179,0.00326743897194453,-0.0241796521172292,-0.0113712913472066,5.43564594595407e-08
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SATB1,DNA-binding protein SATB1,40481,0.0162996063997883,0.00300144303396307,0.0104167780532206,0.0221824347463559,5.73324171645841e-08
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DCTN2,Dynactin subunit 2,42586,0.0518296205963129,0.00954580417063703,0.0331198444218643,0.0705393967707615,5.74746181456443e-08
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CEACAM21,Carcinoembryonic antigen-related cell adhesion molecule 21,42593,0.0479352919142491,0.0088403278164772,0.0306082493939538,0.0652623344345444,5.98425180507814e-08
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SLURP1,Secreted Ly-6/uPAR-related protein 1,40456,0.0209866807430296,0.00388126512537684,0.013379401097291,0.0285939603887682,6.53344295825701e-08
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PRTN3,Myeloblastin,42275,0.0268746424952676,0.00497264093244254,0.0171282662676802,0.036621018722855,6.61285416189466e-08
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,BRDT,Bromodomain testis-specific protein,40115,0.0205939610869197,0.00381106199148195,0.013124279583615,0.0280636425902243,6.66399896159121e-08
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ENPP2,Ectonucleotide pyrophosphatase/phosphodiesterase family member 2,42793,0.0151651916932741,0.00280948463836036,0.00965860180208784,0.0206717815844604,6.8573862703939e-08
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ADGRE2,Adhesion G protein-coupled receptor E2,42675,0.0155720667347901,0.00288784837657587,0.00991188391670139,0.0212322495528788,7.07449097861925e-08
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ITGB2,Integrin beta-2,42568,0.0156615976007841,0.00291661046901298,0.00994504108151865,0.0213781541200495,8.01446048179346e-08
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PDIA5,Protein disulfide-isomerase A5,40079,0.0337558751060146,0.00628722683338587,0.0214329105125783,0.0460788396994509,8.0820036732567e-08
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TK1,"Thymidine kinase, cytosolic",40301,0.0249886110187772,0.00465658057731019,0.0158617130872492,0.0341155089503051,8.19841780549396e-08
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MKI67,Proliferation marker protein Ki-67,40198,0.0212272636766533,0.00396632118867798,0.0134532741468445,0.0290012532064622,8.87950432860494e-08
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,AKR1C4,Aldo-keto reductase family 1 member C4,42356,0.0292968833988565,0.00551331222832827,0.0184907914313331,0.0401029753663799,1.09087053619956e-07
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FES,Tyrosine-protein kinase Fes/Fps,42345,0.0257026920515189,0.00484977500753792,0.0161971330367445,0.0352082510662932,1.17822037500979e-07
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RCC1,Regulator of chromosome condensation,40450,0.0284925067832188,0.00538033578723243,0.0179470486402433,0.0390379649261944,1.20812078084642e-07
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,STAM,Signal transducing adapter molecule 1,40450,0.0202805714102422,0.00382982912401979,0.0127741063271634,0.027787036493321,1.20976969911765e-07
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PFDN2,Prefoldin subunit 2,42310,0.0298789781206277,0.00565943988132001,0.0187864759532405,0.040971480288015,1.31608712736226e-07
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NRTN,Neurturin,42369,0.0264915682453016,0.00502036663310462,0.0166516496444165,0.0363314868461866,1.33529593200566e-07
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CLEC4M,C-type lectin domain family 4 member M,40503,-0.0266356921333451,0.00505366193222198,-0.0365408695205002,-0.01673051474619,1.38502253362103e-07
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DCC,Netrin receptor DCC,40181,0.0125010878496358,0.00237761442047309,0.00784096358550853,0.017161212113763,1.48503217705846e-07
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,AFAP1,Actin filament-associated protein 1,40282,0.0447859640213403,0.00852412971477058,0.02807866978039,0.0614932582622906,1.51573456161138e-07
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,COL2A1,Collagen alpha-1(II) chain,40222,0.0434492949025932,0.00827547951364559,0.0272293550558478,0.0596692347493385,1.54620810567468e-07
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CLEC4C,C-type lectin domain family 4 member C,42593,0.0256539387890436,0.00488737695435756,0.0160746799585027,0.0352331976195844,1.55245912581204e-07
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,BCL2,Apoptosis regulator Bcl-2,40448,0.0308012652191591,0.00586768074945699,0.0193006109502234,0.0423019194880948,1.55451386324781e-07
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ARID4B,AT-rich interactive domain-containing protein 4B,42310,0.0223889976273061,0.00428149034034064,0.0139972765602384,0.0307807186943737,1.72813051688239e-07
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CHL1,Neural cell adhesion molecule L1-like protein,42667,-0.0162566266059364,0.00311216804802934,-0.0223564759800739,-0.0101567772317988,1.78122042117708e-07
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RABEPK,Rab9 effector protein with kelch motifs,42345,0.0306013573328738,0.00586571023709339,0.0191045652681707,0.0420981493975768,1.84616542284654e-07
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CLEC1A,C-type lectin domain family 1 member A,42356,0.0186932003564338,0.00358699503535294,0.011662690087142,0.0257237106257256,1.90273350334834e-07
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NXPH3,Neurexophilin-3,40198,0.0163978333067217,0.00314780996023871,0.0102281257846538,0.0225675408287895,1.92998773060795e-07
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,REPS1,RalBP1-associated Eps domain-containing protein 1,40198,0.0206911909951148,0.00397264554242766,0.0129048057319566,0.028477576258273,1.93900377723773e-07
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IL22,Interleukin-22,40450,0.0372849553177308,0.00717825464808244,0.0232155762074892,0.0513543344279724,2.0924666553342e-07
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,HLA_A,,40481,0.0176411942111564,0.0034010853299282,0.0109750669644971,0.0243073214578156,2.17492865832467e-07
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SUSD2,Sushi domain-containing protein 2,42610,-0.0152816295079449,0.00294802903241067,-0.0210597664114698,-0.00950349260441997,2.20714332902376e-07
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SERPINI2,Serpin I2,40448,0.0296910783234449,0.00574091047494617,0.0184388937925505,0.0409432628543394,2.35781559170678e-07
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LRP1,Prolow-density lipoprotein receptor-related protein 1,42586,-0.0140067114845364,0.00271421788652624,-0.0193265785421278,-0.00868684442694497,2.49818477917736e-07
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PVALB,Parvalbumin alpha,42653,0.0577278867057057,0.0112032335075084,0.0357695490309892,0.0796862243804222,2.60273034390293e-07
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CNTNAP2,Contactin-associated protein-like 2,42593,0.0219367610203437,0.00426352229012519,0.0135802573316984,0.0302932647089891,2.70982986278997e-07
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DGCR6,Protein DGCR6,40135,0.0233566040118186,0.00455309572664124,0.0144325363876018,0.0322806716360355,2.94971780970361e-07
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MNAT1,CDK-activating kinase assembly factor MAT1,40301,0.0230975395712513,0.00451676784697224,0.0142446745911857,0.0319504045513169,3.21119029730013e-07
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RHOC,Rho-related GTP-binding protein RhoC,42442,0.0596916310514899,0.0117156859008132,0.036728886685896,0.0826543754170838,3.53505657180626e-07
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,WASF3,Wiskott-Aldrich syndrome protein family member 3,42310,0.043877488839322,0.00861736332863393,0.0269874567151995,0.0607675209634445,3.59685485854612e-07
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,KIAA0319,Dyslexia-associated protein KIAA0319,40482,0.0163380951650828,0.00321173163197107,0.0100431011664196,0.0226330891637461,3.69605602674465e-07
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PRRT3,Proline-rich transmembrane protein 3,40222,0.0208018097021849,0.00410177388165062,0.0127623328941497,0.0288412865102201,4.01279153012627e-07
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GPC1,Glypican-1,42720,0.0154715201376065,0.0030530230910868,0.00948759487907639,0.0214554453961366,4.08164234766279e-07
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PMS1,PMS1 protein homolog 1,40181,0.0269669105847417,0.00533367726015882,0.0165129031548304,0.037420918014653,4.35111690613971e-07
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CLEC14A,C-type lectin domain family 14 member A,42610,0.0171902696878908,0.00340841543029137,0.0105097754445197,0.0238707639312619,4.63114295636049e-07
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ANGPTL4,Angiopoietin-related protein 4,42653,0.0229675545568927,0.00456190379549483,0.0140262231177228,0.0319088859960625,4.84931202983513e-07
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,APOE,Apolipoprotein E,40538,0.0372154970345272,0.00743732838253795,0.0226383334047529,0.0517926606643016,5.70302527966304e-07
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SIRPA,Tyrosine-protein phosphatase non-receptor type substrate 1,42675,0.0293492488243005,0.00586763922683928,0.0178486759396955,0.0408498217089055,5.74873402027994e-07
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,APOL1,Apolipoprotein L1,40531,0.0297771479838009,0.00595913236300694,0.0180972485523073,0.0414570474152945,5.91306612143709e-07
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ADAMTS16,A disintegrin and metalloproteinase with thrombospondin motifs 16,42356,0.0161327325916717,0.0032330064245957,0.00979603999946409,0.0224694251838792,6.11475554807873e-07
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CENPF,Centromere protein F,40301,0.0278711841973632,0.00558886659937314,0.0169170056625918,0.0388253627321345,6.22794052229103e-07
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SAT2,Thialysine N-epsilon-acetyltransferase,40301,0.0345174062485216,0.0069274254007394,0.0209396524630723,0.0480951600339708,6.36418970815149e-07
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DNAJB8,DnaJ homolog subfamily B member 8,42356,0.029572388529746,0.00594053632272297,0.017928937337209,0.041215839722283,6.5035145249012e-07
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CD248,Endosialin,40526,-0.0207110571145083,0.00416750557554495,-0.0288793680425764,-0.0125427461864402,6.80530429592306e-07
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,EIF1AX,"Eukaryotic translation initiation factor 1A, X-chromosomal",40482,0.0276597861741775,0.00556943188577752,0.0167436996780536,0.0385758726703015,6.92207674657456e-07
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TBC1D17,TBC1 domain family member 17,42310,0.0229746524763322,0.00463381171627892,0.0138923815124255,0.0320569234402388,7.20959358688359e-07
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TF,Serotransferrin,40538,0.0107984705574318,0.00218035580599444,0.00652497317768271,0.0150719679371809,7.4276270555225e-07
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NAPRT,Nicotinate phosphoribosyltransferase,40482,0.0171780523589735,0.00346929472920866,0.0103782346897245,0.0239778700282225,7.47266297911004e-07
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RAB39B,Ras-related protein Rab-39B,40115,0.0468803220605983,0.00947233335373147,0.0283145486872846,0.065446095433912,7.56376713784947e-07
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ICAM2,Intercellular adhesion molecule 2,42793,0.0163799749989329,0.00331028969430706,0.00989180719809107,0.0228681427997747,7.5799151859632e-07
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RGL2,Ral guanine nucleotide dissociation stimulator-like 2,40301,0.0330252924258437,0.00668227203535329,0.0199280392365513,0.0461225456151362,7.83633104526693e-07
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ECE1,Endothelin-converting enzyme 1,42310,0.0179566591795337,0.00363586601200375,0.0108303617960063,0.025082956563061,7.95903506262977e-07
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NTF4,Neurotrophin-4,42345,0.0196595066375156,0.00398809684755023,0.0118428368163172,0.0274761764587141,8.34260201952857e-07
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IGDCC4,Immunoglobulin superfamily DCC subclass member 4,40526,-0.0136847530424046,0.00277597944457115,-0.019125672753764,-0.00824383333104512,8.35214152652255e-07
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SUSD4,Sushi domain-containing protein 4,40450,0.0211986261057872,0.00430447129325809,0.0127618623710014,0.0296353898405731,8.56497792409082e-07
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,OLFM4,Olfactomedin-4,39869,0.0621939498034328,0.012658417219098,0.0373834520540007,0.0870044475528649,9.09096672853733e-07
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,COL1A1,Collagen alpha-1(I) chain,42793,-0.0125535845790211,0.00255967058260375,-0.0175705389209245,-0.00753663023711775,9.48086568861379e-07
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FAM3D,Protein FAM3D,40448,0.0431047859695698,0.00879726810198724,0.0258621404896748,0.0603474314494648,9.72745471615654e-07
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TYMP,Thymidine phosphorylase,42562,0.0324317711132904,0.00662289863448082,0.0194508897897079,0.0454126524368728,9.84911141582026e-07
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CA3,Carbonic anhydrase 3,42769,0.0297522627378169,0.00608133200596538,0.0178328520061248,0.0416716734695091,1.00760251294298e-06
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CPVL,Probable serine carboxypeptidase CPVL,42697,0.0206144744582053,0.00421829318052862,0.0123466198243692,0.0288823290920414,1.03600144681823e-06
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,VSTM1,V-set and transmembrane domain-containing protein 1,42310,0.0252098366428696,0.005163442989263,0.0150894883839141,0.0353301849018251,1.0605338816165e-06
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ITGA2,Integrin alpha-2,40282,0.0174744253748361,0.00357903415509909,0.0104595184308419,0.0244893323188303,1.06241687580232e-06
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RBP1,Retinol-binding protein 1,40181,0.0342414490717913,0.00701404973590561,0.0204939115894163,0.0479889865541663,1.06580759459647e-06
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NINJ1,Ninjurin-1,42345,0.0268677181547759,0.00551491285028181,0.0160584889682236,0.0376769473413283,1.11857496385069e-06
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CLASP1,CLIP-associating protein 1,40079,0.0362899973513047,0.0074546599387214,0.0216788638714108,0.0509011308311987,1.14261740498118e-06
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,AHSP,Alpha-hemoglobin-stabilizing protein,42589,0.0413200580954223,0.00849237626203314,0.0246750006218374,0.0579651155690073,1.15439537880796e-06
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GALNT7,N-acetylgalactosaminyltransferase 7,42586,0.0105314710229354,0.0021685506646043,0.00628111172031101,0.0147818303255599,1.20855849507018e-06
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RALB,Ras-related protein Ral-B,40198,0.0149007570619331,0.00307102524212532,0.00888154758736748,0.0209199665364987,1.2387036824227e-06
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NELL1,Protein kinase C-binding protein NELL1,42678,-0.0216297807359515,0.0044590550647097,-0.0303695286627825,-0.0128900328091205,1.24366998533988e-06
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SFTPD,Pulmonary surfactant-associated protein D,42635,0.0335641005810061,0.00692924969226366,0.0199827711841693,0.0471454299778429,1.28780264330287e-06
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IL3RA,Interleukin-3 receptor subunit alpha,42369,0.0161478020302401,0.00334071393481227,0.00960000271800805,0.0226956013424721,1.35572560935516e-06
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ITGB1BP1,Integrin beta-1-binding protein 1,42345,0.0203036335840708,0.00420231177130328,0.0120671025123164,0.0285401646558253,1.37010212014826e-06
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DDI2,Protein DDI1 homolog 2,40282,0.0388486461191593,0.00804429757106127,0.0230818228798792,0.0546154693584394,1.38817933501073e-06
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FOSB,Protein fosB,42310,0.018922355227592,0.00392158702913686,0.0112360446504837,0.0266086658047002,1.41452725210575e-06
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TNN,Tenascin-N,40526,0.0217223361455034,0.00450710374493064,0.0128884128054394,0.0305562594855675,1.45729570814087e-06
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CLC,Galectin-10,42610,0.0322809227059551,0.00671777665287118,0.0191140804663276,0.0454477649455826,1.56193960186377e-06
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TFRC,Transferrin receptor protein 1,42672,0.0185037351255833,0.00386232602918577,0.0109335761083792,0.0260738941427874,1.67864975217852e-06
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MDM1,Nuclear protein MDM1,40181,0.0153798068764376,0.00321009482722899,0.00908802101506875,0.0216715927378064,1.68060166521525e-06
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PAEP,Glycodelin,42494,0.0440613042159875,0.00920030366098033,0.026028709040466,0.0620938993915089,1.69325386928214e-06
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PADI2,Protein-arginine deiminase type-2,42369,0.0271708447080717,0.00568406047878647,0.0160300861696502,0.0383116032464931,1.77029023515036e-06
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PLA2G2A,"Phospholipase A2, membrane associated",42601,0.0278045373104179,0.00582200439142791,0.0163934087032192,0.0392156659176166,1.80917688275716e-06
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PLAU,Urokinase-type plasminogen activator,42610,0.0143275711204992,0.00301126722938302,0.0084254873509085,0.0202296548900899,1.97570806430383e-06
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FAM171B,Protein FAM171B,40450,0.0128803066885973,0.00270909157141444,0.00757048720862505,0.0181901261685696,2.0142985087984e-06
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,UBE2B,Ubiquitin-conjugating enzyme E2 B,40450,0.0140474862728242,0.00295625151752247,0.00825323329848018,0.0198417392471683,2.04117857618919e-06
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TREH,Trehalase,40526,0.0357837653464467,0.00757996488593406,0.0209270341700159,0.0506404965228774,2.37692102167308e-06
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MAEA,E3 ubiquitin-protein transferase MAEA,42345,0.0190341510553502,0.00404142381306989,0.0111129603817332,0.0269553417289672,2.50539715728733e-06
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ENTPD5,Ectonucleoside triphosphate diphosphohydrolase 5,42356,-0.0102798527359038,0.00218568192223296,-0.0145637893034804,-0.00599591616832715,2.58628661201613e-06
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PKD1,Polycystin-1,40510,0.0129095162320213,0.0027457198392255,0.00752790534713935,0.0182911271169033,2.61067799090528e-06
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,B4GAT1,"Beta-1,4-glucuronyltransferase 1",42610,0.0113945047196009,0.00242508624392063,0.00664133568151643,0.0161476737576853,2.64554957436962e-06
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IFNAR1,Interferon alpha/beta receptor 1,40448,0.0123573601607411,0.00263355278623047,0.00719559669972937,0.0175191236217528,2.73364474373007e-06
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NME3,Nucleoside diphosphate kinase 3,42637,0.0114552255889194,0.002441509181538,0.00666986759310489,0.0162405835847338,2.73396988770419e-06
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ICOSLG,ICOS ligand,42586,0.00927172701054175,0.00197787999593463,0.00539508221850987,0.0131483718025736,2.79003547121103e-06
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PRKD2,Serine/threonine-protein kinase D2,40115,0.0219412188078423,0.00468347342807209,0.012761610888821,0.0311208267268635,2.83591867048436e-06
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MMP10,Stromelysin-2,42607,-0.027952091621876,0.00598131827965634,-0.0396754754500024,-0.0162287077937495,2.99379617258699e-06
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,42612,0.0155045550704096,0.00331792627818417,0.00900141956516858,0.0220076905756505,2.99767646445272e-06
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,AFP,Alpha-fetoprotein,42458,0.0318463715301873,0.00683433084905031,0.0184510830660487,0.0452416599943259,3.19651069547818e-06
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SERPINC1,Antithrombin-III,40515,0.00700461886329233,0.00150465546958037,0.0040554941429148,0.00995374358366986,3.27189177010318e-06
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ATXN10,Ataxin-10,42310,0.0343514415125607,0.00738187931118809,0.019882958062632,0.0488199249624893,3.29570552272738e-06
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PTPN6,Tyrosine-protein phosphatase non-receptor type 6,42653,0.0418238167767042,0.00899149018821688,0.0242004960077991,0.0594471375456093,3.32684605809559e-06
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NDRG1,Protein NDRG1,42310,0.0308161469043867,0.00666055104939114,0.0177614668475801,0.0438708269611934,3.75155334482949e-06
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SLIRP,"SRA stem-loop-interacting RNA-binding protein, mitochondrial",40079,0.0274808628712837,0.00596037484365083,0.0157985281777281,0.0391631975648393,4.06094540032522e-06
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ANXA5,Annexin A5,42260,0.0144618681194744,0.00313847912269253,0.00831044903899702,0.0206132871999517,4.10559702461028e-06
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IL17RA,Interleukin-17 receptor A,42610,0.0207000267917494,0.0044950617648282,0.0118897057326861,0.0295103478508127,4.16137336827525e-06
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,F3,Tissue factor,42635,-0.012829680164969,0.00278617526369951,-0.0182905836818201,-0.007368776648118,4.16720150620712e-06
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,UNG,Uracil-DNA glycosylase,40450,0.0161065206332417,0.00349947807525531,0.0092475436057413,0.0229654976607421,4.21915404561835e-06
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,OMD,Osteomodulin,42675,-0.0198041085712122,0.00430466213670765,-0.0282412463591592,-0.0113669707832652,4.25076198400256e-06
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MELTF,Melanotransferrin,40510,0.0142070567194294,0.00308926896299741,0.0081520895519545,0.0202620238869043,4.29455665136995e-06
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,C1QL2,Complement C1q-like protein 2,40198,0.0207620987707241,0.00451575382385349,0.0119112212759713,0.029612976265477,4.31932956991874e-06
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MSTN,Growth/differentiation factor 8,42356,0.0250020351645521,0.00544159133601995,0.014336516145953,0.0356675541831512,4.37568070757678e-06
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RNASE10,Inactive ribonuclease-like protein 10,40222,0.0232898319017603,0.00507367597152054,0.0133454269975801,0.0332342368059406,4.4744273880724e-06
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LRRC38,Leucine-rich repeat-containing protein 38,40181,0.0227215638215378,0.0049614426797154,0.0129971361692956,0.03244599147378,4.70923431464958e-06
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MAPK13,Mitogen-activated protein kinase 13,40079,0.0196407385767569,0.00429025740038434,0.0112318340720036,0.0280496430815102,4.74676385411571e-06
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CRTAP,Cartilage-associated protein,40181,0.0224973838336188,0.00491543125223546,0.0128631385792373,0.0321316290880003,4.77117657584748e-06
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,COL24A1,Collagen alpha-1(XXIV) chain,40448,0.0260554020053249,0.0057149536255463,0.0148540928992541,0.0372567111113956,5.18997553675834e-06
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PDRG1,p53 and DNA damage-regulated protein 1,40181,0.0238586536418586,0.00525768734353745,0.0135535864485252,0.034163720835192,5.74308142089927e-06
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RBPMS,RNA-binding protein with multiple splicing,40198,0.0296282085491118,0.00654032205245927,0.0168091773262916,0.042447239771932,5.95808643228421e-06
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IL17A,Interleukin-17A,42346,0.0199368092755848,0.00440584228314401,0.0113013584006226,0.0285722601505471,6.09004394751956e-06
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TDO2,"Tryptophan 2,3-dioxygenase",40181,0.0178190405552705,0.00396886141967438,0.0100400721727087,0.0255980089378322,7.2046362446113e-06
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MET,Hepatocyte growth factor receptor,42653,-0.00908887885894802,0.00202799338950644,-0.0130637459023806,-0.0051140118155154,7.46583028688125e-06
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GUCA2A,Guanylin,42562,0.0166744510793679,0.00372133551154558,0.00938063347673855,0.0239682686819972,7.49914641212388e-06
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,STX1B,Syntaxin-1B,40181,0.01865092147529,0.00416476461490738,0.0104879828300715,0.0268138601205085,7.60110404684048e-06
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CBLN4,Cerebellin-4,42720,0.0147716359021327,0.00332174517428484,0.00826101536053437,0.0212822564437309,8.77921245579865e-06
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LYSMD3,LysM and putative peptidoglycan-binding domain-containing protein 3,40181,0.0490326674742642,0.0110264795498063,0.0274207675566438,0.0706445673918847,8.80102036086614e-06
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CA14,Carbonic anhydrase 14,42720,-0.0163201777402667,0.00367476652737574,-0.0235227201339232,-0.00911763534661029,9.01903060803377e-06
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,HMBS,Porphobilinogen deaminase,42720,0.0195414999971257,0.00440860915057849,0.0109006260619919,0.0281823739322596,9.38463446431335e-06
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CILP,Cartilage intermediate layer protein 1,40526,0.0250012801953669,0.00564132070289901,0.0139442916176848,0.0360582687730489,9.43218055380541e-06
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,AHSA1,Activator of 90 kDa heat shock protein ATPase homolog 1,40450,0.0299156035836672,0.00676017874502404,0.0166656532434201,0.0431655539239143,9.722849054215e-06
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,EP300,Histone acetyltransferase p300,40198,0.0140176229919975,0.00317239721375906,0.00779972445302974,0.0202355215309653,1.00282576936641e-05
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,INPP5J,"Phosphatidylinositol 4,5-bisphosphate 5-phosphatase A",40481,0.0194210690575778,0.00439663709933932,0.0108036603428727,0.0280384777722828,1.00893149968998e-05
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IFNGR2,Interferon gamma receptor 2,42494,0.0234542922816833,0.00531388003190376,0.013039087419152,0.0338694971442147,1.02381747694197e-05
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,VIM,Vimentin,42356,0.052226994820767,0.011840754195203,0.0290191165981692,0.0754348730433649,1.03815256739048e-05
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DSG3,Desmoglein-3,42650,0.015809088499301,0.00359030209210944,0.00877209639876653,0.0228460805998355,1.07451269771098e-05
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ARHGAP30,Rho GTPase-activating protein 30,40301,0.0172165070075944,0.00391390325304798,0.00954525663162041,0.0248877573835685,1.0986123194938e-05
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IFIT1,Interferon-induced protein with tetratricopeptide repeats 1,40301,0.023695810685675,0.0053967689418772,0.0131181435595957,0.0342734778117543,1.14010313161475e-05
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IL10RA,Interleukin-10 receptor subunit alpha,42369,0.0259388860572795,0.00592003251952308,0.0143356223190142,0.0375421497955447,1.18752016121803e-05
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PRDX1,Peroxiredoxin-1,42260,-0.0397623738792988,0.00912051757234607,-0.0576385883210971,-0.0218861594375005,1.31259734992774e-05
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DNER,Delta and Notch-like epidermal growth factor-related receptor,42586,-0.0110440170437236,0.00254518699548601,-0.0160325835548762,-0.00605545053257106,1.44065283110352e-05
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FLRT2,Leucine-rich repeat transmembrane protein FLRT2,42494,0.0127958881474856,0.00296361282394587,0.00698720701255169,0.0186045692824195,1.58829972900267e-05
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,HSD17B3,Testosterone 17-beta-dehydrogenase 3,40115,0.0217390527475107,0.00503838203013054,0.0118638239684548,0.0316142815265665,1.6123387727181e-05
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CPQ,Carboxypeptidase Q,40515,0.015740079741747,0.0036515883943936,0.00858296648873559,0.0228971929947585,1.6428181178655e-05
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,EBI3_IL27,Interleukin-27,42688,0.0135750996708819,0.00315022306870639,0.00740066245621736,0.0197495368855464,1.64969071243213e-05
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,KLK4,Kallikrein-4,42720,0.0279803374731543,0.00649680317188615,0.0152466032562574,0.0407140716900511,1.66811950160046e-05
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MANSC4,MANSC domain-containing protein 4,40115,0.0315622170269636,0.00734789055177511,0.0171603515454844,0.0459640825084429,1.75877421995318e-05
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,USP47,Ubiquitin carboxyl-terminal hydrolase 47,40115,0.0368103765494514,0.00857818430964978,0.0199971353025378,0.0536236177963649,1.79272324496387e-05
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TPSAB1,Tryptase alpha/beta-1,42740,0.0229336777243767,0.00534715788146879,0.0124532482766979,0.0334141071720555,1.80765964657518e-05
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DPEP1,Dipeptidase 1,42475,-0.0218643575299704,0.00510063484653293,-0.0318616018291749,-0.0118671132307658,1.82711972147558e-05
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,AIF1L,Allograft inflammatory factor 1-like,40222,0.0244652984217808,0.00570996966213752,0.0132737578839913,0.0356568389595703,1.8456863998118e-05
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GPNMB,Transmembrane glycoprotein NMB,42314,0.0127073117173451,0.00296950109124691,0.00688708957850114,0.018527533856189,1.88833080667644e-05
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DUSP3,Dual specificity protein phosphatase 3,42310,0.0374242255725537,0.00875027557988864,0.020273685435972,0.0545747657091355,1.90838874530508e-05
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CDON,Cell adhesion molecule-related/down-regulated by oncogenes,42637,0.0112329587283465,0.00263607148041769,0.00606625862672782,0.0163996588299652,2.04671673104595e-05
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SYT1,Synaptotagmin-1,40482,0.0184463775439984,0.0043419666962843,0.00993612281928119,0.0269566322687157,2.17037558048199e-05
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,COL3A1,Collagen alpha-1(III) chain,40526,0.0101196766962497,0.00238855562140761,0.00543810767829081,0.0148012457142087,2.2858724670423e-05
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PSMD1,26S proteasome non-ATPase regulatory subunit 1,40481,0.0214273642558199,0.00506891121489167,0.0114922982746322,0.0313624302370076,2.38466809634168e-05
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RAB37,Ras-related protein Rab-37,42369,0.0348004600387392,0.00824572880470362,0.0186388315815201,0.0509620884959583,2.45478477818016e-05
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CEACAM20,Carcinoembryonic antigen-related cell adhesion molecule 20,40301,0.0197013168549575,0.0046681112917708,0.0105518187230867,0.0288508149868283,2.45803466872514e-05
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CA7,Carbonic anhydrase 7,40301,-0.0152527998118823,0.0036154403360946,-0.0223390628706277,-0.0081665367531369,2.47561928788082e-05
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PODXL,Podocalyxin,42586,0.0065796809226867,0.0015608360377656,0.00352044228866613,0.00963891955670727,2.50877350059159e-05
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,AHNAK2,Protein AHNAK2,40222,0.0130332886482266,0.00309975733682726,0.00695776426804512,0.019108813028408,2.63590515735099e-05
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CELA3A,Chymotrypsin-like elastase family member 3A,42780,0.0254919513478503,0.00606390347312758,0.0136067005405202,0.0373772021551803,2.64051744778154e-05
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,YY1,Transcriptional repressor protein YY1,40198,0.0121141677120586,0.00288929754411177,0.00645114452559949,0.0177771908985176,2.77722323878125e-05
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PTPRF,Receptor-type tyrosine-protein phosphatase F,42793,-0.012343419188074,0.00295634534270959,-0.0181378560597848,-0.00654898231636324,2.99540653100835e-05
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,REN,Renin,42635,0.036419787315634,0.00873023156617122,0.0193085334459384,0.0535310411853296,3.04253209373947e-05
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SPRED2,"Sprouty-related, EVH1 domain-containing protein 2",40198,0.0185163545815834,0.00443851403744831,0.00981686706818471,0.0272158420949821,3.04594914228768e-05
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CPA4,Carboxypeptidase A4,40059,0.0189012067883747,0.00453893811869981,0.0100048880757231,0.0277975255010264,3.14810400957425e-05
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,HAGH,"Hydroxyacylglutathione hydrolase, mitochondrial",42673,0.0304722390832777,0.00732179249427464,0.0161215257944994,0.044822952372056,3.17632570890359e-05
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TGFB2,Transforming growth factor beta-2 proprotein,40450,0.022200314403123,0.0053475010070008,0.0117192124294014,0.0326814163768445,3.3269232873097e-05
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,REG1A,Lithostathine-1-alpha,42574,0.0221221034188195,0.00533285021817689,0.0116697169911928,0.0325744898464462,3.37066272607443e-05
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TNXB,Tenascin-X,42610,-0.0109385644023331,0.00263820551489642,-0.0161094472115301,-0.00576768159313616,3.40096509137821e-05
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",42678,0.0148158420662138,0.00357391063128347,0.00781097722889817,0.0218207069035294,3.41064687607209e-05
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,EFNB2,Ephrin-B2,40181,0.0231289682073686,0.00560180018697889,0.01214943984089,0.0341084965738472,3.67284437616859e-05
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ARG1,Arginase-1,42487,0.0217835955430228,0.00528464373110172,0.0114256938300634,0.0321414972559822,3.77785564574959e-05
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CNTN4,Contactin-4,42610,-0.0101192186127527,0.00245756240240898,-0.0149360409214743,-0.00530239630403109,3.85158616243894e-05
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NTproBNP,N-terminal prohormone of brain natriuretic peptide,42635,-0.0484472398591417,0.0117676103551921,-0.0715117561553182,-0.0253827235629651,3.86130996916419e-05
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ACY3,N-acyl-aromatic-L-amino acid amidohydrolase,40115,0.0235453243614911,0.00572282135801498,0.0123285944997818,0.0347620542232005,3.9122954847948e-05
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,HEPACAM2,HEPACAM family member 2,40482,-0.017724034617513,0.00431709967259795,-0.026185549975805,-0.00926251925922105,4.0620819888623e-05
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IVD,"Isovaleryl-CoA dehydrogenase, mitochondrial",42310,0.0212953293507478,0.00519602044077642,0.011111129286826,0.0314795294146696,4.18533784783708e-05
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ENTPD6,Ectonucleoside triphosphate diphosphohydrolase 6,42356,0.0115958059473034,0.00283344989031594,0.00604224416228419,0.0171493677323227,4.2934981855184e-05
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CNPY2,Protein canopy homolog 2,42356,0.0255253296305039,0.00630559131389462,0.0131663706552705,0.0378842886057374,5.19423090459534e-05
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SPRING1,SREBP regulating gene protein,40079,0.0245953087217576,0.00607563291078262,0.0126870682166237,0.0365035492268916,5.19728396726705e-05
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,COL9A2,Collagen alpha-2(IX) chain,40301,0.0185313472459804,0.00459164118408901,0.00953173052516591,0.0275309639667948,5.47610638151837e-05
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NUDT2,Bis(5'-nucleosyl)-tetraphosphatase [asymmetrical],42586,0.0229529985035169,0.00570107844501718,0.0117788847512833,0.0341271122557506,5.70267840707744e-05
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TCN1,Transcobalamin-1,40336,0.0140413418925173,0.00350245787386509,0.00717652445974169,0.0209061593252928,6.13746925967353e-05
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CCL28,C-C motif chemokine 28,42537,0.0239429091389407,0.00598405714811647,0.0122141571286324,0.035671661149249,6.33847607894271e-05
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ITGAM,Integrin alpha-M,42610,-0.0129000655961118,0.00323224177122771,-0.0192352594677181,-0.0065648717245055,6.61289838615301e-05
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SPTBN2,"Spectrin beta chain, non-erythrocytic 2",40135,0.0132939585014637,0.00333458148462809,0.00675817879159267,0.0198297382113348,6.74355250115694e-05
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,AIDA,"Axin interactor, dorsalization-associated protein",40181,0.0344068554463802,0.00863077368895898,0.0174905390160206,0.0513231718767398,6.74798838279098e-05
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MSMB,Beta-microseminoprotein,42558,0.0294591691300131,0.00740446220134113,0.0149464232153845,0.0439719150446417,6.96969377437511e-05
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,HPGDS,Hematopoietic prostaglandin D synthase,42345,0.0155779002841634,0.00391572337893038,0.00790308246145989,0.023252718106867,6.97835299119168e-05
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DDA1,DET1- and DDB1-associated protein 1,40115,0.0164354851565379,0.00413324031977621,0.00833433412977654,0.0245366361832993,7.04125685690464e-05
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,STX5,Syntaxin-5,40198,0.0167063926632806,0.00420613549851106,0.00846236708619896,0.0249504182403623,7.17528043143294e-05
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MMP3,Stromelysin-1,42610,-0.020444526465295,0.00515710937177779,-0.0305524608339795,-0.0103365920966105,7.39814553050764e-05
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CD70,CD70 antigen,42593,0.0174967244040443,0.00441369564276119,0.00884588094423236,0.0261475678638562,7.40281657864622e-05
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ERC2,ERC protein 2,40181,0.0307993474950169,0.00778846858982481,0.0155339490589603,0.0460647459310736,7.71824142424462e-05
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NUBP1,Cytosolic Fe-S cluster assembly factor NUBP1,40450,0.0391311981645507,0.00991346491868388,0.0197008069239303,0.0585615894051711,7.95256776045533e-05
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CHP1,Calcineurin B homologous protein 1,40135,0.0300841738131603,0.00762340141386143,0.0151423070419919,0.0450260405843287,7.98667946921277e-05
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NOS1,"Nitric oxide synthase, brain",42310,0.0218753053802042,0.00555019715685052,0.0109969189527772,0.0327536918076312,8.14425263499106e-05
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DLL4,Delta-like protein 4,40222,0.0346596482077161,0.00879663304685721,0.017418247435876,0.0519010489795562,8.19485189842799e-05
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,C1GALT1C1,C1GALT1-specific chaperone 1,40115,0.0131620731046994,0.00334378246831617,0.00660825946679974,0.0197158867425991,8.32668536426976e-05
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PDCD6,Programmed cell death protein 6,42635,-0.0283015908839962,0.00719045859991206,-0.0423948897398239,-0.0142082920281686,8.32709123773134e-05
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PADI4,Protein-arginine deiminase type-4,42291,0.0288934521916954,0.00734883020219802,0.0144897449953873,0.0432971593880035,8.47788208642871e-05
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ASS1,Argininosuccinate synthase,40115,0.0312291950230184,0.00796175390178364,0.0156241573755224,0.0468342326705143,8.82074069344891e-05
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,40222,-0.0141792394161851,0.00362144878409298,-0.0212772790330074,-0.00708119979936288,9.0816653901104e-05
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IL33,Interleukin-33,42369,0.0154591800086889,0.0039565933808125,0.00770425698229637,0.0232141030350814,9.38406686788526e-05
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ELAVL4,ELAV-like protein 4,40135,0.0339313648514357,0.0087355452810949,0.0168096961004897,0.0510530336023817,0.000103234944187224
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MILR1,Allergin-1,42369,0.0203625056561305,0.00525591720747978,0.0100609079294701,0.0306641033827909,0.000107490713307698
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CSF2RA,Granulocyte-macrophage colony-stimulating factor receptor subunit alpha,42494,0.0243561286125755,0.00630897470301537,0.0119905381946654,0.0367217190304857,0.000113666139347314
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TGFBR1,TGF-beta receptor type-1,40198,0.00854986671150426,0.00221482040924284,0.0042088187093883,0.0128909147136202,0.000113896510435228
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,BCL7B,B-cell CLL/lymphoma 7 protein family member B,40450,0.0175485246238347,0.00455132964094699,0.00862791852757858,0.0264691307200908,0.0001160450558383
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CLU,Clusterin,40538,0.0124490118674339,0.00322970657916689,0.00611878697226683,0.018779236762601,0.000116590136784996
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,APOB,Apolipoprotein B-100,40531,0.00882052606125003,0.00228928813396247,0.00433352131868359,0.0133075308038165,0.000117343568404482
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PGA4,Pepsin A-4,40531,0.0316825224002506,0.00827993546193873,0.0154538488948507,0.0479111959056505,0.000130717686468156
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ENTPD2,Ectonucleoside triphosphate diphosphohydrolase 2,42345,0.0170724187874153,0.00446718129513306,0.00831674344895448,0.0258280941258761,0.000133122080833609
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NECTIN1,Nectin-1,40198,0.0127959578385325,0.00335201553476261,0.00622600739039773,0.0193659082866672,0.000135609129831307
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ENO1,Alpha-enolase,42587,0.0305155715279112,0.00803309215686547,0.0147707109004549,0.0462604321553675,0.000146080638960612
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DCN,Decorin,42356,0.00930723819152923,0.00245756792257335,0.00449040506328546,0.014124071319773,0.000153047763425032
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IL2RG,Cytokine receptor common subunit gamma,40450,0.0142182189380322,0.00375655061297683,0.00685537973659757,0.0215810581394667,0.000154560034376709
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TSPAN8,Tetraspanin-8,40448,0.0396190562347149,0.0105142858303942,0.0190110560071422,0.0602270564622875,0.000165323343378248
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IL34,Interleukin-34,42291,0.01405472716065,0.00374104879872426,0.0067222715151504,0.0213871828061495,0.000172780616417531
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CXCL14,C-X-C motif chemokine 14,42369,0.0215880563222565,0.00575149921772516,0.0103151178555152,0.0328609947889978,0.00017515538260829
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GC,Vitamin D-binding protein,40538,0.00993429539699559,0.00264891977829341,0.0047424126315405,0.0151261781624507,0.00017748788790612
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ARTN,Artemin,42369,0.017110438773701,0.00456441952097993,0.00816417651258029,0.0260567010348216,0.000178544681062919
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MB,Myoglobin,42793,0.0203106388517744,0.0054209658231727,0.00968554583835591,0.0309357318651929,0.000179929090738035
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IL6ST,Interleukin-6 receptor subunit beta,42635,0.00668085241731712,0.00178621122633522,0.00317987841370009,0.0101818264209341,0.000184611003877747
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NUDT15,Nucleotide triphosphate diphosphatase NUDT15,40115,0.0201064837184936,0.00538132062897016,0.00955909528571211,0.0306538721512751,0.000187663904159603
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PPM1A,Protein phosphatase 1A,42345,0.0121448197745343,0.0032521441318269,0.00577061727615355,0.018519022272915,0.000188954623115455
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CDH15,Cadherin-15,42691,0.0237272633513286,0.00636351089887814,0.0112547819895275,0.0361997447131298,0.000193300535687603
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CSF2,Granulocyte-macrophage colony-stimulating factor,40115,0.0140198582922939,0.00376664962378709,0.00663722502967126,0.0214024915549166,0.000198562537956441
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CNTN1,Contactin-1,42793,-0.0105665085488662,0.0028409178633548,-0.0161347075610416,-0.00499830953669077,0.000200499914045535
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ACTA2,"Actin, aortic smooth muscle",42356,0.0166125019755855,0.00449389143499758,0.00780447476299028,0.0254205291881808,0.000219319738396777
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TCN2,Transcobalamin-2,42770,0.0115745600914865,0.00315078830016446,0.00539901502316416,0.0177501051598088,0.000240128828952468
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,M6PR,Cation-dependent mannose-6-phosphate receptor,40222,0.0150635434412007,0.00410341514892653,0.00702084974930465,0.0231062371330967,0.000242765683168016
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CCDC50,Coiled-coil domain-containing protein 50,40481,0.0284056327668085,0.00774098051046425,0.0132333109662986,0.0435779545673185,0.00024413175968584
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MFAP4,Microfibril-associated glycoprotein 4,40282,0.0122306283844944,0.00334400496019664,0.00567637866250901,0.0187848781064798,0.000255887580884225
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PAFAH1B3,Platelet-activating factor acetylhydrolase IB subunit alpha1,40481,0.0431705648609833,0.0118229698007146,0.0199975440515827,0.0663435856703839,0.000261978910665359
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NPTXR,Neuronal pentraxin receptor,42635,0.012641106128652,0.00346894892673521,0.00584196623225099,0.019440246025053,0.000269367283040764
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,BRD2,Bromodomain-containing protein 2,40135,0.0133947704062759,0.00367840172948773,0.00618510301647994,0.0206044377960719,0.000272342774099415
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SOX9,Transcription factor SOX-9,40181,0.0102994668191582,0.00284356388037154,0.00472608161362998,0.0158728520246864,0.00029362006797864
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DPP10,Inactive dipeptidyl peptidase 10,42593,0.0132542357243551,0.00366267216828526,0.00607539827451604,0.0204330731741942,0.000297137770560635
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LSM8,U6 snRNA-associated Sm-like protein LSm8,40301,0.0320766229719704,0.00886645608541883,0.0146983690445495,0.0494548768993913,0.000298493778477712
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SELENOP,Selenoprotein P,40538,-0.00852903989300873,0.0023577002513541,-0.0131501323856628,-0.00390794740035469,0.00029872543321619
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SUMF1,Formylglycine-generating enzyme,40198,0.0237308944401495,0.00657790264339505,0.0108382052590952,0.0366235836212038,0.000310329954386543
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PEAR1,Platelet endothelial aggregation receptor 1,42793,0.00832633756991474,0.00232361707594729,0.00377204810105804,0.0128806270387714,0.000340399070291089
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PTX3,Pentraxin-related protein PTX3,42593,-0.0178407632049758,0.00498382307677614,-0.027609056435457,-0.00807246997449454,0.000345159324887263
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CCAR2,Cell cycle and apoptosis regulator protein 2,40482,0.019799999968396,0.00554182590329456,0.00893802119793864,0.0306619787388533,0.000354615892465645
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,42673,0.0127178707686511,0.0035625996467985,0.00573517546092607,0.0197005660763762,0.000358456869049589
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IGF2BP3,Insulin-like growth factor 2 mRNA-binding protein 3,40115,0.0163424180031817,0.00459080440490903,0.00734444136956001,0.0253403946368034,0.000372691654697044
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CD33,Myeloid cell surface antigen CD33,42678,0.0290719892028579,0.008177086114314,0.0130449004188025,0.0450990779869134,0.000378841530675673
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LACRT,Extracellular glycoprotein lacritin,40418,0.0188077146309943,0.00529050788305813,0.00843831918020032,0.0291771100817882,0.00037954472076627
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FABP9,Fatty acid-binding protein 9,42593,0.0205681940910766,0.00578906968272285,0.00922161751293978,0.0319147706692134,0.000382266416788175
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SOD3,Extracellular superoxide dismutase,40531,-0.0212892980899347,0.00599494854455213,-0.0330393972372568,-0.0095391989426125,0.00038502504567835
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GFAP,Glial fibrillary acidic protein,42325,0.0177349300577992,0.00499864336094354,0.00793758907034982,0.0275322710452485,0.000389598332334272
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LYZL2,Lysozyme-like protein 2,40079,0.013075365509984,0.00369347321177386,0.00583615801490718,0.0203145730050607,0.000401603682857178
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,UNC5D,Netrin receptor UNC5D,40198,0.00941761893714137,0.00268205901665493,0.0041607832644977,0.014674454609785,0.000447641002075172
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,F11,Coagulation factor XI,40382,0.0107989724842978,0.0030827348558455,0.00475681216684066,0.016841132801755,0.000461760280490907
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MFAP3,Microfibril-associated glycoprotein 3,42356,0.0173669622108403,0.00496451894389438,0.00763650508080732,0.0270974193408733,0.000469927111974565
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PROCR,Endothelial protein C receptor,40115,-0.0125315534888891,0.00358707586602044,-0.0195622221862892,-0.00550088479148906,0.000478568934403502
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PALM3,Paralemmin-3,40115,0.0256120669493303,0.00734610819231125,0.0112136948924002,0.0400104390062603,0.000491343649067105
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CDK1,Cyclin-dependent kinase 1,40079,0.0131927691050958,0.0037848483527249,0.00577446633375504,0.0206110718764367,0.000492822452536731
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,VTA1,Vacuolar protein sorting-associated protein VTA1 homolog,42710,0.0253583045263384,0.00728526485921058,0.0110791854022857,0.0396374236503912,0.000501559234349984
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ALDH2,"Aldehyde dehydrogenase, mitochondrial",40450,0.0189041701297098,0.00543588008847045,0.00824984515630772,0.0295584951031119,0.000507712155032136
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FGL1,Fibrinogen-like protein 1,40531,-0.0234204451758092,0.00673559397390459,-0.0366222093646622,-0.0102186809869562,0.000508737162059492
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TXNL1,Thioredoxin-like protein 1,40123,0.0352364519055127,0.0101369946851101,0.0153679423226969,0.0551049614883285,0.000510880328179879
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LRG1,Leucine-rich alpha-2-glycoprotein,40538,-0.00950538986413152,0.00273467276396815,-0.0148653484815091,-0.00414543124675395,0.00051108795807514
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GPR158,Probable G-protein coupled receptor 158,40481,0.0128278154277018,0.0036937786835456,0.00558800920795241,0.0200676216474512,0.000516957438068196
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NOP56,Nucleolar protein 56,40115,0.0398916621212421,0.0114893791803375,0.0173724789277807,0.0624108453147035,0.000518505150289794
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SIRT1,NAD-dependent protein deacetylase sirtuin-1,40198,0.0296186197688034,0.00853470929737185,0.0128905895459546,0.0463466499916522,0.000521729754654683
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ITGB5,Integrin beta-5,42678,-0.0131497829008697,0.0037936514961969,-0.0205853398334157,-0.0057142259683238,0.000529395946023929
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PCDH12,Protocadherin-12,40481,0.00914963748521951,0.00264565981199016,0.0039641442537188,0.0143351307167202,0.000545484855353478
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,VIT,Vitrin,40510,0.0136368583874655,0.00394435274263691,0.00590592701189712,0.0213677897630338,0.000547598170566083
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DKKL1,Dickkopf-like protein 1,42586,-0.031067352264256,0.00898865734946727,-0.0486851206692119,-0.0134495838593002,0.000549376972504501
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PRND,Prion-like protein doppel,40482,0.018487326287649,0.00536570869433572,0.00797053724675094,0.029004115328547,0.000572165724739904
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,KIRREL2,Kin of IRRE-like protein 2,42310,0.0142446083704854,0.00413459394851899,0.0061408042313882,0.0223484125095827,0.000572369066351929
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PBK,Lymphokine-activated killer T-cell-originated protein kinase,40079,-0.0108738086278147,0.00315803042948156,-0.0170635482695985,-0.00468406898603083,0.000576984915575602
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MST1,Hepatocyte growth factor-like protein,40369,0.0231047741783369,0.00671212789447552,0.00994900350516492,0.0362605448515089,0.000579024890679779
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GP2,Pancreatic secretory granule membrane major glycoprotein GP2,42172,-0.0302300159141498,0.0087917804657405,-0.0474619056270012,-0.0129981262012984,0.000586911765449058
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,COL28A1,Collagen alpha-1(XXVIII) chain,40181,0.0267775463320915,0.00780748541555244,0.0114748749176087,0.0420802177465742,0.000606408262278232
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SH3BGRL2,SH3 domain-binding glutamic acid-rich-like protein 2,40135,0.021772172366151,0.00635949345157372,0.00930756520106647,0.0342367795312355,0.0006203083385187
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ARHGEF5,Rho guanine nucleotide exchange factor 5,40135,0.0260602026488453,0.00765069537034897,0.0110648397229613,0.0410555655747293,0.000660980669810096
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,AMPD3,AMP deaminase 3,40482,0.0246895400228637,0.00724929501934955,0.0104809217849386,0.0388981582607889,0.000662040128488165
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IL10,Interleukin-10,42369,0.0295302985231787,0.00867197089958013,0.0125332355600017,0.0465273614863558,0.000662987673773584
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NPR1,Atrial natriuretic peptide receptor 1,40115,-0.0143443631508461,0.00421427595952901,-0.022604344031523,-0.00608438227016922,0.000667051940098572
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NCAM1,Neural cell adhesion molecule 1,42688,-0.010496114274484,0.00308741797302419,-0.0165474535016115,-0.00444477504735663,0.000676695885802283
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DOC2B,Double C2-like domain-containing protein beta,40181,0.0126175171993696,0.00371777011243838,0.0053306877789904,0.0199043466197489,0.000691634676634168
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NPPB,Natriuretic peptides B,42356,-0.0489423018824209,0.0144666093286396,-0.0772968561665545,-0.0205877475982873,0.000718757207542326
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CSF2RB,Cytokine receptor common subunit beta,40198,0.0150434388850237,0.00446026088055359,0.00630132755913863,0.0237855502109087,0.000746723403895653
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,AOC1,Amiloride-sensitive amine oxidase [copper-containing],42369,0.0195356282582822,0.00580124819583979,0.00816518179443617,0.0309060747221281,0.000760736982276326
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,KLK14,Kallikrein-14,42720,0.0161675410475777,0.00481933916378644,0.00672163628655627,0.0256134458085991,0.000796632783749429
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MANEAL,"Glycoprotein endo-alpha-1,2-mannosidase-like protein",40079,0.0177245657712941,0.00529003934192572,0.00735608866111965,0.0280930428814685,0.000809241647430805
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IL17C,Interleukin-17C,42369,0.0255469660725119,0.00762562136005969,0.0106007482067949,0.0404931839382289,0.000809949479945307
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SCARB1,Scavenger receptor class B member 1,42310,0.0198772887881304,0.00595071723908945,0.00821388299951511,0.0315406945767458,0.000839159273903561
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ADAMTS8,A disintegrin and metalloproteinase with thrombospondin motifs 8,42678,-0.0152764523897796,0.00457352193097105,-0.0242405553744828,-0.0063123494050763,0.000839469166036584
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GNPDA1,Glucosamine-6-phosphate isomerase 1,40222,0.011484806317474,0.00343960773273289,0.00474317516131757,0.0182264374736305,0.000843630588782625
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FOLH1,Glutamate carboxypeptidase 2,40198,0.0345825122703048,0.0104151700518607,0.0141687789686578,0.0549962455719519,0.000901815210281
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ITM2A,Integral membrane protein 2A,42593,0.0208690771251459,0.00629388607317657,0.00853306042171987,0.033205093828572,0.000916339323720245
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CYB5A,Cytochrome b5,40079,0.0248565525330363,0.00750751527644555,0.010141822591203,0.0395712824748696,0.000933025601158321
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DNAJA4,DnaJ homolog subfamily A member 4,40482,0.0239636592928487,0.00724483064415968,0.00976379123029568,0.0381635273554016,0.000943627017846094
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PRDX2,Peroxiredoxin-2,40332,0.0212063195128344,0.00641391662070492,0.00863504293625279,0.0337775960894161,0.000948365556596412
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ITGB7,Integrin beta-7,42720,0.0155483143774401,0.00471001021787829,0.00631669435039865,0.0247799344044816,0.000965486445842166
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TRIM26,Tripartite motif-containing protein 26,40079,0.0190057545759148,0.00577303800027589,0.00769060009537405,0.0303209090564555,0.000997384138267467
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TNFSF11,Tumor necrosis factor ligand superfamily member 11,42593,0.0201477555927841,0.00613458590534861,0.0081239672183008,0.0321715439672673,0.00102502108508838
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,VIPR1,Vasoactive intestinal polypeptide receptor 1,40222,-0.00789740841610419,0.00242089602069217,-0.0126423646166608,-0.00315245221554754,0.00110893423324928
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MYOM2,Myomesin-2,40115,-0.0168817019674428,0.0051749946222516,-0.0270246914270559,-0.00673871250782963,0.00110902988916054
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SIRT5,"NAD-dependent protein deacylase sirtuin-5, mitochondrial",42310,0.017653111727879,0.00541464886567093,0.007040399951164,0.0282658235045941,0.0011159770669862
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SNX18,Sorting nexin-18,40448,0.0146523605958553,0.00449920081272913,0.00583392700290622,0.0234707941888044,0.0011306568369818
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,THAP12,52 kDa repressor of the inhibitor of the protein kinase,40064,0.0291513548179846,0.00900615242383285,0.0114992960672722,0.046803413568697,0.00121228954558316
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SEMA4C,Semaphorin-4C,42586,0.00916872630926093,0.00284413187167468,0.00359422784077855,0.0147432247777433,0.00126833733902807
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,C1QTNF6,Complement C1q tumor necrosis factor-related protein 6,40481,0.0107099319269713,0.00333272270113738,0.00417779543274199,0.0172420684212005,0.00131464989977154
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CLSPN,Claspin,42291,0.0115126694324111,0.00358782402295209,0.00448053434742504,0.0185448045173972,0.00133603414049175
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SEMA6C,Semaphorin-6C,40198,0.0086257185578956,0.00269077960980259,0.00335179052268252,0.0138996465931087,0.00135139020999772
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SLC28A1,Sodium/nucleoside cotransporter 1,40079,0.0194433842050237,0.00606760113919428,0.00755088597220287,0.0313358824378445,0.00135706328241826
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CEP164,Centrosomal protein of 164 kDa,42369,0.0215660760706698,0.006737719982792,0.00836014490439749,0.0347720072369421,0.00137372947378234
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GSAP,Gamma-secretase-activating protein,42345,0.0280091765333563,0.00875174988769821,0.0108557467534678,0.0451626063132448,0.00137558775698142
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CSPG4,Chondroitin sulfate proteoglycan 4,40526,-0.010800900000738,0.00339003496873709,-0.0174453685394626,-0.00415643146201326,0.00144609066683856
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CDH4,Cadherin-4,40135,0.0162929991397527,0.00511776894738942,0.0062621720028694,0.0263238262766359,0.00145856306736714
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RNF43,E3 ubiquitin-protein ligase RNF43,40301,0.0186498075812472,0.00588457343771671,0.00711604364332248,0.030183571519172,0.00153236463694281
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TNFAIP8,Tumor necrosis factor alpha-induced protein 8,42369,0.0119928271813555,0.00378546064879869,0.00457332430971008,0.0194123300530009,0.00153773884634239
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SPARCL1,SPARC-like protein 1,42643,-0.00894521891211283,0.00282781004493313,-0.0144877266001818,-0.0034027112240439,0.00156337126980641
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CLEC3B,Tetranectin,40268,0.00675916290364299,0.00215100027269874,0.00254320236915345,0.0109751234381325,0.00168048251714334
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PCARE,Photoreceptor cilium actin regulator,40135,0.0271732068326383,0.00864783143020864,0.0102234572294294,0.0441229564358473,0.00168131526110317
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MYOM1,Myomesin-1,40135,0.0155167711135925,0.00495165296677823,0.00581153129870719,0.0252220109284779,0.00173099940373601
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FGF16,Fibroblast growth factor 16,40198,0.0151939162830511,0.00485349333881159,0.00568106933898043,0.0247067632271219,0.0017495891528132
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TPM3,Tropomyosin alpha-3 chain,40115,-0.0140849996790819,0.00450009541033288,-0.0229051866833344,-0.00526481267482948,0.00175306602479654
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CNTNAP4,Contactin-associated protein-like 4,40181,0.0330696106515067,0.0105661133105052,0.0123600285629165,0.0537791927400969,0.00175395383737106
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MRPL24,"39S ribosomal protein L24, mitochondrial",40115,0.0125053013363076,0.00400866232598898,0.0046483231773692,0.020362279495246,0.00181586936489323
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SCN2A,Sodium channel protein type 2 subunit alpha,40135,0.0160063213070392,0.00513773552040139,0.00593635968705244,0.0260762829270259,0.0018414390432039
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SEPTIN7,Septin-7,40301,0.0173582923189752,0.00558832918887724,0.00640516710877581,0.0283114175291746,0.00190006180294159
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,KIR2DL3,Killer cell immunoglobulin-like receptor 2DL3,42345,0.0255481493461437,0.00822940468459108,0.00941851616434514,0.0416777825279422,0.00191008609795012
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CST1,Cystatin-SN,39041,0.035177544845738,0.0113448337244704,0.0129416707457759,0.0574134189457,0.00193573337345686
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,EIF2AK3,Eukaryotic translation initiation factor 2-alpha kinase 3,40115,0.0212575331395509,0.00686570514482515,0.00780075105569362,0.0347143152234082,0.00196520587093406
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NRXN3,Neurexin-3,40181,0.0112875926635429,0.00365092448665348,0.00413178066970209,0.0184434046573837,0.00199506742604904
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CEP112,Centrosomal protein of 112 kDa,40115,0.0142388605940895,0.0046068279837608,0.0052094777459183,0.0232682434422606,0.00200109121613898
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DYNC1H1,Cytoplasmic dynein 1 heavy chain 1,40450,0.0148050359694741,0.00479272779481641,0.00541128949163391,0.0241987824473142,0.00201278332434269
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LILRA6,Leukocyte immunoglobulin-like receptor subfamily A member 6,40510,0.0235387679042142,0.0076280941108741,0.00858770344690099,0.0384898323615275,0.00203495806715153
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GPA33,Cell surface A33 antigen,42586,-0.0435228025540822,0.0142018187735739,-0.0713583673502871,-0.0156872377578773,0.00218399430555837
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RGS8,Regulator of G-protein signaling 8,42369,0.0201333464868504,0.00658437480889705,0.00722797186141214,0.0330387211122886,0.00223455539873643
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,WFIKKN2,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2",42637,-0.0106489160028079,0.00348373562271596,-0.0174770378233312,-0.00382079418228464,0.00224188402382757
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,AGT,Angiotensinogen,40531,0.00748959148347859,0.00245121760702648,0.00268520497370669,0.0122939779932505,0.00225239560807431
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GSN,Gelsolin,40487,-0.00608073096748935,0.00199232881139883,-0.00998569543783105,-0.00217576649714764,0.00227795613604156
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MTR,Methionine synthase,40115,0.0207887729586468,0.00681460557264573,0.00743214603626117,0.0341453998810324,0.00228917019375321
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MYL3,Myosin light chain 3,40222,-0.0229653907907406,0.00752867555695794,-0.0377215948823781,-0.00820918669910303,0.00229087639444421
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FBN2,Fibrillin-2,40181,0.0190364980699098,0.00625329673166228,0.00678003647585177,0.0312929596639679,0.00233825542049319
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SLC12A2,Solute carrier family 12 member 2,40115,-0.00845595429198003,0.00279713696337994,-0.0139383427402047,-0.00297356584375534,0.00250800912072115
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SPOCK1,Testican-1,42494,0.00794953455634526,0.0026305192480601,0.00279371683014748,0.0131053522825431,0.00251554987775081
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LYPD3,Ly6/PLAUR domain-containing protein 3,42571,0.0105183143079708,0.00348655490386529,0.00368466669639486,0.0173519619195468,0.00255920188051697
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SPESP1,Sperm equatorial segment protein 1,40510,0.00978687999347119,0.00325316442431804,0.00341067772180784,0.0161630822651345,0.00263188887255147
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ODAM,Odontogenic ameloblast-associated protein,42291,0.0173135729875562,0.00575785671509502,0.00602817382596997,0.0285989721491424,0.00264385894526498
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,INSL3,Insulin-like 3,40482,0.0240910035393152,0.00801332171545741,0.00838489297701871,0.0397971141016118,0.00264969326525346
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GBP6,Guanylate-binding protein 6,40115,-0.0142031291695061,0.00473580508029601,-0.0234853071268862,-0.0049209512121259,0.0027139311132402
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IL36G,Interleukin-36 gamma,40153,0.021104405889515,0.00705156881944636,0.00728333100340012,0.0349254807756299,0.00276986337553022
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SMPDL3A,Acid sphingomyelinase-like phosphodiesterase 3a,42657,-0.0198553376849465,0.00663596582662613,-0.0328618307051337,-0.00684884466475927,0.00277586196040625
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CHGB,Secretogranin-1,42663,0.0130859846840589,0.00438987230188412,0.004481834972366,0.0216901343957517,0.00287870312035185
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,OSMR,Oncostatin-M-specific receptor subunit beta,42704,0.00614811716542564,0.00206392333422443,0.00210282743034576,0.0101934069005055,0.0028984691543872
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GFOD2,Glucose-fructose oxidoreductase domain-containing protein 2,42345,0.0373441045486365,0.0125539735110978,0.0127383164668848,0.0619498926303883,0.00293823155861521
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SPINK5,Serine protease inhibitor Kazal-type 5,42610,0.0104756806843794,0.0035220550268869,0.00357245283168109,0.0173789085370777,0.00294171564214107
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,EIF5,Eukaryotic translation initiation factor 5,40115,0.013441429415017,0.00452301060936104,0.00457632862066933,0.0223065302093646,0.00296716185088565
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,HDDC2,5'-deoxynucleotidase HDDC2,40448,0.0133882430026041,0.00451171408104958,0.00454528340374693,0.0222312026014613,0.00300922156443557
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DDX25,ATP-dependent RNA helicase DDX25,40181,-0.0115188193746164,0.00389121509208192,-0.019145600955097,-0.00389203779413587,0.00308084601781358
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RAD51,DNA repair protein RAD51 homolog 1,40301,0.016501133208888,0.00557587579005681,0.00557241666037666,0.0274298497573993,0.00308909714540524
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,UROS,Uroporphyrinogen-III synthase,40181,0.0205561019035307,0.00696529469295786,0.00690412430533333,0.0342080795017281,0.00317192194455608
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RPS10,40S ribosomal protein S10,40115,-0.0123221213770801,0.00418107015021348,-0.0205170188714985,-0.00412722388266168,0.00321425408514706
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CRTAC1,Cartilage acidic protein 1,42793,-0.00893495225355859,0.00305139220018247,-0.0149156809659162,-0.00295422354120094,0.00341544430459862
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DOCK9,Dedicator of cytokinesis protein 9,40135,0.0363632380054825,0.0124179789990156,0.0120239991674119,0.0607024768435531,0.00341552898763033
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ENPP6,Glycerophosphocholine cholinephosphodiesterase ENPP6,40222,-0.0111361176547396,0.00380440053867991,-0.0185927427105522,-0.00367949259892694,0.00342763318771847
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TDGF1,Teratocarcinoma-derived growth factor 1,42310,0.0446856655462185,0.0152746305460791,0.0147473896759035,0.0746239414165336,0.00344511834007298
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SIGLEC15,Sialic acid-binding Ig-like lectin 15,42310,0.0230878901974065,0.00790690439079849,0.00759035759144145,0.0385854228033715,0.00350665663036535
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,WFDC12,WAP four-disulfide core domain protein 12,42697,0.0195259136338696,0.00668781605222232,0.00641779417151386,0.0326340330962253,0.00351032171240362
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CENPJ,Centromere protein J,40301,0.0212383504487113,0.00727654384416995,0.00697632451413816,0.0355003763832844,0.00352152889166589
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CEP152,Centrosomal protein of 152 kDa,40079,0.0124866954370314,0.00428113176896882,0.00409567716985255,0.0208777137042103,0.00354500118482058
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,42635,0.00984486266554861,0.00337682801755312,0.0032262797511445,0.0164634455799527,0.00355799914993211
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PRKCQ,Protein kinase C theta type,42369,0.0130362309099948,0.00447316805403726,0.00426882152408175,0.0218036402959078,0.00357067192928111
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MAPRE3,Microtubule-associated protein RP/EB family member 3,40079,0.0428870579363057,0.0147206157103177,0.0140346511440829,0.0717394647285284,0.0035824238289948
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RNF31,E3 ubiquitin-protein ligase RNF31,40198,0.0105827214699246,0.00363407997994719,0.00345992470922808,0.0177055182306211,0.00359755191043371
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,C9orf40,Uncharacterized protein C9orf40,40448,0.0242761326742641,0.00834344987311245,0.00792297092296372,0.0406292944255646,0.00362595992660865
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,EXTL1,Exostosin-like 1,40115,0.014098792936893,0.00486017414704506,0.00457285160868464,0.0236247342651013,0.00372856475396974
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CEP350,Centrosome-associated protein 350,40079,0.0113284286002998,0.0039051776758402,0.00367428035565301,0.0189825768449466,0.00372868681789801
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SLC13A1,Solute carrier family 13 member 1,40450,0.0186014629351999,0.00642155234698235,0.00601522033511446,0.0311877055352853,0.00377808197643613
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ANPEP,Aminopeptidase N,42665,0.00816826397237204,0.00283378408481768,0.0026140471661294,0.0137224807786147,0.00395209474947729
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,C1QTNF9,Complement C1q and tumor necrosis factor-related protein 9A,40254,-0.0143209765818155,0.00497057499088512,-0.0240633035639503,-0.00457864959968064,0.0039698777667914
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CREBZF,CREB/ATF bZIP transcription factor,40079,-0.00772562958665844,0.00268572480337307,-0.0129896502012697,-0.00246160897204722,0.00402825708785
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,BATF,Basic leucine zipper transcriptional factor ATF-like,40181,0.0248234390673668,0.00863223886578688,0.00790425089042447,0.041742627244309,0.00403950620957431
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,HLA_DRA,,42548,0.010821890154026,0.00376633102128412,0.00343988135230915,0.0182038989557429,0.00406817479939224
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ATP1B2,Sodium/potassium-transporting ATPase subunit beta-2,40115,-0.00954977402275168,0.00333509166371861,-0.0160865536836401,-0.00301299436186321,0.00419890354124147
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FMR1,Synaptic functional regulator FMR1,42345,0.0103568646865225,0.00362239003422069,0.00325698021945,0.0174567491535951,0.00425479870992386
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ACTN4,Alpha-actinin-4,42369,0.00954451479573691,0.00334335318249511,0.00299154255804648,0.0160974870334273,0.00431348165837883
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ZCCHC8,Zinc finger CCHC domain-containing protein 8,40115,0.0176558624189494,0.00619487109526968,0.0055139150722208,0.0297978097656779,0.00437904184925513
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TLR2,Toll-like receptor 2,40301,0.00681627891244863,0.00240534241050444,0.00210180778785992,0.0115307500370373,0.00460798773662393
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IDI2,Isopentenyl-diphosphate delta-isomerase 2,42310,0.0139973101176986,0.00495099761562443,0.00429335479107475,0.0237012654443225,0.00470325414338279
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,JCHAIN,Immunoglobulin J chain,42369,0.0180639042667232,0.00639394538936338,0.00553177130357102,0.0305960372298755,0.00473283881123276
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,THSD1,Thrombospondin type-1 domain-containing protein 1,40109,0.00992453498502805,0.0035220622805056,0.00302129291523708,0.016827777054819,0.00484379382066938
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,HSD11B1,Corticosteroid 11-beta-dehydrogenase isozyme 1,42593,-0.0113102790057222,0.00401545356925562,-0.0191805680014632,-0.00343999000998114,0.00485926177864616
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CNDP1,Beta-Ala-His dipeptidase,42688,-0.0132349398087806,0.00470698952888427,-0.0224606392853937,-0.00400924033216741,0.00493418518927579
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MYL6B,Myosin light chain 6B,40181,0.0261415327904724,0.00934253192559783,0.00783017021630065,0.0444528953646441,0.0051490388864735
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FGFR4,Fibroblast growth factor receptor 4,40282,0.0151792128184745,0.00546050567132303,0.00447662170268133,0.0258818039342676,0.00544809925292789
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CRIM1,Cysteine-rich motor neuron 1 protein,42675,0.00586461017809948,0.0021133855437017,0.00172237451244415,0.0100068458437548,0.00552805200750475
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,C1QBP,"Complement component 1 Q subcomponent-binding protein, mitochondrial",40481,0.0205000983992746,0.00739820860821003,0.00599960952718293,0.0350005872713662,0.00559837200577501
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LYPD8,Ly6/PLAUR domain-containing protein 8,42345,0.0143208222887616,0.005180251675972,0.00416752900385652,0.0244741155736668,0.00570889412685332
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CTRL,Chymotrypsin-like protease CTRL-1,40482,-0.0200329467658918,0.00724687385560802,-0.0342368195228835,-0.00582907400890008,0.00571276168285716
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,UGDH,UDP-glucose 6-dehydrogenase,40115,0.0270766367880686,0.00982320434339682,0.00782315627501089,0.0463301173011264,0.00585392550580636
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NEO1,Neogenin,40481,0.00628252855644715,0.00227964953029221,0.00181441547707442,0.0107506416358199,0.0058621472794361
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IL22RA1,Interleukin-22 receptor subunit alpha-1,42369,0.0121225302991807,0.00440457183251807,0.00348956950744525,0.0207554910909161,0.00592663375291399
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CTSV,Cathepsin L2,42676,-0.0117649743803371,0.00427812267471246,-0.0201500948227735,-0.00337985393790064,0.00596688713033599
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,EPN1,Epsin-1,40301,0.0125424370369522,0.00457233132172123,0.00358066764637858,0.0215042064275258,0.00609566972524397
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CLEC2L,C-type lectin domain family 2 member L,40181,0.0138316862798674,0.00506021759483174,0.00391365979399716,0.0237497127657376,0.00627811860053913
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IL31,Interleukin-31,40198,0.0157606780928147,0.0057787089852079,0.00443440848180724,0.0270869477038222,0.00639426025801379
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CCDC28A,Coiled-coil domain-containing protein 28A,40181,0.00840608736305413,0.00308913736479925,0.00235137812804761,0.0144607965980607,0.00651525093056703
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ACP1,Low molecular weight phosphotyrosine protein phosphatase,40198,0.0123702043087313,0.00457382295690445,0.00340551131319853,0.021334897304264,0.00684989713014545
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PDGFRA,Platelet-derived growth factor receptor alpha,42635,0.00796014998127822,0.00295293693430661,0.00217239359003727,0.0137479063725192,0.00703341841686936
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,XPNPEP2,Xaa-Pro aminopeptidase 2,42678,0.0266860345681389,0.00993465748746353,0.00721410589271035,0.0461579632435674,0.00723679857301699
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ACADM,"Medium-chain specific acyl-CoA dehydrogenase, mitochondrial",40301,0.0193769610322198,0.0072623726780624,0.00514271058321745,0.0336112114812221,0.00763852638058545
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,BRD1,Bromodomain-containing protein 1,40301,-0.00837920111544944,0.00314181774509065,-0.0145371638958271,-0.00222123833507176,0.00766445534337065
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ESM1,Endothelial cell-specific molecule 1,42617,-0.00931558186687144,0.00349803144221278,-0.0161717234936085,-0.00245944024013439,0.00775184675278915
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RAB6B,Ras-related protein Rab-6B,42310,0.0134303929467038,0.00504366921757572,0.0035448012802554,0.0233159846131522,0.00775829927257873
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CHIT1,Chitotriosidase-1,42698,0.0418885130911653,0.015756020595966,0.011006712723072,0.0727703134592587,0.00785651131538801
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LILRA3,Leukocyte immunoglobulin-like receptor subfamily A member 3,40526,0.0384695920138652,0.0145361025929636,0.00997883093165665,0.0669603530960738,0.00814452799883339
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PTEN,"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN",42310,0.00814338538339802,0.003078252062586,0.00211001134072946,0.0141767594260666,0.00816777803021923
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,KIF20B,Kinesin-like protein KIF20B,40135,0.0212108064722368,0.00805046027641485,0.00543190433046367,0.0369897086140099,0.0084322337373675
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FOLR3,Folate receptor gamma,42628,0.0498474936494832,0.0189406587260636,0.0127238025463986,0.0869711847525679,0.00850379361336871
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NRP2,Neuropilin-2,42610,0.00768020724225647,0.00293447924480612,0.00192862792243647,0.0134317865620765,0.00887460322469546
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TSC1,Hamartin,40198,0.0196515579137251,0.00752617024108031,0.00490026424120766,0.0344028515862425,0.00903748132112183
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MDGA1,MAM domain-containing glycosylphosphatidylinositol anchor protein 1,42494,0.0183812703652788,0.00704518956774287,0.00457269881250279,0.0321898419180548,0.00908948907096803
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SSBP1,"Single-stranded DNA-binding protein, mitochondrial",40198,0.00943360628634811,0.0036188647424115,0.00234063139122157,0.0165265811814746,0.00915196912701632
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LIFR,Leukemia inhibitory factor receptor,42593,0.00641007411363827,0.00246206812519775,0.00158442058825068,0.0112357276390259,0.00923702793124281
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ACHE,Acetylcholinesterase,40282,0.00886916224843956,0.003418667747285,0.00216857346376097,0.0155697510331182,0.00948993657479257
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CA9,Carbonic anhydrase 9,42720,0.0128441335507475,0.00495434564032506,0.00313361609571033,0.0225546510057846,0.00953841068676683
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IL20RA,Interleukin-20 receptor subunit alpha,42369,0.0118974198651717,0.0045914908892775,0.00289809772218779,0.0208967420081556,0.0095750445065477
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FUCA1,Tissue alpha-L-fucosidase,42720,0.0222206798028391,0.00858918916113442,0.00538586904701566,0.0390554905586626,0.00969043194854517
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,BTLA,B- and T-lymphocyte attenuator,40079,0.0233518529026438,0.00904741077844873,0.00561892777688432,0.0410847780284033,0.00986288919279866
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,BABAM1,BRISC and BRCA1-A complex member 1,40198,0.00769319286453847,0.00298262422344561,0.00184724938658507,0.0135391363424919,0.00991187382994737
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CEP290,Centrosomal protein of 290 kDa,40301,0.0144349102279467,0.00560130648475056,0.00345634951783558,0.0254134709380578,0.00997720828243174
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MMUT,"Methylmalonyl-CoA mutase, mitochondrial",40115,0.0131036152670105,0.00508831189577871,0.00313052395128425,0.0230767065827368,0.0100301412901577
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ART3,Ecto-ADP-ribosyltransferase 3,42688,0.00945457576779463,0.00367679358112033,0.00224806034879878,0.0166610911867905,0.0101388888002538
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,EDIL3,EGF-like repeat and discoidin I-like domain-containing protein 3,42356,0.00877863185056711,0.00342552200892825,0.00206460871306773,0.0154926549880665,0.0103967881987878
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TPPP3,Tubulin polymerization-promoting protein family member 3,42310,0.0103464057717531,0.00404911082475868,0.00241014855522609,0.0182826629882801,0.0106229758374182
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GART,Trifunctional purine biosynthetic protein adenosine-3,40481,0.00710515410409295,0.0027887061982504,0.00163928995552216,0.0125710182526637,0.0108526129174868
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MTPN,Myotrophin,42356,0.00864546283666129,0.00339372810207343,0.00199375575659736,0.0152971699167252,0.0108616027383298
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,EPHX2,Bifunctional epoxide hydrolase 2,42356,0.0161222622344945,0.00636299705073902,0.00365078801504605,0.028593736453943,0.0112963288492445
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SCG3,Secretogranin-3,42637,0.0088162172732298,0.00348449055724401,0.00198661578103154,0.0156458187654281,0.0114133177259726
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,HRAS,GTPase Hras,40285,0.0259039174384008,0.0102393496465664,0.00583479213113055,0.045973042745671,0.0114251786912288
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ST8SIA1,"Alpha-N-acetylneuraminide alpha-2,8-sialyltransferase",40198,0.0121677343177442,0.00483936785245521,0.00268257332693203,0.0216528953085565,0.0119402604053905
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,STOML2,"Stomatin-like protein 2, mitochondrial",40079,0.0238246749029875,0.00949237658064171,0.0052196168049298,0.0424297330010453,0.0120917980897421
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,EDNRB,Endothelin receptor type B,40198,0.0114376858691763,0.00457199419091836,0.00247657725497628,0.0203987944833763,0.0123748152592216
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PNMA2,Paraneoplastic antigen Ma2,40135,0.0114283766522978,0.00456960898393447,0.00247194304378621,0.0203848102608094,0.0124004689557801
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DCUN1D2,DCN1-like protein 2,40079,0.0205185111466638,0.00823324430403445,0.00438135231075626,0.0366556699825713,0.0127118625645406
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CD34,Hematopoietic progenitor cell antigen CD34,42673,-0.00616627632754516,0.00247831064684077,-0.0110237651953531,-0.00130878745973724,0.0128548693716339
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CASP4,Caspase-4,40301,0.0441391033887548,0.0177449131229036,0.00935907366786379,0.0789191331096458,0.0128817931065201
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MYBPC2,"Myosin-binding protein C, fast-type",40222,0.0216022791225714,0.00870422989946011,0.00454198851962961,0.0386625697255132,0.013086329067451
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IL17F,Interleukin-17F,42369,0.0191545239468476,0.00771847421435982,0.00402631448670233,0.0342827334069928,0.0130900692206871
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ATP6V1D,V-type proton ATPase subunit D,42586,0.00661847985115442,0.00267382261818204,0.00137778751951761,0.0118591721827912,0.0133251731828975
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TCL1B,T-cell leukemia/lymphoma protein 1B,42356,0.019660775666264,0.007951558174342,0.00407572164455371,0.0352458296879743,0.0134271248983119
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IL2RB,Interleukin-2 receptor subunit beta,42369,0.00988625243623059,0.00400935401494048,0.00202791856694724,0.0177445863055139,0.0136835299514692
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IL31RA,Interleukin-31 receptor subunit alpha,40144,0.00965641073144288,0.00392590649084225,0.00196163400939206,0.0173511874534937,0.0139220578168505
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FZD8,Frizzled-8,40135,0.0115730855631082,0.00470774987311938,0.00234589581179421,0.0208002753144222,0.0139748351409606
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,HNF1A,Hepatocyte nuclear factor 1-alpha,40181,0.0180308361935806,0.00736580263096404,0.00359386303689104,0.0324678093502701,0.0143842113303101
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RAB3GAP1,Rab3 GTPase-activating protein catalytic subunit,40135,0.0146006242912462,0.00597167154244118,0.00289614806806147,0.0263051005144309,0.014501632684721
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CDSN,Corneodesmosin,42709,0.011049385236143,0.00455103783885068,0.00212935107199563,0.0199694194002903,0.0152002295743452
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LSM1,U6 snRNA-associated Sm-like protein LSm1,42345,0.0139988670626791,0.0057857312128122,0.00265883388556724,0.0253389002397911,0.0155531886488542
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DSG4,Desmoglein-4,42542,0.0123616044760856,0.00512349191398078,0.00231956032468328,0.0224036486274879,0.0158469199598758
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LYPLA2,Acyl-protein thioesterase 2,40135,0.0276434529389222,0.0115251461981551,0.00505416639053819,0.0502327394873061,0.0164774942103444
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PDCL2,Phosducin-like protein 2,40079,0.0129993953436425,0.00545048130820592,0.00231645197955889,0.0236823387077261,0.0170961547706424
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PPM1B,Protein phosphatase 1B,40198,0.0147792670600576,0.00625558569492703,0.00251831909800064,0.0270402150221146,0.0181659519861675
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TXK,Tyrosine-protein kinase TXK,40301,0.0181944989351662,0.0077082435621427,0.00308634155336651,0.0333026563169659,0.0182726752089423
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,KRT14,"Keratin, type I cytoskeletal 14",41947,0.00707663225273778,0.00300128471691476,0.00119411420758485,0.0129591502978907,0.0183952563165478
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CAPS,Calcyphosin,40482,0.0249900506328891,0.0106153881767147,0.00418388980652837,0.0457962114592498,0.0185829353594171
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NMRK2,Nicotinamide riboside kinase 2,40079,-0.0102421991214169,0.00436119103591123,-0.0187901335518029,-0.00169426469103084,0.0188676634143808
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TPSD1,Tryptase delta,40481,0.00923676494940325,0.00394087609991966,0.00151264779356071,0.0169608821052458,0.0191038449998517
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TSLP,Thymic stromal lymphopoietin,42356,0.0145778454384244,0.00624258055568825,0.00234238754927547,0.0268133033275734,0.0195464891847371
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ATF2,Cyclic AMP-dependent transcription factor ATF-2,42310,0.0159395834830728,0.00682769762459765,0.00255729613886136,0.0293218708272841,0.0195820906025966
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CPE,Carboxypeptidase E,42587,-0.00916112910198393,0.00394267982578821,-0.0168887815605288,-0.00143347664343904,0.020162946264197
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RGMA,Repulsive guidance molecule A,42710,-0.00759609767890292,0.0032718377675612,-0.0140088997033229,-0.00118329565448296,0.0202659932244184
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,VSTM2B,V-set and transmembrane domain-containing protein 2B,40301,0.00964409066041894,0.0041628467614482,0.00148491100798047,0.0178032703128574,0.0205378718786074
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MCEE,"Methylmalonyl-CoA epimerase, mitochondrial",40481,0.00969447684791398,0.00419066280815575,0.0014807777439287,0.0179081759518993,0.0207211927655506
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GFRAL,GDNF family receptor alpha-like,40108,-0.014929139696425,0.00645805668098339,-0.0275869307911524,-0.00227134860169752,0.0208123214281671
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TNNI3,"Troponin I, cardiac muscle",42356,0.0197964068633257,0.00862568572086716,0.00289006285042605,0.0367027508762253,0.0217457374795463
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ARNT,Aryl hydrocarbon receptor nuclear translocator,42369,0.00854221879465067,0.00374027190648419,0.00121128585794166,0.0158731517313597,0.0223962054844147
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CDH6,Cadherin-6,42635,0.00902366559967057,0.00395276931705077,0.00127623773825106,0.0167710934610901,0.0224534631549313
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GH2,Growth hormone variant,42345,0.0388808621994776,0.0170603491828126,0.00544257780116501,0.0723191465977902,0.0226818806514497
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,C1QA,Complement C1q subcomponent subunit A,42700,0.00512537416916617,0.0022495987837234,0.000716160553068299,0.00953458778526403,0.0227212570010636
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,BRD3,Bromodomain-containing protein 3,40115,0.0116348742689222,0.00510770573669082,0.00162377102500821,0.0216459775128362,0.0227514043767186
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,KIAA2013,Uncharacterized protein KIAA2013,40450,0.0125192923512901,0.00551031067794821,0.00171908342251159,0.0233195012800686,0.0231067573065145
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PKLR,Pyruvate kinase PKLR,42635,0.0150845665212055,0.00664845789997568,0.00205358903725313,0.0281155440051578,0.0232912849939916
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PCNA,Proliferating cell nuclear antigen,40079,0.0144936183590839,0.00642578385143552,0.0018990820102703,0.0270881547078975,0.0241191698552967
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,AGBL2,Cytosolic carboxypeptidase 2,40135,0.0210778973085722,0.00934801645661165,0.00275578505361337,0.039400009563531,0.0241656406579118
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TGM2,Protein-glutamine gamma-glutamyltransferase 2,42617,0.0171570176360947,0.00762300984589766,0.00221591833813527,0.0320981169340541,0.0244214150752913
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PNLIPRP2,Pancreatic lipase-related protein 2,42617,0.0678284686364344,0.0302330925613264,0.00857160721623472,0.127085330056634,0.0248797099923318
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,VASN,Vasorin,42448,0.00629845533983906,0.0028119892648666,0.000786956380700538,0.0118099542989776,0.0251166834771806
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NENF,Neudesin,40450,0.0252972549912138,0.0112970295629285,0.00315507704787389,0.0474394329345537,0.0251569107752679
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PTPRZ1,Receptor-type tyrosine-protein phosphatase zeta,40510,0.00733594016359042,0.00329268737398156,0.000882272910586551,0.0137896074165943,0.025903482528419
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,OFD1,Oral-facial-digital syndrome 1 protein,40301,0.0149969677951492,0.00676030739143429,0.001746765307938,0.0282471702823604,0.0265487038455207
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MANSC1,MANSC domain-containing protein 1,42678,0.00634537979090745,0.0028652749298545,0.00072944092839262,0.0119613186534223,0.0268055811839935
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,KIR2DL2,Killer cell immunoglobulin-like receptor 2DL2,40450,0.0205522698116654,0.00929864631260221,0.00232692303896508,0.0387776165843657,0.0271083298135522
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GUK1,Guanylate kinase,40115,-0.00871941189379875,0.00394623977152945,-0.0164540418459965,-0.000984781941601035,0.0271571182898369
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ACTN2,Alpha-actinin-2,40115,-0.013494914323386,0.00610849477970348,-0.0254675640916048,-0.0015222645551672,0.0271810963021788
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,VTCN1,V-set domain-containing T-cell activation inhibitor 1,42345,0.00718960188074577,0.00325772336237712,0.000804464090486619,0.0135747396710049,0.0273354215732001
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PAPPA,Pappalysin-1,42369,0.010486011526578,0.00477140773125283,0.00113405237332243,0.0198379706798335,0.0279894924495428
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CD3E,T-cell surface glycoprotein CD3 epsilon chain,40301,0.00830692399516465,0.00378490517523859,0.000888509851697009,0.0157253381386323,0.0282020984061268
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CD58,Lymphocyte function-associated antigen 3,42599,-0.00396642726996429,0.00180900529218499,-0.00751207764264687,-0.000420776897281718,0.0283532469634604
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MED21,Mediator of RNA polymerase II transcription subunit 21,40115,0.0107980081145052,0.00493307748196076,0.00112917624986213,0.0204668399791483,0.0286252837168082
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TLR4,Toll-like receptor 4,40198,0.00656276071533401,0.00300501614194016,0.000672929077131294,0.0124525923535367,0.0289880458027857
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ITGAX,Integrin alpha-X,40301,0.0122054513296146,0.00559166892692035,0.00124578023285074,0.0231651224263785,0.0290719845007845
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SERPINB5,Serpin B5,42356,0.0108329218053252,0.00497752219707243,0.00107697829906325,0.0205888653115872,0.0295454469875453
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NFKB2,Nuclear factor NF-kappa-B p100 subunit,40301,0.0116725158438817,0.00537680479296431,0.00113397844967163,0.0222110532380917,0.0299596947286442
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SULT1A1,Sulfotransferase 1A1,42710,-0.028088260732194,0.0130141883279327,-0.0535960698549421,-0.00258045160944603,0.030923630987319
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PTPRS,Receptor-type tyrosine-protein phosphatase S,42793,0.00547136483316943,0.00253526738435152,0.000502240759840453,0.0104404889064984,0.0309373743499828
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SH3GL3,Endophilin-A3,40249,0.0186485832148089,0.00877075227064811,0.00145790876433856,0.0358392576652792,0.0335067142378632
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ENDOU,Poly(U)-specific endoribonuclease,39633,0.011953473988154,0.00562698784372573,0.00092457781445161,0.0229823701618565,0.0336675573936465
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LHB,Lutropin subunit beta,42345,0.0182971554929558,0.00861434522132365,0.00141303885916145,0.0351812721267502,0.0336859738572308
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,S100A14,Protein S100-A14,40481,0.0119121193481379,0.00562434763196586,0.000888397989484827,0.022935840706791,0.0342006143952558
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,EPB41L5,Band 4.1-like protein 5,40181,0.0133232740468962,0.00629500906843742,0.000985056272758826,0.0256614918210335,0.0343262476933493
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GID8,Glucose-induced degradation protein 8 homolog,40481,0.0074396756541446,0.00351515587967909,0.00054997012997358,0.0143293811783156,0.0343278000872115
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MEP1B,Meprin A subunit beta,42635,0.0254493554684962,0.0120487432796358,0.00183381864040998,0.0490648922965823,0.0346876955730094
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NCAN,Neurocan core protein,42710,0.00818126285091476,0.00387967244297379,0.000577104862686129,0.0157854208391434,0.0349844355046666
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,BCL7A,B-cell CLL/lymphoma 7 protein family member A,40079,0.013855092439907,0.00657674713181799,0.00096466806154377,0.0267455168182703,0.035168273214938
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,COL9A1,Collagen alpha-1(IX) chain,42593,0.0104282200408059,0.00495684980646702,0.000712794420130544,0.0201436456614813,0.0354144947811482
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IL5,Interleukin-5,42369,0.029952636757764,0.0142379089528167,0.00204633521024318,0.0578589383052848,0.0354213979634403
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TMPRSS11B,Transmembrane protease serine 11B,40135,0.0167954126305906,0.00801821305552707,0.0010797150417576,0.0325111102194237,0.0362243625539543
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CGN,Cingulin,40181,0.00884206950856717,0.00423354728625494,0.000544316827507487,0.0171398221896268,0.0367692036189961
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MORF4L2,Mortality factor 4-like protein 2,40079,0.00788663155665826,0.00377663337440331,0.000484430142827783,0.0152888329704887,0.0367966350637705
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IFNW1,Interferon omega-1,40115,-0.00789348699143577,0.00378624377798071,-0.015314524796278,-0.000472449186593575,0.037112406859149
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ZPR1,Zinc finger protein ZPR1,40135,0.0208984142121862,0.0100331173780221,0.00123350415126287,0.0405633242731096,0.0372795608921457
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DEFB118,Beta-defensin 118,40135,0.0122117881454753,0.00586735677775379,0.00071176886107786,0.0237118074298727,0.0374287395232327
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IL1R1,Interleukin-1 receptor type 1,42589,0.00500617348923204,0.00240881595593418,0.000284894215601058,0.00972745276286303,0.0377033556464843
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IL36A,Interleukin-36 alpha,40198,0.0122647655206709,0.00590380597288383,0.000693305813818587,0.0238362252275232,0.0377846844675455
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PLB1,"Phospholipase B1, membrane-associated",40482,-0.0127928027264129,0.00616193022957446,-0.0248701859763788,-0.000715419476446958,0.0379069911666162
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PTPN9,Tyrosine-protein phosphatase non-receptor type 9,40176,0.00808234791025133,0.00389807718751939,0.000442116622713332,0.0157225791977893,0.0381565462089713
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",40135,0.0120869004840785,0.00586093513588081,0.000599467617752113,0.0235743333504049,0.0392044592297032
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,BCAM,Basal cell adhesion molecule,42610,0.00517857211362372,0.00251987260769675,0.000239621802538079,0.0101175224247094,0.0398893578573829
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CFHR4,Complement factor H-related protein 4,40508,0.0156857029432918,0.00764524759747989,0.000701017652231238,0.0306703882343524,0.0402224504086582
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SAA4,Serum amyloid A-4 protein,40538,0.0067859593744741,0.00331852841533042,0.000281643680426472,0.0132902750685217,0.0408906991607454
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TNR,Tenascin-R,42494,-0.00884587683885493,0.00433124889874435,-0.0173351246803939,-0.000356628997315998,0.0411376343602445
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,OPTC,Opticin,42586,0.00962477134042869,0.00473838144354133,0.000337543711087691,0.0189119989697697,0.0422507606439113
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,HIP1,Huntingtin-interacting protein 1,40115,0.00696489872539905,0.00343196490390955,0.00023824751373633,0.0136915499370618,0.0424397152555585
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SCN2B,Sodium channel subunit beta-2,40181,-0.00607100176835157,0.00299238670636843,-0.0119360797128337,-0.00020592382386945,0.0425011099207212
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IGSF21,Immunoglobulin superfamily member 21,40222,0.00823905373432493,0.00406358430431583,0.000274428497865898,0.016203678970784,0.0426318707141158
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PYDC1,Pyrin domain-containing protein 1,40222,0.00890453678200826,0.00439350659821844,0.000293263849500132,0.0175158097145164,0.0427120628127229
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DDX39A,ATP-dependent RNA helicase DDX39A,40198,0.00504969537324745,0.00249492473833255,0.000159642886115656,0.00993974786037924,0.0429955985017571
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SBSN,Suprabasin,40510,-0.00724923421188336,0.00358315477870296,-0.0142722175781412,-0.000226250845625566,0.0430818793081597
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ASPN,Asporin,40510,0.00581574823363222,0.00287837121137288,0.000174140659341367,0.0114573558079231,0.0433550887899553
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FABP2,"Fatty acid-binding protein, intestinal",42635,-0.0163022847433344,0.00807256145624059,-0.0321245051975659,-0.00048006428910282,0.0434583408535987
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NTF3,Neurotrophin-3,42593,0.00738145244422155,0.00365930371646027,0.00020921715995943,0.0145536877284837,0.0436972576925898
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NDST1,Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 1,40450,0.0131668743152695,0.00654100646706332,0.000346501639825374,0.0259872469907136,0.0441411554611342
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MRPL52,"39S ribosomal protein L52, mitochondrial",40058,0.00546402316365438,0.00272005881517823,0.000132707885905054,0.0107953384414037,0.0445842526756361
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RASA1,Ras GTPase-activating protein 1,42310,0.00659678666905591,0.0033157222021481,9.79711528456368e-05,0.0130956021852662,0.0466615415774491
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IL25,Interleukin-25,40035,0.00710674088944077,0.00359202112421826,6.63794859729764e-05,0.0141471022929086,0.0478998875377628
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CRHR1,Corticotropin-releasing factor receptor 1,42356,0.0121150521508999,0.00612525945350584,0.000109543622028484,0.0241205606797714,0.0479626271157351
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SCGB2A2,Mammaglobin-A,40115,-0.00644843846125666,0.00326526056742165,-0.0128483491734031,-4.85277491102335e-05,0.0483089768046428
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,VCPKMT,Protein-lysine methyltransferase METTL21D,40079,0.017495749876093,0.00889457432557029,6.23841979752286e-05,0.0349291155542108,0.0492069874627015
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,B3GAT3,Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3,40115,-0.00419664554429377,0.002134002350322,-0.0083792901509249,-1.40009376626447e-05,0.0492591410774811
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RIPK4,Receptor-interacting serine/threonine-protein kinase 4,40115,0.0144677085504053,0.00736159797544745,3.89765185282963e-05,0.0288964405822823,0.0494054582344021
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LMOD2,Leiomodin-2,40135,0.0126124067619499,0.00641913965059455,3.08930467845595e-05,0.0251939204771152,0.0494611925121694
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SERPINA3,Alpha-1-antichymotrypsin,40501,0.00305377533432329,0.00155655073729788,2.93588921944669e-06,0.00610461477942714,0.0498002353859617
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TYRO3,Tyrosine-protein kinase receptor TYRO3,42635,0.00568193803934857,0.00289927110319,-6.33322903832896e-07,0.011364509401601,0.0500419612279191
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FUT1,"Galactoside alpha-(1,2)-fucosyltransferase 1",40267,-0.0127819012464269,0.00652649070151909,-0.0255738230214043,1.00205285505396e-05,0.0502005838949521
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ADGRB3,Adhesion G protein-coupled receptor B3,42474,0.00682313382631955,0.00350461225279622,-4.59061891610341e-05,0.0136921738418001,0.0515676337186153
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MYO6,Unconventional myosin-VI,40481,0.00726115485786823,0.00373022082414686,-5.00779574596124e-05,0.0145723876731961,0.0516104765046376
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,BLOC1S2,Biogenesis of lysosome-related organelles complex 1 subunit 2,40135,0.0150356550971132,0.0077809883140326,-0.00021508199839068,0.0302863921926171,0.0533411153062278
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SPON2,Spondin-2,42561,0.00706993173074893,0.00366142622663805,-0.000106463673461653,0.0142463271349595,0.0535137094131557
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RAP1A,Ras-related protein Rap-1A,40198,0.0140402310625874,0.00728161074100244,-0.000231725989777436,0.0283121881149521,0.0538588688419164
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CTRC,Chymotrypsin-C,42625,0.0129840342196476,0.00675171737831532,-0.000249331841850416,0.0262174002811456,0.0544922085313233
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TEF,Thyrotroph embryonic factor,40115,0.00857713865308563,0.0044618728544128,-0.00016813214156346,0.0173224094477347,0.0545917354091971
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CTHRC1,Collagen triple helix repeat-containing protein 1,40526,0.00577968133718596,0.0030093785808405,-0.000118700681261406,0.0116780633556333,0.0548127209902342
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SEZ6L2,Seizure 6-like protein 2,42586,0.00464946719321847,0.0024278702777415,-0.000109158551154867,0.00940809293759181,0.055508759729596
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LPO,Lactoperoxidase,42133,0.0117935648559946,0.00620580514396948,-0.00036981322618561,0.0239569429381747,0.0574017367109453
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,BCAT2,"Branched-chain-amino-acid aminotransferase, mitochondrial",40135,-0.0105807300475026,0.00564882096648158,-0.0216524191418065,0.000490959046801262,0.0610830892004101
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,BHLHE40,Class E basic helix-loop-helix protein 40,40135,0.0134574319602623,0.00722107208139444,-0.000695869319270846,0.0276107332397954,0.062399955849986
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PTTG1,Securin,40301,0.00781012501623709,0.00420823916401599,-0.00043802374523424,0.0160582737777084,0.0634924530833798
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NOTCH2,Neurogenic locus notch homolog protein 2,40526,0.00402592454151809,0.00217311267949953,-0.000233376310300988,0.00828522539333718,0.0639646403272245
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CNTN5,Contactin-5,42639,-0.00720653746776931,0.00389130483207829,-0.0148334949386428,0.00042042000310414,0.0640536001296647
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CLNS1A,Methylosome subunit pICln,40181,0.00629631743534246,0.00342611557154191,-0.000418869084879676,0.0130115039555646,0.0661273760929203
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FGFBP2,Fibroblast growth factor-binding protein 2,40526,-0.00964494231414079,0.00525606495528986,-0.0199468296265089,0.000656944998227344,0.0665301060754612
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ATP1B4,Protein ATP1B4,40079,-0.00797059498796442,0.00434379535585508,-0.0164844338854404,0.000543243909511534,0.0665421550648764
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IGFL4,Insulin growth factor-like family member 4,40198,0.0137074240211414,0.00754951771774703,-0.00108963070564277,0.0285044787479256,0.0694483923995588
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TET2,Methylcytosine dioxygenase TET2,40285,0.0190825540924327,0.0105168415107621,-0.00153045526866107,0.0396955634535265,0.0696315145263974
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SSB,Lupus La protein,42310,0.0108150072450893,0.00596199919033481,-0.000870511167966961,0.0225005256581455,0.0697020966740075
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FCER1A,High affinity immunoglobulin epsilon receptor subunit alpha,40481,0.00434877626658328,0.00243589119142328,-0.00042557046860634,0.00912312300177291,0.0742408618402881
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TMOD4,Tropomodulin-4,40079,-0.00755785231240455,0.00423893335512459,-0.0158661616884487,0.000750457063639637,0.0746205317306949
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CRX,Cone-rod homeobox protein,42356,0.0193646686199554,0.0108726428853883,-0.00194571143540558,0.0406750486753164,0.0749281195042193
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TYRP1,"5,6-dihydroxyindole-2-carboxylic acid oxidase",40198,0.0117562655529864,0.00660384489653669,-0.00118727044422553,0.0246998015501983,0.0750683219533018
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PI16,Peptidase inhibitor 16,40531,-0.00457708132993504,0.00257734987467354,-0.00962868708429519,0.000474524424425097,0.075778412623258
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GATA3,Trans-acting T-cell-specific transcription factor GATA-3,40079,0.0048989863800654,0.00276372004232384,-0.00051790490288932,0.0103158776630201,0.0763220008275137
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,42171,0.0120852813286569,0.00682585301907244,-0.00129339058872509,0.0254639532460389,0.0766647097447728
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LBP,Lipopolysaccharide-binding protein,42688,-0.0105937057763453,0.00599744496644889,-0.0223486979105852,0.00116128635789448,0.0773564306464445
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PGM2,Phosphoglucomutase-2,40181,0.0108317901353342,0.00614259802369699,-0.00120770199111189,0.0228712822617803,0.0778626859409329
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SCT,Secretin,40181,0.00902481715517838,0.00512799605964449,-0.00102605512172482,0.0190756894320816,0.0784507061790872
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TNPO1,Transportin-1,40301,0.00639378286227375,0.00364074341279454,-0.000742074226803559,0.0135296399513511,0.0790860754685361
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ZP3,Zona pellucida sperm-binding protein 3,40222,0.0487889299833971,0.0278150099049806,-0.00572848943036491,0.103306349397159,0.0794496410322276
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GPR101,Probable G-protein coupled receptor 101,40135,-0.0108954917362623,0.00621512279375773,-0.0230771324120274,0.00128614893950287,0.0796194757277413
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LTO1,Protein LTO1 homolog,42369,0.0075269722999504,0.00429974530958395,-0.000900528506834143,0.0159544731067349,0.0800445974843145
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CCNE1,G1/S-specific cyclin-E1,40198,0.0158886907848349,0.00908891727862817,-0.00192558708127635,0.0337029686509461,0.0804678478749356
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TAP1,Antigen peptide transporter 1,40301,0.0110446195476869,0.00632888659387185,-0.00135999817630188,0.0234492372716758,0.0809929305408757
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PRSS53,Serine protease 53,40482,0.00665704340238339,0.00382551550150987,-0.000840966980575958,0.0141550537853427,0.0818566032508138
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,HEBP1,Heme-binding protein 1,42356,0.00936748781889798,0.00539353735427075,-0.00120384539547269,0.0199388210332686,0.082446131927979
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RPGR,X-linked retinitis pigmentosa GTPase regulator,40181,0.00762151175574973,0.00439790713123483,-0.000998386221470535,0.01624140973297,0.0831262047081315
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IL9,Interleukin-9,40301,0.0100093972738035,0.00577898809228378,-0.00131741938707274,0.0213362139346797,0.0832954748190638
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GPHA2,Glycoprotein hormone alpha-2,40448,0.00824434011144619,0.00478438765579538,-0.00113305969391276,0.0176217399168051,0.0848842418124184
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,OSBPL2,Oxysterol-binding protein-related protein 2,40482,0.00704720230146962,0.00409407254499907,-0.000977179886728567,0.0150715844896678,0.0852204666614995
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SCP2,Non-specific lipid-transfer protein,42345,0.013015386691334,0.0075621044033039,-0.00180633793914163,0.0278371113218097,0.0852502296565802
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MUC2,Mucin-2,40526,0.0163194719209927,0.00951547757652778,-0.00233086412900177,0.0349698079709871,0.0863643221141448
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PRR5,Proline-rich protein 5,40198,0.0083881305652758,0.00490189945724785,-0.00121959237093,0.0179958535014816,0.0870723726342786
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PRR4,Proline-rich protein 4,40197,0.0122175277729292,0.00714923373860647,-0.00179497035473952,0.0262300259005979,0.087492434656599
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,THRAP3,Thyroid hormone receptor-associated protein 3,40115,0.0193479333446063,0.0113228614608134,-0.00284487511858783,0.0415407418078005,0.0875257829504875
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DCUN1D1,DCN1-like protein 1,40135,0.0131574674595623,0.00771218246866363,-0.00195841017901841,0.028273345098143,0.0880247724303662
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MYH7B,Myosin-7B,40079,-0.00785831231784328,0.00460883779848699,-0.0168916344028778,0.00117500976719121,0.0882130902434436
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,BMP4,Bone morphogenetic protein 4,42474,0.0080796790127248,0.00475984599526916,-0.00124961913800276,0.0174089771634524,0.0896319343078678
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ARG2,"Arginase-2, mitochondrial",40450,0.00741927836726424,0.00438588865220247,-0.0011770633910526,0.0160156201255811,0.0907452002099534
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DAND5,DAN domain family member 5,40198,0.00961496887293041,0.00568473115243979,-0.00152710418585158,0.0207570419317124,0.090794973379402
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CACNA1C,Voltage-dependent L-type calcium channel subunit alpha-1C,40135,0.00578273366178116,0.00342318765233033,-0.000926714136786292,0.0124921814603486,0.091193648696357
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PDXDC1,Pyridoxal-dependent decarboxylase domain-containing protein 1,40079,0.0100108835234947,0.00594994114215678,-0.00165100111513263,0.0216727681621219,0.0924971035526454
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MEGF11,Multiple epidermal growth factor-like domains protein 11,40115,0.00578481395184129,0.00345711166858896,-0.00099112491859306,0.0125607528222756,0.0942952416790829
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,OSTN,Osteocrin,40181,0.00718442249341895,0.00429781480670639,-0.00123929452772557,0.0156081395145635,0.0946227368511398
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,METAP1,Methionine aminopeptidase 1,42310,0.00499397275134936,0.00298874104116875,-0.000863959689341396,0.0108519051920401,0.0947596480062762
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PPIE,Peptidyl-prolyl cis-trans isomerase E,40301,0.0109193418957813,0.00653909035373206,-0.00189727519753356,0.0237359589890961,0.0949759564931645
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,KIAA1549,UPF0606 protein KIAA1549,40301,0.0121214740494955,0.0072726949049184,-0.00213300796414453,0.0263759560631356,0.0956002588973133
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RNF168,E3 ubiquitin-protein ligase RNF168,40198,0.00684783945086381,0.00411545771546796,-0.00121845767145339,0.014914136573181,0.0961546062608957
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ZNF174,Zinc finger protein 174,40198,0.00635086221556337,0.00383963570785126,-0.0011748237718251,0.0138765482029518,0.0981504915265044
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,40510,0.00478513556646838,0.00290851255056663,-0.000915549032642213,0.010485820165579,0.0999527526656037
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MICB_MICA,MHC class I polypeptide-related sequence A_MHC class I polypeptide-related sequence B,42593,0.0252913366821833,0.0153855456060723,-0.00486433270571852,0.055447006070085,0.100233236024578
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NLGN1,Neuroligin-1,40181,0.0117873395784411,0.00717173731667172,-0.00226926556223548,0.0258439447191177,0.100291152078221
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SUSD5,Sushi domain-containing protein 5,40234,0.0058533805235013,0.00357468315397721,-0.00115299845829404,0.0128597595052966,0.101564067388918
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,OMG,Oligodendrocyte-myelin glycoprotein,42586,0.0110803300840023,0.00676851952409439,-0.00218596818322271,0.0243466283512273,0.101645827677207
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PRTG,Protogenin,42720,0.00414125924478358,0.00254401992207201,-0.00084501980247757,0.00912753829204472,0.103581952679694
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TNFRSF10C,Tumor necrosis factor receptor superfamily member 10C,42661,0.00820171664739971,0.00504135508418518,-0.00167933931760323,0.0180827726124027,0.103784427675136
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NUDT10,Diphosphoinositol polyphosphate phosphohydrolase 3-alpha,40222,-0.00427527440992816,0.00263162154604025,-0.00943325264016706,0.000882703820310731,0.104281090230233
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,JMJD1C,Probable JmjC domain-containing histone demethylation protein 2C,40079,0.00978553027799121,0.00603258416213462,-0.00203833467979264,0.0216093952357751,0.104808219728309
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TRAF3IP2,E3 ubiquitin ligase TRAF3IP2,40115,-0.00809393498330574,0.00499585668570308,-0.0178858140872838,0.00169794412067229,0.105233325524731
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,S100A16,Protein S100-A16,42291,-0.00999948568902673,0.00621705330044721,-0.0221849101579032,0.0021859387798498,0.107772508932058
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CACNB1,Voltage-dependent L-type calcium channel subunit beta-1,40135,0.0100214196310378,0.00623164455442342,-0.00219260369563207,0.0222354429577077,0.107831168744482
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,AMIGO1,Amphoterin-induced protein 1,40181,0.00834089007530607,0.00519478915988593,-0.00184089667807034,0.0185226768286825,0.108384783263094
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CA11,Carbonic anhydrase-related protein 11,42345,0.00531895973822026,0.00332152943499245,-0.00119123795436495,0.0118291574308055,0.109321534338076
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,KIAA1549L,UPF0606 protein KIAA1549L,40301,-0.00472697191159264,0.00297611523838519,-0.0105601577788276,0.00110621395564234,0.112246367534664
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SPINK8,Serine protease inhibitor Kazal-type 8,40115,0.00611724308834188,0.00388331320524752,-0.00149405079394326,0.013728536970627,0.115224509705009
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CD93,Complement component C1q receptor,42140,0.00516362216706019,0.00329606585310188,-0.00129666690501949,0.0116239112391399,0.117232275549996
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MRPS16,"28S ribosomal protein S16, mitochondrial",40198,0.00456661089611292,0.00291624919091282,-0.0011492375180762,0.010282459310302,0.117396265277308
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GABARAPL1,Gamma-aminobutyric acid receptor-associated protein-like 1,40301,0.0101776240304665,0.00651181366454925,-0.00258553075204999,0.0229407788129831,0.118093392116791
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SMPD3,Sphingomyelin phosphodiesterase 3,40198,0.00875218917064309,0.0056223816028144,-0.00226767877087313,0.0197720571121593,0.119577764881783
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TMPRSS5,Transmembrane protease serine 5,42437,-0.00605594973798298,0.00389061700076312,-0.0136815590594787,0.00156965958351274,0.119600657490314
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MORF4L1,Mortality factor 4-like protein 1,40301,0.00637778223175933,0.00410300114188243,-0.00166410000633024,0.0144196644698489,0.120113036193507
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SLK,STE20-like serine/threonine-protein kinase,40301,0.0127550483757101,0.00820949360136677,-0.00333555908296874,0.028845655834389,0.120285700648678
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RAC3,Ras-related C3 botulinum toxin substrate 3,40181,0.0113472907225857,0.00732257203344613,-0.00300495046296877,0.0256995319081401,0.121258710198518
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SLC39A14,Zinc transporter ZIP14,42310,0.00544266854965454,0.00353343088851123,-0.00148285599182747,0.0123681930911365,0.123502751985813
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CA4,Carbonic anhydrase 4,42793,-0.0037913329505049,0.00246228296340008,-0.00861740755876906,0.00103474165775925,0.123641326587492
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,S100G,Protein S100-G,40481,0.00758609743268739,0.00494969626405629,-0.00211530724486293,0.0172875021102377,0.125392858341927
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SHD,SH2 domain-containing adapter protein D,40082,0.0138100352496145,0.00902286925943111,-0.00387478849887042,0.0314948589980995,0.125907431747487
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RANGAP1,Ran GTPase-activating protein 1,42345,0.00755706448861014,0.00493979195563951,-0.0021249277444433,0.0172390567216636,0.126081734743226
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SLC4A1,Band 3 anion transport protein,40526,-0.00731693432292461,0.00480115353092404,-0.0167271952435357,0.00209332659768651,0.127537847336372
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,INSL4,Early placenta insulin-like peptide,40450,0.00760256255560514,0.00499812037025064,-0.00219375337008611,0.0173988784812964,0.128266766599373
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,AMBN,Ameloblastin,42369,-0.00443762086857685,0.00292624601329693,-0.0101730630546388,0.00129782131748514,0.129419656888416
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IKZF2,Zinc finger protein Helios,42345,0.0136435610997815,0.00899694778942565,-0.00399045656749281,0.0312775787670558,0.1294257181793
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FAP,Prolyl endopeptidase FAP,42793,0.00422515475281651,0.00278858027265341,-0.00124046258158418,0.00969077208721721,0.129754272227504
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,HBZ,Hemoglobin subunit zeta,40510,0.0164292526047131,0.0108961139689365,-0.00492713077440256,0.0377856359838287,0.131631477561098
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CPLX2,Complexin-2,40079,-0.00491167292222875,0.00326279299940228,-0.0113067472010572,0.00148340135659973,0.132260968313113
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ATP1B3,Sodium/potassium-transporting ATPase subunit beta-3,40115,-0.00600280740990881,0.00399151226376058,-0.0138261714468796,0.00182055662706193,0.132637832760117
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IL5RA,Interleukin-5 receptor subunit alpha,42593,0.00881154821366585,0.00588794142863244,-0.00272881698645372,0.0203519134137854,0.134536176651812
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TBR1,T-box brain protein 1,40181,0.00745869232641316,0.0049847849552299,-0.00231148618583745,0.0172288708386638,0.134606382021859
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IFNL2,Interferon lambda-2,40135,0.00952050257857537,0.00636994233612527,-0.00296458440023016,0.0220055895573809,0.135048248276893
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NXPE4,NXPE family member 4,40115,0.00517010423719614,0.00346287764949846,-0.00161713595582085,0.0119573444302131,0.135463965102588
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IGDCC3,Immunoglobulin superfamily DCC subclass member 3,40135,0.00771163346403619,0.00517655427897403,-0.00243441292275291,0.0178576798508253,0.136325833551519
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CEACAM18,Carcinoembryonic antigen-related cell adhesion molecule 18,40301,0.0106804280240571,0.0071758020204684,-0.00338414393606091,0.0247449999841752,0.136675138080444
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TP53BP1,TP53-binding protein 1,40198,0.0132456912992074,0.0089033279699947,-0.00420483152198216,0.030696214120397,0.13685245011947
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,BTN1A1,Butyrophilin subfamily 1 member A1,40428,0.00602557850034182,0.00405260908765924,-0.00191753531147029,0.0139686923121539,0.137085320724722
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CD276,CD276 antigen,42617,-0.00555845213833427,0.00374115501393096,-0.012891115965639,0.00177421168897042,0.137366546810848
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GADD45B,Growth arrest and DNA damage-inducible protein GADD45 beta,40301,0.00722459694584003,0.00486445908895155,-0.00230974286850502,0.0167589367601851,0.137524550399761
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MN1,Transcriptional activator MN1,40181,0.00903439327624463,0.00609140839223303,-0.00290476717253211,0.0209735537250214,0.138066693657233
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MFAP3L,Microfibrillar-associated protein 3-like,40181,0.0102707423930893,0.00693379932253897,-0.00331950427908709,0.0238609890652657,0.138566640120295
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FH,"Fumarate hydratase, mitochondrial",40135,0.0130475942055401,0.00880947472209128,-0.00421897624975883,0.030314164660839,0.138612317631335
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PGR,Progesterone receptor,40198,0.0148437599099029,0.0100317950810307,-0.00481855844891735,0.0345060782687231,0.138989598001265
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NTRK2,BDNF/NT-3 growth factors receptor,42635,0.00386252069908906,0.002612283870222,-0.00125755568654605,0.00898259708472418,0.139270914464572
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NUP50,Nuclear pore complex protein Nup50,40115,-0.00525919426138632,0.00356599670174158,-0.0122485477967998,0.00173015927402718,0.140290447333456
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ATP5F1D,"ATP synthase subunit delta, mitochondrial",40115,0.00786555359117148,0.00533889944888079,-0.00259868932863488,0.0183297965109778,0.140711449062677
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DCDC2C,Doublecortin domain-containing protein 2C,40079,0.00958502201440597,0.00650697055315893,-0.00316864026978553,0.0223386842985975,0.140769409165791
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DUSP29,Dual specificity phosphatase 29,40181,0.0101868504200965,0.00691883761728907,-0.00337407130979007,0.0237477721499831,0.14095893803407
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SCIN,Adseverin,40135,0.0110464485710349,0.00750470606106615,-0.00366277530865476,0.0257556724507246,0.141066867641672
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,AKAP12,A-kinase anchor protein 12,40282,-0.00333437656427008,0.00226623026308599,-0.00777618787991861,0.00110743475137846,0.14122979665403
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TEX101,Testis-expressed protein 101,40181,0.00799221334516339,0.00543640886269783,-0.00266314802572435,0.0186475747160511,0.141555901560487
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CADPS,Calcium-dependent secretion activator 1,40181,0.00644611867037654,0.00440039419871299,-0.00217865395910092,0.015070891299854,0.14297798127112
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,KLK12,Kallikrein-12,42345,0.0208315125731824,0.0142785779589439,-0.00715450022634762,0.0488175253727124,0.144606969716136
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,40448,0.00531157717374601,0.00364674024709794,-0.00183603371056596,0.012459188058058,0.1452747723803
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TMED10,Transmembrane emp24 domain-containing protein 10,40115,-0.00721427915676368,0.00495352298287814,-0.0169231842032048,0.00249462588967748,0.145312592365367
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CNGB3,Cyclic nucleotide-gated cation channel beta-3,40135,0.00805401622608447,0.00554195068101063,-0.00280820710869637,0.0189162395608653,0.146174200632872
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MLLT1,Protein ENL,40079,0.0099024129091436,0.006821448568404,-0.00346762628492824,0.0232724521032154,0.146625440168464
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FLT3,Receptor-type tyrosine-protein kinase FLT3,42345,0.00454930296504474,0.0031406101839948,-0.00160629299558508,0.0107048989256746,0.147489618449076
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DKK3,Dickkopf-related protein 3,42793,0.00442755915150618,0.00308240282456011,-0.00161395038463162,0.010469068687644,0.150911950271764
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ANKRA2,Ankyrin repeat family A protein 2,40079,0.00841774797102052,0.00589868500041012,-0.00314367462978331,0.0199791705718243,0.153592723448409
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CYP24A1,"1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial",40115,0.0128875738689982,0.00903797625949955,-0.00482685959962096,0.0306020073376173,0.153915458092401
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LRP2BP,LRP2-binding protein,40181,0.0126244074802191,0.00886581802851028,-0.00475259585566108,0.0300014108160992,0.15449176450913
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DPP4,Dipeptidyl peptidase 4,42440,0.00410024088538571,0.00288086641029379,-0.00154625727879011,0.00974673904956153,0.154682442852585
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ECM1,Extracellular matrix protein 1,40268,0.00539902577530663,0.00382494109487331,-0.00209785877064506,0.0128959103212583,0.158115977404583
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,VWA5A,von Willebrand factor A domain-containing protein 5A,40079,0.0112675322808392,0.00798548686077056,-0.00438402196627111,0.0269190865279495,0.1582728122267
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DDX4,Probable ATP-dependent RNA helicase DDX4,40198,0.00774877856062554,0.00550266317001118,-0.00303644125259637,0.0185339983738474,0.159103965225884
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CDH5,Cadherin-5,42793,-0.00432140004017529,0.00307682372859796,-0.0103519745482273,0.00170917446787671,0.160192743028156
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IL24,Interleukin-24,42369,0.00724282283051802,0.00516253145165354,-0.00287573881472292,0.017361384475759,0.160652464592361
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CLEC10A,C-type lectin domain family 10 member A,42494,-0.00521531106382148,0.00372207559024597,-0.0125105792207036,0.00207995709306062,0.161182526849266
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FOS,Proto-oncogene c-Fos,40064,0.00512563373612032,0.00367175364341148,-0.00207100340496618,0.0123222708772068,0.162754023486641
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PGLYRP4,Peptidoglycan recognition protein 4,40115,0.00845743182133514,0.00608140442942242,-0.0034621208603328,0.0203769845030031,0.164343622027021
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SRPX,Sushi repeat-containing protein SRPX,40510,0.00522183417359753,0.00378867121140446,-0.00220396140075522,0.0126476297479503,0.16814537448092
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ADRA2A,Alpha-2A adrenergic receptor,40115,0.00978792608589085,0.00714516239156042,-0.00421659220156756,0.0237924443733493,0.170756414025228
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ATP2B4,Plasma membrane calcium-transporting ATPase 4,40115,0.00858028094724437,0.00629610584871174,-0.00376008651623065,0.0209206484107194,0.172976259031703
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PPP1R14D,Protein phosphatase 1 regulatory subunit 14D,40481,0.00538416055874823,0.00400799873248695,-0.00247151695692619,0.0132398380744227,0.179184428227656
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RNF4,E3 ubiquitin-protein ligase RNF4,40301,0.00923077331729298,0.00688763112547596,-0.0042689836886399,0.0227305303232259,0.180209157524903
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CAPN3,Calpain-3,40450,-0.00524965208880604,0.00392500001427799,-0.0129426521167909,0.00244334793917883,0.181089451259198
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MORC3,MORC family CW-type zinc finger protein 3,40482,0.00387988466385925,0.00290098991272472,-0.00180605556508121,0.0095658248927997,0.181107721167472
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SMC3,Structural maintenance of chromosomes protein 3,40079,0.00763248586673865,0.00570832532227129,-0.00355583176491308,0.0188208034983904,0.181224566363158
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CNTN2,Contactin-2,42720,0.00609542620085069,0.00455897345604734,-0.0028401617730021,0.0150310141747035,0.181239487953998
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FHIP2A,FHF complex subunit HOOK interacting protein 2A,40115,-0.00651597224402562,0.00488782328096179,-0.0160961058747107,0.00306416138665949,0.182525788333135
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,EXOSC10,Exosome component 10,40115,0.00827098595983204,0.00620439261102468,-0.00388962355777634,0.0204315954774404,0.182531547739976
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FGF7,Fibroblast growth factor 7,40079,0.0108187167527214,0.00814709345890785,-0.00514958642673798,0.0267870199321808,0.184231229496614
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LIPF,Gastric triacylglycerol lipase,40222,0.00846212421425792,0.00638940051019622,-0.00406110078572667,0.0209853492142425,0.185397567350662
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CD200,OX-2 membrane glycoprotein,42593,0.00368780219327106,0.00279932905971226,-0.00179888276376497,0.00917448715030709,0.18773116559194
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,KHDC3L,KH domain-containing protein 3,40079,-0.00931605580504675,0.00709245334115657,-0.0232172643537136,0.00458515274362013,0.189036587280225
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,KLK15,Kallikrein-15,40428,0.00717220673874191,0.00548086892302186,-0.00357029635038094,0.0179147098278648,0.190700258147801
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LCN15,Lipocalin-15,40481,0.00838170126119113,0.00642347201300335,-0.00420830388429544,0.0209717064066777,0.191968739498994
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ISM2,Isthmin-2,40526,0.00577223120948942,0.00443693000402319,-0.00292415159839604,0.0144686140173749,0.193301472586461
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GABRA4,Gamma-aminobutyric acid receptor subunit alpha-4,40135,0.00853805242234502,0.00656435438184112,-0.00432808216606358,0.0214041870107536,0.193399162698532
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MMP13,Collagenase 3,42310,-0.00442791447825296,0.003413890885413,-0.0111191406136624,0.00226331165715653,0.194644124922351
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SLC1A4,Neutral amino acid transporter A,40181,0.00689322277899049,0.00535395855340786,-0.00360053598568891,0.0173869815436699,0.197947114802558
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,S100A3,Protein S100-A3,40450,0.00573337962492676,0.00446771888096667,-0.00302334938176791,0.0144901086316214,0.199416862859391
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TPBGL,Trophoblast glycoprotein-like,40181,-0.00553379774684381,0.00431583356833252,-0.0139928315407756,0.00292523604708793,0.19979662842633
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IDS,Iduronate 2-sulfatase,42753,-0.00114250400314171,0.000892339613712058,-0.00289148964601735,0.000606481639733921,0.200445162898683
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MAG,Myelin-associated glycoprotein,40181,0.00644766750427269,0.00504037395554623,-0.00343146544859792,0.0163268004571433,0.200852174213229
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LTBP2,Latent-transforming growth factor beta-binding protein 2,42793,-0.00428996813638291,0.00336241918115649,-0.0108803097314496,0.00230037345868381,0.202027645810437
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CLSTN2,Calsyntenin-2,42753,-0.00515719116935974,0.00405127072422107,-0.013097681788833,0.00278329945011356,0.203046564793002
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,HMGCS1,"Hydroxymethylglutaryl-CoA synthase, cytoplasmic",40115,-0.0056632032881451,0.00444892066971572,-0.0143830878007879,0.00305668122449771,0.203066892358459
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,42675,-0.00548775903992584,0.00431264546996437,-0.013940544161056,0.00296502608120432,0.203224248394143
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NME1,Nucleoside diphosphate kinase A,40198,-0.00286766542517751,0.0022575799686658,-0.00729252216376248,0.00155719131340746,0.204026476438604
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CHEK2,Serine/threonine-protein kinase Chk2,42356,-0.0043189998831836,0.00340213663535668,-0.0109871876884827,0.0023491879221155,0.2042865536774
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,UPK3A,Uroplakin-3a,40135,0.00667318440219554,0.00526059136795318,-0.00363757467899268,0.0169839434833838,0.204638010450649
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,BEX3,Protein BEX3,40079,0.00620379835933378,0.00491264049412026,-0.00342497700914192,0.0158325737278095,0.206679632086566
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CUZD1,CUB and zona pellucida-like domain-containing protein 1,40181,0.00517260107402453,0.00410266024474157,-0.00286861300566895,0.013213815153718,0.207410581799712
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GJA8,Gap junction alpha-8 protein,40079,0.00842399062978909,0.00670552768060594,-0.00471884362419855,0.0215668248837767,0.209043036211004
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FSHB,Follitropin subunit beta,40222,-0.00697724349316232,0.0055584068592541,-0.0178717209373003,0.00391723395097571,0.209411138690401
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LPA,Apolipoprotein(a),40323,-0.0231487734282031,0.0186270264430453,-0.0596577452565719,0.0133601984001657,0.213985437008287
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FGF9,Fibroblast growth factor 9,40064,0.00524169788397186,0.00423422727649922,-0.00305738757796661,0.0135407833459103,0.215766922841859
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LXN,Latexin,42460,-0.00855726691454534,0.00691612124518003,-0.0221128645550982,0.00499833072600753,0.216000305809934
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NGFR,Tumor necrosis factor receptor superfamily member 16,40510,0.00373177944886931,0.00303066908632035,-0.00220833196031857,0.00967189085805719,0.218221887222191
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CDHR1,Cadherin-related family member 1,42310,0.00535982384741592,0.00438064387538411,-0.00322623814833694,0.0139458858431688,0.221153745061949
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,OMP,Olfactory marker protein,40135,0.00633360170463804,0.0051793309982249,-0.00381788705188276,0.0164850904611588,0.221408553621271
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,VCAN,Versican core protein,42710,0.00381569413012739,0.00312232331710978,-0.00230405957140779,0.00993544783166256,0.22170289565717
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CEND1,Cell cycle exit and neuronal differentiation protein 1,40135,0.00737753118548731,0.00609420543760415,-0.00456711147221682,0.0193221738431914,0.226082062527558
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NPHS1,Nephrin,40198,0.00416095221454737,0.00344564203761863,-0.00259250617918514,0.0109144106082799,0.227227684345694
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IL20,Interleukin-20,42369,0.00605010322007874,0.00502253166888701,-0.00379405885093981,0.0158942652910973,0.228382350076588
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NOS2,"Nitric oxide synthase, inducible",40115,0.00492571233444979,0.00409211445660521,-0.00309483200049642,0.012946256669396,0.228728414354214
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ENG,Endoglin,42793,0.00213581897052478,0.00177660903185099,-0.00134633473190316,0.00561797267295271,0.22931143157696
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,VEGFD,Vascular endothelial growth factor D,42733,-0.00442097192376069,0.00368475846579789,-0.0116430985167245,0.00280115466920317,0.230238154225301
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TMED1,Transmembrane emp24 domain-containing protein 1,40301,0.00665877187599532,0.00555381860162708,-0.00422671258319376,0.0175442563351844,0.230571491559926
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CTLA4,Cytotoxic T-lymphocyte protein 4,40526,0.00368477245017036,0.00307687043336185,-0.00234589359921886,0.00971543849955958,0.23110891180906
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RANBP2,E3 SUMO-protein ligase RanBP2,40135,-0.00397009244365993,0.00334109370883886,-0.0105186361129841,0.00257845122566424,0.234756261321693
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CBX2,Chromobox protein homolog 2,40115,-0.00489626984563114,0.00412342472914017,-0.0129781823147459,0.00318564262348359,0.235084679581377
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IL1A,Interleukin-1 alpha,42369,0.00702388209334866,0.00595496111328767,-0.00464784168869517,0.0186956058753925,0.238220069794909
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IL18RAP,Interleukin-18 receptor accessory protein,42424,0.0207045591191584,0.0175962746478327,-0.0137841391905937,0.0551932574289106,0.239358613159887
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IL11,Interleukin-11,42369,0.0074988577333005,0.0064010676160874,-0.0050472347942308,0.0200449502608318,0.241418602651361
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CLINT1,Clathrin interactor 1,40079,0.00554412064915643,0.00474643321913964,-0.00375888846035727,0.0148471297586701,0.242807988332452
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PPT1,Palmitoyl-protein thioesterase 1,40181,0.00923296857771409,0.00791611495248315,-0.00628261672915289,0.0247485538845811,0.2434978780361
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DDX1,ATP-dependent RNA helicase DDX1,40448,0.00599280715493792,0.00513888633016755,-0.00407941005219048,0.0160650243620663,0.24357105460122
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ANK2,Ankyrin-2,40115,0.00881862468085662,0.00756362392516697,-0.00600607821247065,0.0236433275741839,0.243669886903945
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TAGLN3,Transgelin-3,40079,0.00732039541451896,0.00629882305301798,-0.00502529776939629,0.0196660885984342,0.245185952519367
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MMP15,Matrix metalloproteinase-15,40510,0.0057668108613802,0.00500463739230639,-0.00404227842754032,0.0155759001503007,0.249224851811849
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SOX2,Transcription factor SOX-2,40460,0.00282291401364707,0.00245566208195537,-0.00199018366698545,0.00763601169427958,0.250352377953497
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SEPTIN3,Neuronal-specific septin-3,40481,0.00880743586314843,0.00768735628390026,-0.00625978245329608,0.0238746541795929,0.251941883798619
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DPP6,Dipeptidyl aminopeptidase-like protein 6,42586,-0.00392819679383666,0.00346706219453479,-0.0107236386951248,0.00286724510745152,0.257232680391442
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MAGEA3,Melanoma-associated antigen 3,40301,0.0100744472333849,0.00892077899414997,-0.00741027959514902,0.0275591740619189,0.258785691616493
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ALMS1,Alstrom syndrome protein 1,40301,-0.0051685629971404,0.00458243518118451,-0.014150135952262,0.00381300995798124,0.259383350672958
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ACRV1,Acrosomal protein SP-10,40198,0.00925940531773014,0.00822164804356629,-0.00685502484765979,0.0253738354831201,0.260095896737817
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DDX53,Probable ATP-dependent RNA helicase DDX53,40181,0.00419724786150572,0.00372710676381545,-0.00310788139557256,0.011502377118584,0.260130424845542
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,POLR2A,DNA-directed RNA polymerase II subunit RPB1,40198,0.00337616078834516,0.00300621921126116,-0.00251602886572672,0.00926835044241704,0.261437045429567
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,BMP10,Bone morphogenetic protein 10,40282,-0.00331613154325313,0.00295566303605721,-0.00910923109392527,0.002476968007419,0.261904341153117
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CD99,CD99 antigen,42610,-0.00231347383449465,0.00206614594468697,-0.00636311988608111,0.00173617221709181,0.262859561614899
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,HIF1A,Hypoxia-inducible factor 1-alpha,40198,0.00707365108622786,0.00637020852448336,-0.00541195762175952,0.0195592597942152,0.2668393631203
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,APOA4,Apolipoprotein A-IV,40538,-0.0040424882863226,0.00369718108058662,-0.0112889632042724,0.00320398663162717,0.274242559589379
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IL21R,Interleukin-21 receptor,40198,0.00627159556593654,0.00573947135415945,-0.00497776828821598,0.0175209594200891,0.274543705384731
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TG,Thyroglobulin,40450,0.0128964919067385,0.0118233603608963,-0.0102772944006183,0.0360702782140954,0.275400236006498
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CTNNA1,Catenin alpha-1,40135,-0.00394732801828935,0.00361992582366263,-0.0110423826326681,0.0031477265960894,0.275541425698476
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,WASL,Neural Wiskott-Aldrich syndrome protein,40198,-0.00684456672524442,0.0063074466594288,-0.0192071621777249,0.00551802872723603,0.277876120540254
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ID4,DNA-binding protein inhibitor ID-4,40301,-0.00482135865216313,0.00446202008137635,-0.0135669180116608,0.00392420070733451,0.279928489948146
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ACAN,Aggrecan core protein,42487,0.0030612612963604,0.00283414319211715,-0.00249365936018922,0.00861618195291003,0.280101030087819
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CCND2,G1/S-specific cyclin-D2,40301,0.00407067760110009,0.00379198037719635,-0.00336160393820477,0.0115029591404049,0.283071737000374
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DEFB116,Beta-defensin 116,40135,0.00850403195062445,0.00792518853153473,-0.00702933757118362,0.0240374014724325,0.283277534769607
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CDH17,Cadherin-17,42635,-0.00759911812715155,0.00710077902880851,-0.0215166450236162,0.00631840876931314,0.284557104716124
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LRP2,Low-density lipoprotein receptor-related protein 2,40181,0.00405244879819602,0.00378679113944243,-0.00336966183511115,0.0114745594315032,0.284573609983285
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ESPL1,Separin,40079,0.00631941685945126,0.0059108948687212,-0.00526593708324229,0.0179047708021448,0.285042285768847
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CRNN,Cornulin,42208,0.00755359929083066,0.00707527595828083,-0.00631394158739977,0.0214211401690611,0.285718575244042
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CHRM1,Muscarinic acetylcholine receptor M1,40181,-0.0040734575375096,0.00382042910279334,-0.0115614985789845,0.00341458350396535,0.286342945354361
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GIPR,Gastric inhibitory polypeptide receptor,40198,0.00531329505115088,0.00502221319965555,-0.00453024282017399,0.0151568329224758,0.290097413149778
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IMPG1,Interphotoreceptor matrix proteoglycan 1,40135,0.00327382937804037,0.00310615320071937,-0.00281423089536958,0.00936188965145033,0.291914460200693
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CDH23,Cadherin-23,40482,-0.00282241105555377,0.00267824531764939,-0.00807177187814657,0.00242694976703902,0.291984031410055
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CRYBB2,Beta-crystallin B2,40482,0.00882175491036562,0.0083744784885813,-0.00759222292725373,0.025235732747985,0.292175915488574
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IL2,Interleukin-2,42369,-0.00344241146385955,0.00327699328421532,-0.00986531830092157,0.00298049537320247,0.293517371964599
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,EIF5A,Eukaryotic translation initiation factor 5A-1,42369,0.00316735377857355,0.00303897233025922,-0.00278903198873452,0.00912373954588162,0.297317219250897
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IL12RB2,Interleukin-12 receptor subunit beta-2,40198,0.00445358475984883,0.0042766343901431,-0.00392861864483165,0.0128357881645293,0.297723918049035
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CHGA,Chromogranin-A,40526,0.0103989100776957,0.0100211709997414,-0.00924258508179744,0.0300404052371888,0.299434631344212
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FAM171A2,Protein FAM171A2,40481,0.0170151124395447,0.0164146277660381,-0.01515755798189,0.0491877828609794,0.299952777137862
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,HDAC9,Histone deacetylase 9,40135,0.00697594028735096,0.00675427463903832,-0.00626243800516414,0.0202143185798661,0.301711639598789
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TGFBR3,Transforming growth factor beta receptor type 3,42793,-0.00334342493044153,0.00323811919397836,-0.00969013855063912,0.00300328868975606,0.301846641448556
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SCN3A,Sodium channel protein type 3 subunit alpha,40181,-0.0039113957797256,0.00381247349795587,-0.0113838438357191,0.00356105227626792,0.304939149588168
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TPSG1,Tryptase gamma,40198,0.00278280752738443,0.00272706455593352,-0.00256223900224528,0.00812785405701413,0.30754195702059
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PEPD,Xaa-Pro dipeptidase,40531,-0.00276234035375758,0.00271360016365354,-0.00808099667451852,0.00255631596700337,0.308718000033406
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,COPE,Coatomer subunit epsilon,42310,0.00494277280001821,0.0048568653383612,-0.00457668326316974,0.0144622288632061,0.308845098952663
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SLC51B,Organic solute transporter subunit beta,40115,-0.00804631802585038,0.00791496051988297,-0.023559640644821,0.00746700459312024,0.309368129006187
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PLXDC1,Plexin domain-containing protein 1,42345,-0.00326280969419049,0.00322485346326749,-0.00958352248219477,0.0030579030938138,0.311666695117162
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ACSL1,Long-chain-fatty-acid--CoA ligase 1,40115,-0.0040481457236295,0.00400732608991857,-0.0119025048598699,0.0038062134126109,0.312428445128826
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CRISP2,Cysteine-rich secretory protein 2,42720,-0.00610007139304033,0.00607221573335378,-0.0180016142304137,0.00580147144433307,0.315113539584402
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DLGAP5,Disks large-associated protein 5,40481,0.00521451311340312,0.00521502112008546,-0.00500692828196437,0.0154359545087706,0.317379087398861
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RBP2,Retinol-binding protein 2,42586,-0.00779504942253175,0.0078936309914212,-0.0232665661657173,0.00767646732065381,0.323409910549998
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,HBQ1,Hemoglobin subunit theta-1,42720,0.00607605693415379,0.0061614194391708,-0.00600032516662097,0.0181524390349286,0.324079288101441
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SOWAHA,Ankyrin repeat domain-containing protein SOWAHA,40181,0.00521940181164777,0.0053216438242844,-0.00521102008394965,0.0156498237072452,0.32671913307935
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PDIA2,Protein disulfide-isomerase A2,40079,0.00423814630205274,0.00433057608985144,-0.00424978283405608,0.0127260754381616,0.327771497835371
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,KRT17,"Keratin, type I cytoskeletal 17",40115,0.00394596583979391,0.00404971998152459,-0.00399148532399428,0.0118834170035821,0.329889516142504
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,OBP2B,Odorant-binding protein 2b,42461,0.00608011968016359,0.00627395862656922,-0.00621683922791207,0.0183770785882393,0.3325108668061
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GAGE2A,G antigen 2A,40079,0.006612237083247,0.00685029400331394,-0.00681433916324833,0.0200388133297423,0.334441725495346
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SLITRK6,SLIT and NTRK-like protein 6,42356,-0.00349931056965349,0.00363314397796959,-0.0106202727664739,0.0036216516271669,0.33548332563039
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TP53INP1,Tumor protein p53-inducible nuclear protein 1,42356,0.0030212379344865,0.00314129354569876,-0.00313569741508307,0.00917817328405607,0.336177054662581
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GFRA3,GDNF family receptor alpha-3,42473,0.00282163000661969,0.00294176495841596,-0.0029442293118756,0.00858748932511498,0.337494458940867
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NAAA,N-acylethanolamine-hydrolyzing acid amidase,42438,-0.00583066748042306,0.00611988836635418,-0.0178256486784772,0.00616431371763112,0.340738791287261
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ENPEP,Glutamyl aminopeptidase,40115,0.00465798951818858,0.00490034253117138,-0.00494668184290732,0.0142626608792845,0.341857116069861
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SSH3,Protein phosphatase Slingshot homolog 3,40079,0.00281505978955361,0.00297226293165733,-0.00301057555649476,0.00864069513560197,0.343603780928927
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CSRP3,Cysteine and glycine-rich protein 3,40115,0.00971921608238765,0.0102673895319533,-0.0104048674002407,0.0298432995650161,0.343858367131172
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PLCB1,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1",40198,0.00410213587432299,0.00435493872628802,-0.00443354402920153,0.0126378157778475,0.346238760002626
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CNTF,Ciliary neurotrophic factor,40135,-0.00332974244410573,0.00353730160118238,-0.0102628535824232,0.00360336869421173,0.346560274297688
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SPACA5_SPACA5B,Sperm acrosome-associated protein 5,40481,0.002835771087535,0.00302383763747373,-0.00309095068191351,0.00876249285698352,0.34836452193246
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GLT8D2,Glycosyltransferase 8 domain-containing protein 2,42310,0.00437365854042667,0.00466868923102311,-0.00477697235237863,0.013524289433232,0.348875336359788
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,L1CAM,Neural cell adhesion molecule L1,42678,-0.0027875268193677,0.00298688453627014,-0.00864182051045717,0.00306676687172177,0.350704707101781
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CLSTN1,Calsyntenin-1,42310,0.00506126823393748,0.00544061535539423,-0.00560233786263522,0.0157248743305102,0.352245860163275
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TOP1,DNA topoisomerase 1,40448,0.0107065078677126,0.0115279759847828,-0.0118883250624618,0.0333013407978869,0.35304306983093
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GLP1R,Glucagon-like peptide 1 receptor,40135,-0.00359521570428021,0.00390450778518409,-0.011248050963241,0.00405761955468061,0.357182520957442
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ABO,Histo-blood group ABO system transferase,40531,0.0135958962356758,0.0149166396833186,-0.0156407175436286,0.0428325100149802,0.36207328519369
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CDC123,Cell division cycle protein 123 homolog,40079,0.00590977020571445,0.00648803147061378,-0.00680677147668855,0.0186263118881174,0.362382665410886
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DEFB104A_DEFB104B,Beta-defensin 104,40135,0.00501441348018727,0.00551551756829762,-0.00579600095367607,0.0158248279140506,0.363292827366373
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ESR1,Estrogen receptor,40198,0.00514262811223791,0.00567309259148444,-0.00597663336707159,0.0162618895915474,0.364693941377271
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,UBQLN3,Ubiquilin-3,40115,0.00502848850766597,0.00557315123642059,-0.00589488791571837,0.0159518649310503,0.366933228795535
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TIMP2,Metalloproteinase inhibitor 2,40510,0.00257305067332914,0.00285314485676412,-0.00301911324592854,0.00816521459258681,0.367166552242473
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PSMC3,26S proteasome regulatory subunit 6A,40079,0.00283032073323076,0.00314711246286287,-0.00333801969398047,0.00899866116044198,0.368492055234083
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,OGT,UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit,40301,0.00580629558588257,0.00646642296479554,-0.0068678934251167,0.0184804845968818,0.369250543796184
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SERPINA6,Corticosteroid-binding globulin,40538,0.00144408119282282,0.0016089476228411,-0.00170945614794573,0.00459761853359138,0.369454413769458
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IGLON5,IgLON family member 5,40079,-0.00870551917882066,0.0097385409998005,-0.0277930595384296,0.0103820211807883,0.371382119046947
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MYL4,Myosin light chain 4,40222,0.00478367363146067,0.00535625368062666,-0.00571458358256758,0.0152819308454889,0.371822764365995
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GAMT,Guanidinoacetate N-methyltransferase,40115,0.00347378134572929,0.00389260920917265,-0.0041557327042491,0.0111032953957077,0.372195909026508
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PFDN4,Prefoldin subunit 4,40079,0.00479967135203821,0.00539613515390011,-0.005776753549606,0.0153760962536824,0.373773081191942
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MYBPC1,"Myosin-binding protein C, slow-type",40510,0.00653136750130315,0.0073439620573936,-0.00786279813118831,0.0209255331337946,0.373832826850401
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,C8B,Complement component C8 beta chain,40538,0.00276470528902707,0.00311183274611436,-0.00333448689335708,0.00886389747141122,0.374318012143823
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CACNA1H,Voltage-dependent T-type calcium channel subunit alpha-1H,40115,-0.00546239535529252,0.00615382912382871,-0.0175239004379968,0.00659910972741176,0.374753062218819
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,KCNC4,Potassium voltage-gated channel subfamily C member 4,40135,0.00512976159507476,0.00578344321440593,-0.00620578710516087,0.0164653102953104,0.375112596499825
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RELB,Transcription factor RelB,40198,0.0044860073790448,0.00509602917582322,-0.00550220980556871,0.0144742245636583,0.378718917701494
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,KIRREL1,Kin of IRRE-like protein 1,40135,0.00519509250423802,0.0059225105016069,-0.0064130280789115,0.0168032130873875,0.380409536462053
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SHH,Sonic hedgehog protein,40198,-0.00380015719386928,0.00433288214333943,-0.0122926061948146,0.004692291807076,0.380478262670756
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SAT1,Diamine acetyltransferase 1,40115,-0.00458999309891811,0.00527885791671938,-0.0149365546156881,0.00575656841785187,0.384590109969465
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RUVBL1,RuvB-like 1,42345,0.0093287076654517,0.0108096175111027,-0.0118581426563096,0.030515557987213,0.388152810185814
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PNPT1,"Polyribonucleotide nucleotidyltransferase 1, mitochondrial",42369,0.00999224143030105,0.0116398666377933,-0.0128218971797739,0.032806380040376,0.390659744303105
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,VWC2L,von Willebrand factor C domain-containing protein 2-like,40481,0.00397284390867729,0.00465151163282542,-0.00514411889166054,0.0130898067090151,0.393069160687936
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CALY,Neuron-specific vesicular protein calcyon,40115,-0.00342471408187806,0.00402339638055548,-0.0113105709877668,0.00446114282401068,0.394677052451998
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,C7,Complement component C7,40250,-0.00286885435616516,0.00337876806508046,-0.00949123976372287,0.00375353105139255,0.395853520965036
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,COMMD9,COMM domain-containing protein 9,40450,0.0034305724733062,0.00407451487402934,-0.00455547667979131,0.0114166216264037,0.399829065439037
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PSMA1,Proteasome subunit alpha type-1,42345,0.00397724000348652,0.00472848427041959,-0.00529058916653589,0.0132450691735089,0.40029395407261
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ERCC1,DNA excision repair protein ERCC-1,40079,0.00294520986648604,0.00351084057976649,-0.00393603766985628,0.00982645740282837,0.401549331975392
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IL13RA2,Interleukin-13 receptor subunit alpha-2,40135,-0.00249813095336338,0.00298665947233207,-0.00835198351913423,0.00335572161240747,0.402931427129341
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RYR1,Ryanodine receptor 1,40115,-0.0029634946892551,0.00354334917404544,-0.00990845907038416,0.00398146969187396,0.402974012685351
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SLITRK1,SLIT and NTRK-like protein 1,40198,0.0028090897608323,0.0033646331657093,-0.00378559124395792,0.00940377076562252,0.403799247340402
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TERF1,Telomeric repeat-binding factor 1,40198,-0.00252938221558655,0.00303294327279922,-0.00847395103027302,0.00341518659909991,0.40431626809673
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PM20D1,N-fatty-acyl-amino acid synthase/hydrolase PM20D1,42569,0.0155898117109006,0.0187142575056722,-0.0210901330002168,0.0522697564220181,0.404834434642887
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CHAD,Chondroadherin,40282,0.00443430963065607,0.00534025958582793,-0.00603259915756666,0.0149012184188788,0.406356149278694
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TFAP2A,Transcription factor AP-2-alpha,40135,0.00521197278756422,0.00627831550721836,-0.00709352560658376,0.0175174711817122,0.406469467297386
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,KCNIP4,Kv channel-interacting protein 4,42310,0.00418868580477946,0.00504828677564126,-0.0057059562754774,0.0140833278850363,0.406709825483127
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MAP1LC3B2,Microtubule-associated proteins 1A/1B light chain 3 beta 2,40115,-0.00573491492522178,0.00694390510115018,-0.0193449689234761,0.00787513907303257,0.408883461417093
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TSPAN15,Tetraspanin-15,40115,0.00441835139926186,0.00535366164115249,-0.00607482541739702,0.0149115282159207,0.409222027567262
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NPTX2,Neuronal pentraxin-2,40526,-0.00273985223542027,0.00336279954195669,-0.00933093933765538,0.00385123486681485,0.415230623134278
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CDC25A,M-phase inducer phosphatase 1,40079,-0.00320619913052132,0.00400605531648836,-0.0110580675508385,0.00464566928979586,0.423532338808475
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ZNF75D,Zinc finger protein 75D,40301,0.0050290180244437,0.00630430437564669,-0.00732741855182381,0.0173854546007112,0.425054805114668
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SMPD1,Sphingomyelin phosphodiesterase,42643,0.0040166975597317,0.00503701361064606,-0.00585584911713458,0.013889244236598,0.425211755365221
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SCN3B,Sodium channel subunit beta-3,40135,0.00394395026965035,0.00495555132685572,-0.00576893033098686,0.0136568308702876,0.426127724528249
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NLGN2,Neuroligin-2,40135,-0.00393089074790518,0.00494679174146181,-0.0136266025611703,0.00576482106535996,0.426843454313474
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NEB,Nebulin,40115,0.00313380323881305,0.00394488699302332,-0.00459817526751266,0.0108657817451388,0.426982077093887
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CBLN1,Cerebellin-1,40135,0.00775141439182944,0.00976659543758643,-0.01139111266584,0.0268939414494988,0.427407131176311
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FGF12,Fibroblast growth factor 12,40198,0.0038028823723609,0.00480285347581613,-0.00561071044023872,0.0132164751849605,0.428496435159139
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RLN1,Prorelaxin H1,40481,-0.00392709075341874,0.00496957597150278,-0.0136674596575642,0.00581327815072671,0.429412089297187
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GHRHR,Growth hormone-releasing hormone receptor,42310,0.00444531523149929,0.0057569780741875,-0.0068383617939082,0.0157289922569068,0.440032857427932
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IL4,Interleukin-4,42369,0.0073855345252186,0.00956775040004492,-0.0113672562588694,0.0261383253093066,0.440175864464685
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LILRB5,Leukocyte immunoglobulin-like receptor subfamily B member 5,42793,0.00551353667731536,0.00717953733992652,-0.00855835650894062,0.0195854298635713,0.442529316396684
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,BTNL10,Butyrophilin-like protein 10,40079,0.00335928586603817,0.00438238363782412,-0.00523018606409711,0.0119487577961735,0.44336985049474
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MYLPF,"Myosin regulatory light chain 2, skeletal muscle isoform",40181,0.00392786389566988,0.00512608720399219,-0.00611926702415481,0.0139749948154946,0.443544074037018
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PRL,Prolactin,42710,-0.00583548760159919,0.00764525200992332,-0.0208201815410489,0.00914920633785051,0.445308216840002
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SLC44A4,Choline transporter-like protein 4,40181,-0.00554684539418758,0.00732712318220121,-0.0199080068313019,0.00881431604292679,0.449048668284974
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ARMCX2,Armadillo repeat-containing X-linked protein 2,40135,-0.00486804420211667,0.00644309511135839,-0.0174965106203791,0.00776042221614577,0.449938688351675
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ITIH5,Inter-alpha-trypsin inhibitor heavy chain H5,40450,0.0034815364795606,0.00460944583923554,-0.00555297736534106,0.0125160503244623,0.450081934682604
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LRTM2,Leucine-rich repeat and transmembrane domain-containing protein 2,40481,0.00206119193046449,0.00274823509689365,-0.00332534885944706,0.00744773272037603,0.45326691700465
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RICTOR,Rapamycin-insensitive companion of mTOR,40198,0.00375160640709684,0.00502134380961335,-0.00609022745974532,0.013593440273939,0.454999877741449
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,KLK1,Kallikrein-1,42504,-0.00986952867404822,0.0132413247543789,-0.0358225251926308,0.0160834678445344,0.456068427524811
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ROBO4,Roundabout homolog 4,40222,-0.00139121630082875,0.00186877872439042,-0.00505402260063397,0.00227158999897647,0.456618854386626
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RBM25,RNA-binding protein 25,40079,-0.00361411568940536,0.00487794964156671,-0.0131748969868761,0.0059466656080654,0.458764737511743
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FGF20,Fibroblast growth factor 20,40198,0.00342753193273548,0.00462895097685671,-0.00564521198190367,0.0125002758473746,0.459039487984882
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,HMCN2,Hemicentin-2,40268,-0.00440042190953365,0.00601231468975345,-0.0161845587014504,0.00738371488238311,0.464244202125985
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DNLZ,DNL-type zinc finger protein,40135,0.0068304726479191,0.00936976861051541,-0.0115342738286911,0.0251952191245293,0.466023055212694
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SAG,S-arrestin,40135,-0.00392111499955364,0.00539309559837633,-0.0144915823723712,0.00664935237326396,0.467203517390443
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,EPGN,Epigen,40450,-0.00337203886844272,0.00467208457582098,-0.0125293246370518,0.0057852469001664,0.470468211618522
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GDF2,Growth/differentiation factor 2,42635,0.00261535798894026,0.00365893496782999,-0.00455615454800652,0.00978687052588704,0.474753279280759
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CELA2A,Chymotrypsin-like elastase family member 2A,40526,0.00462091990161212,0.00649215180440393,-0.00810369763501959,0.0173455374382438,0.476621768263936
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,AMY2B,Alpha-amylase 2B,41778,-0.00363630143831199,0.00511092115855694,-0.0136537069090836,0.00638110403245961,0.47680205796825
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CREB3,Cyclic AMP-responsive element-binding protein 3,40079,-0.00420780244336369,0.00592595949871764,-0.0158226830608503,0.00740707817412289,0.477680504058885
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,EVI2B,Protein EVI2B,40079,0.00295621933539092,0.00420741853860212,-0.00529032100026924,0.0112027596710511,0.482307187531718
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,42345,0.00256248123215373,0.00369174006703618,-0.00467332929923717,0.00979829176354464,0.487624208651486
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,AMDHD2,N-acetylglucosamine-6-phosphate deacetylase,40526,0.00178937541291434,0.00258806801530774,-0.00328323789708883,0.0068619887229175,0.489331963489966
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,EDDM3B,Epididymal secretory protein E3-beta,40450,0.00373788793684602,0.00540972804559386,-0.00686517903251793,0.01434095490621,0.489606989623364
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ATF4,Cyclic AMP-dependent transcription factor ATF-4,40079,0.0024326028541605,0.00355439778486262,-0.00453401680417024,0.00939922251249124,0.493741980357375
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CA8,Carbonic anhydrase-related protein,40198,0.00200764032303169,0.0029374835686414,-0.00374982747150544,0.00776510811756883,0.494333230587092
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NGF,Beta-nerve growth factor,42494,0.000838131155297663,0.00122691777663991,-0.00156662768691657,0.0032428899975119,0.49454338949276
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FGF6,Fibroblast growth factor 6,40198,0.00290211973019953,0.00425402188614688,-0.00543576316664835,0.0112400026270474,0.495122989947984
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,EPHA10,Ephrin type-A receptor 10,42310,0.00465676154709087,0.00685702951829613,-0.00878301630876955,0.0180965394029513,0.497072367583044
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CLIC5,Chloride intracellular channel protein 5,40181,-0.00220523166745238,0.00324938883713029,-0.00857403378822776,0.00416357045332299,0.497367329747875
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IL13,Interleukin-13,42369,0.00328003517877479,0.00485030826434011,-0.00622656901933181,0.0127866393768814,0.4988919425462
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PRC1,Protein regulator of cytokinesis 1,40450,0.00307952165478789,0.00457131899470946,-0.00588026357484265,0.0120393068844184,0.500540370255912
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ART5,Ecto-ADP-ribosyltransferase 5,40135,0.00445450589861535,0.0066236379837939,-0.00852782454962069,0.0174368363468514,0.501269135559818
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TEX33,Testis-expressed protein 33,40301,0.00262275037070272,0.00392038344476475,-0.00506120118103619,0.0103067019224416,0.503507129495756
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IL3,Interleukin-3,40079,0.00419471193501064,0.00634970912234696,-0.00825071794478939,0.0166401418148107,0.508873343807209
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GUCY2C,Heat-stable enterotoxin receptor,40301,-0.00546445752176844,0.00827960570385442,-0.0216924847013231,0.0107635696577862,0.509273889127806
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SPRR1B,Cornifin-B,40301,0.00559369883198908,0.00853479845996013,-0.0111345061495328,0.0223219038135109,0.512224434699295
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ENOPH1,Enolase-phosphatase E1,40450,0.00367877812716059,0.00564515797960074,-0.00738573151285687,0.014743287767178,0.514627610269363
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,HSP90B1,Endoplasmin,42246,0.00441495817196184,0.00683351232236222,-0.00897872597986811,0.0178086423237918,0.518242456782349
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TJP3,Tight junction protein ZO-3,40135,-0.00279284138880789,0.00433046892383636,-0.0112805604795272,0.00569487770191138,0.518987259194979
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ATP5PO,"ATP synthase subunit O, mitochondrial",42310,0.00268459714433557,0.00418868036461935,-0.00552521637031835,0.0108944106589895,0.521587700807835
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DENND2B,DENN domain-containing protein 2B,40115,-0.00327786196599516,0.00513156736151948,-0.0133357339945733,0.00678001006258301,0.522989679902615
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PHLDB2,Pleckstrin homology-like domain family B member 2,40079,0.00625971813916202,0.00989350425061035,-0.0131315501920343,0.0256509864703583,0.526936390832118
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MYOC,Myocilin,42610,0.00284930665161777,0.0045704982269583,-0.0061088698732205,0.011807483176456,0.533023950752674
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MYH4,Myosin-4,40115,-0.00290223983212087,0.00465856731545414,-0.012033031770411,0.00622855210616925,0.533304245977343
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SMPDL3B,Acid sphingomyelinase-like phosphodiesterase 3b,40450,0.0048598693698583,0.007867069648277,-0.0105595871407646,0.0202793258804812,0.53675372616874
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GSTP1,Glutathione S-transferase P,42236,-0.00440784293896086,0.00718458447272086,-0.0184896285054937,0.00967394262757203,0.539547248342916
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,EVPL,Envoplakin,40301,-0.0022187215681214,0.0036167220173854,-0.00930749672219678,0.00487005358595399,0.53958345542903
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LRFN2,Leucine-rich repeat and fibronectin type-III domain-containing protein 2,40181,-0.00288656614185221,0.0047352953737609,-0.0121677450744236,0.00639461279071916,0.542149200622578
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,HDAC8,Histone deacetylase 8,40198,0.00368958600697482,0.00606259520659463,-0.00819310059795066,0.0155722726119003,0.54281413413661
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TPRKB,EKC/KEOPS complex subunit TPRKB,40079,0.0040779286087045,0.00678195318250728,-0.00921469962900976,0.0173705568464188,0.547658586782597
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CD82,CD82 antigen,40301,-0.00252026717147505,0.00420917340331994,-0.0107702470419821,0.00572971269903203,0.54934792264323
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DUOX2,Dual oxidase 2,42356,0.00435288234777254,0.0073148837717707,-0.00998428984489802,0.0186900545404431,0.551805589614304
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GAD1,Glutamate decarboxylase 1,40079,-0.0015904867984151,0.00268953148598373,-0.0068619685109432,0.003680994914113,0.554290155991952
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ARID3A,AT-rich interactive domain-containing protein 3A,40135,0.00245056578459621,0.00418152034078193,-0.00574521408333638,0.0106463456525288,0.557856287874178
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FGF5,Fibroblast growth factor 5,42369,-0.00197641902316653,0.00337446902785342,-0.00859037831775924,0.00463754027142617,0.558088657440212
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MATN3,Matrilin-3,42474,0.00195589085577982,0.00334617220715587,-0.00460260667024569,0.00851438838180534,0.558883201173688
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DCLRE1C,Protein artemis,40079,0.00185420063762676,0.0032112073891004,-0.00443976584501002,0.00814816712026354,0.563670807934057
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,40115,-0.00223216365532853,0.00387661161597503,-0.0098303224226396,0.00536599511198254,0.564760374415773
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TIMD4,T-cell immunoglobulin and mucin domain-containing protein 4,42688,-0.00260334281690666,0.00453160750836268,-0.0114852935332975,0.0062786078994842,0.56564888473117
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,KRT6C,"Keratin, type II cytoskeletal 6C",40115,-0.00227846393531873,0.00402459827731248,-0.0101666765588512,0.00560974868821374,0.571313984275056
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CPOX,"Oxygen-dependent coproporphyrinogen-III oxidase, mitochondrial",40198,0.00164108317475592,0.00291393248330623,-0.00407022449252429,0.00735239084203613,0.573320365214685
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CKMT1A_CKMT1B,"Creatine kinase U-type, mitochondrial",42581,-0.00388618990065051,0.00692688523386113,-0.0174628849590183,0.00969050515771731,0.574786527641543
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NCLN,Nicalin,42369,0.00296394658412618,0.00529602503529031,-0.00741626248504283,0.0133441556532952,0.575724335637177
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PXDNL,Peroxidasin-like protein,40450,0.00319808564604629,0.0057225328913441,-0.00801807882098814,0.0144142501130807,0.576269471453897
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CRH,Corticoliberin,42321,0.00486179859787113,0.00878185168750509,-0.0123506307096388,0.0220742279053811,0.579849154610473
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MRPL28,"39S ribosomal protein L28, mitochondrial",40481,0.00208766707105681,0.00380978290223838,-0.00537950741733041,0.00955484155944403,0.58371967381766
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,KIR3DL1,Killer cell immunoglobulin-like receptor 3DL1,42345,0.00701836485172179,0.0129770085635322,-0.0184165719328013,0.0324533016362449,0.588633428243173
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SCGN,Secretagogin,42369,-0.00248725913351981,0.00461808502630746,-0.0115387057850824,0.0065641875180428,0.590178183222371
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RBM19,Probable RNA-binding protein 19,40115,-0.00261998174354072,0.00496022394048808,-0.0123420206668973,0.00710205717981591,0.59737245683504
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TARM1,"T-cell-interacting, activating receptor on myeloid cells protein 1",40181,0.00426857820830811,0.0080981839249599,-0.0116038622846133,0.0201410187012295,0.598132605761606
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,AOC3,Membrane primary amine oxidase,42688,0.00161812409444226,0.00308714560266896,-0.00443268128678889,0.00766892947567342,0.600183560626447
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SYNGAP1,Ras/Rap GTPase-activating protein SynGAP,40135,0.00313914156551489,0.00601835738228817,-0.00865683890376993,0.0149351220347997,0.601963314473209
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,REST,RE1-silencing transcription factor,40079,0.00178987994539938,0.00352520038701861,-0.00511951281315711,0.00869927270395586,0.611647034543133
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CGA,Glycoprotein hormones alpha chain,42610,-0.00325997354635755,0.00644368832135932,-0.0158896026562218,0.00936965556350672,0.612923003177907
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SERPINA11,Serpin A11,42793,0.00210625949556356,0.00417637312611727,-0.00607943183162629,0.0102919508227534,0.614039480836765
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RASGRF1,Ras-specific guanine nucleotide-releasing factor 1,40079,-0.00231437849040033,0.00464691766011216,-0.0114223371042202,0.00679358012341949,0.618461722006906
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GAD2,Glutamate decarboxylase 2,40198,-0.0022923660901773,0.00472979502627725,-0.0115627643416807,0.00697803216132612,0.62792364699118
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ZP4,Zona pellucida sperm-binding protein 4,40079,-0.00156968496836436,0.00324143576380339,-0.00792289906541901,0.0047835291286903,0.628213886335239
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ISLR2,Immunoglobulin superfamily containing leucine-rich repeat protein 2,42112,-0.00185624552624794,0.00385201709060983,-0.0094061990238432,0.00569370797134732,0.6298928053781
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LYPD1,Ly6/PLAUR domain-containing protein 1,42310,-0.00298477070758275,0.00627949820372016,-0.0152925871868743,0.00932304577170876,0.634566864126525
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CGB3_CGB5_CGB8,Choriogonadotropin subunit beta 3,40531,0.00183576329533145,0.00387307238429893,-0.00575545857789445,0.00942698516855735,0.635522478485521
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DIPK1C,Divergent protein kinase domain 1C,40181,0.00203794426113191,0.00431770975969721,-0.00642476686787463,0.0105006553901384,0.636938599815646
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,KLHL41,Kelch-like protein 41,40481,0.00231358909688491,0.00491844535802586,-0.00732656380484577,0.0119537419986156,0.638085266194783
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SLC34A3,Sodium-dependent phosphate transport protein 2C,40079,0.00241675814869813,0.00519503287851677,-0.00776550629319474,0.012599022590591,0.641793568035757
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TUBB3,Tubulin beta-3 chain,40135,0.00134572465990579,0.00289517343231422,-0.00432881526743009,0.00702026458724166,0.642072051763637
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GKN1,Gastrokine-1,42016,0.00131983587468263,0.00287400033911232,-0.00431320478997753,0.00695287653934278,0.646074621148442
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PSMD5,26S proteasome non-ATPase regulatory subunit 5,40181,0.00263683372197219,0.0057487931709337,-0.00863080089305787,0.0139044683370022,0.646475890771077
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CPTP,Ceramide-1-phosphate transfer protein,40115,0.00184547380703889,0.00410697527573705,-0.00620419773340572,0.00989514534748351,0.653187326827524
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TPT1,Translationally-controlled tumor protein,42369,0.00298356447084031,0.00667637772522293,-0.0101021358705966,0.0160692648122772,0.654966369394783
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GRIK2,"Glutamate receptor ionotropic, kainate 2",40481,0.0020469455603838,0.00459604560405102,-0.00696130382355621,0.0110551949443238,0.656060186457372
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,42672,0.00146806282939952,0.00331474153265592,-0.00502883057460608,0.00796495623340512,0.657853073835736
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GLI2,Zinc finger protein GLI2,40198,-0.00145546874874327,0.00329188518971553,-0.00790756372058571,0.00499662622309917,0.658397769999866
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MAPT,Microtubule-associated protein tau,42310,0.00240076460612047,0.005450238890532,-0.00828170361932225,0.0130832328315632,0.65959099038628
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IZUMO1,Izumo sperm-egg fusion protein 1,40079,0.00214889182446879,0.00489830298497544,-0.00745178202608307,0.0117495656750207,0.660886701245188
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CTSB,Cathepsin B,42658,0.00240027554488093,0.00548805139209255,-0.00835630518362046,0.0131568562733823,0.661854477273205
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,KDM3A,Lysine-specific demethylase 3A,40198,-0.00391942657897545,0.00898872318738307,-0.0215373240262463,0.0136984708682954,0.662817575994242
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NRN1,Neuritin,40481,0.00162599943793172,0.00373401405309555,-0.00569266810613556,0.008944666981999,0.663239677307817
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TP73,Tumor protein p73,40181,0.00153469184018938,0.00355196251654131,-0.00542715469223159,0.00849653837261035,0.665699959021918
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CSH1,Chorionic somatomammotropin hormone 1,40531,-0.00126390177876689,0.00292737588771389,-0.00700155851868612,0.00447375496115234,0.665929536013577
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SPP1,Osteopontin,42770,0.00208322528292319,0.00482790921339428,-0.00737947677532961,0.011545927341176,0.666114345877539
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LEG1,Protein LEG1 homolog,39925,-0.00308724149179905,0.00720003465789052,-0.0171993094212645,0.0110248264376664,0.668090867193516
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PFDN6,Prefoldin subunit 6,40181,0.002835661409141,0.00665617455482512,-0.0102104407183162,0.0158817635365982,0.670101845086254
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IL1RL1,Interleukin-1 receptor-like 1,42759,-0.00197137654329484,0.00467525712894573,-0.0111348805160285,0.00719212742943879,0.673278696267333
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MSLNL,Mesothelin-like protein,40181,-0.00170352173763702,0.0040444081592405,-0.0096305617297484,0.00622351825447437,0.673614210823253
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LRTM1,Leucine-rich repeat and transmembrane domain-containing protein 1,40181,-0.00177016086712587,0.00421138501751674,-0.0100244755014587,0.00648415376720695,0.674254455102391
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ECSCR,Endothelial cell-specific chemotaxis regulator,40135,0.00220522229627608,0.00530940540689225,-0.00820121230123273,0.0126116568937849,0.677899257859066
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LRRN1,Leucine-rich repeat neuronal protein 1,42369,0.00167852474097352,0.0040477691456377,-0.00625510278447637,0.0096121522664234,0.678383680874046
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FGF3,Fibroblast growth factor 3,40198,0.00122515053481274,0.00298452920196729,-0.00462452670104315,0.00707482777066863,0.681446877091537
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ERVV_1,,40115,0.00177473817894745,0.00448291297111132,-0.00701177124443073,0.0105612476023256,0.692194280322034
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LMOD1,Leiomodin-1,40481,0.00143271935876453,0.00366779739427317,-0.00575616353401088,0.00862160225153993,0.696084637268098
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GNGT1,Guanine nucleotide-binding protein G(T) subunit gamma-T1,40181,0.00199121494846096,0.00523414210562456,-0.00826770357856318,0.0122501334754851,0.703634983305165
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CD109,CD109 antigen,42610,-0.00130481545444799,0.00344012803863118,-0.00804746641016511,0.00543783550126913,0.704476522352414
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,BST1,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2,42710,0.00184285638498726,0.00486442795646966,-0.00769142240969328,0.0113771351796678,0.704810113761548
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,KIR2DS4,Killer cell immunoglobulin-like receptor 2DS4,40448,-0.00662686225404797,0.0179976465916095,-0.0419022495736026,0.0286485250655067,0.71272570065301
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PLA2G1B,Phospholipase A2,42781,0.00171353393826111,0.00465902583169641,-0.00741815669186385,0.0108452245683861,0.71303702309356
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ITGB1,Integrin beta-1,42637,-0.000799691765960445,0.00218337664433521,-0.00507910998885747,0.00347972645693658,0.714174023615852
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ACE,Angiotensin-converting enzyme,40531,0.00100899987764402,0.00275645799359738,-0.00439365778980684,0.00641165754509489,0.714335021603632
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PDGFRB,Platelet-derived growth factor receptor beta,42793,0.00129251154612839,0.00353236805281933,-0.0056309298373975,0.00821595292965428,0.714441569438178
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SCARF2,Scavenger receptor class F member 2,42710,-0.00112473180814475,0.00309423913534816,-0.00718944051342715,0.00493997689713764,0.716242919274125
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FRMD7,FERM domain-containing protein 7,40181,0.00123805059218813,0.00343903811726965,-0.00550246411766038,0.00797856530203664,0.718854733761904
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RTKN2,Rhotekin-2,40115,-0.00190140860613334,0.00530140714164249,-0.0122921666037526,0.00848934939148594,0.719855552788214
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MYL1,"Myosin light chain 1/3, skeletal muscle isoform",40115,0.00150285825979058,0.00419065471960167,-0.00671082499062869,0.00971654151020985,0.719885303711409
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PLXDC2,Plexin domain-containing protein 2,40482,-0.000992011466270412,0.00279929977345872,-0.0064786390222495,0.00449461608970868,0.723061915046184
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DHODH,Dihydroorotate dehydrogenase,40115,0.00176171342826658,0.00499646567786198,-0.00803135930034289,0.0115547861568761,0.724401199921954
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ADAMTSL5,ADAMTS-like protein 5,40510,0.00139213036413117,0.0040438181104257,-0.0065337531323032,0.00931801386056554,0.730656129722068
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MBL2,Mannose-binding protein C,40378,-0.00376661996927171,0.0111529905754791,-0.0256264814972107,0.0180932415586672,0.735578378115746
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PDE1C,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C",40079,0.00192505814487121,0.0057060500623938,-0.00925879997742064,0.0131089162671631,0.735843440561453
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MORN4,MORN repeat-containing protein 4,40079,-0.00261086183821228,0.00790141402494911,-0.0180976333271125,0.012875909650688,0.741081665341863
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CTSF,Cathepsin F,42678,-0.00132948713972216,0.00403854470199667,-0.00924503475563563,0.0065860604761913,0.742009968262036
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MEGF10,Multiple epidermal growth factor-like domains protein 10,42617,-0.00124920295029568,0.00386878809824162,-0.00883202762284925,0.00633362172225789,0.746781629243081
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,BCAN,Brevican core protein,42494,0.00112383995916798,0.00353885514159631,-0.00581231611836079,0.00805999603669675,0.750814890051227
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,COMP,Cartilage oligomeric matrix protein,42510,-0.00108392612904429,0.00344266904445063,-0.00783155745616753,0.00566370519807895,0.752880086903281
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,BHMT2,S-methylmethionine--homocysteine S-methyltransferase BHMT2,40115,0.000820570798026596,0.00265727321427297,-0.00438768470194842,0.00602882629800161,0.757478176902365
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LELP1,Late cornified envelope-like proline-rich protein 1,40135,0.00221373958990473,0.00754900008449191,-0.0125823005756994,0.0170097797555089,0.76933710463261
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,WIF1,Wnt inhibitory factor 1,42720,0.00103128496599388,0.00352508340833946,-0.00587787851435146,0.00794044844633923,0.76986589311131
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RRP15,RRP15-like protein,40135,-0.00270755534543103,0.00945250939786048,-0.0212344737652376,0.0158193630743755,0.774548302953489
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PRG3,Proteoglycan 3,40526,0.001460523377909,0.00510006989297784,-0.00853561361232755,0.0114566603681456,0.774597527556848
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PALLD,Palladin,40198,0.00112415349297431,0.00399771347382872,-0.00671136491572998,0.0089596719016786,0.778562970122939
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TMEM25,Transmembrane protein 25,40481,0.00130131839838678,0.00468107135087832,-0.00787358144933473,0.0104762182461083,0.781020638151815
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CTAG1A_CTAG1B,Cancer/testis antigen 1,40286,-0.00143155093923987,0.00515647441186292,-0.0115382407864912,0.00867513890801147,0.781307686450651
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,HMMR,Hyaluronan mediated motility receptor,40058,0.00140168389821027,0.00510513793497817,-0.00860438645434695,0.0114077542507675,0.783656928822978
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ARNTL,Aryl hydrocarbon receptor nuclear translocator-like protein 1,40115,0.00150369811012066,0.00548380218384925,-0.00924455417022388,0.0122519503904652,0.783930571988038
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CD177,CD177 antigen,42594,0.00364963452644521,0.0134756542807862,-0.0227626478638958,0.0300619169167862,0.786524639420661
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CSPG5,Chondroitin sulfate proteoglycan 5,40135,0.00141134686510189,0.00528688540807525,-0.00895094853472561,0.0117736422649294,0.78951082491466
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CASQ2,Calsequestrin-2,40115,-0.00131866998702586,0.00504498695732032,-0.0112068444233737,0.00856950444932197,0.793802681203266
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PRKAG3,5'-AMP-activated protein kinase subunit gamma-3,40181,0.000838820953734795,0.00325756903229319,-0.00554601434955985,0.00722365625702944,0.79679836552839
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SEZ6,Seizure protein 6 homolog,40181,0.000824084610407674,0.00322358078278942,-0.00549413372385959,0.00714230294467494,0.798231597554395
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CDAN1,Codanin-1,40482,0.000590627753324469,0.00231986516120503,-0.00395630796263739,0.00513756346928633,0.799039998904199
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,APOH,Beta-2-glycoprotein 1,42610,0.00093318880779262,0.00372464439175992,-0.00636711420005682,0.00823349181564206,0.802170206869595
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PSCA,Prostate stem cell antigen,40448,-0.00683023656252094,0.0273479653357423,-0.0604322486205758,0.0467717754955339,0.802782922001568
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,H2AP,Huntingtin-interacting protein M,40079,-0.00135038657017156,0.00541257611049238,-0.0119590357467366,0.00925826260639351,0.802986060490191
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,BSND,Barttin,40079,0.000863114924827457,0.00350839516445322,-0.00601333959750085,0.00773956944715576,0.805675901950606
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DNAJA1,DnaJ homolog subfamily A member 1,40079,0.00120332975253801,0.00489863765569563,-0.00839800005262543,0.0108046595577014,0.805961065351538
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IL20RB,Interleukin-20 receptor subunit beta,40198,0.0010332822685489,0.00421390973985805,-0.00722598082157288,0.00929254535867068,0.806300342767936
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,KCNH2,Potassium voltage-gated channel subfamily H member 2,40181,0.00195668435923978,0.00807338766332406,-0.0138671554608754,0.0177805241793549,0.808504010172993
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ATP1B1,Sodium/potassium-transporting ATPase subunit beta-1,40115,0.00120336763288258,0.00497226597020387,-0.00854227366871701,0.0109490089344822,0.808772354611419
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PDE4D,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",40115,0.00147954927731676,0.0061602653767739,-0.0105945708611601,0.0135536694157936,0.810198152640232
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,VSIG10L,V-set and immunoglobulin domain-containing protein 10-like,40115,0.00083102870742368,0.00348674837506277,-0.00600299810769934,0.00766505552254671,0.811622516305214
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,KIR3DL2,Killer cell immunoglobulin-like receptor 3DL2,40079,0.00206203982840328,0.00869148165324845,-0.0149732642119637,0.0190973438687702,0.812468580694265
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FZD10,Frizzled-10,40181,0.00147679752689303,0.00623451064222831,-0.0107428433318745,0.0136964383856605,0.812758452771623
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CINP,Cyclin-dependent kinase 2-interacting protein,40301,-0.00106445024001484,0.00451023425641479,-0.00990450938258783,0.00777560890255814,0.813431007804733
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ITIH1,Inter-alpha-trypsin inhibitor heavy chain H1,40538,0.000443806118942124,0.00191995060984016,-0.00331929707634459,0.00420690931422884,0.817198582939144
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TMED4,Transmembrane emp24 domain-containing protein 4,40115,0.00135760206033381,0.00588725061008667,-0.0101814091354361,0.0128966132561037,0.817629613906094
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,AMY2A,Pancreatic alpha-amylase,42113,-0.00112190867850663,0.00499430294947668,-0.0109107424594809,0.00866692510246765,0.822264694284135
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TNC,Tenascin,42688,0.00110614070661106,0.00493497060120598,-0.00856640167175266,0.0107786830849748,0.822649176959087
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SHPK,Sedoheptulokinase,40301,-0.000938815194906516,0.00422045259490758,-0.00921090228092538,0.00733327189111235,0.823972198168141
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CA12,Carbonic anhydrase 12,42586,0.000743753131462914,0.00338561089712408,-0.00589204422690028,0.00737955048982611,0.826123240167209
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NPTX1,Neuronal pentraxin-1,42610,-0.00089288887731494,0.00409826360034583,-0.00892548553399276,0.00713970777936288,0.82753368016887
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,HK2,Hexokinase-2,42356,-0.000597213200755593,0.00282304283052406,-0.00613037714858275,0.00493595074707157,0.832461813286452
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SKIV2L,Helicase SKI2W,40115,-0.000857652011599564,0.00408990545939511,-0.00887386671201398,0.00715856268881485,0.83390595910111
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ITPRIP,"Inositol 1,4,5-trisphosphate receptor-interacting protein",40135,0.000956305675296134,0.00459061385345035,-0.00804129747746655,0.00995390882805882,0.834984865412001
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LAMA1,Laminin subunit alpha-1,40115,-0.0011521538560381,0.00553915785913521,-0.0120089032599431,0.00970459554786691,0.835231574324509
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,HTR1A,5-hydroxytryptamine receptor 1A,40135,0.00167731661516016,0.00807459691244842,-0.0141488933332388,0.0175035265635591,0.83544553445038
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DBH,Dopamine beta-hydroxylase,40514,-0.00227454849558335,0.0112517317261529,-0.024327942678843,0.0197788456876763,0.839802333768399
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PRG2,Bone marrow proteoglycan,40526,0.00106409723187164,0.00540673102799998,-0.00953309558300832,0.0116612900467516,0.843979972131201
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TMEM132A,Transmembrane protein 132A,40222,-0.00126252870082102,0.00643412057231353,-0.0138734050225555,0.0113483476209135,0.84443848070212
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SHC1,SHC-transforming protein 1,40079,0.00234926132995869,0.0121403226140977,-0.0214457709936728,0.0261442936535902,0.846563992047052
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CLEC5A,C-type lectin domain family 5 member A,42602,0.000591608399851406,0.00307760568301409,-0.00544049873885621,0.00662371553855902,0.847564892644498
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LYVE1,Lymphatic vessel endothelial hyaluronic acid receptor 1,40538,-0.000385136006640116,0.00202639308757653,-0.00435686645829011,0.00358659444500987,0.849265616696377
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CD3G,T-cell surface glycoprotein CD3 gamma chain,40198,0.0017334334456581,0.00928999189284708,-0.0164749506643222,0.0199418175556384,0.851984377875788
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PSAPL1,Proactivator polypeptide-like 1,40448,-0.000967846887583045,0.00524722184469519,-0.0112524017031856,0.00931670792801953,0.853664247383014
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CRISP3,Cysteine-rich secretory protein 3,40438,0.000516817107893501,0.00280501849503842,-0.0049810191423818,0.00601465335816881,0.853822770548109
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TSPAN7,Tetraspanin-7,40135,-0.00178649031574149,0.00970122357050435,-0.02080088851393,0.017227907882447,0.853898387361691
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PAIP2B,Polyadenylate-binding protein-interacting protein 2B,40064,-0.000959432265940018,0.00534821589275013,-0.0114419354157303,0.00952307088385023,0.857632504486923
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CDH22,Cadherin-22,40301,0.000515670272667036,0.00288793120701527,-0.0051446748930829,0.00617601543841697,0.858286114597545
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,VWF,von Willebrand factor,42793,0.00130551301095917,0.0073402266749349,-0.0130813312719132,0.0156923572938316,0.858837682745298
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,REXO2,"Oligoribonuclease, mitochondrial",40115,-0.00084623739300778,0.00492346546907889,-0.0104962297124024,0.00880375492638685,0.86353630871367
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CEACAM6,Carcinoembryonic antigen-related cell adhesion molecule 6,40526,-0.000671136705284222,0.00405388357597581,-0.0086167485141968,0.00727447510362836,0.86851089116978
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PCDHB15,Protocadherin beta-15,40450,0.000679431622238579,0.00413584741851507,-0.00742682931805095,0.00878569256252811,0.869514701384993
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SPINT3,Kunitz-type protease inhibitor 3,40448,-0.00243237473194855,0.0152663384899451,-0.0323543981722409,0.0274896487083438,0.873412311840128
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TPPP2,Tubulin polymerization-promoting protein family member 2,40301,0.00131511819212697,0.0083363445437236,-0.0150241171135713,0.0176543534978252,0.874651010568646
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,HTR1B,5-hydroxytryptamine receptor 1B,40135,0.000691151325232134,0.00445069011551879,-0.00803220130118469,0.00941450395164896,0.876594915731824
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ALPI,Intestinal-type alkaline phosphatase,40198,0.00197353236612248,0.012858384034618,-0.0232289003417287,0.0271759650739737,0.878020883859957
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CD3D,T-cell surface glycoprotein CD3 delta chain,40135,0.000532465121954854,0.00350160087903768,-0.00633067260095899,0.0073956028448687,0.879139782843671
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ZNF830,Zinc finger protein 830,40450,-0.00120242039352746,0.00796112436842317,-0.0168062241556369,0.014401383368582,0.879949626609448
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PITHD1,PITH domain-containing protein 1,40064,0.00122138081262474,0.0082966878754511,-0.0150401274232594,0.0174828890485089,0.882966582488006
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RECK,Reversion-inducing cysteine-rich protein with Kazal motifs,40222,-0.000314137405314312,0.00215553701440361,-0.00453898995354538,0.00391071514291676,0.884133173824949
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,COL4A4,Collagen alpha-4(IV) chain,40283,0.000776657657824708,0.00549804965074257,-0.00999951965763073,0.0115528349732802,0.887666659405729
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,UPK3BL1,Uroplakin-3b-like protein 1,40280,0.000744374897521515,0.00559276747363745,-0.0102174493508079,0.0117061991458509,0.894119885866005
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,HCG22,Protein PBMUCL2,40115,0.000777279927108336,0.00585610815127466,-0.01070069204939,0.0122552519036067,0.894409538171463
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,KLRC1,NKG2-A/NKG2-B type II integral membrane protein,40135,-0.000826777705401906,0.00634147840590246,-0.0132560753809707,0.0116025199701669,0.896271211285373
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,OTOA,Otoancorin,40135,0.000727877216327115,0.00562411786294776,-0.0102953937950505,0.0117511482277047,0.897027155865505
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GPIHBP1,Glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1,40448,0.000833982191418222,0.00724125645818407,-0.0133588804666225,0.015026844849459,0.908311699936255
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,AMY1A_AMY1B_AMY1C,Alpha-amylase 1A_Alpha-amylase 1B_Alpha-amylase 1C,39844,0.000576441754515771,0.00529217202653142,-0.00979621541748581,0.0109490989265173,0.913265241072448
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CDKL5,Cyclin-dependent kinase-like 5,40135,0.000507722347605063,0.00556000551741603,-0.0103898884665304,0.0114053331617405,0.927242478741113
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,BRME1,Break repair meiotic recombinase recruitment factor 1,40135,0.000391829519738362,0.00431465788001201,-0.00806489992508518,0.0088485589645619,0.927642383422116
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TRPV3,Transient receptor potential cation channel subfamily V member 3,40115,0.000447074750182197,0.00499553648290583,-0.00934417675631323,0.0102383262566776,0.928690293419336
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CORO6,Coronin-6,40135,-0.00034058512921842,0.00382981077578617,-0.00784701424975932,0.00716584399132248,0.929139157320833
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ANP32C,Acidic leucine-rich nuclear phosphoprotein 32 family member C,40222,0.000349596926397755,0.00406728604277049,-0.00762228371743241,0.00832147757022792,0.931505048794262
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MTHFD2,"Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial",40482,0.000227254830001345,0.00267970796446424,-0.00502497278034857,0.00547948244035126,0.932417270856279
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MUCL3,Mucin-like protein 3,40079,-0.000359218680387091,0.00437474396767181,-0.00893371685702384,0.00821527949624966,0.934559214343185
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ADGRV1,Adhesion G-protein coupled receptor V1,40135,0.000573886448973155,0.00732856577955225,-0.0137901024789493,0.0149378753768956,0.937584364390264
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SAP18,Histone deacetylase complex subunit SAP18,40301,-0.000577661984867573,0.00760960769722909,-0.0154924930714366,0.0143371691017014,0.939490325883433
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NPHS2,Podocin,40198,-0.000724426953966661,0.0107737101313136,-0.0218408988113414,0.0203920449034081,0.946391664995261
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,UHRF2,E3 ubiquitin-protein ligase UHRF2,40115,-0.000247295275900093,0.00372459294440638,-0.00754749744693659,0.0070529068951364,0.947064367975494
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SERPINA1,Alpha-1-antitrypsin,40326,4.96940547835544e-05,0.000838880193543445,-0.0015945111245616,0.00169389923412871,0.952763160340351
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SERPING1,Plasma protease C1 inhibitor,40515,0.000107305557178254,0.0018745804185604,-0.00356687206320014,0.00378148317755664,0.954353081538663
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CX3CL1,Fractalkine,42494,0.000201248458002935,0.00351825379640744,-0.00669452898295564,0.00709702589896151,0.954385754621488
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ADAM15,Disintegrin and metalloproteinase domain-containing protein 15,42356,0.000177378328329937,0.00317553139301368,-0.00604666320197688,0.00640141985863675,0.95545590403785
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NPTN,Neuroplastin,42345,-0.000428618453092656,0.00804473093067304,-0.0161962910772118,0.0153390541710265,0.957510100990439
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MAP1LC3A,Microtubule-associated proteins 1A/1B light chain 3A,40135,0.000170314484095011,0.00325780247897378,-0.0062149783746936,0.00655560734288362,0.958307382412776
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CD164L2,CD164 sialomucin-like 2 protein,40181,-0.000185502652333374,0.00374476568016729,-0.00752524338546127,0.00715423808079452,0.960492636230403
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DTX2,Probable E3 ubiquitin-protein ligase DTX2,40181,0.000290349872906764,0.00651457073007265,-0.0124782087580356,0.0130589085038492,0.964451421424649
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CYTH3,Cytohesin-3,40079,0.000314160884675346,0.00767580610033762,-0.0147304190719864,0.0153587408413371,0.96735347555603
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GTF2IRD1,General transcription factor II-I repeat domain-containing protein 1,40301,-0.000288597900958134,0.00724487631512017,-0.0144885554785937,0.0139113596766774,0.968225580606974
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TCP11,T-complex protein 11 homolog,40301,0.000203750018965298,0.00608303531305605,-0.0117189991946246,0.0121264992325552,0.973280618596966
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PRAME,Melanoma antigen preferentially expressed in tumors,40079,-8.34094030573619e-05,0.00259134897332947,-0.00516245339078312,0.00499563458466839,0.974323004552063
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,STEAP4,Metalloreductase STEAP4,40135,0.000232474467908958,0.00749545172767166,-0.0144586109183275,0.0149235598541454,0.975257820221312
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GSTM4,Glutathione S-transferase Mu 4,40115,-0.000218133955194042,0.00765258278820544,-0.0152171962200767,0.0147809283096886,0.977260205099606
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IL15,Interleukin-15,42593,-9.49728685847517e-05,0.00338461046722156,-0.006728809384339,0.0065388636471695,0.977614550083169
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,HGFAC,Hepatocyte growth factor activator,40427,7.10893230479334e-05,0.00284618571882125,-0.00550743468584171,0.00564961333193758,0.98007371299875
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PMCH,Pro-MCH,40115,0.000180494727566567,0.00869903585351597,-0.0168696155453247,0.0172306050004579,0.983446403853803
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,HADH,"Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial",40115,0.000133617570512556,0.00718202860616764,-0.013943158497576,0.0142103936386011,0.985157006233573
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TTN,Titin,40115,0.000125213574298138,0.00674266092912211,-0.0130904018467812,0.0133408289953775,0.985184195161006
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,KLK3,Prostate-specific antigen,40526,-0.000167996195064171,0.0100543725483233,-0.0198745663897779,0.0195385739996496,0.986669245108625
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GGA1,ADP-ribosylation factor-binding protein GGA1,42310,0.000107818112764606,0.00671984314318894,-0.0130630744478857,0.0132787106734149,0.987198945730261
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LILRA4,Leukocyte immunoglobulin-like receptor subfamily A member 4,40115,-2.97395820179533e-05,0.00522941132597752,-0.0102793857809339,0.010219906616898,0.995462571069708
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TOP1MT,"DNA topoisomerase I, mitochondrial",40079,-3.77327013948585e-07,0.00503118916297139,-0.00986150808643787,0.00986075343240997,0.999940161962866
